"companyid","keydevid","transcriptid","headline","mostimportantdateutc","keydeveventtypename","companyname","speakertypename","componenttextpreview","word_count","componenttext"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","Good morning, and welcome to the Coventry Health Care's Fourth Quarter 2011 Earnings Conference Call. Today's conference is being recorded [Operator Instructions] Today's call will begin with opening remarks by Chief Executive Officer of Coventry Health C",54,"Good morning, and welcome to the Coventry Health Care's Fourth Quarter 2011 Earnings Conference Call. Today's conference is being recorded [Operator Instructions] Today's call will begin with opening remarks by Chief Executive Officer of Coventry Health Care, Mr. Allen Wise, after a brief forward-looking statement read by Mr. Drew Asher. Please go ahead, Drew."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Ladies and gentlemen, during this call, we will make forward-looking statements. Certain risks and uncertainties, including those referenced in our press release and described in the company's filings with the SEC on Form 10-K for the year ended December",71,"Ladies and gentlemen, during this call, we will make forward-looking statements. Certain risks and uncertainties, including those referenced in our press release and described in the company's filings with the SEC on Form 10-K for the year ended December 31, 2010, may materially impact those statements and could cause actual future results to differ materially from those anticipated and discussed. Allen? and Form 10-Q for the quarter ended September 30, 2011"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Good morning, and thank you for your interest in Coventry Health Care. Today, I'd like to share with you our outlook for 2012. And in addition, some very brief comments and overview of 2011.We're increasingly positive about the opportunities ahead of us",163,"Good morning, and thank you for your interest in Coventry Health Care. Today, I'd like to share with you our outlook for 2012. And in addition, some very brief comments and overview of 2011.
We're increasingly positive about the opportunities ahead of us which includes our projected double-digit revenue growth in 2012. On an overall basis, we ended 2011 above our previous forecast at $3.02 of earnings per share, of which $2.87 of the EPS represents our core 2011 results as presented in our press release, excluding the private fee-for-service runout.
And we're also pleased to forecast 2012 EPS of $3.10 to $3.30 which is an 8% to 15% growth rate compared to 2011's core EPS of $2.87.
I want to spend most my time is morning talking about the 2012 and the future which much of the groundwork is based on work that we completed in 2010 and 2011. Randy Giles, our CFO, will review the quarter and provide more detailed guidance."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","2011 is a year where we're able to surpass our early financial expectations, and more importantly, laid the foundation for prospective growth. Early 2012 financial expectations were a bit cautious it's because it was year marked by a transition to the fir",2107,"2011 is a year where we're able to surpass our early financial expectations, and more importantly, laid the foundation for prospective growth. Early 2012 financial expectations were a bit cautious it's because it was year marked by a transition to the first major impact of health care reform with a very considerable task of implementing minimum MLRs in our commercial business.
I'd like to begin a more detailed discussion about our future discussing our Medicaid business and the various significant products that we're making in seizing opportunities and growing this business.
We were awarded the Kentucky contract in July of 2011, with the contract commencing in November of the same year. Based on our positioning and network efforts throughout the Commonwealth of Kentucky, we we're able to achieve an outsized membership allocation compared to the other participants. In fact, we've grown again this past month and we're now up to approximately 232,000 members.
One of the key elements to this recent growth was our ability to rapidly execute on building out a cost-competitive network. We're able to bring our collective resources to bear, including leveraging our centralized operational functions and we imported one of our experienced executives to Kentucky from our existing business. The point of all this is that we're a resourceful company with over 14,000 employees with experience in all lines of business and the ability to execute simultaneous opportunities. It's really early in the Kentucky contract and we're still refining operational processes and programs as this was a previously unmanaged population entering managed care. Even though it's really, we're very optimistic and confident that we'll have a successful partnership with the Commonwealth of Kentucky for years to come.
I want to continue on the Medicaid topic, and we have some additional news to report, which is another recent win that we would like to highlight this morning. Our company has been notified by the state of Nebraska of its intent to award a contract to Coventry to provide services for the state's expansion of the existing Medicaid managed care program. The Nebraska Department of Health and Human Services intends to expand managed Medicare services from the existing 10-county program to cover all 93 counties in the state, which is an estimated incremental 70,000 additional Nebraskans.
As you may recall, we won a bid in 2010 for the original program and currently serve approximately 50,000 members in the existing Medicaid program. So subject to the finalization of the contract with the state of Nebraska, we expect to be 1 of 2 managed-care contractors providing services to this expanded population later this year.
Staying with Medicaid, also during 2011, we were able to seize an attractive 2-state Medicaid acquisition opportunity while by acquiring Family Health Partners and entering into a long-term relationship with its previous owner, Children's Mercy of Kansas City. This acquisition, which closed effective January 1 of 2012, has Medicaid contracts in both Kansas and Missouri. We were able to expand in Missouri, a state we have served for over 15 years, and entered the Kansas Medicaid program, where there's an expansion opportunity for 2013 and beyond.
Including this acquisition, we have a meaningful multiline presence throughout our Midwest 7-State region which now serves 1.5 million members. We were able to execute on this multifaceted transaction for a reasonable net investment of approximately $50 million, net of tax benefit and statutory capital, we were able to leave behind based on the structure of this transaction.
To summarize the Medicaid discussion and quantify the growth for you, we started 2011 with 470,000 Medicaid members and reported $1.38 billion of Medicaid revenue in 2011 which represented approximately 11% of our total revenue. We expect to double these figures with more than 915,000 members beginning in 2012 with a full-year revenue forecast of around $2.7 billion.
Medicaid is projected to represent just under 20% of the company's revenue in 2012. Investors should think of Coventry as having a meaningful exposure to Medicare growth and penetration opportunities with a proven track record of winning new business, executing and operating these Medicaid businesses but without the concentrated risk and the inherent volatility and contract alliance of a single line carrier. While the process of winning new business is competitive, we very strongly believe that we'll get our share in the future. We know both how to compete and how to manage this business.
Moving away from Medicaid and talking about Medicare, we're equally enthusiastic about the recent results in Medicare. As you may have seen in our press lease a few weeks ago, we had a very successful 2012 annual election period. As most of you know, a lot of this worked to achieve success has done well in advance. And as we have previously promised, we focused on laying the foundation during 2011 to grow both Medicare Advantage and Part D in 2012.
In Medicare Advantage, we are in 15 states and we have seen 2012 growth across 14 of those 15 states. The most recent enrollment for Medicare Advantage is approximately 250,000 members which is ahead of our previous estimate and results in membership growth of about 13% so far in 2012. We've grown from 137,000 Medicare court Medicare members at the end of 2008 to 250,000 today for a compounded annual growth rate of 16%. We're well-proportioned -- or well-positioned where positioned to continue to taking advantage of this attractive demographic growth opportunity where we're able to provide a tangible value proposition to seniors and to the Federal Government.
On Part D, we had a successful enrollment period, growing membership of about 25% out of the gate and adding almost 300,000 members.
2011, as you know, we spent a lot of time talking about the work we were doing on product design and developing, creating partnerships and we had successfully launched the third product with a preferred network in 2012's annual election period. We increased both our auto-assign footprint and our mainstream membership coming into 2012. Our company has consistently been profitable in Part D and both membership channels since we launched in 2006 and 2011 was no exception, with an aggregate Part D loss ratio of 81.7% for the year.
During 2011, a lot of effort went into forming attractive set of products and establishing partnerships with Walgreens, Walmart and Target for our newest product. We also renegotiated our PBM contract with an improved Part D cost structure and enhanced other areas of Part D, including distribution. I think Part D is a great example of our abilities to successfully execute on multiple growth opportunities given our focus on resources, touching multiple product lines. Our cross-functional teams are back to the drawing board after 2010 and created a product that is low-cost structure and which has proven to be attractive to the senior population.
And if you might well imagine, we're currently hard at work on our products and positioning for 2013 and very optimistic about our prospects in the future.
Think about our company with Medicare at about 30% of the company revenues and Medicaid at about 20%. So we've evolved about half of our revenue coming from government programs. There continues to be attractive opportunity to grow in the current programs while there is a significant longer-term opportunity to serve the due eligible population. Medicaid and Medicare experience, footprint and capabilities are all important ingredients in positioning to serve due eligibles. We are currently in 10 states for Medicaid and 15 states for Medicare Advantage. 8 of our 10 Medicaid states have filed letters of intent with CMS, they integrated to do eligible population and their states. And for decades, we have provided complex care management and then served members across population, products and geographies with a cross-section of product condition, diseases and needs. We currently serve aged line to disabled members and other high-risk patients in Medicaid. We currently serve Medicaid members up-and-down the risk score spectrum including due eligibles.
Serving members with the most product have debilitating disease should not be taken lightly but this population is one that can significantly benefit by coordination of care or active chronic condition management, pharmacy management, social services and all other programs that we have built our past decade to manage our current diverse population.
Managed care should be able to make a meaningful, positive impact on the lives of due eligible population, and therefore, provide a valuable -- a value proposition for the states and Federal Government. Based on our footprint, exposure to both Medicaid and Medicare capabilities and a history of managing diverse populations, we like our early and positioning for this longer-term significant opportunity and our company will continue to invest in Medicare and Medicaid growth, along with eligible populations.
Moving to our commercial business. Our Commercial Risk revenue was up 8% for 2011 with stable membership versus 2010 which is reasonably satisfying given the first year impact of health care reform including minimum MLRs which were effective January 1st of last year.
We knew it wasn't going to be easy managing 121 different measurement sales in our Commercial business and dealing with the burdens imposed by the new laws and regulations, many of which fell very short on clarity coming into the beginning of 2011. As Randy Giles will cover, as expected, we entered the year with significant minimum Medical Loss Ratio rebate accrual which will get finalized and paid out in 2012. Our goal for 2012 and beyond in the Commercial business is to maintain margin and see the growth opportunities that we expect to develop as a result of consolidating market conditions driven by a commitment in this sophistication required to operate health care in the health care reform environment.
And in this context, we're actively preparing for the potential 2014 expansion  . We'll continue to look for attractive commercial expansion opportunities, both through acquisitions and organic growth and increase our footprint with providers and high-performance networks which will drive lower-cost products to complement our product portfolio.
As of today, we have signed approximately 30 high-performance network contracts across our product lines. These arrangements run the spectrum from large-scale health systems to local-based primary multispecialty provider groups. 17 of these 30 high-performance networks covers our commercial product in 14 states, and we feel should position us very well especially in an exchange environment.
As you can tell, we're very positive about our opportunities across the diverse footprint in Medicare, Medicaid and Commercial lines of business. We feel that the commercial business could represent a meaningful growth opportunity in 2014 and 2015 and allow us to be diversified in addition to key substantial Medicaid and Medicare growth opportunities.
In addition, we have over $1.1 billion in higher-margin and diversified fee-based revenue that complement our risk business and provide free cash flow for deployment to increase shareholder value.
Continuing on my comments regarding our future plans, we're going to pursue organic growth in our existing businesses. We're going to pursue selected RFPs. We're going to deploy capital for acquisitions, and in addition, consider future share repurchase. I think we're not only positioned well from a business and growth perspective heading into 2012, but we also accomplished a good deal relative to our balance sheet in the past year and Randy will address that later. We sit here with $900 million in deployable cash and that's after posting on a meaningful transaction flying back over 10 million shares in 2011 and paying off our 2012 note that recently came due.
We're exiting 2011 on track after increasing EPS guidance 3x during the year, and were able to provide 2012 guidance which results in 18% to 15% core EPS growth in 2012 and coupled with double-digit revenue growth. We continue to have a strong and flexible balance sheet with a combination of free cash and additional debt capacity.
I like our positioning and balanced exposure across Medicaid, Medicare and the commercial line, as well as our capability in seeking and seizing the right M&A opportunities. We're getting results from the work we have done and we'll continue on this path to deliver more growth.
So what does it take to deliver growth? Well, it takes capital. It takes capable, experienced executive team. It takes experience in the M&A area. It takes focus. It takes discipline. It takes the ability to move quickly. These are all capabilities our company has. I am more optimistic about our future than I have been any time in the recent past.
And Randy Giles is going to walk you through the results and provide detailed guidance with additional commentary on our business. And with that, Randy?"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Thank you, Allen. I'll begin this morning by discussing our performance in the fourth quarter and then spend a majority of my time reviewing our detailed guidance for 2012. Before I go through the details for each of our businesses, I want to first start",2849,"Thank you, Allen. I'll begin this morning by discussing our performance in the fourth quarter and then spend a majority of my time reviewing our detailed guidance for 2012. Before I go through the details for each of our businesses, I want to first start at the consolidated level. Our GAAP EPS for the fourth quarter was $0.60 which includes $0.02 related to the runout of the Medicare Advantage private fee-for-service business. For the full year, we reported EPS of $3.02, excluding the litigation gain in the second quarter, compared to our previous EPS guidance of $2.95 to $3. This includes $0.15 of earnings related to private fee-for-service and $2.87 of core EPS for 2011.
Similar to last quarter, we have provided a table and reconciliation of these earnings metrics on Page 3 of our earnings press release. I'm very pleased with these results for 2011 as we were able to outperform our earnings guidance in each quarter during the year, grew our Health Plan membership by more than 7% from the prior year, position ourselves for continued growth in 2012, deliver the largest Medicaid RFP win in the company's history and utilized the strength of our balance sheet to seize an exciting growth opportunity while repurchasing more than 7% of our outstanding share count.
These successes have positioned our portfolio of businesses very well for 2012 which I will highlight in detail after first giving you a little more color on the 2011 performance.
In our commercial business, first, one housekeeping item. You'll notice that we have now aligned our reporting of revenue PMPM and MLR percentage metrics to be consistent with the rest of the industry by disclosing Commercial Risk as opposed our historical disclosure of Commercial Group Risk statistics which excluded the commercial individual business. In addition to creating a better comparison our peer group, we also wanted to grow impact that individual businesses having on our commercial results, as we continue to increase our market share and invest in building out our capabilities in advance of the potential membership opportunity in the exchanges.
In 2008, for instance, we had 123,000 individual numbers. Whereas today, we have slightly more than 200,000 members. Also, the individual MLR has become much more comparable to the small group MLR due to health care reform regulations. This new disclosure structure is reflected in the earnings release issued this morning for both the current period as well as all historical periods disclosed.
Our commercial MLR was 83.7% in the fourth quarter and 81.6% for the full year which is slightly above our previously provided guidance. As we continue to gain parity on the minimum MLR regulations during the back half of 2011, we had to refine our rebate calculations to reflect the allowable underlying cost of certain internal and external medical related vendors. We began the year expecting to be able to reflect medical related payments to internal and external vendors in their entirety as such in the minimum MLR calculations. But based upon clarity we gained in MLR rules Q3 and subsequent data-gathering from our vendors Q4, including our external PBM, we made adjustments that increased the Medical Loss Ratio. I'll highlight this for you as it had about a 50 basis point impact on our full-year 2011 commercial MLR relative to our initial guidance.
Within our commercial book, our view of fundamental prospective trend remains unchanged in the range of 8% plus or minus 50 basis points, with unit cost trend continuing to be the largest driver, albeit stable. In the rearview mirror, we can see trends the mid-7s that continue to move higher off of the extreme low levels seen during the second half of 2010. These trends include the impact of the health care reform regulations implemented on September 23, 2010, which just had between 150 and 200 basis points from the impact of the trend this year that will not recur in 2012.
Inpatient utilization lows late 2010 continues to show a negative as it has throughout 2011. Similar to what we disclosed to you last quarter, we're seeing outpatient physician trends creep up and move from negative in the slightly positive territory. Just to put it in context, remember today's trends are being compared to the lowest level of utilization trends seen in years, a historically low base line from late 2010.
And probably most importantly, our pricing structure is predicated on a forward view of trend in which we have anticipated return in more levels -- normally levels of utilization above what we've seen in the rearview mirror. This pricing expected to generate higher absolute rate increases than we're seeing throughout 2011 as we've established a new baseline with many of the adjustments related to health care reform already addressed and the benefit of the extremely low utilization 2010 has already been passed through to our experience-rated customers.
Finally, the commercial results. I want to share our customary statistics around health care reform which are consistent with the projections from the last call. For 2011, we generate total Commercial Risk revenues of just under $6 billion. Of that total, individual business generate approximately $375 million of revenue with the vast majority of this business in a rebate position. The remaining $5.6 billion of group risk revenues were split roughly 40% small group and 60% large group with approximately half of our small group business in a rebate position and a little less than 0.25 of our large group business in a rebate position.
It's important to note that rebate exposure is something that we've been managing carefully with a number of actions taken to utilize rebate capital during the year, including providing more value to our customers, also promoting quality nations providers to improve stores, strengthen the overall quality of care and to create opportunities to lower future medical costs. This has driven our rebate estimates down significantly from our initial view in 2011. In 2012, we expected it to get from certain vendor contracts which will serve to decrease our overall cost structure and reduce our rebate accrual in 2012. We view our estimated rebate for 2011 as reasonable given the size of our book of business, this being the first year navigating these new regulations and the inherent loss ratio variablity that exists when calculated the market side segment in the state level.
While we're not assuming a benefit from multiple states with minimal MLR pending with HSS, we were disappointed to see waiver request denied in some of our larger states, including Florida and Kansas. This result creates more challenging operating individual business in these markets will force us to continue to evaluate our participation in that product on a market-by-market basis. Of the states with currently pending with HHS, North Carolina is the only state where Coventry has an individual price presence.
Moving on to government programs, our Medicare results for the fourth quarter were a continuation of strong results that we saw throughout 2011 and an even better result in 2010. Our Medicare Advantage MLR of 82.3% for the quarter and 82.9% for the full year was a very strong result and one that gives us confidence in our bid positioning, as we look to towards 2012. Our Medicare Part D results were also strong as the fourth quarter MLR of 60.5%, full-year MLR of 81.7% were both better than our expectations and an improvement from the prior year.
As Alen already highlighted, we are excited about that growth trajectory that we built for the Medicare business with revenue growth of more than 20% and membership growth of nearly 50% in 2011. Our Medicaid results in the quarter were consistent with our expectation as we saw an uptick in our reported revenue PMPM as well as MLR percentage, wit the inclusion of the new content Kentucky contract which was effective on November 1.
Finally, we closed out 2011 with another excellent SG&A result, reporting a full-year expense of $2.015 billion as compared to our initial guidance of $2.02 billion. This accomplishment is particularly impressive when you consider that while we were holding absolute SG&A spend just below our initial guidance for the year, we were simultaneously able to grow revenue above the initial guidance midpoint by more than $425 million.
Full-year expense, including the elevated level of spend during the fourth quarter related to the successful Medicare enrollment period and the launch of the new Kentucky Medicaid contract, which together, about more than 0.5 million new members to the company.
Before we get into 2012 guidance, let me first review some metrics on our balance sheet and cash flows. Our investment portfolio remains in a high-quality position with a net unrealized gain of $97 million at year-end, an increase from $90 million in the prior quarter. As of January 31, we had $900 million of deployable free cash available which is after retiring $234 million of senior notes earlier in January, as well as the deployment of $100 million during the fourth quarter for share repurchase. Recall that one of our accomplishments in 2011 was repositioning our balance sheet 10-year $600 million senior notes in June 2011 and renewing our credit facility. We have no scheduled the debt maturities now until 2014 having undrawn $750 million credit facility that isn't scheduled to expire until 2016. This gives us a great deal of flexibility as we pursue capital deployment opportunities. And as you have seen throughout 2011, while acquisitions remain our first priority for capital deployment, we're also committed to returning capital to shareholders through opportunistic share repurchases, as seen through our deployment of $328 million in 2011.
Moving on to our cash flow results, you recall that we received an extra payment from CMS in the third quarter, so you can see the impact from that under the deferred revenue line in fourth quarter results and impact preferred revenue for the full year. The full-year result was impacted by the second quarter litigation settlement. So after adjusting earnings for the litigation items, our cash flow from operations was $496 million or 112% of net income for the year. As you can see on the other receivables line of the balance sheet and cash flow statement, cash flow from operations was negatively impacted by the timing of certain Medicare Part D receivables related to the 2011 program here that we will collect from CMS in 2012.
So with a successful 2011 behind us, let's now discuss our outlook for 2012.
Today, we are providing initial 2012 EPS guidance in the range of $3.10 to $3.30 which is an increase of 8% at the low end and 15% at the high end versus the comparable 2011 EPS of $2.87. In that area, we are projecting revenues of nearly $14 billion, a growth of approximately $1.75 billion which is up roughly 15% of the midpoint. We are forecasting an increase in consolidated MLR percentage which is driven by changes in the mix across our portfolio businesses toward growth in government programs.
In 2011, commercial revenue represented approximately 50% of the company total with an additional 30% Medicare, 10% Medicaid and 10% other including fee businesses. Our guidance for 2012 projects around new composition of just over 40% commercial, 30% Medicare, 20% Medicaid and just under 10% fee and other. This is consistent with our goal to have a balanced portfolio with the ability to seize opportunities across the product spectrum.
On the topic of medical cost structure, we have recently negotiated extended our PBM contract with Medco for a multiyear period effective January 1, 2012. We're able to secure an improved cost structure and contract terms that give us more flexibility, as we continue to react to the rapidly evolving health care marketplace. Given that pharmacy spend represents nearly 20% of our medical expenditures, this is an important improvement to a critical part of our overall cost structure across our product portfolio.
Moving onto SG&A, I'm particularly pleased with efforts that the organization has put forth on driving down our SG&A percentage of revenue from 16.5% in 2011 to a midpoint of 15.4% on our 2012 guidance 2012. I'm personally involved in working to identify cost reduction opportunities for the company that have allowed us forecast the strong result for 2012 while simultaneously also making critical investments for the feature in our core businesses. These investments include improved direct distribution capabilities from individual business, enhanced care management tools, the addition of substantial Medicare Medicaid resources, not to mention the ongoing increased compliance costs. And that's just to name a few.
Other nonoperating items, you'll note that the tax rate is increased over 2011 which is primarily driven by a shift in the mix of earnings towards states with higher tax rates and also about compliance with new health care reform regulations.
Finally, you will see our share count guidance which assumes that we essentially hold the share count flat from where we ended 2011. It's important to note that today's EPS guidance range does not as not incorporate any meaningful deployment of the free cash that is sitting on our balance sheet.
Now moving more specifically into our largest lines of business. For Commercial Risk, we are forecasting membership levels to be slightly down for 2011 levels with a decrease in Q1 2012 driven by a handful of large group terminations followed by growth during the remainder of the year. We continue to price ahead of trend and remain disciplined in our objective of maintaining margin while pursuing membership gains. On the expense side, we are projecting MLR of 81.5%, plus or minus 50 basis points. This MLR guidance incorporates mechanics minimum MLR rules, our view of pricing by market, a forward view on medical trends, our mix of business and fragmented view that you always have deviations from the mean as you manage your portfolio of 121 measurements cells. This is a slight improvement from 2011 as that 11 that we view as sustainable under health care reform in today's operating environment.
In Medicare, the membership story is excellent for both Medicare Advantage and Medicare Part D. As Allen noted earlier, we're starting the year with approximately 250,000 Medicare Advantage members which is an impressive growth result of about 13% from 2011. Our Medicare Part D business was also very successful during the annual election period as we grew by almost 300,000 members or about 25%, and we are forecasting continued growth throughout 2012. This growth is a nice mix of retail purchase in our innovative new value plus product and partnership with Walgreens, Walmart and Target, as well as our increased auto assignment presence in 23 regions for 2012, up from 15 regions in 2011. Based upon our bids and our view of where we exited 2011, we are forecasting MLRs in the low- to mid-80s for both Medicare Advantage and Part D.
Staying within government programs, our 10-state Medicaid business is the biggest part of or 2012 growth story with total revenue expected to nearly double with just under $1.4 billion in 2011 to nearly $2.7 million in 2012. Today, we are just about 915,000 members and expect to be in the zone of 950,000 Medicaid numbers upon implementation of the new Nebraska contract. We are projecting MLR of approximately 90% in 2012 which is a combination of our same-store business, which runs in the mid- to high-80s, and MLRs in the 90s for RFP wins in the newly acquired Family Health Partners business in the Midwest.
So now we've covered the large risk business, you'll notice that although we are still forecasting over $1.1 billion of fee-based revenue, our guidance for fee revenue is down a little, more than 3% due to the loss of 1 Workers' Compensation Services account. However, you also see a decrease in cost of sales expense item directly associated with Workers' Compensation Services which more than offset the aggregate fee revenue reduction. Our fee businesses continue to be an important part of our overall product portfolio, providing valuable unregulated cash flows and are an area that we intend to grow and adjust .
So in conclusion, our efforts in 2011 lay the foundation for the 2012 guidance that we provided today. We firmly believe that growing the top line is critical in today's environment and are pleased to see 2011's efforts bearing fruit in 2012 with the revenue guidance midpoint of nearly $14 billion, up with an increase in both operating earnings and EPS. So while we may be pleased with the 2012 growth outlook, by no means are we satisfied. We will continue to invest in the future, focus on managing our portfolio businesses in a manner that allows us to seize growth opportunities while also maintaining the right balance lending our exposure to any one area. We will continue to reduce growth opportunities, both organically and through acquisition to strategically position Coventry to deliver the long-term results that our shareholders have come to expect.
Operator, this now concludes our prepared remarks, and we are ready to open the lines for questions."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","[Operator Instructions] We'll go first to Doug Simpson with Morgan Stanley.",11,"[Operator Instructions] We'll go first to Doug Simpson with Morgan Stanley."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So Randy, maybe just to expand a little bit. I think you said 81.5 for the commercial MLR in 2012? Did I hear you right?",25,"So Randy, maybe just to expand a little bit. I think you said 81.5 for the commercial MLR in 2012? Did I hear you right?"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes.",1,"Yes."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. So can you just sort of walk us through, the Q4 MLR came in I think on the commercial side higher than people were expecting. You talked about the inclusion of -- or the inability to include certain costs in the rebate calc. And that's obviously, I",68,"Okay. So can you just sort of walk us through, the Q4 MLR came in I think on the commercial side higher than people were expecting. You talked about the inclusion of -- or the inability to include certain costs in the rebate calc. And that's obviously, I think, you said 50 bps for the year, so roughly 200 basis points into the Q4 number. Is that fair?"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","It's more like 140 into the Q4 result.",9,"It's more like 140 into the Q4 result."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So it added 140 to the commercial MLR in Q4?",10,"So it added 140 to the commercial MLR in Q4?"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes.",1,"Yes."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. So can you just help us think about sort of a map from the 2011 experience into 2012? Just how -- sort of maybe walk us through your thoughts around the commercial MLR from 1 year to the next given sort of those dynamics and your Q4 jumping off poin",51,"Okay. So can you just help us think about sort of a map from the 2011 experience into 2012? Just how -- sort of maybe walk us through your thoughts around the commercial MLR from 1 year to the next given sort of those dynamics and your Q4 jumping off point."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","As we think about 2012, there were certain trend drivers that we think are not going of recur into 2012. One of the things which, as you might recall, we experienced lower prior period of during 2011 and 2010, if you can see from today's earnings release",115,"As we think about 2012, there were certain trend drivers that we think are not going of recur into 2012. One of the things which, as you might recall, we experienced lower prior period of during 2011 and 2010, if you can see from today's earnings release that our DCP increased by 4% from the prior year-end. So I feel comfortable that that pressure is not going to recur. As we go in, we've also improved our cost structure, as I mentioned, around our pharmacy, and particularly, and we have some other actions we're taking around cost structure that give us a pretty good feeling about where we're going to be in 2012 versus 2011."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. And just in terms of your commentary on utilization and trends in the Q4 period, it didn't sound like you did saw anything new or different there. But can you just give us a little more color on that front?",41,"Okay. And just in terms of your commentary on utilization and trends in the Q4 period, it didn't sound like you did saw anything new or different there. But can you just give us a little more color on that front?"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Sure. As we think about trend in general, what we're seeing, as I talked about inpatient, commercial bed days were down low- to mid-single digits in Q4 2010. Medicare Advantage bed days were down low to mid-single digits and commercial admits were down mi",100,"Sure. As we think about trend in general, what we're seeing, as I talked about inpatient, commercial bed days were down low- to mid-single digits in Q4 2010. Medicare Advantage bed days were down low to mid-single digits and commercial admits were down mid-single digits from Q4 and Medicare Advantage admits were down low to mid-single digits from Q4 2010. So position we're seeing somewhat uniform utilization trends across primary care surgical specialists in lab. And on the outpatient side, areas that we see utilization include areas like dialysis, injectable drugs and cardiovascular, other areas where we're seeing trend pressuring."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. And then maybe just switching gears on the use of capital. You guys obviously bought back some stock in Q4. I think the cash balance right about $900 million now. How do you think about deploying that, thinking about the M&A backdrop, the opportunit",117,"Okay. And then maybe just switching gears on the use of capital. You guys obviously bought back some stock in Q4. I think the cash balance right about $900 million now. How do you think about deploying that, thinking about the M&A backdrop, the opportunity to buy back stock? I mean, if you look out 12 months, would you expect to still have that sizable of a cash balance or if you don't see things out there on the M&A front, would you look to kind of bring that down and think about keeping your debt capacity to the extent they present themselves. How long would you guys kind of run rate with a heavy cash balance?"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think that 2012 to look like 2011. We spent $328 million in share repurchase that made a major transaction and worked on some things that didn't materialize. We will continue looking for significant size to M&A transactions and if those opportunities do",103,"I think that 2012 to look like 2011. We spent $328 million in share repurchase that made a major transaction and worked on some things that didn't materialize. We will continue looking for significant size to M&A transactions and if those opportunities don't present themselves, we will opportunistically do share repurchase. We're going to use the whole $900 million up and live with our credit line. I doubt it because there's going to be continuing consolidation. The margins are under pressure, the business is going to get tougher and we feel like there will be opportunities to grow our business substantially and better."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then maybe just sneak just one last thing. In this call you talked a little bit more than the deals that you have in the past. Can you just give us a sense -- I mean, how -- what's your expectation for that in terms of timing with respect to your book",72,"And then maybe just sneak just one last thing. In this call you talked a little bit more than the deals that you have in the past. Can you just give us a sense -- I mean, how -- what's your expectation for that in terms of timing with respect to your book of business and how much effort are you making on that front at this point in terms of resources?"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, we're making -- what we're doing today is making certain that we can absorb almost a 0.25 million of new members that have never been in managed-care before across the whole spectrum in Kentucky. We are investing in a new IT system that improves our",141,"Well, we're making -- what we're doing today is making certain that we can absorb almost a 0.25 million of new members that have never been in managed-care before across the whole spectrum in Kentucky. We are investing in a new IT system that improves our patient management capabilities. And we think that we can't predict exactly what to eligible population. But when we work on it all the time, the timeframe on these things present themselves are uncertain. We worked on an opportunity in Kansas which has not yet born any fruit, but we're working on RFPs in -- all the time. And so we'll have opportunities, I can't predict which quarter they present themselves but we are investing in systems, we're in we are investing in staff and infrastructure for the Medicaid business and we're going to grow it."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","We'll take our next question from Tom Carroll with Stifel Nicolaus.",12,"We'll take our next question from Tom Carroll with Stifel Nicolaus."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I wanted to come back to your commentary on the Kentucky Medicaid business. It sounds like things are well there. But I guess, maybe just 2 questions. Was Kentucky the primary reason for the large MLR increase in your Medicaid book? And then secondly, it",101,"I wanted to come back to your commentary on the Kentucky Medicaid business. It sounds like things are well there. But I guess, maybe just 2 questions. Was Kentucky the primary reason for the large MLR increase in your Medicaid book? And then secondly, it seems like there might be some issues in the market transitioning from fee-for-service to managed-care. I think we saw that the Secretary of health and family services resigned yesterday. Just maybe just, again, reiterate -- is there any reason we should assume or anything and reason to believe this could drag earnings a bit in 2012?"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","I'd answer that by saying there are no surprises in Kentucky. We understood what it would be like to convert. I think we have more enrollment success than maybe we have asked but we understood when we embarked on this that it would be an arduous, difficul",226,"I'd answer that by saying there are no surprises in Kentucky. We understood what it would be like to convert. I think we have more enrollment success than maybe we have asked but we understood when we embarked on this that it would be an arduous, difficult first 6 months or 8 months or 10 months to convert the population and the providers and the experience base there to a managed population. We have only 2 months of experience in terms of cost there and with that 2 months of experience, there are a lot of unknowns and a lot of the gaps in terms of the billing process to the providers. Do we have the bills on this same schedule that we would on existing businesses. And so there are a lot of questions because it's so new and I think that our reserves on that front would reflect Coventry's -- in my own personal, long-term view, which is make certain if you don't know that you're properly reserved and those will come down as we gain experience and as we get data and as we know more about the population. But there are no surprises there. It's -- we understood what we are embarking on and I would say that it's going reasonably well with a lot of work left to be done."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Do you expect any type of MLR improvement throughout the year or is this more of a 2013 effort?",19,"Do you expect any type of MLR improvement throughout the year or is this more of a 2013 effort?"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","No, I expect us to gain experience and knowledge and improve our ability to make progress there as the year progresses. It's something I can't predict by month or anything like that. But no, I have a high degree of confidence that we will improve the care",120,"No, I expect us to gain experience and knowledge and improve our ability to make progress there as the year progresses. It's something I can't predict by month or anything like that. But no, I have a high degree of confidence that we will improve the care for that population, improve communication with the providers, get to know the Commonwealth of Kentucky better and just a lot of work to be done there. But we have every confidence that it'll get better as the year progresses. And at long-term, this will be a good opportunity for us. There haven't been any surprises. We understood when we bid and was awarded the business, we had a lot of work to do."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","One last one on your commercial rebates. Is there any chance you could quantify that for us?",17,"One last one on your commercial rebates. Is there any chance you could quantify that for us?"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","We don't disclose the amount of our rebate. I would just say we have a normal level of what we would anticipate and that was significantly reduced from our initial view going into 2011.",35,"We don't disclose the amount of our rebate. I would just say we have a normal level of what we would anticipate and that was significantly reduced from our initial view going into 2011."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","We'll take our next question from Carl McDonald with Citi.",11,"We'll take our next question from Carl McDonald with Citi."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","On the cost trend, it sounds like you're seeing the same type of utilization that pretty much everything and everybody else in the industry seeing which is, say, not very much. And yet your overall trend at, call it 7%, 8% is meaningfully higher than sort",81,"On the cost trend, it sounds like you're seeing the same type of utilization that pretty much everything and everybody else in the industry seeing which is, say, not very much. And yet your overall trend at, call it 7%, 8% is meaningfully higher than sort of 5% to 5.5% that a lot of other companies are talking about. So within the unit cost, can you talk about where you think the biggest area of differential is and what's driving that?"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","I really can't comment on what they're included in their numbers, Carl. But as far as ours are concerned, we feel like we're reporting them on a consistent basis as it relates to unit costs for inpatient, we're seeing high single digits, which is mostly u",203,"I really can't comment on what they're included in their numbers, Carl. But as far as ours are concerned, we feel like we're reporting them on a consistent basis as it relates to unit costs for inpatient, we're seeing high single digits, which is mostly unit cost driven in terms of what we're looking at in inpatient, outpatients, low double digits which is mostly unit cost driven. Positions mid single-digit which is kind of split evenly. So we're kind of seeing -- we don't really see a change there. We see -- one of the things contributing to the trend year-over-year for us is the impact of -- as I mentioned in my script, was the impact of health care reform changes from September 23 of 2010 that required us to get a 0 on amount of things of up to 200 basis point impact on our trend number. So depending on the mix of business between us and the competition and the benefit designs that they may have had with us having more small group business with maybe higher deductibles and copayments to begin with, we might have had a bigger impact than they did. But that's speculation on my part."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Back in Kentucky, what loss ratio did you assume for November and December there?",14,"Back in Kentucky, what loss ratio did you assume for November and December there?"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","We don't really break out loss ratios by market like that. I would just say that we've assumed a loss ratio in the early months with normal transition of care and pacing in the managed care processes, a higher loss ratio in the first 2 months that would -",59,"We don't really break out loss ratios by market like that. I would just say that we've assumed a loss ratio in the early months with normal transition of care and pacing in the managed care processes, a higher loss ratio in the first 2 months that would -- we'd expect that to go down throughout the year."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","As this consists with our long-standing practices adequate.",9,"As this consists with our long-standing practices adequate."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then if you -- I'm just going to pick a number in say it's 100% that you assumed in the fourth quarter. It looks like the loss ratio and the other Medicaid the markets would have been would've deteriorated by something like 350 basis points. Is the dr",50,"And then if you -- I'm just going to pick a number in say it's 100% that you assumed in the fourth quarter. It looks like the loss ratio and the other Medicaid the markets would have been would've deteriorated by something like 350 basis points. Is the driver there?"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","You shouldn't make those assumptions.",6,"You shouldn't make those assumptions."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","I would just comment on that is that the loss ratios in our other Medicaid markets did not deteriorate in the fourth quarter.",23,"I would just comment on that is that the loss ratios in our other Medicaid markets did not deteriorate in the fourth quarter."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Did not deteriorate? I'm sorry, I didn't get that. You said did not deteriorate in the fourth quarter?",18,"Did not deteriorate? I'm sorry, I didn't get that. You said did not deteriorate in the fourth quarter?"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Did not deteriorate.",3,"Did not deteriorate."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","We'll take our next question from Josh Raskin with Barclays.",11,"We'll take our next question from Josh Raskin with Barclays."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just on the 2 big new drivers 2012, Kentucky and PDP, when do you think you're going to have enough claims data to start getting a better sense of where their trends are relative to sort of your underwritten expectations?",40,"Just on the 2 big new drivers 2012, Kentucky and PDP, when do you think you're going to have enough claims data to start getting a better sense of where their trends are relative to sort of your underwritten expectations?"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","I'll feel better in 3 or 4 months. I'm -- we're learning about billing practices and it's new to all the providers so I think that -- heard but not received information is not going to be good for them. We have a large team on the ground there in the next",88,"I'll feel better in 3 or 4 months. I'm -- we're learning about billing practices and it's new to all the providers so I think that -- heard but not received information is not going to be good for them. We have a large team on the ground there in the next couple of weeks making the rounds with all the major large provider groups, and -- but I think if you would think 3 to 4 months, we should have a much better feel on cost."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then I guess, in Kentucky, I keep on this but it's a big win for you guys pretty big move into the member selection period. So I'm just curious if you guys put in some consideration, changed to your thoughts about potential adverse selection some of t",60,"And then I guess, in Kentucky, I keep on this but it's a big win for you guys pretty big move into the member selection period. So I'm just curious if you guys put in some consideration, changed to your thoughts about potential adverse selection some of these members you're doing based on the difference and benefits in the market?"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","No, the benefits are very close to the same. We think that the very outsized enrollment period has a direct portion of the large team with but on the ground there and the numbers of providers that we that we got early at competitive rates. We did not use",119,"No, the benefits are very close to the same. We think that the very outsized enrollment period has a direct portion of the large team with but on the ground there and the numbers of providers that we that we got early at competitive rates. We did not use a third-party to the contracting. We've got a lot of health plans, a lot of people, a lot of experience there. We put 60 or 70 of our own people on the ground there for 2 months. So we think the enrollment is unrelated to very, very minor difference in benefits and much more directly related to having people's current primary care physician or physician groups in our network earlier."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. Just the one last question on the PBM contract. Could you just give us the length on that and that any color on the improvement in terms of your cost for drugs now?",34,"Okay. Just the one last question on the PBM contract. Could you just give us the length on that and that any color on the improvement in terms of your cost for drugs now?"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","In terms of the contract extended for Medicare through funny 15, the commercial contract will be extended through 2016. And I can't really comment on 2015, the impacts on our cost structure but just to say that it was a key driver for our product position",140,"In terms of the contract extended for Medicare through funny 15, the commercial contract will be extended through 2016. And I can't really comment on 2015, the impacts on our cost structure but just to say that it was a key driver for our product positioning in Part D for 2012 and a key factor for us in terms of our cost in preparing for the exchanges going forward. And the other aspect about this is it really increased flexibility that we have regarding elements of the contract for the future as we are able to adapt more easily to changes in the marketplace going forward. So Medco has been a critical partner for us, and strategic partner for us and we continue to work that relationship and work with them to try and get to the best possible results."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. Is that through the end of '15 for Medicare and then the '16 for commercial?",16,"Okay. Is that through the end of '15 for Medicare and then the '16 for commercial?"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes.",1,"Yes."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","We'll take our next question from Charles Boorady with Crdit Suisse.",12,"We'll take our next question from Charles Boorady with Crdit Suisse."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","on Kentucky but I just wanted to recall, was that in your original guidance? It couldn't have been right because you were awarded during the year but basically, it looks like the fourth quarter and your full year results would've been much stronger withou",85,"on Kentucky but I just wanted to recall, was that in your original guidance? It couldn't have been right because you were awarded during the year but basically, it looks like the fourth quarter and your full year results would've been much stronger without Kentucky. While you're not seeing it, we can back in to the fact that it was pretty dilutive to your quarter if that's what drove up the Medicaid loss ratio that wouldn't have deteriorated without Kentucky. Am I reading that right?"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes.",1,"Yes."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Got it, good. And then the Nebraska expansion, did you say that is in your 2012 guidance?",17,"Got it, good. And then the Nebraska expansion, did you say that is in your 2012 guidance?"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","It's not a case of new information. At this particular point in time, we don't know. And no one -- neither would anyone else after 60 days. And it's just consistent with our current practices here to not overpromise and to make certain that our reserve ph",103,"It's not a case of new information. At this particular point in time, we don't know. And no one -- neither would anyone else after 60 days. And it's just consistent with our current practices here to not overpromise and to make certain that our reserve physician is adequate. It's nothing more than not knowing, and I don't know how else you would know. We started, acquired new businesses for 15 years here and started new businesses, maybe one not quite as large. We just don't know at this particular point in time. There isn't any unknown, adverse information that we have."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Got it, totally understood, and I think it's a prudent way to companies book new business in new markets especially in that space. I was really more getting at what your results would look like were it not for that new business because it would be ironic",61,"Got it, totally understood, and I think it's a prudent way to companies book new business in new markets especially in that space. I was really more getting at what your results would look like were it not for that new business because it would be ironic to be penalized by investors for a big penalized because of some upfront dilution."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","It's very short term and it's getting all rolled out here in a few months. And I would rather that people wonder if we're too conservative today and that's it in front of you to quarters from now and say we didn't know and we're not going to make our numb",71,"It's very short term and it's getting all rolled out here in a few months. And I would rather that people wonder if we're too conservative today and that's it in front of you to quarters from now and say we didn't know and we're not going to make our numbers. So it's very consistent with the prudence that we run our business here and it will develop relatively quickly."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Yes, got it. And in terms of the comments on the minimum MLR and the 50 bps higher impact from classifications, did that get offset by SG&A or was there a net income impact because of the need to rebate some of the impact of that 50 bps?",48,"Yes, got it. And in terms of the comments on the minimum MLR and the 50 bps higher impact from classifications, did that get offset by SG&A or was there a net income impact because of the need to rebate some of the impact of that 50 bps?"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes, there was an MLR impact on that additional rebate.",10,"Yes, there was an MLR impact on that additional rebate."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","There was an MLR impact but was there net income impact also?",12,"There was an MLR impact but was there net income impact also?"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes.",1,"Yes."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay, got it. And then in the Workers' Comp business, we really haven't talked about this a lot for a while but could you just tell us a little bit more about what you're us prospects are for that business talk about your desire to grow your fee-based ser",80,"Okay, got it. And then in the Workers' Comp business, we really haven't talked about this a lot for a while but could you just tell us a little bit more about what you're us prospects are for that business talk about your desire to grow your fee-based services. But what drove the account loss the Workers Comp and can you tell us about your backlog or give us other indications of your growth prospects in the fee-based business probably?"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Most of you have not met Mike Bahr. Mike runs most of the commercial business in our company, which includes workers comp and that's relatively new since October of this year to enroll in his company but is due to running all of our government business. I",101,"Most of you have not met Mike Bahr. Mike runs most of the commercial business in our company, which includes workers comp and that's relatively new since October of this year to enroll in his company but is due to running all of our government business. I'm going to let Mike Bahr answer the question about workers comp because we changed it in October because there's so many common network issues and development of network resources that across the 2 companies, and we think it will run better integrated with the management leadership in our company and the commercial area. Mike?"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Charles, Workers Comp, it is an area we're looking to grow. It's an area we're looking for opportunities to grow. As you said, it's unregulated revenue and that's a great place to be these days. So the loss of the group it was our second largest group, if",127,"Charles, Workers Comp, it is an area we're looking to grow. It's an area we're looking for opportunities to grow. As you said, it's unregulated revenue and that's a great place to be these days. So the loss of the group it was our second largest group, if I recall, and it was just a competitive environment. And so for us, it's -- we're in a position where we continue to look for opportunities to grow and invest in that line of business. But there's nothing specific with workers comp that created the issue. So I mean, it's a line that runs well. We're centralizing some of our businesses to improve our network structure, particularly areas where we don't have health plans. And so we're pretty optimistic."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I know that's a long lead time sale, but can you give any give a sense for what your backlog looks like generally in either Workers Comp or the fee-based business more probably?",34,"I know that's a long lead time sale, but can you give any give a sense for what your backlog looks like generally in either Workers Comp or the fee-based business more probably?"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","I really can't. To be honest, not in the detail on that side of it. So I can't answer that. I know that the large group we lost, some of the employers they work with are looking to come back to us for services and we're certainly open to doing that.",52,"I really can't. To be honest, not in the detail on that side of it. So I can't answer that. I know that the large group we lost, some of the employers they work with are looking to come back to us for services and we're certainly open to doing that."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","It's been stable for a number of years. Stable meaning slight increases in revenue. We're heavily affected by the recession and the employment market and employers be much more careful about occupational safety. So it's a transaction-based business that's",86,"It's been stable for a number of years. Stable meaning slight increases in revenue. We're heavily affected by the recession and the employment market and employers be much more careful about occupational safety. So it's a transaction-based business that's an acronym for claim-based or accident-based business. And in a tough environment, it's continued to add new customers and grow revenues slightly and EBITDA a little more than revenues. So it's working well for us, and we're trying to figure out how to make it better."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Was the capability or price that you lost the business on when you said things are getting more competitive?",19,"Was the capability or price that you lost the business on when you said things are getting more competitive?"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","It was price.",3,"It was price."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","And we'll take our last question from Kevin Fischbeck with Bank of America.",14,"And we'll take our last question from Kevin Fischbeck with Bank of America."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","You mentioned that the rebate position it sounds like in Q4 was actually kind of similar to where it was I guess, in Q3. But -- and you said that in 2012, it will be probably a little bit lower. Can you just give a little sense of where you think your poo",61,"You mentioned that the rebate position it sounds like in Q4 was actually kind of similar to where it was I guess, in Q3. But -- and you said that in 2012, it will be probably a little bit lower. Can you just give a little sense of where you think your pools will be across the 3 areas of business?"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes, I think the -- as we look at the rebate and where we do have rebates that are concentrated still in our top 5 rate cells and small-business, large group and individual, and at various , where those are located. But generally, if you think about the r",101,"Yes, I think the -- as we look at the rebate and where we do have rebates that are concentrated still in our top 5 rate cells and small-business, large group and individual, and at various , where those are located. But generally, if you think about the rebates, for us, they're predominantly in small group and then individual and in large group kind of in that, it's relative size. In terms of rebates, we think we've done a good job of managing them. We think we can get better at it in 2012 and we'll continue to work on it."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","We need to get better and we will.",8,"We need to get better and we will."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Is it a matter -- do you think the blocks of business will be relatively similar as far as percentage in the rebates paid a little bit less of rebates or would you expect that to change?",37,"Is it a matter -- do you think the blocks of business will be relatively similar as far as percentage in the rebates paid a little bit less of rebates or would you expect that to change?"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","We hope there will be less than rebates and we translate that to be in a better position in the market from a price standpoint. But not an exact science, not easy.",32,"We hope there will be less than rebates and we translate that to be in a better position in the market from a price standpoint. But not an exact science, not easy."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","And remember, your leveraging over the multiple years as you move out to 3 years so it becomes more predictable.",20,"And remember, your leveraging over the multiple years as you move out to 3 years so it becomes more predictable."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. And then given that this is the first year of rebates be the first year actually paying the rebates, can you just go through end of the cash bridge for 2012 for us?",34,"Okay. And then given that this is the first year of rebates be the first year actually paying the rebates, can you just go through end of the cash bridge for 2012 for us?"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, as it relates to rebates, there's a runout period in 2012 that that will firm up the rebate calculations to what the actual results are once it's finalized, the payments will be made midyear. So that's the timeframe for when that gets transacted.",44,"Well, as it relates to rebates, there's a runout period in 2012 that that will firm up the rebate calculations to what the actual results are once it's finalized, the payments will be made midyear. So that's the timeframe for when that gets transacted."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","The way to think about you have $90 million of cash at corporate as of now where that number might be at year-end if you don't deploy any capital?",29,"The way to think about you have $90 million of cash at corporate as of now where that number might be at year-end if you don't deploy any capital?"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","All of the rebates are regulated subs to accrued forward the cash backing in, separate and apart from the $900 million which is sitting at the corporate entity. So it will have no impact in the $900 million.",38,"All of the rebates are regulated subs to accrued forward the cash backing in, separate and apart from the $900 million which is sitting at the corporate entity. So it will have no impact in the $900 million."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So. I guess it's kind of too early with the dividens might be for 2012?.",15,"So. I guess it's kind of too early with the dividens might be for 2012?."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Typically, we run 85% to 90% of the current year the income so we're scoping of the level of dividends that we expect inclusive with our free cash from nonregulated subs. We don't expect it'll be any different than that historical zone.",42,"Typically, we run 85% to 90% of the current year the income so we're scoping of the level of dividends that we expect inclusive with our free cash from nonregulated subs. We don't expect it'll be any different than that historical zone."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","One more question please.",4,"One more question please."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","Okay. We'll take that from Matt Borsch from Goldman Sachs.",10,"Okay. We'll take that from Matt Borsch from Goldman Sachs."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Yes, just wondering if you could talk about the dual opportunity and how you see yourselves positioned in that. And I'm curious if you think that going there is going to be more a function of your Medicaid markets, your Medicaid experience or Medicare? Or",92,"Yes, just wondering if you could talk about the dual opportunity and how you see yourselves positioned in that. And I'm curious if you think that going there is going to be more a function of your Medicaid markets, your Medicaid experience or Medicare? Or do you really think it's important to build to blend the two together? I guess, alternatively, is this going to be wide open where companies that you wouldn't normally expect to participate will be competing with this -- with a solid basis for being in that business?"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","I don't know if I can say much more than I did in my prepared comments. I think that the fact that 8 of the 10 states that we currently do Medicaid in are applied to CMS to competing eligible's and managed care. Than some of the new RFPs are going to -- w",220,"I don't know if I can say much more than I did in my prepared comments. I think that the fact that 8 of the 10 states that we currently do Medicaid in are applied to CMS to competing eligible's and managed care. Than some of the new RFPs are going to -- while they didn't in the past, argon include new eligibles as part of what we're bidding on. The -- so over time, there'll be plenty of opportunities, we'll get some. It's just unpredictable in terms of when the RFPs come out schedule and how quickly we can grow the business. I wouldn't mind having a little more experience with what we have, too. Not like I'd like to take on 300,000 new eligibles tomorrow but we will, over time, get our share. The timeframe's just not predictable. But I think in terms of where we do business, the resources we have now to respond to RFPs, what we've learned about this business and the last few years, if you think back with we didn't have any Medicaid business for 5 years in one particular point in time. And we didn't have any infrastructure. Didn't really have department people and expertise 3 years ago. So we're learning quickly and adding resources quickly and we'll get our share."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And just last on a different topic on the commercial -- when we look at the Commercial Risk per member revenue. Is that -- how much is that impacted the PMPMs on the statistics? How much are they impacted by the rebating are they a little bit lower becaus",87,"And just last on a different topic on the commercial -- when we look at the Commercial Risk per member revenue. Is that -- how much is that impacted the PMPMs on the statistics? How much are they impacted by the rebating are they a little bit lower because the rebating? And I was just wondering if you would be able to provide the fourth quarter group Commercial Risk, PMPM and MLR, just given that that would tie up the year on the old basis of reporting?"
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","In terms of -- the rebates does in fact obviously, the revenue level. Then in terms of tying up the MLR on a group risk basis, we anticipate that the MLR was -- will be 40 basis points higher on a separate basis.",43,"In terms of -- the rebates does in fact obviously, the revenue level. Then in terms of tying up the MLR on a group risk basis, we anticipate that the MLR was -- will be 40 basis points higher on a separate basis."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Thank you for joining us today. Operator, we're complete. Thank you.",11,"Thank you for joining us today. Operator, we're complete. Thank you."
27133,157003674,217160,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","Great. Thank you. This will conclude today's conference call.",9,"Great. Thank you. This will conclude today's conference call."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","Good morning, and welcome to the Coventry Health Care's Fourth Quarter 2011 Earnings Conference Call. Today's conference is being recorded [Operator Instructions] Today's call will begin with an opening remarks by Chief Executive Officer of Coventry Healt",55,"Good morning, and welcome to the Coventry Health Care's Fourth Quarter 2011 Earnings Conference Call. Today's conference is being recorded [Operator Instructions] Today's call will begin with an opening remarks by Chief Executive Officer of Coventry Health Care, Mr. Allen Wise, after a brief forward-looking statement read by Mr. Drew Asher. Please go ahead, Drew."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Ladies and gentlemen, during this call, we will make forward-looking statements. Certain risks and uncertainties, including those referenced in our press release and described in the company's filings with the SEC on Form 10-K for the year ended December",71,"Ladies and gentlemen, during this call, we will make forward-looking statements. Certain risks and uncertainties, including those referenced in our press release and described in the company's filings with the SEC on Form 10-K for the year ended December 31, 2010, and Form 10-Q for the quarter ended September 30, 2011, may materially impact those statements and could cause actual future results to differ materially from those anticipated and discussed. Allen?"
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Good morning, and thank you for your interest in Coventry Health Care. Today, I'd like to share with you our outlook for 2012, and in addition, some very brief comments and overview of 2011.We're increasingly positive about the opportunities ahead of us",163,"Good morning, and thank you for your interest in Coventry Health Care. Today, I'd like to share with you our outlook for 2012, and in addition, some very brief comments and overview of 2011.
We're increasingly positive about the opportunities ahead of us, which includes our projected double-digit revenue growth in 2012. On an overall basis, we ended 2011 above our previous forecast at $3.02 of earnings per share, of which $2.87 of the EPS represents our core 2011 results, as presented in our press release, excluding the private fee-for-service runout. And we're also pleased to forecast 2012 EPS of $3.10 to $3.30, which is an 8% to 15% growth rate compared to 2011's core EPS of $2.87.
I want to spend most my time this morning talking about the 2012 and the future, which much of the groundwork is based on work that we completed in 2010 and 2011. Randy Giles, our CFO, will review the quarter and provide more detailed guidance."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","2011 is a year where we're able to surpass our early financial expectations, and more importantly, lay the foundation for prospective growth. If early 2012 financial expectations were a bit cautious, it's because it was a year marked by a transition to th",2109,"2011 is a year where we're able to surpass our early financial expectations, and more importantly, lay the foundation for prospective growth. If early 2012 financial expectations were a bit cautious, it's because it was a year marked by a transition to the first major impact of health care reform with a very considerable task of implementing minimum MLRs in our commercial business.
I'd like to begin a more detailed discussion about our future, discussing our Medicaid business and the various significant progress that we are making in seizing opportunities and growing this business.
We were awarded the Kentucky contract in July of 2011, with the contract commencing in November of the same year. Based on our positioning and network efforts throughout the Commonwealth of Kentucky, we're able to achieve an outsized membership allocation compared to the other participants. In fact, we've grown again this past month, and we're now up to approximately 232,000 members.
One of the key elements to this recent growth was our ability to rapidly execute on building out a cost-competitive network. We're able to bring our collective resources to bear, including leveraging our centralized operational functions, and we imported one of our experienced executives to Kentucky from our existing business. The point of all this is that we're a resourceful company with over 14,000 employees with experience in all lines of business and the ability to execute simultaneous opportunities. It's really early in the Kentucky contract, and we're still refining operational processes and programs as this was a previously unmanaged population entering managed care. Even though it's really, we're very optimistic and confident that we'll have a successful partnership with the Commonwealth of Kentucky for years to come.
I want to continue on the Medicaid topic, and we have some additional news to report, which is another recent win that we would like to highlight this morning. Our company has been notified by the state of Nebraska of its intent to award a contract to Coventry to provide services for the state's expansion of the existing Medicaid managed care program. The Nebraska Department of Health and Human Services intends to expand managed Medicare services from the existing 10-county program to cover all 93 counties in the state, which is an estimated incremental 70,000 additional Nebraskans.
As you may recall, we won a bid in 2010 for the original program and currently serve approximately 50,000 members in the existing Medicaid program. So subject to the finalization of the contract with the state of Nebraska, we expect to be 1 of 2 managed care contractors providing services to this expanded population later this year.
Staying with Medicaid, also during 2011, we were able to seize an attractive 2-state Medicaid acquisition opportunity by acquiring Family Health Partners and entering into a long-term relationship with its previous owner, Children's Mercy of Kansas City. This acquisition, which closed effective January 1 of 2012, has Medicaid contracts in both Kansas and Missouri. We were able to expand in Missouri, a state we have served for over 15 years, and entered the Kansas Medicaid program, where there's an expansion opportunity for 2013 and beyond.
Including this acquisition, we have a meaningful multiline presence throughout our Midwest 7-state region, which now serves 1.5 million members. We were able to execute on this multifaceted transaction for a reasonable net investment of approximately $50 million, net of tax benefit and statutory capital we were able to leave behind based on the structure of this transaction.
To summarize the Medicaid discussion and quantify the growth for the year, we started 2011 with 470,000 Medicaid members and reported $1.38 billion of Medicaid revenue in 2011, which represented approximately 11% of our total revenue. We expect to double these figures with more than 915,000 members beginning in 2012 with a full year revenue forecast of around $2.7 billion.
Medicaid is projected to represent just under 20% of the company's revenue in 2012. I think that investors should think of Coventry as having a meaningful exposure to Medicare growth and penetration opportunities with a proven track record of winning new business, executing and operating these Medicaid businesses but without the concentrated risk and the inherent volatility and contract alliance of a single-line carrier. While the process of winning new business is competitive, we very strongly believe that we'll get our share in the future. We know both how to compete and how to manage this business.
Moving away from Medicaid and talking about Medicare. We're equally enthusiastic about the recent results in Medicare. As you may have seen in our press release a few weeks ago, we had a very successful 2012 annual election period. As most of you know, a lot of this work to achieve success was done well in advance. And as we have previously promised, we focused on laying the foundation during 2011 to grow both Medicare Advantage and Part D in 2012.
In Medicare Advantage, we're in 15 states, and we have seen 2012 growth across 14 of those 15 states. The most recent enrollment for Medicare Advantage is approximately 250,000 members, which is ahead of our previous estimate, and results in membership growth of about 13% so far in 2012. We've grown from 137,000 Medicare Coordinated Care members at the end of 2008 to 250,000 today for a compounded annual growth rate of 16%. We're well proportioned -- or positioned to continue taking the advantage of this attractive demographic growth opportunity where we're able to provide a tangible value proposition to seniors and to the federal government.
On Part D, we had a successful enrollment period, growing membership of about 25% out of the gate and adding almost 300,000 members.
2011, as you know, we spent a lot of time talking about the work we were doing on product design and developing, creating partnerships, and we had successfully launched the third product with a preferred network in 2012's annual election period. We increased both our auto-assign footprint and our mainstream membership coming into 2012. Our company has consistently been profitable in Part D in both membership channels since we launched in 2006, and 2011 was no exception, with an aggregate Part D loss ratio of 81.7% for the year.
During 2011, a lot of effort went into forming an attractive set of products and establishing partnerships with Walgreens, Walmart and Target for our newest product. We also renegotiated our PBM contract with an improved Part D cost structure and enhanced other areas of Part D, including distribution. I think Part D is a great example of our abilities to successfully execute on multiple growth opportunities given our focus on resources, touching multiple product lines. Our cross-functional teams were back to the drawing board after 2010 and created a product that is low-cost structure and which is proven to be attractive to the senior population.
And as you might well imagine, we're currently hard at work on our products and positioning for 2013 and very optimistic about our prospects in the future.
Think about our company with Medicare at about 30% of the company revenues and Medicaid at about 20%. So we've evolved about half of our revenue coming from government programs. There continues to be attractive opportunity to grow in the current programs, while there is a significant longer-term opportunity to serve the dual-eligible population. Medicaid and Medicare experience, footprint and capabilities are all important ingredients in positioning to serve dual eligibles. We are currently in 10 states for Medicaid and 15 states for Medicare Advantage. 8 of our 10 Medicaid states have filed letters of intent with CMS to integrate the dual-eligible population in their states. 
And for decades, we have provided complex care management and then served members across population, products and geographies with a cross-section of chronic condition, diseases and needs. We currently serve aged line to disabled members and other high-risk patients in Medicaid. We currently serve Medicaid members up and down the risk score spectrum, including dual eligibles.
Serving members with the most chronic and debilitating disease should not be taken lightly, but this population is one that can significantly benefit by coordination of care or active chronic condition management, pharmacy management, social services and all other programs that we have built over the past decade to manage our current diverse population.
Managed care should be able to make a meaningful, positive impact on the lives of dual-eligible population, and therefore, provide a valuable -- a value proposition for the states and federal government. Based on our footprint, exposure to both Medicaid and Medicare capabilities and a history of managing diverse populations, we like our early positioning for this longer-term significant opportunity, and our company will continue to invest in Medicare and Medicaid growth, along with dual-eligible populations.
Moving to our commercial business. Our Commercial Risk revenue was up 8% for 2011 with stable membership versus 2010, which is reasonably satisfying given the first year impact of health care reform, including minimum MLRs, which were effective January 1 of last year.
We knew it wasn't going to be easy managing 121 different measurement sales in our Commercial business and dealing with the burdens imposed by the new laws and regulations, many of which fell very short on clarity coming into the beginning of 2011. As Randy Giles will cover, as expected, we ended the year with significant minimum medical loss ratio rebate accrual, which will get finalized and paid out in 2012. Our goal for 2012 and beyond in the commercial business is to maintain margin and see the growth opportunities that we expect to develop as a result of consolidating market conditions driven by a commitment in this sophistication required to operate health care in the health care reform environment.
And in this context, we're actively preparing for the potential 2014 expansion [ph]. We'll continue to work on attractive commercial expansion opportunities, both through acquisitions and organic growth and increase our footprint with providers and high-performance networks, which will drive lower-cost products to complement our product portfolio.
As of today, we have signed approximately 30 high-performance network contracts across our product lines. These arrangements run the spectrum from large-scale health systems to local-based primary multispecialty provider groups. 17 of these 30 high-performance networks covers our commercial product in 14 states and we feel should position us very well, especially in an exchange environment.
As you can tell, we're very positive about our opportunities across our diverse footprint in Medicare, Medicaid and commercial lines of business. We feel that the commercial business could represent a meaningful growth opportunity in 2014 and 2015 and allow us to be diversified in addition to key substantial Medicaid and Medicare growth opportunities.
In addition, we have over $1.1 billion in higher-margin and diversified fee-based revenue that complement our risk business and provide free cash flow for deployment to increase shareholder value.
Continuing on my comments regarding our future plans, we're going to pursue organic growth in our existing businesses. We're going to pursue selected RFPs. We're going to deploy capital for acquisitions, and in addition, consider future share repurchase. I think we're not only positioned well from a business and growth perspective heading into 2012, but we also accomplished a good deal relative to our balance sheet in the past year, and Randy will address that later. We sit here with $900 million in deployable cash, and that's after posting on a meaningful transaction, buying back over 10 million shares in 2011 and paying off our 2012 note that recently came due.
We're exiting 2011 on track after increasing EPS guidance 3x during the year, and we're able to provide 2012 guidance, which results in 18% to 15% core EPS growth in 2012, coupled with double-digit revenue growth. We continue to have a strong and flexible balance sheet with a combination of free cash and additional debt capacity.
I like our positioning and balanced exposure across Medicaid, Medicare and the commercial line, as well as our capability in seeking and seizing the right M&A opportunities. We're getting results from the work we have done, and we'll continue on this path to deliver more growth.
So what does it take to deliver growth? Well, it takes capital. It takes capable, experienced executive team. It takes experience in the M&A area. It takes focus. It takes discipline. It takes the ability to move quickly. These are all capabilities our company has. I am more optimistic about our future than I have been any time in the recent past.
Randy Giles is going to walk you through the results and provide detailed guidance with additional commentary on our business. And with that, Randy?"
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Thank you, Allen. I'll begin this morning by discussing our performance in the fourth quarter and then spend a majority of my time reviewing our detailed guidance for 2012. Before I go through the details for each of our businesses, I want to first start",2900,"Thank you, Allen. I'll begin this morning by discussing our performance in the fourth quarter and then spend a majority of my time reviewing our detailed guidance for 2012. Before I go through the details for each of our businesses, I want to first start at the consolidated level. Our GAAP EPS for the fourth quarter was $0.60, which includes $0.02 related to the runout of the Medicare Advantage Private Fee-for-Service business. For the full year, we reported EPS of $3.02, excluding the litigation gain in the second quarter, compared to our previous EPS guidance of $2.95 to $3. This includes $0.15 of earnings related to Private Fee-for-Service and $2.87 of core EPS for 2011.
Similar to last quarter, we have provided a table and reconciliation of these earnings metrics on Page 3 of our earnings press release. I'm very pleased with these results for 2011 as we were able to outperform our earnings guidance each quarter during the year, grew our Health Plan membership by more than 7% from the prior year, position ourselves for continued growth in 2012, deliver the largest Medicaid RFP win in the company's history and utilize the strength of our balance sheet to seize an exciting growth opportunity while repurchasing more than 7% of our outstanding share count.
These successes have positioned our portfolio of businesses very well for 2012, which I will highlight in detail after first giving you a little more color on the 2011 performance.
In our commercial business, first, one housekeeping item. You'll notice that we have now aligned our reporting of revenue PMPM and MLR percentage metrics to be consistent with the rest of the industry by disclosing Commercial Risk as opposed to our historical disclosure of Commercial Group Risk statistics, which excluded the commercial individual business. In addition to creating a better comparison to our peer group, we also wanted to recognize the growing impact that the individual business is having on our commercial results as we continue to increase our market share and invest in building out our capabilities in advance of the potential membership opportunity in the exchanges.
In 2008, for instance, we had 123,000 individual members. Whereas today, we have slightly more than 200,000 members. Also, the individual MLR has become much more comparable to the small group MLR due to health care reform regulations. This new disclosure structure is reflected in the earnings release issued this morning for both the current period as well as all historical periods disclosed.
Our commercial MLR was 83.7% in the fourth quarter and 81.6% for the full year, which is slightly above our previously provided guidance. As we continue to gain clarity on the minimum MLR regulations during the back half of 2011, we had to refine our rebate calculations to reflect the allowable underlying cost of certain internal and external medical-related vendors. We began the year expecting to be able to reflect medical-related payments to internal and external vendors in their entirety as such in the minimum MLR calculations. But based upon clarity we gained in MLR rules Q3 and subsequent data gathering from our vendors in Q4, including our external PBM, we made adjustments that increased the medical loss ratio. I highlight this for you as it had about a 50 basis point impact on our full year 2011 commercial MLR relative to our initial guidance.
Within our commercial book, our view of fundamental prospective trend remains unchanged in the range of 8% plus or minus 50 basis points with unit cost trend continuing to be the largest driver, albeit stable. In the rearview mirror, we can see trends the mid-7s that continue to move higher off of the extreme low levels seen during the second half of 2010. These trends include the impact of the health care reform regulations implemented on September 23, 2010, which just had between 150 and 200 basis points of impact on the trend this year that will not recur in 2012.
Inpatient utilization, realized at the lows of late 2010, continues to show a negative trend, as it has throughout 2011. Similar to what we disclosed to you last quarter, we're seeing outpatient physician trends creep up and move from negative into slightly positive territory. Just to put in context, remember today's trends are being compared to the lowest level of utilization trends seen in years, a historically low base line from late 2010.
And probably most importantly, our pricing structure is predicated on a forward view of trend in which we have anticipated a return to more levels -- normal levels of utilization above what we've seen in the rearview mirror. This pricing is expected to generate higher absolute rate increases than what we're seeing throughout 2011 as we've established a new baseline with many of the adjustments related to health care reform already addressed and the benefit of the extremely low utilization 2010 has already been passed through to our experience-rated customers.
Finally, the commercial results. I want to share our customary statistics around health care reform, which are consistent with the projections from the last call. For 2011, we generate total Commercial Risk revenues of just under $6 billion. Of that total, individual business generate approximately $375 million of revenue with the vast majority of this business in a rebate position. The remaining $5.6 billion of group risk revenues were split roughly 40% small group and 60% large group with approximately half of our small group business in a rebate position and a little less than 1/4 of our large group business in a rebate position.
It's important to note that rebate exposure is something that we've been managing carefully with a number of actions taken to utilize rebate capital during the year, including providing more value to our customers, also promoting quality initiatives with hospitals and providers to improve risk scores, strengthen overall quality of care and to create opportunities to lower future medical costs. This has driven our rebate estimates down significantly from our initial view in 2011. In 2012, we expect to benefit from certain renegotiated external vendor contracts, which will serve to decrease our overall cost structure and reduce our rebate accrual in 2012. We view our estimated rebate for 2011 as reasonable given the size of our book of business, this being the first year navigating these new regulations, and the inherent loss ratio variability that exists when calculated at the market side segment in the state level.
While we're not assuming a benefit from the multiple states that had minimal MLR waiver request pending with HHS, we were disappointed to see waiver request denied in some of our larger states, including Florida and Kansas. This result creates more challenging operating environment for the individual business in these markets or force us to continue to evaluate our participation in that product on a market-by-market basis. Of the states with waivers currently pending with HHS, North Carolina is the only state where Coventry has an individual presence.
Moving on to government programs, our Medicare results for the fourth quarter were a continuation of the strong results that we saw throughout 2011 and an even better result in 2010. Our Medicare Advantage MLR of 82.3% for the quarter and 82.9% for the full year was a very strong result and one that gives us confidence in our bid positioning as we look to towards 2012. Our Medicare Part D results were also strong as the fourth quarter MLR of 60.5%, full year MLR of 81.7% were both better than our expectations and an improvement from the prior year.
As Allen already highlighted, we are excited about that growth trajectory that we've built for the Medicare business with revenue growth of more than 20% and membership growth of nearly 50% in 2011. Our Medicaid results in the quarter were consistent with our expectation as we saw an uptick in our reported revenue PMPM, as well as MLR percentage, with the inclusion of the new Kentucky contract, which was effective on November 1.
Finally, we closed out 2011 with another excellent SG&A result, reporting a full year expense of $2.015 billion as compared to our initial guidance of $2.02 billion. This accomplishment is particularly impressive when you consider that while we were holding absolute SG&A spend just below our initial guidance for the year, we were simultaneously able to grow revenue above the initial guidance midpoint by more than $425 million.
Full year expense, including the elevated level of spend during the fourth quarter related to the successful Medicare enrollment period and the launch of the new Kentucky Medicaid contract, which together, bought more than 0.5 million new members to the company.
Before we get into 2012 guidance, let me first review some metrics on our balance sheet and cash flows. Our investment portfolio remained in a high-quality position with a net unrealized gain of $97 million at year end, an increase from $90 million in the prior quarter. As of January 31, we had $900 million of deployable free cash available, which is after retiring $234 million of senior notes earlier in January, as well as the deployment of $100 million during the fourth quarter for share repurchase. Recall that one of our accomplishments in 2011 was repositioning our balance sheet by issuing 10-year $600 million senior notes in June 2011 and renewing our credit facility. 
We have no scheduled debt maturities now until 2014, having an undrawn $750 million credit facility that isn't scheduled to expire until 2016. This gives us a great deal of flexibility as we pursue capital deployment opportunities. And as you have seen throughout 2011, while acquisitions remain our first priority for capital deployment, we're also committed to returning capital to shareholders through opportunistic share repurchases, as seen through our deployment of $328 million in 2011.
Moving on to our cash flow results. You'll recall that we received an extra payment from CMS in the third quarter, so you can see the impact from that under deferred revenue line in the fourth quarter results and then in the immaterial impact from deferred revenue for the full year. The full year result was impacted by the second quarter litigation settlement. So after adjusting earnings for the litigation items, our cash flow from operations was $496 million or 112% of net income for the year. As you can see on the other receivables line of the balance sheet and cash flow statement, cash flow from operations was negatively impacted by the timing of certain Medicare Part D receivables related to the 2011 program here that we will collect from CMS in 2012.
So with a successful 2011 behind us, let's now discuss our outlook for 2012. Today, we are providing initial 2012 EPS guidance in the range of $3.10 to $3.30, which is an increase of 8% at the low end and 15% at the high end, versus the comparable 2011 EPS of $2.87. In that area, we are projecting total revenues are nearly $14 billion, a growth of approximately $1.75 billion, which is up roughly 15% at the midpoint. We are forecasting an increase in consolidated MLR percentage, which is driven by changes in the mix across our portfolio businesses towards the growth in government programs.
In 2011, commercial revenue represented approximately 50% of the company total with an additional 30% Medicare, 10% Medicaid and 10% other, including Fee businesses. Our guidance for 2012 projects around new composition of just over 40% commercial, 30% Medicare, 20% Medicaid and just under 10% Fee and other. This is consistent with our goal to have a balanced portfolio with the ability to seize opportunities across the product spectrum.
On the topic of medical cost structure, we have recently renegotiated and extended our PBM contract with Medco for a multiyear period effective January 1, 2012. We're able to secure an improved cost structure and contract terms that give us more flexibility as we continue to react to the rapidly evolving health care marketplace. Given that pharmacy spend represents nearly 20% of our medical expenditures, this is an important improvement to a critical part of our overall cost structure across our product portfolio.
Moving on to SG&A. I'm particularly pleased with the efforts that the organization has put forth on driving down our SG&A percentage of revenue from 16.5% in 2011 to a midpoint of 15.4% on our 2012 guidance. I've been personally involved in working to identify cost reduction opportunities across the company that have allowed us to forecast a strong result for 2012 while simultaneously also making critical investments for the future in our core businesses. These investments include improved direct distribution capabilities from the individual business, enhanced care management tools, the addition of substantial Medicare and Medicaid resources, not to mention the ongoing increased compliance costs. And that's just to name a few.
On the non-operating items, you'll note that the tax rate is increased over 2011, which is primarily driven by a shift in the mix of earnings towards states with higher tax rates and also about compliance with new health care reform regulations.
Finally, you will see our share count guidance which assumes that we essentially hold the share count flat from where we ended 2011. It's important to note that today's EPS guidance range does not incorporate any meaningful deployment of the free cash that is sitting on our balance sheet.
Now moving more specifically into our largest lines of business. For Commercial Risk, we are forecasting membership levels to be slightly down for 2011 levels with a decrease in Q1 2012 driven by a handful of large group terminations followed by growth during the remainder of the year. We continue to price ahead of trend and remain disciplined in our objective of maintaining margin over pursuing membership gains. 
On the expense side, we are projecting MLR of 81.5% plus or minus 50 basis points. This MLR guidance incorporates mechanics of the minimum MLR rules, our view of pricing by market, a forward view on medical trends, our mix of business and a fragmented view that you always have deviations from the mean as you manage your portfolio of 121 measurement cells. This is a slight improvement from 2011, and it's that '11 that we view as sustainable under health care reform in today's operating environment.
In Medicare, the membership story is excellent for both Medicare Advantage and Medicare Part D. As Allen noted earlier, we're starting the year with approximately 250,000 Medicare Advantage members, which is an impressive growth result of about 13% from 2011. Our Medicare Part D business was also very successful during the annual election period as we grew by almost 300,000 members, or about 25%, and we are forecasting continued growth throughout 2012. This growth is a nice mix of retail purchase just in our innovative new value plus product and partnership with Walgreens, Walmart and Target, as well as our increased auto-assignment presence in 23 regions for 2012, up from 15 regions in 2011. Based upon our bids and our view of where we exited 2011, we are forecasting MLRs in the low to mid-80s for both Medicare Advantage and Part D.
Staying within government programs, our 10-state Medicaid business is the biggest part of our 2012 growth story with total revenue expected to nearly double with just under $1.4 billion in 2011 to nearly $2.7 million in 2012. Today, we are just about 915,000 members and expect to be in the zone of 950,000 Medicaid members upon implementation of the new Nebraska contract. We are projecting MLR of approximately 90% in 2012, which is a combination of our same-store business, which runs in the mid- to high-80s, and MLRs in the 90s for the year 1 RFP wins and the newly acquired Family Health Partners business in the Midwest.
So now we've covered the large risk business, you'll notice that although we are still forecasting over $1.1 billion of fee-based revenue, our guidance for fee revenue is down a little, more than 3% due to the loss of one Workers' Compensation Services account. However, you also see a decrease in cost of sales expense item directly associated with Workers' Compensation Services, which more than offset the aggregate fee revenue reduction. Our Fee businesses continue to be an important component of our overall product portfolio, providing valuable unregulated cash flows and are an area that we intend to grow and adjust in prospective.
So in conclusion, our efforts in 2011 lay the foundation for the 2012 guidance that we provided today. We firmly believe that growing the top line is critical in today's environment and are pleased to see 2011's efforts bearing fruit in 2012 with the revenue guidance midpoint of nearly $14 billion, up with an increase in both operating earnings and EPS. So while we may be pleased with the 2012 growth outlook, by no means are we satisfied. We will continue to invest in the future, focus on managing our portfolio of businesses in a manner that allows us to seize growth opportunities while also maintaining the right balance, limiting our exposure to any one area. We will continue to introduce growth opportunities, both organically and through acquisition, to strategically position Coventry to deliver the long-term results that our shareholders have come to expect.
Operator, this now concludes our prepared remarks, and we are ready to open the line for questions."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","[Operator Instructions] We'll go first to Doug Simpson with Morgan Stanley.",11,"[Operator Instructions] We'll go first to Doug Simpson with Morgan Stanley."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So Randy, maybe just to expand a little bit. I think you said 81.5% for the commercial MLR in 2012. Did I hear you right?",25,"So Randy, maybe just to expand a little bit. I think you said 81.5% for the commercial MLR in 2012. Did I hear you right?"
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes.",1,"Yes."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Is that -- okay. So can you just sort of walk us through -- the Q4 MLR came in, I think, on the commercial side higher than people were expecting. You talked about the inclusion of -- or the inability to include certain costs in the rebate calc, and that",72,"Is that -- okay. So can you just sort of walk us through -- the Q4 MLR came in, I think, on the commercial side higher than people were expecting. You talked about the inclusion of -- or the inability to include certain costs in the rebate calc, and that obviously, I think you said 50 bps for the year. So roughly 200 basis points into the Q4 number. Is that fair?"
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","It's more like 140 into the Q4 result.",9,"It's more like 140 into the Q4 result."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So it added 140 to the commercial MLR in Q4?",10,"So it added 140 to the commercial MLR in Q4?"
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes.",1,"Yes."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. So can you just help us sort of think about a map from the 2011 experience into 2012? Just how -- sort of maybe walk us through your thoughts around the commercial MLR from 1 year to the next given sort of those dynamics and your Q4 jumping off poin",51,"Okay. So can you just help us sort of think about a map from the 2011 experience into 2012? Just how -- sort of maybe walk us through your thoughts around the commercial MLR from 1 year to the next given sort of those dynamics and your Q4 jumping off point."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","As we think about 2012, there were certain trend drivers that we think are not going to recur into 2012. One of the things, as you might recall, we experienced lower prior period of volume during 2011 and 2010. And you can see from today's earnings releas",115,"As we think about 2012, there were certain trend drivers that we think are not going to recur into 2012. One of the things, as you might recall, we experienced lower prior period of volume during 2011 and 2010. And you can see from today's earnings release that our DCP increased by 4% from the prior year end. So I feel comfortable that, that pressure is not going to recur. As we go in, we've also improved our cost structure, as I mentioned, around our pharmacy particularly, and we have some other actions we're taking around cost structure that give us a pretty good feeling about where we're going to be in 2012 versus 2011."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. And then -- and just in terms of your commentary on utilization and trend in the Q4 period, it didn't sound like you saw anything new or different there. But can you just give us maybe more color on that front?",42,"Okay. And then -- and just in terms of your commentary on utilization and trend in the Q4 period, it didn't sound like you saw anything new or different there. But can you just give us maybe more color on that front?"
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Sure. As we think about trend in general, what we're seeing, as I talk about inpatient, commercial bed days were down low- to mid-single digits in Q4 2010. Medicare Advantage bed days were down low- to mid-single digits. And commercial admits were down mi",104,"Sure. As we think about trend in general, what we're seeing, as I talk about inpatient, commercial bed days were down low- to mid-single digits in Q4 2010. Medicare Advantage bed days were down low- to mid-single digits. And commercial admits were down mid-single digits from Q4, and Medicare Advantage admits were down low- to mid-single digits from Q4 2010. So the position we're seeing is somewhat uniform utilization trends across primary care, surgical specialists and lab. And on the outpatient side, the areas that we see are utilization and include areas like dialysis, injectable drugs and cardiovascular, other areas we're seeing trend pressuring."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. And then maybe just switching gears on the use of capital. You guys obviously bought back some stock in Q4. I think the cash balance is right about $900 million now. How do you think about deploying that, thinking about the M&A backdrop, the opportu",122,"Okay. And then maybe just switching gears on the use of capital. You guys obviously bought back some stock in Q4. I think the cash balance is right about $900 million now. How do you think about deploying that, thinking about the M&A backdrop, the opportunity to buy back stock? I mean, if you look out 12 months, would you expect to still have that sizable of a cash balance? Or if you don't see things out there on the M&A front, would you look to kind of bring that down and think about keeping your debt capacity as your drive for deals to the extent they present themselves. How long would you guys kind of run with a heavy cash balance?"
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think you're going to expect 2012 to look like 2011. We spent $328 million in share repurchase, did a major transaction and worked on some things that didn't materialize. We will continue looking for significant size to M&A transactions, and if those op",115,"I think you're going to expect 2012 to look like 2011. We spent $328 million in share repurchase, did a major transaction and worked on some things that didn't materialize. We will continue looking for significant size to M&A transactions, and if those opportunities don't present themselves, we will opportunistically do share repurchase where we're going to use the whole $900 million up and live with our credit line. I doubt it because we think that there's going to be continuing consolidation. The margins are under pressure. The business is going to get tougher, and we feel like there will be opportunities to grow our business substantially, and we're going to keep working better."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. And then maybe just sneak just one last one in. Just on, I think, this call you probably talked a little bit more about the duals than you have in the past. Can you just give us a sense, I mean, how -- what's your expectation for that in terms of ti",77,"Okay. And then maybe just sneak just one last one in. Just on, I think, this call you probably talked a little bit more about the duals than you have in the past. Can you just give us a sense, I mean, how -- what's your expectation for that in terms of timing with respect to your book of business and how much effort are you making on that front at this point in terms of resources?"
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, we're making -- what we're doing today is making certain that we can absorb almost a 0.25 million of new members that have never been in managed-care before across the whole spectrum in Kentucky. We are investing in a new IT system that improves our",141,"Well, we're making -- what we're doing today is making certain that we can absorb almost a 0.25 million of new members that have never been in managed-care before across the whole spectrum in Kentucky. We are investing in a new IT system that improves our patient management capabilities. And we think that we can't predict exactly what dual-eligible population will be, but we work on it all the time. The timeframe when these things present themselves are uncertain. We worked on an opportunity in Kansas, which has not yet born any fruit, but we're working on RFPs in -- all the time. And so we'll have opportunities. I can't predict which quarter they present themselves, but we're investing in experience. We're investing in systems. We're investing in staff and infrastructure for the Medicaid business, and we're going to grow it."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","We'll take our next question from Tom Carroll with Stifel Nicolaus.",12,"We'll take our next question from Tom Carroll with Stifel Nicolaus."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I wanted to come back to your commentary on the Kentucky Medicaid business. It sounds like things are well there. But I guess maybe just 2 questions. Was Kentucky the primary reason for the large MLR increase in your Medicaid book? And then secondly, it s",100,"I wanted to come back to your commentary on the Kentucky Medicaid business. It sounds like things are well there. But I guess maybe just 2 questions. Was Kentucky the primary reason for the large MLR increase in your Medicaid book? And then secondly, it seems like there might be some issues in the market transitioning from Fee-for-Service to Managed Care. I think we saw that the secretary of Health and Family Services resigned yesterday. Just maybe just, again, reiterate, is there any reason we should assume or any reason to believe this could drag earnings a bit in 2012?"
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","I'd answer that by saying there are no surprises in Kentucky. We understood what it would be like to convert. I think we had more enrollment success than maybe we have asked, but we understood when we embarked on this that it would be an arduous, difficul",226,"I'd answer that by saying there are no surprises in Kentucky. We understood what it would be like to convert. I think we had more enrollment success than maybe we have asked, but we understood when we embarked on this that it would be an arduous, difficult first 6 months or 8 months or 10 months to convert the population and the providers and the experience base there to a managed population. We have only 2 months of experience in terms of cost there, and with that 2 months of experience, there are a lot of unknowns and a lot of gaps in terms of the billing process to the providers, do we have the bills on the same schedule than we would have on existing businesses. And so there are a lot of questions because it's so new, and I think that our reserves on that front would reflect Coventry's -- in my own personal, long-term view, which is make certain if you don't know that you're properly reserved, and those will come down as we gain experience and as we get data and as we know more about the population. But there are no surprises there. It's -- we understood what we are embarking on, and I would say that it's going reasonably well with a lot of work left to be done."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","That's great to hear. Do you expect any type of MLR improvement throughout the year? Or is this more of a 2013 effort?",24,"That's great to hear. Do you expect any type of MLR improvement throughout the year? Or is this more of a 2013 effort?"
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","No, I expect us to gain experience and knowledge and improve our ability to make progress there as the year progresses. It's something I can't predict by month or anything like that. But no, I have a high degree of confidence that we will improve the care",121,"No, I expect us to gain experience and knowledge and improve our ability to make progress there as the year progresses. It's something I can't predict by month or anything like that. But no, I have a high degree of confidence that we will improve the care for that population, improve communication with the providers, get to know the Commonwealth of Kentucky better. And just a lot of work to be done there, but we have every confidence that it'll get better as the year progresses in that long term, this will be a good opportunity for us. There haven't been any surprises. We understood when we bid and was awarded the business, we had a lot of work to do."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","One last one on your commercial rebates. Is there any chance you could quantify that for us?",17,"One last one on your commercial rebates. Is there any chance you could quantify that for us?"
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","We generally don't disclose the amount of our rebate. I would just say we have a normal level of what we would anticipate, and that was significantly reduced from our initial view going into 2011.",36,"We generally don't disclose the amount of our rebate. I would just say we have a normal level of what we would anticipate, and that was significantly reduced from our initial view going into 2011."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","We'll take our next question from Carl McDonald with Citi.",11,"We'll take our next question from Carl McDonald with Citi."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","On the cost trend, it sounds like you're seeing the same type of utilization that pretty much everybody else in the industry is seeing, which is, say, not very much. And yet, your overall trend at, call it, 7%, 8% is meaningfully higher than the sort of 5",81,"On the cost trend, it sounds like you're seeing the same type of utilization that pretty much everybody else in the industry is seeing, which is, say, not very much. And yet, your overall trend at, call it, 7%, 8% is meaningfully higher than the sort of 5% to 5.5% that a lot of other companies are talking about. So within the unit cost, can you talk about where you think the biggest area of differential is and what's driving that?"
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","I really can't comment on what they're including in their numbers, Carl. But as far as ours are concerned, we feel like we're reporting them on a consistent basis. As it relates to unit costs for inpatient, we're seeing high single digits, which is -- it'",209,"I really can't comment on what they're including in their numbers, Carl. But as far as ours are concerned, we feel like we're reporting them on a consistent basis. As it relates to unit costs for inpatient, we're seeing high single digits, which is -- it's mostly unit cost driven in terms of what we're looking at in inpatient, outpatients, low double digits, which is mostly unit cost driven. Positions mid-single-digit, which is kind of split evenly. So we're kind of seeing -- we don't really see a change there. We see -- one of the things contributing to the trend year-over-year for us is the impact of the -- as I mentioned in my script, was the impact of the health care reform changes from September 23 of 2010, that required us to get a 0 on [ph] amount of things of up to 200 basis point impact on our trend number. So depending on the mix of business between us and the competition and the benefit designs that they may have had with us having more small group business with maybe higher deductibles and copayments to begin with, we might have had a bigger impact from that than they did. But that's speculation on my part."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then back in Kentucky, what loss ratio did you assume for November and December there?",16,"And then back in Kentucky, what loss ratio did you assume for November and December there?"
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","We don't really break out loss ratios by market like that. I would just say that we've assumed a loss ratio in the early months with normal transition of care and pacing in the managed care processes, a higher loss ratio in the first 2 months that would -",59,"We don't really break out loss ratios by market like that. I would just say that we've assumed a loss ratio in the early months with normal transition of care and pacing in the managed care processes, a higher loss ratio in the first 2 months that would -- we had expected to go down throughout the year."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","As consistent with our long-standing practices, adequate.",8,"As consistent with our long-standing practices, adequate."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then if you -- I'm just going to pick a number and say it's 100% that you assumed in the fourth quarter. It looks like the loss ratio in the other Medicaid the markets would have deteriorated something like 350 basis points. Is [ph] the driver there?",48,"And then if you -- I'm just going to pick a number and say it's 100% that you assumed in the fourth quarter. It looks like the loss ratio in the other Medicaid the markets would have deteriorated something like 350 basis points. Is [ph] the driver there?"
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","You shouldn't make those assumptions.",6,"You shouldn't make those assumptions."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","I would just comment on that, that the loss ratios in our other Medicaid markets did not deteriorate in the fourth quarter.",22,"I would just comment on that, that the loss ratios in our other Medicaid markets did not deteriorate in the fourth quarter."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Did not deteriorate? I'm sorry, I didn't get that. You said did not deteriorate in the fourth quarter?",18,"Did not deteriorate? I'm sorry, I didn't get that. You said did not deteriorate in the fourth quarter?"
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Did not deteriorate.",3,"Did not deteriorate."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","We'll take our next question from Josh Raskin with Barclays.",11,"We'll take our next question from Josh Raskin with Barclays."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just on the 2 big new drivers for 2012, Kentucky and PDP, when do you think you're going to have enough claims data to start getting a better sense of where their trends are relative to sort of your underwritten expectations?",41,"Just on the 2 big new drivers for 2012, Kentucky and PDP, when do you think you're going to have enough claims data to start getting a better sense of where their trends are relative to sort of your underwritten expectations?"
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","I'll feel better in 3 or 4 months. It's -- I'm -- we're learning about billing practices, and it's new to all the providers, so I think that the -- heard but not received information is not going to be good for them. We have a large team on the ground the",93,"I'll feel better in 3 or 4 months. It's -- I'm -- we're learning about billing practices, and it's new to all the providers, so I think that the -- heard but not received information is not going to be good for them. We have a large team on the ground there in the next couple of weeks, making the rounds with all the major large provider groups. And -- but I think if you would think of the 3 to 4 months, we should have a much better feel on cost."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. And then I guess in Kentucky, I hate to sort of keep harping on this, but it's a big win for you guys. There was a pretty big move into the member selection period. And so I'm just curious, have you guys put in some consideration, changed your thoug",71,"Okay. And then I guess in Kentucky, I hate to sort of keep harping on this, but it's a big win for you guys. There was a pretty big move into the member selection period. And so I'm just curious, have you guys put in some consideration, changed your thoughts around potential adverse selection or what some of these members you're doing based on the difference in benefits in the market?"
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","No, the benefits are very close to the same. We think that the very outsized enrollment period has a direct proportion to the large team we put on the ground there and the numbers of providers that we got early at competitive rates. And we did not use a t",123,"No, the benefits are very close to the same. We think that the very outsized enrollment period has a direct proportion to the large team we put on the ground there and the numbers of providers that we got early at competitive rates. And we did not use a third party to do the contracting. We've got a lot of health plans and a lot of people and a lot of experience there, and we put 60 or 70 of our own people on the ground there for 2 months. So we think the enrollment is unrelated to very, very minor difference in benefits and much more directly related to having people's current primary care physician or physician groups in our network earlier."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. And then just last quick question on the PBM contract. Could you just give us the length on that and that any color on the improvement in terms of your costs for drugs now?",35,"Okay. And then just last quick question on the PBM contract. Could you just give us the length on that and that any color on the improvement in terms of your costs for drugs now?"
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","In terms of the contract extended for Medicare through 2015, the commercial contract will be extended through 2016. And I can't really comment on the impacts on our cost structure, but just to say that it was a key driver for our product positioning in Pa",141,"In terms of the contract extended for Medicare through 2015, the commercial contract will be extended through 2016. And I can't really comment on the impacts on our cost structure, but just to say that it was a key driver for our product positioning in Part D for 2012 and a key factor for us in terms of our cost in preparing for the exchanges going forward. And the other aspect about it is really increased flexibility that we have regarding elements of the contract for the future as we're able -- so we can adapt more easily to haelth care changes in the marketplace going forward. So Medco has been a critical partner for us and strategic partner for us, and we continue to work that relationship and work with them to try and get to the best possible results."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. Is that through the end of '15 for Medicare and end of '16 for commercial?",16,"Okay. Is that through the end of '15 for Medicare and end of '16 for commercial?"
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes.",1,"Yes."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","We'll take our next question from Charles Boorady with Crdit Suisse.",12,"We'll take our next question from Charles Boorady with Crdit Suisse."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I'm not harped on Kentucky but I just wanted to recall. Was that in your original guidance? It couldn't have been, right, because you were awarded during the year? But basically, it looks like the fourth quarter and your full year results would have been",90,"I'm not harped on Kentucky but I just wanted to recall. Was that in your original guidance? It couldn't have been, right, because you were awarded during the year? But basically, it looks like the fourth quarter and your full year results would have been much stronger without Kentucky. While you're not seeing it, we can back in to the fact that it was pretty dilutive to your quarter if that's what drove up the Medicaid loss ratio that wouldn't have deteriorated without Kentucky. Am I reading that right?"
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes.",1,"Yes."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Got it. Good. And then the Nebraska expansion, did you say that is in your 2012 guidance?",17,"Got it. Good. And then the Nebraska expansion, did you say that is in your 2012 guidance?"
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","It's not a case of new information. At this particular point in time, we don't know, and no one -- neither would anyone else after 60 days. And it's just consistent with our current practices here to not overpromise and to make certain that our reserve po",105,"It's not a case of new information. At this particular point in time, we don't know, and no one -- neither would anyone else after 60 days. And it's just consistent with our current practices here to not overpromise and to make certain that our reserve position is adequate. It's nothing more than not knowing, and I don't know how else you would know. We started -- acquired new businesses for 15 years here and started new businesses, maybe one not quite as large. We just don't know at this particular point in time. But there isn't any unknown, adverse information that we have."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Got it. Totally understood, and I think it's a prudent way that companies book new business in new markets, especially in that space. I was really more getting at what your results would look like were it not for that new business because it would be iron",62,"Got it. Totally understood, and I think it's a prudent way that companies book new business in new markets, especially in that space. I was really more getting at what your results would look like were it not for that new business because it would be ironic to be penalized by investors for a big win just because of some upfront dilution."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","It's very short term, and it's getting all rolled out here in a few months. And I would rather that people wonder if we're too conservative today and then sit in front of you 2 quarters from now and say we didn't know and we're not going to make our numbe",71,"It's very short term, and it's getting all rolled out here in a few months. And I would rather that people wonder if we're too conservative today and then sit in front of you 2 quarters from now and say we didn't know and we're not going to make our numbers. So it's very consistent with the prudence that we run our business here, and it will develop relatively quickly."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Got it. Got it. And in terms of the comments on the minimum MLR and the 50 bps higher impact from classifications, did that get offset by SG&A? Or was there a net income impact because of the need to rebate some of the impact of that 50 bps?",49,"Got it. Got it. And in terms of the comments on the minimum MLR and the 50 bps higher impact from classifications, did that get offset by SG&A? Or was there a net income impact because of the need to rebate some of the impact of that 50 bps?"
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes, there was an MLR impact of that additional rebate.",10,"Yes, there was an MLR impact of that additional rebate."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","There was an MLR impact. But was there net income impact also?",12,"There was an MLR impact. But was there net income impact also?"
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes.",1,"Yes."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay, got it. And then finally, in the Workers' Comp business, we didn't really talk about this in a while, but could you just tell us a little bit more about what you're are for that business? You talked about your desire to grow your fee-based services.",78,"Okay, got it. And then finally, in the Workers' Comp business, we didn't really talk about this in a while, but could you just tell us a little bit more about what you're are for that business? You talked about your desire to grow your fee-based services. But what drove the account loss in Workers' Comp? And can you tell us about your backlog or give us other indications of your growth prospects in the fee-based businesses broadly?"
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","I'm going to let -- most of you have not met Mike Bahr. Mike runs all of the commercial business in our company, which includes Workers' Comps. And that's relatively new since October of this year to enroll in his -- not new to our company but is due to r",114,"I'm going to let -- most of you have not met Mike Bahr. Mike runs all of the commercial business in our company, which includes Workers' Comps. And that's relatively new since October of this year to enroll in his -- not new to our company but is due to running all of our government business. I'm going to let Mike Bahr answer the question about Workers' Comp because we changed it in October because there's so many common network issues and development of network resources that -- across the 2 companies, and we think it will run better integrated with the management and leadership in our company and the commercial area. Mike?"
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Charles, Workers' Comp, it is an area we're looking to grow. It's an area we're looking for opportunities to grow. As you said, it's unregulated revenue, and that's a great place to be these days. So the loss of the group, it was our second largest group,",128,"Charles, Workers' Comp, it is an area we're looking to grow. It's an area we're looking for opportunities to grow. As you said, it's unregulated revenue, and that's a great place to be these days. So the loss of the group, it was our second largest group, if I recall, and it was just a competitive environment. And so for us, it's -- we're in a position where we continue to look for opportunities to grow and invest in that line of business. But there's nothing specific with Workers' Comp that created the issue. So I mean, it's a line that runs well. We're centralizing some of our businesses to improve our network structure, particularly in areas where we don't have health plans. And so we're pretty optimistic."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I know that's a long lead time sale, but can you give any give a sense for what your backlog looks like generally in either Workers' Comp or the fee-based business more broadly?",34,"I know that's a long lead time sale, but can you give any give a sense for what your backlog looks like generally in either Workers' Comp or the fee-based business more broadly?"
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","I really can't. To be honest, I'm not in the detail on that side of it. So I can't answer that. I know that the large group we lost, some of the employers they work with are looking to come back to us for services, and we're certainly open to doing that.",53,"I really can't. To be honest, I'm not in the detail on that side of it. So I can't answer that. I know that the large group we lost, some of the employers they work with are looking to come back to us for services, and we're certainly open to doing that."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","It's been stable for a number of years, stable meaning slight increases in revenue. We're heavily affected by the recession and the employment market and employers being much more careful about occupational safety. So it's a transaction-based business tha",86,"It's been stable for a number of years, stable meaning slight increases in revenue. We're heavily affected by the recession and the employment market and employers being much more careful about occupational safety. So it's a transaction-based business that's an acronym for claim-based or accident-based business. And in a tough environment, it's continued to add new customers and grow revenues slightly and EBITDA a little more than revenues. So it's working well for us, and we're trying to figure out how to make it better."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Was the capability or price that you lost the business on when you said things are getting more competitive?",19,"Was the capability or price that you lost the business on when you said things are getting more competitive?"
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","No, no, no, it's price.",5,"No, no, no, it's price."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","And we'll take our last question from Kevin Fischbeck with Bank of America.",14,"And we'll take our last question from Kevin Fischbeck with Bank of America."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","You mentioned that the rebate position, it sounds like, in Q4 was actually kind of similar to where it was, I guess, in Q3. But -- and you said that in 2012, it will be probably a little bit lower. Can you just give a little -- a sense of where you think",63,"You mentioned that the rebate position, it sounds like, in Q4 was actually kind of similar to where it was, I guess, in Q3. But -- and you said that in 2012, it will be probably a little bit lower. Can you just give a little -- a sense of where you think your pools will be across the 3 areas of business?"
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes. I think the -- as we look at the rebate and where we do have rebates that are concentrated still in our top 5 rate cells and small business, large group and individual. And it varies by state where those are located. But generally, if you think about",103,"Yes. I think the -- as we look at the rebate and where we do have rebates that are concentrated still in our top 5 rate cells and small business, large group and individual. And it varies by state where those are located. But generally, if you think about the rebates, for us, they're predominantly in small group and then individual and in large group kind of in that. It's relative size. In terms of rebates, we think we've done a good job of managing them. We think we can get better at it in 2012, and we'll continue to work on that."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","We need to get better, and we will.",8,"We need to get better, and we will."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Is it a matter -- do you think the blocks of business will be relatively similar as far as percentage in rebates, it's just that they'll be paying a little bit less of the rebate? Or would you expect that to change?",42,"Is it a matter -- do you think the blocks of business will be relatively similar as far as percentage in rebates, it's just that they'll be paying a little bit less of the rebate? Or would you expect that to change?"
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","No. We would hope there will be less than rebates, and we translate that to being better position in the market from a price standpoint. But not an exact science, not easy.",32,"No. We would hope there will be less than rebates, and we translate that to being better position in the market from a price standpoint. But not an exact science, not easy."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","And remember, your leveraging over the multiple years as you move out to 3 years, so it becomes more predictable.",20,"And remember, your leveraging over the multiple years as you move out to 3 years, so it becomes more predictable."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. And then given that this is the first year of rebates, 2012 being the first year actually paying the rebates, can you just go through the kind of the cash flow, maybe bridge for 2012 for us?",38,"Okay. And then given that this is the first year of rebates, 2012 being the first year actually paying the rebates, can you just go through the kind of the cash flow, maybe bridge for 2012 for us?"
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, as it relates to rebates, there's a runout period in 2012 that, that will firm up the rebate calculations to what the actual results are. Once that's finalized, the payments will be made midyear. So that's the timeframe for when that gets transacted",44,"Well, as it relates to rebates, there's a runout period in 2012 that, that will firm up the rebate calculations to what the actual results are. Once that's finalized, the payments will be made midyear. So that's the timeframe for when that gets transacted."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","But I guess is there a way to think if you have $90 million of cash at corporate as of now where that number might be at year end if you don't deploy any capital?",35,"But I guess is there a way to think if you have $90 million of cash at corporate as of now where that number might be at year end if you don't deploy any capital?"
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","All of the rebates are in regulated subs, so accrued forward the cash backing in, separate and apart from the $900 million, which is sitting at the corporate entity. So it will have no impact in the $900 million.",39,"All of the rebates are in regulated subs, so accrued forward the cash backing in, separate and apart from the $900 million, which is sitting at the corporate entity. So it will have no impact in the $900 million."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. So -- but I guess it's still too early to kind of say at this point where the dividends of the subs might be for 2012?.",27,"Okay. So -- but I guess it's still too early to kind of say at this point where the dividends of the subs might be for 2012?."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Typically, we run 85% to 90% of the current year net income, and so we're scoping out the level of dividends that we expect, inclusive of our free cash from nonregulated subs. We don't expect it'll be any different than that historical zone.",43,"Typically, we run 85% to 90% of the current year net income, and so we're scoping out the level of dividends that we expect, inclusive of our free cash from nonregulated subs. We don't expect it'll be any different than that historical zone."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","One more question, please.",4,"One more question, please."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","Okay. We'll take that from Matt Borsch with Goldman Sachs.",10,"Okay. We'll take that from Matt Borsch with Goldman Sachs."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Yes. Just wondering if you could talk a little bit about the dual opportunity and how you see yourselves positioned. And I'm curious if you think that growing there is going to be more a function of your Medicaid markets, your Medicaid experience or Medic",93,"Yes. Just wondering if you could talk a little bit about the dual opportunity and how you see yourselves positioned. And I'm curious if you think that growing there is going to be more a function of your Medicaid markets, your Medicaid experience or Medicare? Or do you really think it's important to build to blend the 2 together? I guess alternatively, is this going to be wide open where companies that you wouldn't normally expect to participate will be competing for this -- with a solid basis for being in that business?"
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","I don't know if I can say much more than I did in my prepared comment. And I think that the fact that 8 of the 10 states that we currently do Medicaid in are applied to CMS, so to dual eligibles into managed care that some of the new RFPs are going to --",237,"I don't know if I can say much more than I did in my prepared comment. And I think that the fact that 8 of the 10 states that we currently do Medicaid in are applied to CMS, so to dual eligibles into managed care that some of the new RFPs are going to -- where they didn't in the past, are going to include dual eligibles as part of what we're bidding on. The -- and so over time, there'll be plenty of opportunities. We'll get some. You did -- it's just unpredictable in terms of when the RFPs come out with a key original schedule and how quickly we can grow the business. And I wouldn't mind having a little more experience with what we have, too. And so not like I'd like to take on 300,000 dual eligibles tomorrow, but we will, over time, get our share. The timeframe is just not predictable. But I think in terms of where we do business, the resources we have now to respond to RFPs, what we've learned about this business in the last 3 years. If you think back, we didn't have any Medicaid business for 5 years at one particular point in time. And we didn't have any infrastructure, didn't really have a department, any people, any expertise 3 years ago. So we're learning quickly and adding resources quickly, and we'll get our share."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. And -- okay. Just last on a different topic on the commercial. When we look at the Commercial Risk per member revenue, is that -- how much has that impacted the PMPMs statistics? How much are they impacted by the rebating? Are they a little bit lowe",88,"Okay. And -- okay. Just last on a different topic on the commercial. When we look at the Commercial Risk per member revenue, is that -- how much has that impacted the PMPMs statistics? How much are they impacted by the rebating? Are they a little bit lower because of the rebating? And I was just wondering if you would be able to provide the fourth quarter group Commercial Risk, PMPM and MLR, just given that, that would tie up the year on the old basis of reporting?"
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","In terms of -- the rebates does impact, obviously, the revenue level. Then in terms of tying up the MLR on a Group Risk basis, we anticipate that the MLR was -- will be 40 basis points higher on a separate basis.",42,"In terms of -- the rebates does impact, obviously, the revenue level. Then in terms of tying up the MLR on a Group Risk basis, we anticipate that the MLR was -- will be 40 basis points higher on a separate basis."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Thank you for joining us today. Operator, we're complete. Thank you.",11,"Thank you for joining us today. Operator, we're complete. Thank you."
27133,157003674,217413,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","All right. Thank you. This will conclude today's conference call.",10,"All right. Thank you. This will conclude today's conference call."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","Good morning, and welcome to the Coventry Health Care's Fourth Quarter 2011 Earnings Conference Call. Today's conference is being recorded [Operator Instructions] Today's call will begin with an opening remarks by Chief Executive Officer of Coventry Healt",55,"Good morning, and welcome to the Coventry Health Care's Fourth Quarter 2011 Earnings Conference Call. Today's conference is being recorded [Operator Instructions] Today's call will begin with an opening remarks by Chief Executive Officer of Coventry Health Care, Mr. Allen Wise, after a brief forward-looking statement read by Mr. Drew Asher. Please go ahead, Drew."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Ladies and gentlemen, during this call, we will make forward-looking statements. Certain risks and uncertainties, including those referenced in our press release and described in the company's filings with the SEC on Form 10-K for the year ended December",71,"Ladies and gentlemen, during this call, we will make forward-looking statements. Certain risks and uncertainties, including those referenced in our press release and described in the company's filings with the SEC on Form 10-K for the year ended December 31, 2010, and Form 10-Q for the quarter ended September 30, 2011, may materially impact those statements and could cause actual future results to differ materially from those anticipated and discussed. Allen?"
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Good morning, and thank you for your interest in Coventry Health Care. Today, I'd like to share with you our outlook for 2012, and in addition, some very brief comments and overview of 2011.We're increasingly positive about the opportunities ahead of us",2272,"Good morning, and thank you for your interest in Coventry Health Care. Today, I'd like to share with you our outlook for 2012, and in addition, some very brief comments and overview of 2011.
We're increasingly positive about the opportunities ahead of us, which includes our projected double-digit revenue growth in 2012. On an overall basis, we ended 2011 above our previous forecast at $3.02 of earnings per share, of which $2.87 of the EPS represents our core 2011 results, as presented in our press release, excluding the private fee-for-service runout. And we're also pleased to forecast 2012 EPS of $3.10 to $3.30, which is an 8% to 15% growth rate compared to 2011's core EPS of $2.87.
I want to spend most my time this morning talking about the 2012 and the future, which much of the groundwork is based on work that we completed in 2010 and 2011. Randy Giles, our CFO, will review the quarter and provide more detailed guidance.
 2011 is a year where we're able to surpass our early financial expectations, and more importantly, lay the foundation for prospective growth. If early 2012 financial expectations were a bit cautious, it's because it was a year marked by a transition to the first major impact of health care reform with a very considerable task of implementing minimum MLRs in our commercial business.
I'd like to begin a more detailed discussion about our future, discussing our Medicaid business and the various significant progress that we are making in seizing opportunities and growing this business.
We were awarded the Kentucky contract in July of 2011, with the contract commencing in November of the same year. Based on our positioning and network efforts throughout the Commonwealth of Kentucky, we're able to achieve an outsized membership allocation compared to the other participants. In fact, we've grown again this past month, and we're now up to approximately 232,000 members.
One of the key elements to this recent growth was our ability to rapidly execute on building out a cost-competitive network. We're able to bring our collective resources to bear, including leveraging our centralized operational functions, and we imported one of our experienced executives to Kentucky from our existing business. The point to all this is that we're a resourceful company with over 14,000 employees with experience in all lines of business and the ability to execute simultaneous opportunities. It's really early in the Kentucky contract, and we're still refining operational processes and programs as this was a previously unmanaged population entering managed care. Even though it's really, we're very optimistic and confident that we'll have a successful partnership with the Commonwealth of Kentucky for years to come.
I want to continue on the Medicaid topic, and we have some additional news to report, which is another recent win that we would like to highlight this morning. Our company has been notified by the state of Nebraska of its intent to award a contract to Coventry to provide services for the state's expansion of the existing Medicaid managed care program. The Nebraska Department of Health and Human Services intends to expand managed Medicare services from the existing 10 county program to cover all 93 counties in the state, which is an estimated incremental 70,000 additional Nebraskans.
As you may recall, we won a bid in 2010 for the original program and currently serve approximately 50,000 members in the existing Medicaid program. So subject to the finalization of the contract with the state of Nebraska, we expect to be 1 of 2 managed care contractors providing services to this expanded population later this year.
Staying with Medicaid, also during 2011, we were able to seize an attractive 2-state Medicaid acquisition opportunity by acquiring Family Health Partners and entering into a long-term relationship with its previous owner, Children's Mercy of Kansas City. This acquisition, which closed effective January 1 of 2012, has Medicaid contracts in both Kansas and Missouri. We were able to expand in Missouri, a state we have served for over 15 years, and entered the Kansas Medicaid program, where there's an expansion opportunity for 2013 and beyond.
Including this acquisition, we have a meaningful multiline presence throughout our Midwest 7-state region, which now serves 1.5 million members. We were able to execute on this multifaceted transaction for a reasonable net investment of approximately $50 million, net of tax benefit and statutory capital we were able to leave behind based on the structure of this transaction.
To summarize the Medicaid discussion and quantify the growth for the year, we started 2011 with 470,000 Medicaid members and reported $1.38 billion of Medicaid revenue in 2011, which represented approximately 11% of our total revenue. We expect to double these figures with more than 915,000 members beginning in 2012 with a full year revenue forecast of around $2.7 billion.
Medicaid is projected to represent just under 20% of the company's revenue in 2012. I think that investors should think of Coventry as having a meaningful exposure to Medicare growth and penetration opportunities with a proven track record of winning new business, executing and operating these Medicaid businesses but without the concentrated risk and the inherent volatility and contract alliance of a single-line carrier. While the process of winning new business is competitive, we very strongly believe that we'll get our share in the future. We know both how to compete and how to manage this business.
Moving away from Medicaid and talking about Medicare. We're equally enthusiastic about the recent results in Medicare. As you may have seen in our press release a few weeks ago, we had a very successful 2012 annual election period. As most of you know, a lot of this work to achieve success is done well in advance. And as we have previously promised, we focused on laying the foundation during 2011 to grow both Medicare Advantage and Part D in 2012.
In Medicare Advantage, we're in 15 states, and we have seen 2012 growth across 14 of those 15 states. The most recent enrollment for Medicare Advantage is approximately 250,000 members, which is ahead of our previous estimate, and results in membership growth of about 13% so far in 2012. We've grown from 137,000 Medicare Coordinated Care members at the end of 2008 to 250,000 today for a compounded annual growth rate of 16%. We're well proportioned -- or positioned to continue taking the advantage of this attractive demographic growth opportunity where we're able to provide a tangible value proposition to seniors and to the federal government.
On Part D, we had a successful enrollment period, growing membership of about 25% out of the gate and adding almost 300,000 members.
2011, as you know, we spent a lot of time talking about the work we were doing on product design and developing, creating partnerships, and we had successfully launched the third product with a preferred network in 2012's annual election period. We increased both our auto-assign footprint and our mainstream membership coming into 2012. Our company has consistently been profitable in Part D in both membership channels since we launched in 2006, and 2011 was no exception, with an aggregate Part D loss ratio of 81.7% for the year.
During 2011, a lot of effort went into forming an attractive set of products and establishing partnerships with Walgreens, Walmart and Target for our newest product. We also renegotiated our PBM contract with an improved Part D cost structure and enhanced other areas of Part D, including distribution. I think Part D is a great example of our abilities to successfully execute on multiple growth opportunities given our focus on resources, touching multiple product lines. Our cross-functional teams went back to the drawing board after 2010 and created a product that is low-cost structure and which is proven to be attractive to the senior population.
And as you might well imagine, we're currently hard at work on our products and positioning for 2013 and very optimistic about our prospects in the future.
Think about our company with Medicare at about 30% of the company revenues and Medicaid at about 20%. So we've evolved about half of our revenue coming from government programs. There continues to be attractive opportunity to grow in the current programs, while there is a significant longer-term opportunity to serve the dual-eligible population. Medicaid and Medicare experience, footprint and capabilities are all important ingredients in positioning to serve dual eligibles. We are currently in 10 states for Medicaid and 15 states for Medicare Advantage. 8 of our 10 Medicaid states have filed letters of intent with CMS to integrate the dual-eligible population in their states. 
And for decades, we have provided complex care management and have served members across population, products and geographies with a cross-section of chronic condition, diseases and needs. We currently serve aged line to disabled members and other high-risk patients in Medicaid. We currently serve Medicaid members up and down the risk score spectrum, including dual eligibles.
Serving members with the most chronic and debilitating diseases should not be taken lightly, but this population is one that can significantly benefit by coordination of care or active chronic condition management, pharmacy management, social services and all the programs that we have built over the past decade to manage our current diverse population.
Managed care should be able to make a meaningful, positive impact on the lives of dual-eligible population, and therefore, provide a valuable -- a value proposition for the states and federal government. Based on our footprint, exposure to both Medicaid and Medicare capabilities and a history of managing diverse populations, we like our early positioning for this longer-term significant opportunity, and our company will continue to invest in Medicare and Medicaid growth, along with dual-eligible populations.
Moving to our commercial business. Our Commercial Risk revenue was up 8% for 2011 with stable membership versus 2010, which is reasonably satisfying given the first year impact of health care reform, including minimum MLRs, which were effective January 1 of last year.
We knew it wasn't going to be easy managing 121 different measurement sales in our Commercial business and dealing with the burdens imposed by the new laws and regulations, many of which fell very short on clarity coming into the beginning of 2011. As Randy Giles will cover, as expected, we ended the year with significant minimum medical loss ratio rebate accrual, which will get finalized and paid out in 2012. Our goal for 2012 and beyond in the commercial business is to maintain margin and see the growth opportunities that we expect to develop as a result of consolidating market conditions driven by a commitment in this sophistication required to operate health care in the health care reform environment.
And in this context, we're actively preparing for the potential 2014 expansion [indiscernible]. We'll continue to work on attractive commercial expansion opportunities, both through acquisitions and organic growth and increase our footprint with providers and high-performance networks, which will drive lower-cost products to complement our product portfolio.
As of today, we have signed approximately 30 high-performance network contracts across our product lines. These arrangements run the spectrum from large-scale health systems to local-based primary multispecialty provider groups. 17 of these 30 high-performance networks covers our commercial product in 14 states and we feel should position us very well, especially in an exchange environment.
As you can tell, we're very positive about our opportunities across our diverse footprint in Medicare, Medicaid and commercial lines of business. We feel that the commercial business could represent a meaningful growth opportunity in 2014 and 2015 and allow us to be diversified in addition to key substantial Medicaid and Medicare growth opportunities.
In addition, we have over $1.1 billion in higher-margin and diversified fee-based revenue that complement our risk business and provide free cash flow for deployment to increase shareholder value.
Continuing on my comments regarding our future plans, we're going to pursue organic growth in our existing businesses. We're going to pursue selected RFPs. We're going to deploy capital for acquisitions, and in addition, consider future share repurchase. I think we're not only positioned well from a business and growth perspective heading into 2012, but we also accomplished a good deal relative to our balance sheet in the past year, and Randy will address that later. We sit here with $900 million in deployable cash, and that's after posting on a meaningful transaction, buying back over 10 million shares in 2011 and paying off our 2012 note that recently came due.
We're exiting 2011 on track after increasing EPS guidance 3x during the year, and we're able to provide 2012 guidance, which results in 18% to 15% core EPS growth in 2012, coupled with double-digit revenue growth. We continue to have a strong and flexible balance sheet with a combination of free cash and additional debt capacity.
I like our positioning and balanced exposure across Medicaid, Medicare and the commercial line, as well as our capability in seeking and seizing the right M&A opportunities. We're getting results from the work we have done, and we'll continue on this path to deliver more growth.
So what does it take to deliver growth? Well, it takes capital. It takes capable, experienced executive team. It takes experience in the M&A area. It takes focus. It takes discipline. It takes the ability to move quickly. These are all capabilities our company has. I am more optimistic about our future than I have been any time in the recent past.
Randy Giles is going to walk you through the results and provide detailed guidance with additional commentary on our business. And with that, Randy?"
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Thank you, Allen. I'll begin this morning by discussing our performance in the fourth quarter and then spend a majority of my time reviewing our detailed guidance for 2012. Before I go through the details for each of our businesses, I want to first start",2904,"Thank you, Allen. I'll begin this morning by discussing our performance in the fourth quarter and then spend a majority of my time reviewing our detailed guidance for 2012. Before I go through the details for each of our businesses, I want to first start at the consolidated level. Our GAAP EPS for the fourth quarter was $0.60, which includes $0.02 related to the runout of the Medicare Advantage Private Fee-for-Service business. For the full year, we reported EPS of $3.02, excluding the litigation gain in the second quarter, compared to our previous EPS guidance of $2.95 to $3. This includes $0.15 of earnings related to Private Fee-for-Service and $2.87 of core EPS for 2011.
Similar to last quarter, we have provided a table and reconciliation of these earnings metrics on Page 3 of our earnings press release. I'm very pleased with these results for 2011 as we were able to outperform our earnings guidance each quarter during the year, grew our Health Plan membership by more than 7% from the prior year, position ourselves for continued growth in 2012, deliver the largest Medicaid RFP win in the company's history and utilize the strength of our balance sheet to seize an exciting growth opportunity while repurchasing more than 7% of our outstanding share count.
These successes have positioned our portfolio of businesses very well for 2012, which I will highlight in detail after first giving you a little more color on the 2011 performance.
In our commercial business, first, one housekeeping item. You'll notice that we have now aligned our reporting of revenue PMPM and MLR percentage metrics to be consistent with the rest of the industry by disclosing Commercial Risk as opposed to our historical disclosure of Commercial Group Risk statistics, which excluded the commercial individual business. In addition to creating a better comparison to our peer group, we also wanted to recognize the growing impact that the individual business is having on our commercial results as we continue to increase our market share and invest in building out our capabilities in advance of the potential membership opportunity in the exchanges.
In 2008, for instance, we had 123,000 individual members. Whereas today, we have slightly more than 200,000 members. Also, the individual MLR has become much more comparable to the small group MLR due to health care reform regulations. This new disclosure structure is reflected in the earnings release issued this morning for both the current period as well as all historical periods disclosed.
Our commercial MLR was 83.7% in the fourth quarter and 81.6% for the full year, which is slightly above our previously provided guidance. As we continue to gain clarity on the minimum MLR regulations during the back half of 2011, we had to refine our rebate calculations to reflect the allowable underlying cost of certain internal and external medical-related vendors. We began the year expecting to be able to reflect medical-related payments to internal and external vendors in their entirety as such in the minimum MLR calculations. But based upon clarity we gained in MLR rules in Q3 and subsequent data gathering from our vendors in Q4, including our external PBM, we made adjustments that increased the medical loss ratio. I highlight this for you as it had about a 50 basis point impact on our full year 2011 commercial MLR relative to our initial guidance.
Within our commercial book, our view of fundamental prospective trend remains unchanged in the range of 8% plus or minus 50 basis points with unit cost trend continuing to be the largest driver, albeit stable. In the rearview mirror, we can see trends the mid-7s that continue to move higher off of the extreme low levels seen during the second half of 2010. These trends include the impact of the health care reform regulations implemented on September 23, 2010, which has had between 150 and 200 basis points of impact on the trend this year that will not recur in 2012.
Inpatient utilization, realized at[indiscernible] the lows of late 2010, continues to show a negative trend, as it has throughout 2011. Similar to what we disclosed to you last quarter, we're seeing outpatient physician trends creep up and move from negative into slightly positive territory. Just to put in context, remember today's trends are being compared to the lowest level of utilization trends seen in years, a historically low base line from late 2010.
And probably most importantly, our pricing structure is predicated on a forward view of trend in which we have anticipated a return to more levels -- normal levels of utilization above what we've seen in the rearview mirror. This pricing is expected to generate higher absolute rate increases than what we're seeing throughout 2011 as we've established a new baseline with many of the adjustments related to health care reform already addressed and the benefit of the extremely low utilization late 2010 has already been passed through to our experience-rated customers.
Finally, the commercial results. I want to share our customary statistics around health care reform, which are consistent with the projections from the last call. For 2011, we generate total Commercial Risk revenues of just under $6 billion. Of that total, individual business generate approximately $375 million of revenue with the vast majority of this business in a rebate position. The remaining $5.6 billion of group risk revenues were split roughly 40% small group and 60% large group with approximately 1/2 of our small group business in a rebate position and a little less than 1/4 of our large group business in a rebate position.
It's important to note that rebate exposure is something that we've been managing carefully with a number of actions taken to utilize rebate capital during the year, including providing more value to our customers, also promoting quality initiatives with hospitals and providers to improve use scores, strengthen overall quality of care and to create opportunities to lower future medical costs. This has driven our rebate estimates down significantly from our initial view in 2011. In 2012, we expect to benefit from certain renegotiated external vendor contracts, which will serve to decrease our overall cost structure and reduce our rebate accrual in 2012. We view our estimated rebate for 2011 as reasonable given the size of our book of business, this being the first year navigating these new regulations, and the inherent loss ratio variability that exists when calculated at the market size segment and state level.
While we did not assume any benefit from the multiple states that had minimal MLR waiver request pending with HHS, we were disappointed to see waiver request denied in some of our larger states, including Florida and Kansas. This result creates a more challenging operating environment for the individual business in these markets or force us to continue to evaluate our participation in that product on a market-by-market basis. Of the states with waivers currently pending with HHS, North Carolina is the only state where Coventry has an individual presence.
Moving on to government programs, our Medicare results for the fourth quarter were a continuation of the strong results that we saw throughout 2011 and an even better result than 2010. Our Medicare Advantage MLR of 82.3% for the quarter and 82.9% for the full year was a very strong result and one that gives us confidence in our bid positioning as we look to towards 2012. Our Medicare Part D results were also strong as the fourth quarter MLR of 60.5%, full year MLR of 81.7% were both better than our expectations and an improvement from the prior year.
As Allen already highlighted, we are excited about that growth trajectory that we've built for the Medicaid business with revenue growth of more than 20% and membership growth of nearly 50% in 2011. Our Medicaid results in the quarter were consistent with our expectation as we saw an uptick in our reported revenue PMPM, as well as MLR percentage, with the inclusion of the new Kentucky contract, which was effective on November 1.
Finally, we closed out 2011 with another excellent SG&A result, reporting a full year expense of $2.015 billion as compared to our initial guidance of $2.02 billion. This accomplishment is particularly impressive when you consider that while we were holding absolute SG&A spend just below our initial guidance for the year, we were simultaneously able to grow revenue above the initial guidance midpoint by more than $425 million.
Full year expense, including the elevated level of spend during the fourth quarter related to the successful Medicare enrollment period and the launch of the new Kentucky Medicaid contract, which together, bought more than 0.5 million new members to the company.
Before we get into 2012 guidance, let me first review some metrics on our balance sheet and cash flows. Our investment portfolio remained in a high-quality position with a net unrealized gain of $97 million at year end, an increase from $90 million in the prior quarter. As of January 31, we had $900 million of deployable free cash available, which is after retiring $234 million of senior notes earlier in January, as well as the deployment of $100 million during the fourth quarter for share repurchase. Recall that one of our accomplishments in 2011 was repositioning our balance sheet by issuing 10-year $600 million senior notes in June 2011 and renewing our credit facility. 
We have no scheduled debt maturities now until 2014, having an undrawn $750 million credit facility that isn't scheduled to expire until 2016. This gives us a great deal of flexibility as we pursue capital deployment opportunities. And as you have seen throughout 2011, while acquisitions remain our first priority for capital deployment, we're also committed to returning capital to shareholders through opportunistic share repurchases, as seen through our deployment of $328 million in 2011.
Moving on to our cash flow results. You'll recall that we received an extra payment from CMS in the third quarter, so you can see the impact from that on the deferred revenue line in the fourth quarter results and then in the immaterial impact from deferred revenue for the full year. The full year result was impacted by the second quarter litigation settlement. So after adjusting earnings for the litigation items, our cash flow from operations was $496 million or 112% of net income for the year. As you can see on the other receivables line of the balance sheet and cash flow statement, cash flow from operations was negatively impacted by the timing of certain Medicare Part D receivables related to the 2011 program year that we will collect from CMS in 2012.
So with a successful 2011 behind us, let's now discuss our outlook for 2012. Today, we are providing initial 2012 EPS guidance in the range of $3.10 to $3.30, which is an increase of 8% at the low end and 15% at the high end, versus the comparable 2011 EPS of $2.87. In that aggregate, we are projecting total revenues are nearly $14 billion, a growth of approximately $1.75 billion, which is up roughly 15% at the midpoint. We are forecasting an increase in consolidated MLR percentage, which is driven by changes in the mix across our portfolio businesses towards the growth in government programs.
In 2011, commercial revenue represented approximately 50% of the company total with an additional 30% Medicare, 10% Medicaid and 10% other, including Fee businesses. Our guidance for 2012 projects around new composition of just over 40% commercial, 30% Medicare, 20% Medicaid and just under 10% Fee and other. This is consistent with our goal to have a balanced portfolio with the ability to seize opportunities across the product spectrum.
On the topic of medical cost structure, we have recently renegotiated and extended our PBM contract with Medco for a multiyear period effective January 1, 2012. We were able to secure an improved cost structure and contract terms that give us more flexibility as we continue to react to the rapidly evolving health care marketplace. Given that pharmacy spend represents nearly 20% of our medical expenditures, this is an important improvement to a critical part of our overall cost structure across our product portfolio.
Moving on to SG&A. I'm particularly pleased with the efforts that the organization has put forth on driving down our SG&A percentage of revenue from 16.5% in 2011 to a midpoint of 15.4% on our 2012 guidance. I've been personally involved in working to identify cost reduction opportunities across the company that have allowed us to forecast a strong result for 2012 while simultaneously also making critical investments for the future in our core businesses. These investments include improved direct distribution capabilities from the individual business, enhanced care management tools, the addition of substantial Medicare and Medicaid resources, not to mention the ongoing increased compliance costs. And that's just to name a few.
On the non-operating items, you'll note that the tax rate is increased over 2011, which is primarily driven by a shift in the mix of earnings towards states with higher tax rates and also about compliance with new health care reform regulations.
Finally, you will see our share count guidance which assumes that we essentially hold the share count flat from where we ended 2011. It's important to note that today's EPS guidance range does not incorporate any meaningful deployment of the free cash that is sitting on our balance sheet.
Now moving more specifically into our largest lines of business. For Commercial Risk, we are forecasting membership levels to be slightly down for 2011 levels with a decrease in Q1 2012 driven by a handful of large group terminations followed by growth during the remainder of the year. We continue to price ahead of trend and remain disciplined in our objective of maintaining margin over pursuing membership gains. 
On the expense side, we are projecting MLR of 81.5% plus or minus 50 basis points. This MLR guidance incorporates mechanics of the minimum MLR rules, our view of pricing by market, a forward view on medical trends, our mix of business and a pragmatic view that you always have deviations from the mean as you manage your portfolio of 121 measurement cells. This is a slight improvement from 2011, and it's that '11 that we view as sustainable under health care reform in today's operating environment.
In Medicare, the membership story is excellent for both Medicare Advantage and Medicare Part D. As Allen noted earlier, we're starting the year with approximately 250,000 Medicare Advantage members, which is an impressive growth result of about 13% from 2011. Our Medicare Part D business was also very successful during the annual election period as we grew by almost 300,000 members, or about 25%, and we are forecasting continued growth throughout 2012. This growth is a nice mix of retail purchases in our innovative new value plus product and partnership with Walgreens, Walmart and Target, as well as our increased auto-assignment presence in 23 regions for 2012, up from 15 regions in 2011. Based upon our bids and our view of where we exited 2011, we are forecasting MLRs in the low to mid-80s for both Medicare Advantage and Part D.
Staying within government programs, our 10-state Medicaid business is the biggest part of our 2012 growth story with total revenue expected to nearly double from just under $1.4 billion in 2011 to nearly $2.7 billion in 2012. Today, we are just about 915,000 members and expect to be in the zone of 950,000 Medicaid members upon implementation of the new Nebraska contract. We are projecting MLR of approximately 90% in 2012, which is a combination of our same-store business, which runs in the mid- to high-80s, and MLRs in the 90s for the year 1 RFP wins and the newly acquired Family Health Partners business in the Midwest.
So now we've covered the large risk business, you'll notice that although we are still forecasting over $1.1 billion of fee-based revenue, our guidance for fee revenue is down a little, more than 3% due to the loss of one Workers' Compensation Services account. However, you also see a decrease in cost of sales expense item directly associated with Workers' Compensation Services, which more than offset the aggregate fee revenue reduction. Our Fee businesses continue to be an important component of our overall product portfolio, providing valuable unregulated cash flows and are an area that we intend to grow and invest in prospective.
So in conclusion, our efforts in 2011 lay the foundation for the 2012 guidance that we provided today. We firmly believe that growing the top line is critical in today's environment and are pleased to see 2011's efforts bearing fruit in 2012 with the revenue guidance midpoint of nearly $14 billion, coupled with an increase in both operating earnings and EPS. So while we may be pleased with the 2012 growth outlook, by no means are we satisfied. We will continue to invest in the future, focus on managing our portfolio of businesses in a manner that allows us to seize growth opportunities while also maintaining the right balance, limiting our exposure to any one area. We will continue to introduce growth opportunities, both organically and through acquisition, to strategically position Coventry to deliver the long-term results that our shareholders have come to expect.
Operator, this now concludes our prepared remarks, and we are ready to open the line for questions."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","[Operator Instructions] We'll go first to Doug Simpson with Morgan Stanley.",11,"[Operator Instructions] We'll go first to Doug Simpson with Morgan Stanley."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So Randy, maybe just to expand a little bit. I think you said 81.5% for the commercial MLR in 2012. Did I hear you right?",25,"So Randy, maybe just to expand a little bit. I think you said 81.5% for the commercial MLR in 2012. Did I hear you right?"
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes.",1,"Yes."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Is that -- okay. So can you just sort of walk us through -- the Q4 MLR came in, I think, on the commercial side higher than people were expecting. You talked about the inclusion of -- or the inability to include certain costs in the rebate calc, and that",72,"Is that -- okay. So can you just sort of walk us through -- the Q4 MLR came in, I think, on the commercial side higher than people were expecting. You talked about the inclusion of -- or the inability to include certain costs in the rebate calc, and that obviously, I think you said 50 bps for the year. So roughly 200 basis points into the Q4 number. Is that fair?"
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","It's more like 140 into the Q4 result.",9,"It's more like 140 into the Q4 result."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So it added 140 to the commercial MLR in Q4?",10,"So it added 140 to the commercial MLR in Q4?"
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes.",1,"Yes."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. So can you just help us sort of think about a map from the 2011 experience into 2012? Just how -- sort of maybe walk us through your thoughts around the commercial MLR from 1 year to the next given sort of those dynamics and your Q4 jumping off poin",51,"Okay. So can you just help us sort of think about a map from the 2011 experience into 2012? Just how -- sort of maybe walk us through your thoughts around the commercial MLR from 1 year to the next given sort of those dynamics and your Q4 jumping off point."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","As we think about 2012, there were certain trend drivers that we think are not going to recur into 2012. One of the things, was you might recall, we experienced lower prior period of volume during 2011 and 2010. And you can see from today's earnings relea",115,"As we think about 2012, there were certain trend drivers that we think are not going to recur into 2012. One of the things, was you might recall, we experienced lower prior period of volume during 2011 and 2010. And you can see from today's earnings release that our DCP increased by 4% from the prior year end. So I feel comfortable that, that pressure is not going to recur. As we go in, we've also improved our cost structure, as I mentioned, around our pharmacy particularly, and we have some other actions we're taking around cost structure that give us a pretty good feeling about where we're going to be in 2012 versus 2011."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. And then -- and just in terms of your commentary on utilization and trend in the Q4 period, it didn't sound like you saw anything new or different there. But can you just give us maybe more color on that front?",42,"Okay. And then -- and just in terms of your commentary on utilization and trend in the Q4 period, it didn't sound like you saw anything new or different there. But can you just give us maybe more color on that front?"
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Sure. As we think about trend in general, what we're seeing, as I talk about inpatient, commercial bed days were down low- to mid-single digits in Q4 2010. Medicare Advantage bed days were down low- to mid-single digits. And commercial admits were down mi",104,"Sure. As we think about trend in general, what we're seeing, as I talk about inpatient, commercial bed days were down low- to mid-single digits in Q4 2010. Medicare Advantage bed days were down low- to mid-single digits. And commercial admits were down mid-single digits from Q4, and Medicare Advantage admits were down low- to mid-single digits from Q4 2010. So the position we're seeing is somewhat uniform utilization trends across primary care, surgical specialists and lab. And on the outpatient side, the areas that we see higher utilization in include areas like dialysis, injectable drugs and cardiovascular, other areas we're seeing trend pressuring."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. And then maybe just switching gears on the use of capital. You guys obviously bought back some stock in Q4. I think the cash balance is right about $900 million now. How do you think about deploying that, thinking about the M&A backdrop, the opportu",123,"Okay. And then maybe just switching gears on the use of capital. You guys obviously bought back some stock in Q4. I think the cash balance is right about $900 million now. How do you think about deploying that, thinking about the M&A backdrop, the opportunity to buy back stock? I mean, if you look out 12 months, would you expect to still have that sizable of a cash balance? Or if you don't see things out there on the M&A front, would you look to kind of bring that down and think about keeping your debt capacity as your dry powder for deals to the extent they present themselves. How long would you guys kind of run with a heavy cash balance?"
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think you can expect 2012 to look like 2011. We spent $328 million in share repurchase, did a major transaction and worked on some things that didn't materialize. We will continue looking for significant size to M&A transactions, and if those opportunit",114,"I think you can expect 2012 to look like 2011. We spent $328 million in share repurchase, did a major transaction and worked on some things that didn't materialize. We will continue looking for significant size to M&A transactions, and if those opportunities don't present themselves, we will opportunistically do share repurchase are we going to use the whole $900 million up and live with our credit line. I doubt it because we think that there's going to be continuing consolidation. The margins are under pressure. The business is going to get tougher, and we feel like there will be opportunities to grow our business substantially, and we're going to keep some dry powder."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. And then maybe just sneak just one last one in. Just on, I think, this call you probably talked a little bit more about the duals than you have in the past. Can you just give us a sense, I mean, how -- what's your expectation for that in terms of ti",77,"Okay. And then maybe just sneak just one last one in. Just on, I think, this call you probably talked a little bit more about the duals than you have in the past. Can you just give us a sense, I mean, how -- what's your expectation for that in terms of timing with respect to your book of business and how much effort are you making on that front at this point in terms of resources?"
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, we're making -- what we're doing today is making certain that we can absorb almost a 0.25 million of new members that have never been in managed-care before across the whole spectrum in Kentucky. We are investing in a new IT system that improves our",141,"Well, we're making -- what we're doing today is making certain that we can absorb almost a 0.25 million of new members that have never been in managed-care before across the whole spectrum in Kentucky. We are investing in a new IT system that improves our patient management capabilities. And we think that we can't predict exactly what dual-eligible population will be, but we work on it all the time. The timeframe when these things present themselves are uncertain. We worked on an opportunity in Kansas, which has not yet born any fruit, but we're working on RFPs in -- all the time. And so we'll have opportunities. I can't predict which quarter they present themselves, but we're investing in experience. We're investing in systems. We're investing in staff and infrastructure for the Medicaid business, and we're going to grow it."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","We'll take our next question from Tom Carroll with Stifel Nicolaus.",12,"We'll take our next question from Tom Carroll with Stifel Nicolaus."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I wanted to come back to your commentary on the Kentucky Medicaid business. It sounds like things are well there. But I guess maybe just 2 questions. Was Kentucky the primary reason for the large MLR increase in your Medicaid book? And then secondly, it s",100,"I wanted to come back to your commentary on the Kentucky Medicaid business. It sounds like things are well there. But I guess maybe just 2 questions. Was Kentucky the primary reason for the large MLR increase in your Medicaid book? And then secondly, it seems like there might be some issues in the market transitioning from Fee-for-Service to Managed Care. I think we saw that the secretary of Health and Family Services resigned yesterday. Just maybe just, again, reiterate, is there any reason we should assume or any reason to believe this could drag earnings a bit in 2012?"
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","I'd answer that by saying there are no surprises in Kentucky. We understood what it would be like to convert. I think we had more enrollment success than maybe we would've guessed, but we understood when we embarked on this that it would be an arduous, di",226,"I'd answer that by saying there are no surprises in Kentucky. We understood what it would be like to convert. I think we had more enrollment success than maybe we would've guessed, but we understood when we embarked on this that it would be an arduous, difficult first 6 months or 8 months or 10 months to convert the population and the providers and the experience base there to a managed population. We have only 2 months of experience in terms of cost there, and with that 2 months of experience, there are a lot of unknowns and a lot of gaps in terms of the billing process to the providers, do we have the bills on the same schedule that we would have on existing businesses. And so there are a lot of questions because it's so new, and I think that our reserves on that front would reflect Coventry's -- in my own personal, long-term view, which is make certain if you don't know that you're properly reserved, and those will come down as we gain experience and as we get data and as we know more about the population. But there are no surprises there. It's -- we understood what we are embarking on, and I would say that it's going reasonably well with a lot of work left to be done."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","That's great to hear. Do you expect any type of MLR improvement throughout the year? Or is this more of a 2013 effort?",24,"That's great to hear. Do you expect any type of MLR improvement throughout the year? Or is this more of a 2013 effort?"
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","No, I expect us to gain experience and knowledge and improve our ability to make progress there as the year progresses. It's something I can't predict by month or anything like that. But no, I have a high degree of confidence that we will improve the care",121,"No, I expect us to gain experience and knowledge and improve our ability to make progress there as the year progresses. It's something I can't predict by month or anything like that. But no, I have a high degree of confidence that we will improve the care for that population, improve communication with the providers, get to know the Commonwealth of Kentucky better. And just a lot of work to be done there, but we have every confidence that it'll get better as the year progresses and that long term, this will be a good opportunity for us. There haven't been any surprises. We understood when we bid and was awarded the business, we had a lot of work to do."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","One last one on your commercial rebates. Is there any chance you could quantify that for us?",17,"One last one on your commercial rebates. Is there any chance you could quantify that for us?"
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","We generally don't disclose the amount of our rebate. I would just say we're at a normal level of what we would anticipate, and that was significantly reduced from our initial view going into 2011.",36,"We generally don't disclose the amount of our rebate. I would just say we're at a normal level of what we would anticipate, and that was significantly reduced from our initial view going into 2011."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","We'll take our next question from Carl McDonald with Citi.",11,"We'll take our next question from Carl McDonald with Citi."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","On the cost trend, it sounds like you're seeing the same type of utilization that pretty much everybody else in the industry is seeing, which is, say, not very much. And yet, your overall cost trend at, call it, 7%, 8% is meaningfully higher than the sort",82,"On the cost trend, it sounds like you're seeing the same type of utilization that pretty much everybody else in the industry is seeing, which is, say, not very much. And yet, your overall cost trend at, call it, 7%, 8% is meaningfully higher than the sort of 5% to 5.5% that a lot of other companies are talking about. So within the unit cost, can you talk about where you think the biggest area of differential is and what's driving that?"
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","I really can't comment on what they're including in their numbers, Carl. But as far as ours are concerned, we feel like we're reporting them on a consistent basis. As it relates to unit costs for inpatient, we're seeing high single digits, which is -- it'",212,"I really can't comment on what they're including in their numbers, Carl. But as far as ours are concerned, we feel like we're reporting them on a consistent basis. As it relates to unit costs for inpatient, we're seeing high single digits, which is -- it's mostly unit cost driven in terms of what we're looking at in inpatient, outpatients, low double digits, which is mostly unit cost driven. Positions mid-single-digit, which is kind of split evenly. So we're kind of seeing -- we don't really see a change there. We see -- one of the things contributing to the trend year-over-year for us is the impact of the -- as I mentioned in my script, was the impact of the health care reform changes from September 23 of 2010, that required us to go to 0 copays on preventative and other things. It had a up to 200 basis point impact on our trend number. So depending on the mix of business between us and the competition and the benefit designs that they may have had with us having more small group business with maybe higher deductibles and copayments to begin with, we might have had a bigger impact from that than they did. But that's speculation on my part."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then back in Kentucky, what loss ratio did you assume for November and December there?",16,"And then back in Kentucky, what loss ratio did you assume for November and December there?"
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","We don't really break out loss ratios by market like that. I would just say that we've assumed a loss ratio in the early months with normal transition of care and phasing in of managed care processes, a higher loss ratio in the first 2 months that would -",59,"We don't really break out loss ratios by market like that. I would just say that we've assumed a loss ratio in the early months with normal transition of care and phasing in of managed care processes, a higher loss ratio in the first 2 months that would -- we would expect to go down throughout the year."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","As consistent with our long-standing practices, adequate.",8,"As consistent with our long-standing practices, adequate."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then if you -- I'm just going to pick a number and say it's 100% that you assumed in the fourth quarter. It looks like the loss ratio in the other Medicaid the markets would have deteriorated something like 350 basis points. Is the driver there?",47,"And then if you -- I'm just going to pick a number and say it's 100% that you assumed in the fourth quarter. It looks like the loss ratio in the other Medicaid the markets would have deteriorated something like 350 basis points. Is the driver there?"
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","You shouldn't make those assumptions.",6,"You shouldn't make those assumptions."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","I would just comment on that, that the loss ratios in our other Medicaid markets did not deteriorate in the fourth quarter.",22,"I would just comment on that, that the loss ratios in our other Medicaid markets did not deteriorate in the fourth quarter."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Did not deteriorate? I'm sorry, I didn't get that. You said did not deteriorate in the fourth quarter?",18,"Did not deteriorate? I'm sorry, I didn't get that. You said did not deteriorate in the fourth quarter?"
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Did not deteriorate.",3,"Did not deteriorate."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","We'll take our next question from Josh Raskin with Barclays.",11,"We'll take our next question from Josh Raskin with Barclays."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just on the 2 big new drivers for 2012, Kentucky and PDP, when do you think you're going to have enough claims data to start getting a better sense of where those trends are relative to sort of your underwritten expectations?",41,"Just on the 2 big new drivers for 2012, Kentucky and PDP, when do you think you're going to have enough claims data to start getting a better sense of where those trends are relative to sort of your underwritten expectations?"
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","I'll feel better in 3 or 4 months. It's -- I'm -- we're learning about billing practices, and it's new to all the providers, so I think that the -- heard but not received information is not going to be good for a bit. We have a large team on the ground th",93,"I'll feel better in 3 or 4 months. It's -- I'm -- we're learning about billing practices, and it's new to all the providers, so I think that the -- heard but not received information is not going to be good for a bit. We have a large team on the ground there in the next couple of weeks, making the rounds with all the major large provider groups. And -- but I think if you would think of 3 to 4 months, we should have a much better feel on cost."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. And then I guess in Kentucky, I hate to sort of keep harping on this, but it's a big win for you guys. There was a pretty big movement in the member selection period. And so I'm just curious, have you guys put in some consideration, changed your tho",71,"Okay. And then I guess in Kentucky, I hate to sort of keep harping on this, but it's a big win for you guys. There was a pretty big movement in the member selection period. And so I'm just curious, have you guys put in some consideration, changed your thoughts around potential adverse selection or what some of these members you're doing based on the difference in benefits in the market?"
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","No, the benefits are very close to the same. We think that the outsized enrollment period has a direct proportion to the large team we put on the ground there and the numbers of providers that we got early at competitive rates. And we did not use a third",122,"No, the benefits are very close to the same. We think that the outsized enrollment period has a direct proportion to the large team we put on the ground there and the numbers of providers that we got early at competitive rates. And we did not use a third party to do the contracting. We've got a lot of health plans and a lot of people and a lot of experience there, and we put 60 or 70 of our own people on the ground there for 2 months. So we think the enrollment is unrelated to very, very minor difference in benefits and much more directly related to having people's current primary care physician or physician groups in our network earlier."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. And then just last quick question on the PBM contract. Could you just give us the length on that and that any color on the improvement in terms of your costs for drugs now?",35,"Okay. And then just last quick question on the PBM contract. Could you just give us the length on that and that any color on the improvement in terms of your costs for drugs now?"
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","In terms of the contract extended for Medicare through 2015, the commercial contract will be extended through 2016. And I can't really comment on the impacts on our cost structure, but just to say that it was a key driver for our product positioning in Pa",141,"In terms of the contract extended for Medicare through 2015, the commercial contract will be extended through 2016. And I can't really comment on the impacts on our cost structure, but just to say that it was a key driver for our product positioning in Part D for 2012 and a key factor for us in terms of our cost in preparing for the exchanges going forward. And the other aspect about it is really increased flexibility that we have regarding elements of the contract for the future as we're able -- so we can adapt more easily to health care changes in the marketplace going forward. So Medco has been a critical partner for us and strategic partner for us, and we continue to work that relationship and work with them to try and get to the best possible results."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. Is that through the end of '15 for Medicare and end of '16 for commercial?",16,"Okay. Is that through the end of '15 for Medicare and end of '16 for commercial?"
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes.",1,"Yes."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","We'll take our next question from Charles Boorady with Crdit Suisse.",12,"We'll take our next question from Charles Boorady with Crdit Suisse."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Not to harp on Kentucky but I just wanted to recall. Was that in your original guidance? It couldn't have been, right, because you were awarded it during the year? But basically, it looks like the fourth quarter and your full year results would have been",90,"Not to harp on Kentucky but I just wanted to recall. Was that in your original guidance? It couldn't have been, right, because you were awarded it during the year? But basically, it looks like the fourth quarter and your full year results would have been much stronger without Kentucky. While you're not saying it, we can back in to the fact that it was pretty dilutive to your quarter if that's what drove up the Medicaid loss ratio that wouldn't have deteriorated without Kentucky. Am I reading that right?"
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes.",1,"Yes."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Got it. Good. And then the Nebraska expansion, did you say that is in your 2012 guidance?",17,"Got it. Good. And then the Nebraska expansion, did you say that is in your 2012 guidance?"
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","It's not a case of new information. At this particular point in time, we don't know, and no one -- neither would anyone else after 60 days. And it's just consistent with our current practices here to not overpromise and to make certain that our reserve po",105,"It's not a case of new information. At this particular point in time, we don't know, and no one -- neither would anyone else after 60 days. And it's just consistent with our current practices here to not overpromise and to make certain that our reserve position is adequate. It's nothing more than not knowing, and I don't know how else you would know. We started -- acquired new businesses for 15 years here and started new businesses, maybe one not quite this large. We just don't know at this particular point in time. But there isn't any unknown, adverse information that we have."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Got it. Totally understood, and I think it's a prudent way that companies book new business in new markets, especially in that space. I was really more getting at what your results would look like were it not for that new business because it would be iron",62,"Got it. Totally understood, and I think it's a prudent way that companies book new business in new markets, especially in that space. I was really more getting at what your results would look like were it not for that new business because it would be ironic to be penalized by investors for a big win just because of some upfront dilution."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","It's very short term, and it's going to all roll out here in a few months. And I would rather that people wonder if we're too conservative today and then sit in front of you 2 quarters from now and say we didn't know and we're not going to make our number",72,"It's very short term, and it's going to all roll out here in a few months. And I would rather that people wonder if we're too conservative today and then sit in front of you 2 quarters from now and say we didn't know and we're not going to make our numbers. So it's very consistent with the prudence that we run our business here, and it will develop relatively quickly."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Got it. Got it. And in terms of the comments on the minimum MLR and the 50 bps higher impact from classifications, did that get offset by SG&A? Or was there a net income impact because of the need to rebate some of the impact of that 50 bps?",49,"Got it. Got it. And in terms of the comments on the minimum MLR and the 50 bps higher impact from classifications, did that get offset by SG&A? Or was there a net income impact because of the need to rebate some of the impact of that 50 bps?"
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes, there was a MLR impact of that additional rebate.",10,"Yes, there was a MLR impact of that additional rebate."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","There was an MLR impact. But was there net income impact also?",12,"There was an MLR impact. But was there net income impact also?"
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes.",1,"Yes."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay, got it. And then finally, in the Workers' Comp business, we didn't really talk about this in a while, but could you just tell us a little bit more about what your prospects are for that business? You talked about your desire to grow your fee-based s",79,"Okay, got it. And then finally, in the Workers' Comp business, we didn't really talk about this in a while, but could you just tell us a little bit more about what your prospects are for that business? You talked about your desire to grow your fee-based services. But what drove the account loss in Workers' Comp? And can you tell us about your backlog or give us other indications of your growth prospects in the fee-based businesses broadly?"
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","I'm going to let -- most of you have not met Mike Bahr. Mike runs all of the commercial business in our company, which includes Workers' Comps. And that's relatively new since October of this year Tim Nolan is not new to our company but is new to running",112,"I'm going to let -- most of you have not met Mike Bahr. Mike runs all of the commercial business in our company, which includes Workers' Comps. And that's relatively new since October of this year Tim Nolan is not new to our company but is new to running all of our government business. I'm going to let Mike Bahr answer the question about Workers' Comp because we changed it in October because there's so many common network issues and development of network resources that -- across the 2 companies, and we think it will run better integrated with the management and leadership in our company and the commercial area. Mike?"
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Charles, Workers' Comp, it is an area we're looking to grow. It's an area we're looking for opportunities to grow. As you said, it's unregulated revenue, and that's a great place to be these days. So the loss of the group, it was our second largest group,",128,"Charles, Workers' Comp, it is an area we're looking to grow. It's an area we're looking for opportunities to grow. As you said, it's unregulated revenue, and that's a great place to be these days. So the loss of the group, it was our second largest group, if I recall, and it was just a competitive environment. And so for us, it's -- we're in a position where we continue to look for opportunities to grow and invest in that line of business. But there's nothing specific with Workers' Comp that created the issue. So I mean, it's a line that runs well. We're centralizing some of our businesses to improve our network structure, particularly in areas where we don't have health plans. And so we're pretty optimistic."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I know that's a long lead time sale, but can you give any give a sense for what your backlog looks like generally in either Workers' Comp or the fee-based business more broadly?",34,"I know that's a long lead time sale, but can you give any give a sense for what your backlog looks like generally in either Workers' Comp or the fee-based business more broadly?"
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","I really can't. To be honest, I'm not in the detail on that side of it. So I can't answer that. I know that the large group we lost, some of the employers they work with are looking to come back to us for services, and we're certainly open to doing that.",53,"I really can't. To be honest, I'm not in the detail on that side of it. So I can't answer that. I know that the large group we lost, some of the employers they work with are looking to come back to us for services, and we're certainly open to doing that."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","It's been stable for a number of years, stable meaning slight increases in revenue. We're heavily affected by the recession and the employment market and employers being much more careful about occupational safety. So it's a transaction-based business tha",86,"It's been stable for a number of years, stable meaning slight increases in revenue. We're heavily affected by the recession and the employment market and employers being much more careful about occupational safety. So it's a transaction-based business that's an acronym for claim-based or accident-based business. And in a tough environment, it's continued to add new customers and grow revenues slightly and EBITDA a little more than revenues. So it's working well for us, and we're trying to figure out how to make it better."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Was the capability or price that you lost the business on when you said things are getting more competitive?",19,"Was the capability or price that you lost the business on when you said things are getting more competitive?"
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","No, no, no, it was price.",6,"No, no, no, it was price."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","And we'll take our last question from Kevin Fischbeck with Bank of America.",14,"And we'll take our last question from Kevin Fischbeck with Bank of America."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","You mentioned that the rebate position, it sounds like, in Q4 was actually kind of similar to where it was, I guess, in Q3. But -- and you said that in 2012, it will be probably a little bit lower. Can you just give a little -- a sense of where you think",63,"You mentioned that the rebate position, it sounds like, in Q4 was actually kind of similar to where it was, I guess, in Q3. But -- and you said that in 2012, it will be probably a little bit lower. Can you just give a little -- a sense of where you think your pools will be across the 3 areas of business?"
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes. I think the -- as we look at the rebate and where we do have rebates that are concentrated still in our top 5 rate cells and small business, large group and individual. And it varies by state where those are located. But generally, if you think about",102,"Yes. I think the -- as we look at the rebate and where we do have rebates that are concentrated still in our top 5 rate cells and small business, large group and individual. And it varies by state where those are located. But generally, if you think about the rebates, for us, they're predominantly in small group and then individual and in large group kind of in that, relative size. In terms of rebates, we think we've done a good job of managing them. We think we can get better at it in 2012, and we'll continue to work on that."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","We need to get better, and we will.",8,"We need to get better, and we will."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Is it a matter -- do you think the blocks of business will be relatively similar as far as percentage in rebates, it's just that they'll be paying a little bit less of a rebate? Or would you expect that to change?",42,"Is it a matter -- do you think the blocks of business will be relatively similar as far as percentage in rebates, it's just that they'll be paying a little bit less of a rebate? Or would you expect that to change?"
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","No. We would hope there will be less in the way of rebates, and we translate that to being better positioned in the markets from a price standpoint. But not an exact science, not easy.",35,"No. We would hope there will be less in the way of rebates, and we translate that to being better positioned in the markets from a price standpoint. But not an exact science, not easy."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","And remember, your averaging over the multiple years as you move out to 3 years, so it becomes more predictable.",20,"And remember, your averaging over the multiple years as you move out to 3 years, so it becomes more predictable."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. And then given that this is the first year of rebates, 2012 being the first year actually paying the rebates, can you just go through the kind of the cash flow, maybe bridge for 2012 for us?",38,"Okay. And then given that this is the first year of rebates, 2012 being the first year actually paying the rebates, can you just go through the kind of the cash flow, maybe bridge for 2012 for us?"
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, as it relates to rebates, there's a runout period in 2012, that will firm up the rebate calculations to what the actual results are. Once that's finalized, the payments will be made midyear. So that's the timeframe for when that gets transacted.",43,"Well, as it relates to rebates, there's a runout period in 2012, that will firm up the rebate calculations to what the actual results are. Once that's finalized, the payments will be made midyear. So that's the timeframe for when that gets transacted."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","But I guess is there a way to think if you have $900 million of cash at corporate as of now where that number might be at year end if you don't deploy any capital?",35,"But I guess is there a way to think if you have $900 million of cash at corporate as of now where that number might be at year end if you don't deploy any capital?"
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","All of the rebates are in regulated subs, so accrued forward the cash backing in, separate and apart from the $900 million, which is sitting at the corporate entity. So it will have no impact in the $900 million.",39,"All of the rebates are in regulated subs, so accrued forward the cash backing in, separate and apart from the $900 million, which is sitting at the corporate entity. So it will have no impact in the $900 million."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. So -- but I guess it's still too early to kind of say at this point where the dividends of the subs might be for 2012?.",27,"Okay. So -- but I guess it's still too early to kind of say at this point where the dividends of the subs might be for 2012?."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Typically, we run 85% to 90% of the current year net income, and so we're scoping out the level of dividends that we expect, inclusive of our free cash from nonregulated subs. We don't expect it'll be any different than that historical zone.",43,"Typically, we run 85% to 90% of the current year net income, and so we're scoping out the level of dividends that we expect, inclusive of our free cash from nonregulated subs. We don't expect it'll be any different than that historical zone."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","One more question, please.",4,"One more question, please."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","Okay. We'll take that from Matt Borsch with Goldman Sachs.",10,"Okay. We'll take that from Matt Borsch with Goldman Sachs."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Yes. Just wondering if you could talk a little bit about the dual opportunity and how you see yourselves positioned. And I'm curious if you think that growing there is going to be more a function of your Medicaid markets, your Medicaid experience or Medic",93,"Yes. Just wondering if you could talk a little bit about the dual opportunity and how you see yourselves positioned. And I'm curious if you think that growing there is going to be more a function of your Medicaid markets, your Medicaid experience or Medicare? Or do you really think it's important to build to blend the 2 together? I guess alternatively, is this going to be wide open where companies that you wouldn't normally expect to participate will be competing for this -- with a solid basis for being in that business?"
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","I don't know if I can say much more than I did in my prepared comment. And I think that the fact that 8 of the 10 states that we currently do Medicaid in are applied to CMS, so to dual eligibles into managed care that some of the new RFPs are going to --",238,"I don't know if I can say much more than I did in my prepared comment. And I think that the fact that 8 of the 10 states that we currently do Medicaid in are applied to CMS, so to dual eligibles into managed care that some of the new RFPs are going to -- where they didn't in the past, are going to include dual eligibles as part of what we're bidding on. The -- and so over time, there'll be plenty of opportunities. We'll get some. You did -- it's just unpredictable in terms of when the RFPs come out or they keep their original schedule and how quickly we can grow the business. And I wouldn't mind having a little more experience with what we have, too. And so not like I'd like to take on 300,000 dual eligibles tomorrow, but we will, over time, get our share. The timeframe is just not predictable. But I think in terms of where we do business, the resources we have now to respond to RFPs, what we've learned about this business in the last 3 years. If you think back, we didn't add any Medicaid business for 5 years at one particular point in time. And we didn't have any infrastructure, didn't really have a department, any people, any expertise 3 years ago. So we're learning quickly and adding resources quickly, and we'll get our share."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. And -- okay. Just last on a different topic on the commercial. When we look at the Commercial Risk per member revenue, is that -- how much has that impacted the PMPMs statistics? How much are they impacted by the rebating? Are they a little bit lowe",88,"Okay. And -- okay. Just last on a different topic on the commercial. When we look at the Commercial Risk per member revenue, is that -- how much has that impacted the PMPMs statistics? How much are they impacted by the rebating? Are they a little bit lower because of the rebating? And I was just wondering if you would be able to provide the fourth quarter group Commercial Risk, PMPM and MLR, just given that, that would tie up the year on the old basis of reporting?"
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","In terms of -- the rebates does impact, obviously, the revenue level. Then in terms of tying up the MLR on a Group Risk basis, we anticipate that the MLR was -- would be 40 basis points higher on a separate  basis.",42,"In terms of -- the rebates does impact, obviously, the revenue level. Then in terms of tying up the MLR on a Group Risk basis, we anticipate that the MLR was -- would be 40 basis points higher on a separate  basis."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Thank you for joining us today. Operator, we're complete. Thank you.",11,"Thank you for joining us today. Operator, we're complete. Thank you."
27133,157003674,217621,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","All right. Thank you. This will conclude today's conference call.",10,"All right. Thank you. This will conclude today's conference call."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","Good morning, and welcome to the Coventry Health Care's Fourth Quarter 2011 Earnings Conference Call. Today's conference is being recorded [Operator Instructions] Today's call will begin with an opening remarks by Chief Executive Officer of Coventry Healt",55,"Good morning, and welcome to the Coventry Health Care's Fourth Quarter 2011 Earnings Conference Call. Today's conference is being recorded [Operator Instructions] Today's call will begin with an opening remarks by Chief Executive Officer of Coventry Health Care, Mr. Allen Wise, after a brief forward-looking statement read by Mr. Drew Asher. Please go ahead, Drew."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Ladies and gentlemen, during this call, we will make forward-looking statements. Certain risks and uncertainties, including those referenced in our press release and described in the company's filings with the SEC on Form 10-K for the year ended December",71,"Ladies and gentlemen, during this call, we will make forward-looking statements. Certain risks and uncertainties, including those referenced in our press release and described in the company's filings with the SEC on Form 10-K for the year ended December 31, 2010, and Form 10-Q for the quarter ended September 30, 2011, may materially impact those statements and could cause actual future results to differ materially from those anticipated and discussed. Allen?"
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Good morning, and thank you for your interest in Coventry Health Care. Today, I'd like to share with you our outlook for 2012, and in addition, some very brief comments and overview of 2011.We're increasingly positive about the opportunities ahead of us",2272,"Good morning, and thank you for your interest in Coventry Health Care. Today, I'd like to share with you our outlook for 2012, and in addition, some very brief comments and overview of 2011.
We're increasingly positive about the opportunities ahead of us, which includes our projected double-digit revenue growth in 2012. On an overall basis, we ended 2011 above our previous forecast at $3.02 of earnings per share, of which $2.87 of the EPS represents our core 2011 results, as presented in our press release, excluding the private fee-for-service runout. And we're also pleased to forecast 2012 EPS of $3.10 to $3.30, which is an 8% to 15% growth rate compared to 2011's core EPS of $2.87.
I want to spend most my time this morning talking about the 2012 and the future, which much of the groundwork is based on work that we completed in 2010 and 2011. Randy Giles, our CFO, will review the quarter and provide more detailed guidance.
 2011 is a year where we're able to surpass our early financial expectations, and more importantly, lay the foundation for prospective growth. If early 2012 financial expectations were a bit cautious, it's because it was a year marked by a transition to the first major impact of health care reform with a very considerable task of implementing minimum MLRs in our commercial business.
I'd like to begin a more detailed discussion about our future, discussing our Medicaid business and the various significant progress that we are making in seizing opportunities and growing this business.
We were awarded the Kentucky contract in July of 2011, with the contract commencing in November of the same year. Based on our positioning and network efforts throughout the Commonwealth of Kentucky, we're able to achieve an outsized membership allocation compared to the other participants. In fact, we've grown again this past month, and we're now up to approximately 232,000 members.
One of the key elements to this recent growth was our ability to rapidly execute on building out a cost-competitive network. We're able to bring our collective resources to bear, including leveraging our centralized operational functions, and we imported one of our experienced executives to Kentucky from our existing business. The point to all this is that we're a resourceful company with over 14,000 employees with experience in all lines of business and the ability to execute simultaneous opportunities. It's really early in the Kentucky contract, and we're still refining operational processes and programs as this was a previously unmanaged population entering managed care. Even though it's really, we're very optimistic and confident that we'll have a successful partnership with the Commonwealth of Kentucky for years to come.
I want to continue on the Medicaid topic, and we have some additional news to report, which is another recent win that we would like to highlight this morning. Our company has been notified by the state of Nebraska of its intent to award a contract to Coventry to provide services for the state's expansion of the existing Medicaid managed care program. The Nebraska Department of Health and Human Services intends to expand managed Medicare services from the existing 10 county program to cover all 93 counties in the state, which is an estimated incremental 70,000 additional Nebraskans.
As you may recall, we won a bid in 2010 for the original program and currently serve approximately 50,000 members in the existing Medicaid program. So subject to the finalization of the contract with the state of Nebraska, we expect to be 1 of 2 managed care contractors providing services to this expanded population later this year.
Staying with Medicaid, also during 2011, we were able to seize an attractive 2-state Medicaid acquisition opportunity by acquiring Family Health Partners and entering into a long-term relationship with its previous owner, Children's Mercy of Kansas City. This acquisition, which closed effective January 1 of 2012, has Medicaid contracts in both Kansas and Missouri. We were able to expand in Missouri, a state we have served for over 15 years, and entered the Kansas Medicaid program, where there's an expansion opportunity for 2013 and beyond.
Including this acquisition, we have a meaningful multiline presence throughout our Midwest 7-state region, which now serves 1.5 million members. We were able to execute on this multifaceted transaction for a reasonable net investment of approximately $50 million, net of tax benefit and statutory capital we were able to leave behind based on the structure of this transaction.
To summarize the Medicaid discussion and quantify the growth for the year, we started 2011 with 470,000 Medicaid members and reported $1.38 billion of Medicaid revenue in 2011, which represented approximately 11% of our total revenue. We expect to double these figures with more than 915,000 members beginning in 2012 with a full year revenue forecast of around $2.7 billion.
Medicaid is projected to represent just under 20% of the company's revenue in 2012. I think that investors should think of Coventry as having a meaningful exposure to Medicare growth and penetration opportunities with a proven track record of winning new business, executing and operating these Medicaid businesses but without the concentrated risk and the inherent volatility and contract alliance of a single-line carrier. While the process of winning new business is competitive, we very strongly believe that we'll get our share in the future. We know both how to compete and how to manage this business.
Moving away from Medicaid and talking about Medicare. We're equally enthusiastic about the recent results in Medicare. As you may have seen in our press release a few weeks ago, we had a very successful 2012 annual election period. As most of you know, a lot of this work to achieve success is done well in advance. And as we have previously promised, we focused on laying the foundation during 2011 to grow both Medicare Advantage and Part D in 2012.
In Medicare Advantage, we're in 15 states, and we have seen 2012 growth across 14 of those 15 states. The most recent enrollment for Medicare Advantage is approximately 250,000 members, which is ahead of our previous estimate, and results in membership growth of about 13% so far in 2012. We've grown from 137,000 Medicare Coordinated Care members at the end of 2008 to 250,000 today for a compounded annual growth rate of 16%. We're well proportioned -- or positioned to continue taking the advantage of this attractive demographic growth opportunity where we're able to provide a tangible value proposition to seniors and to the federal government.
On Part D, we had a successful enrollment period, growing membership of about 25% out of the gate and adding almost 300,000 members.
2011, as you know, we spent a lot of time talking about the work we were doing on product design and developing, creating partnerships, and we had successfully launched the third product with a preferred network in 2012's annual election period. We increased both our auto-assign footprint and our mainstream membership coming into 2012. Our company has consistently been profitable in Part D in both membership channels since we launched in 2006, and 2011 was no exception, with an aggregate Part D loss ratio of 81.7% for the year.
During 2011, a lot of effort went into forming an attractive set of products and establishing partnerships with Walgreens, Walmart and Target for our newest product. We also renegotiated our PBM contract with an improved Part D cost structure and enhanced other areas of Part D, including distribution. I think Part D is a great example of our abilities to successfully execute on multiple growth opportunities given our focus on resources, touching multiple product lines. Our cross-functional teams went back to the drawing board after 2010 and created a product that is low-cost structure and which is proven to be attractive to the senior population.
And as you might well imagine, we're currently hard at work on our products and positioning for 2013 and very optimistic about our prospects in the future.
Think about our company with Medicare at about 30% of the company revenues and Medicaid at about 20%. So we've evolved about half of our revenue coming from government programs. There continues to be attractive opportunity to grow in the current programs, while there is a significant longer-term opportunity to serve the dual-eligible population. Medicaid and Medicare experience, footprint and capabilities are all important ingredients in positioning to serve dual eligibles. We are currently in 10 states for Medicaid and 15 states for Medicare Advantage. 8 of our 10 Medicaid states have filed letters of intent with CMS to integrate the dual-eligible population in their states. 
And for decades, we have provided complex care management and have served members across population, products and geographies with a cross-section of chronic condition, diseases and needs. We currently serve aged line to disabled members and other high-risk patients in Medicaid. We currently serve Medicaid members up and down the risk score spectrum, including dual eligibles.
Serving members with the most chronic and debilitating diseases should not be taken lightly, but this population is one that can significantly benefit by coordination of care or active chronic condition management, pharmacy management, social services and all the programs that we have built over the past decade to manage our current diverse population.
Managed care should be able to make a meaningful, positive impact on the lives of dual-eligible population, and therefore, provide a valuable -- a value proposition for the states and federal government. Based on our footprint, exposure to both Medicaid and Medicare capabilities and a history of managing diverse populations, we like our early positioning for this longer-term significant opportunity, and our company will continue to invest in Medicare and Medicaid growth, along with dual-eligible populations.
Moving to our commercial business. Our Commercial Risk revenue was up 8% for 2011 with stable membership versus 2010, which is reasonably satisfying given the first year impact of health care reform, including minimum MLRs, which were effective January 1 of last year.
We knew it wasn't going to be easy managing 121 different measurement sales in our Commercial business and dealing with the burdens imposed by the new laws and regulations, many of which fell very short on clarity coming into the beginning of 2011. As Randy Giles will cover, as expected, we ended the year with significant minimum medical loss ratio rebate accrual, which will get finalized and paid out in 2012. Our goal for 2012 and beyond in the commercial business is to maintain margin and see the growth opportunities that we expect to develop as a result of consolidating market conditions driven by a commitment in this sophistication required to operate health care in the health care reform environment.
And in this context, we're actively preparing for the potential 2014 expansion [indiscernible]. We'll continue to work on attractive commercial expansion opportunities, both through acquisitions and organic growth and increase our footprint with providers and high-performance networks, which will drive lower-cost products to complement our product portfolio.
As of today, we have signed approximately 30 high-performance network contracts across our product lines. These arrangements run the spectrum from large-scale health systems to local-based primary multispecialty provider groups. 17 of these 30 high-performance networks covers our commercial product in 14 states and we feel should position us very well, especially in an exchange environment.
As you can tell, we're very positive about our opportunities across our diverse footprint in Medicare, Medicaid and commercial lines of business. We feel that the commercial business could represent a meaningful growth opportunity in 2014 and 2015 and allow us to be diversified in addition to key substantial Medicaid and Medicare growth opportunities.
In addition, we have over $1.1 billion in higher-margin and diversified fee-based revenue that complement our risk business and provide free cash flow for deployment to increase shareholder value.
Continuing on my comments regarding our future plans, we're going to pursue organic growth in our existing businesses. We're going to pursue selected RFPs. We're going to deploy capital for acquisitions, and in addition, consider future share repurchase. I think we're not only positioned well from a business and growth perspective heading into 2012, but we also accomplished a good deal relative to our balance sheet in the past year, and Randy will address that later. We sit here with $900 million in deployable cash, and that's after posting on a meaningful transaction, buying back over 10 million shares in 2011 and paying off our 2012 note that recently came due.
We're exiting 2011 on track after increasing EPS guidance 3x during the year, and we're able to provide 2012 guidance, which results in 18% to 15% core EPS growth in 2012, coupled with double-digit revenue growth. We continue to have a strong and flexible balance sheet with a combination of free cash and additional debt capacity.
I like our positioning and balanced exposure across Medicaid, Medicare and the commercial line, as well as our capability in seeking and seizing the right M&A opportunities. We're getting results from the work we have done, and we'll continue on this path to deliver more growth.
So what does it take to deliver growth? Well, it takes capital. It takes capable, experienced executive team. It takes experience in the M&A area. It takes focus. It takes discipline. It takes the ability to move quickly. These are all capabilities our company has. I am more optimistic about our future than I have been any time in the recent past.
Randy Giles is going to walk you through the results and provide detailed guidance with additional commentary on our business. And with that, Randy?"
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Thank you, Allen. I'll begin this morning by discussing our performance in the fourth quarter and then spend a majority of my time reviewing our detailed guidance for 2012. Before I go through the details for each of our businesses, I want to first start",2904,"Thank you, Allen. I'll begin this morning by discussing our performance in the fourth quarter and then spend a majority of my time reviewing our detailed guidance for 2012. Before I go through the details for each of our businesses, I want to first start at the consolidated level. Our GAAP EPS for the fourth quarter was $0.60, which includes $0.02 related to the runout of the Medicare Advantage Private Fee-for-Service business. For the full year, we reported EPS of $3.02, excluding the litigation gain in the second quarter, compared to our previous EPS guidance of $2.95 to $3. This includes $0.15 of earnings related to Private Fee-for-Service and $2.87 of core EPS for 2011.
Similar to last quarter, we have provided a table and reconciliation of these earnings metrics on Page 3 of our earnings press release. I'm very pleased with these results for 2011 as we were able to outperform our earnings guidance each quarter during the year, grew our Health Plan membership by more than 7% from the prior year, position ourselves for continued growth in 2012, deliver the largest Medicaid RFP win in the company's history and utilize the strength of our balance sheet to seize an exciting growth opportunity while repurchasing more than 7% of our outstanding share count.
These successes have positioned our portfolio of businesses very well for 2012, which I will highlight in detail after first giving you a little more color on the 2011 performance.
In our commercial business, first, one housekeeping item. You'll notice that we have now aligned our reporting of revenue PMPM and MLR percentage metrics to be consistent with the rest of the industry by disclosing Commercial Risk as opposed to our historical disclosure of Commercial Group Risk statistics, which excluded the commercial individual business. In addition to creating a better comparison to our peer group, we also wanted to recognize the growing impact that the individual business is having on our commercial results as we continue to increase our market share and invest in building out our capabilities in advance of the potential membership opportunity in the exchanges.
In 2008, for instance, we had 123,000 individual members. Whereas today, we have slightly more than 200,000 members. Also, the individual MLR has become much more comparable to the small group MLR due to health care reform regulations. This new disclosure structure is reflected in the earnings release issued this morning for both the current period as well as all historical periods disclosed.
Our commercial MLR was 83.7% in the fourth quarter and 81.6% for the full year, which is slightly above our previously provided guidance. As we continue to gain clarity on the minimum MLR regulations during the back half of 2011, we had to refine our rebate calculations to reflect the allowable underlying cost of certain internal and external medical-related vendors. We began the year expecting to be able to reflect medical-related payments to internal and external vendors in their entirety as such in the minimum MLR calculations. But based upon clarity we gained in MLR rules in Q3 and subsequent data gathering from our vendors in Q4, including our external PBM, we made adjustments that increased the medical loss ratio. I highlight this for you as it had about a 50 basis point impact on our full year 2011 commercial MLR relative to our initial guidance.
Within our commercial book, our view of fundamental prospective trend remains unchanged in the range of 8% plus or minus 50 basis points with unit cost trend continuing to be the largest driver, albeit stable. In the rearview mirror, we can see trends the mid-7s that continue to move higher off of the extreme low levels seen during the second half of 2010. These trends include the impact of the health care reform regulations implemented on September 23, 2010, which has had between 150 and 200 basis points of impact on the trend this year that will not recur in 2012.
Inpatient utilization, realized at[indiscernible] the lows of late 2010, continues to show a negative trend, as it has throughout 2011. Similar to what we disclosed to you last quarter, we're seeing outpatient physician trends creep up and move from negative into slightly positive territory. Just to put in context, remember today's trends are being compared to the lowest level of utilization trends seen in years, a historically low base line from late 2010.
And probably most importantly, our pricing structure is predicated on a forward view of trend in which we have anticipated a return to more levels -- normal levels of utilization above what we've seen in the rearview mirror. This pricing is expected to generate higher absolute rate increases than what we're seeing throughout 2011 as we've established a new baseline with many of the adjustments related to health care reform already addressed and the benefit of the extremely low utilization late 2010 has already been passed through to our experience-rated customers.
Finally, the commercial results. I want to share our customary statistics around health care reform, which are consistent with the projections from the last call. For 2011, we generate total Commercial Risk revenues of just under $6 billion. Of that total, individual business generate approximately $375 million of revenue with the vast majority of this business in a rebate position. The remaining $5.6 billion of group risk revenues were split roughly 40% small group and 60% large group with approximately half of our small group business in a rebate position and a little less than 1/4 of our large group business in a rebate position.
It's important to note that rebate exposure is something that we've been managing carefully with a number of actions taken to utilize rebate capital during the year, including providing more value to our customers, also promoting quality initiatives with hospitals and providers to improve risk scores, strengthen overall quality of care and to create opportunities to lower future medical costs. This has driven our rebate estimates down significantly from our initial view in 2011. In 2012, we expect to benefit from certain renegotiated external vendor contracts, which will serve to decrease our overall cost structure and reduce our rebate accrual in 2012. We view our estimated rebate for 2011 as reasonable given the size of our book of business, this being the first year navigating these new regulations, and the inherent loss ratio variability that exists when calculated at the market size segment and state level.
While we did not assume any benefit from the multiple states that had minimal MLR waiver request pending with HHS, we were disappointed to see waiver request denied in some of our larger states, including Florida and Kansas. This result creates a more challenging operating environment for the individual business in these markets or force us to continue to evaluate our participation in that product on a market-by-market basis. Of the states with waivers currently pending with HHS, North Carolina is the only state where Coventry has an individual presence.
Moving on to government programs, our Medicare results for the fourth quarter were a continuation of the strong results that we saw throughout 2011 and an even better result than 2010. Our Medicare Advantage MLR of 82.3% for the quarter and 82.9% for the full year was a very strong result and one that gives us confidence in our bid positioning as we look to towards 2012. Our Medicare Part D results were also strong as the fourth quarter MLR of 60.5%, full year MLR of 81.7% were both better than our expectations and an improvement from the prior year.
As Allen already highlighted, we are excited about that growth trajectory that we've built for the Medicaid business with revenue growth of more than 20% and membership growth of nearly 50% in 2011. Our Medicaid results in the quarter were consistent with our expectation as we saw an uptick in our reported revenue PMPM, as well as MLR percentage, with the inclusion of the new Kentucky contract, which was effective on November 1.
Finally, we closed out 2011 with another excellent SG&A result, reporting a full year expense of $2.015 billion as compared to our initial guidance of $2.02 billion. This accomplishment is particularly impressive when you consider that while we were holding absolute SG&A spend just below our initial guidance for the year, we were simultaneously able to grow revenue above the initial guidance midpoint by more than $425 million.
Full year expense, including the elevated level of spend during the fourth quarter related to the successful Medicare enrollment period and the launch of the new Kentucky Medicaid contract, which together, bought more than 0.5 million new members to the company.
Before we get into 2012 guidance, let me first review some metrics on our balance sheet and cash flows. Our investment portfolio remained in a high-quality position with a net unrealized gain of $97 million at year end, an increase from $90 million in the prior quarter. As of January 31, we had $900 million of deployable free cash available, which is after retiring $234 million of senior notes earlier in January, as well as the deployment of $100 million during the fourth quarter for share repurchase. Recall that one of our accomplishments in 2011 was repositioning our balance sheet by issuing 10-year $600 million senior notes in June 2011 and renewing our credit facility. 
We have no scheduled debt maturities now until 2014, having an undrawn $750 million credit facility that isn't scheduled to expire until 2016. This gives us a great deal of flexibility as we pursue capital deployment opportunities. And as you have seen throughout 2011, while acquisitions remain our first priority for capital deployment, we're also committed to returning capital to shareholders through opportunistic share repurchases, as seen through our deployment of $328 million in 2011.
Moving on to our cash flow results. You'll recall that we received an extra payment from CMS in the third quarter, so you can see the impact from that on the deferred revenue line in the fourth quarter results and then in the immaterial impact from deferred revenue for the full year. The full year result was impacted by the second quarter litigation settlement. So after adjusting earnings for the litigation items, our cash flow from operations was $496 million or 112% of net income for the year. As you can see on the other receivables line of the balance sheet and cash flow statement, cash flow from operations was negatively impacted by the timing of certain Medicare Part D receivables related to the 2011 program year that we will collect from CMS in 2012.
So with a successful 2011 behind us, let's now discuss our outlook for 2012. Today, we are providing initial 2012 EPS guidance in the range of $3.10 to $3.30, which is an increase of 8% at the low end and 15% at the high end, versus the comparable 2011 EPS of $2.87. In that aggregate, we are projecting total revenues are nearly $14 billion, a growth of approximately $1.75 billion, which is up roughly 15% at the midpoint. We are forecasting an increase in consolidated MLR percentage, which is driven by changes in the mix across our portfolio businesses towards the growth in government programs.
In 2011, commercial revenue represented approximately 50% of the company total with an additional 30% Medicare, 10% Medicaid and 10% other, including Fee businesses. Our guidance for 2012 projects around new composition of just over 40% commercial, 30% Medicare, 20% Medicaid and just under 10% Fee and other. This is consistent with our goal to have a balanced portfolio with the ability to seize opportunities across the product spectrum.
On the topic of medical cost structure, we have recently renegotiated and extended our PBM contract with Medco for a multiyear period effective January 1, 2012. We were able to secure an improved cost structure and contract terms that give us more flexibility as we continue to react to the rapidly evolving health care marketplace. Given that pharmacy spend represents nearly 20% of our medical expenditures, this is an important improvement to a critical part of our overall cost structure across our product portfolio.
Moving on to SG&A. I'm particularly pleased with the efforts that the organization has put forth on driving down our SG&A percentage of revenue from 16.5% in 2011 to a midpoint of 15.4% on our 2012 guidance. I've been personally involved in working to identify cost reduction opportunities across the company that have allowed us to forecast a strong result for 2012 while simultaneously also making critical investments for the future in our core businesses. These investments include improved direct distribution capabilities from the individual business, enhanced care management tools, the addition of substantial Medicare and Medicaid resources, not to mention the ongoing increased compliance costs. And that's just to name a few.
On the non-operating items, you'll note that the tax rate is increased over 2011, which is primarily driven by a shift in the mix of earnings towards states with higher tax rates and also about compliance with new health care reform regulations.
Finally, you will see our share count guidance which assumes that we essentially hold the share count flat from where we ended 2011. It's important to note that today's EPS guidance range does not incorporate any meaningful deployment of the free cash that is sitting on our balance sheet.
Now moving more specifically into our largest lines of business. For Commercial Risk, we are forecasting membership levels to be slightly down for 2011 levels with a decrease in Q1 2012 driven by a handful of large group terminations followed by growth during the remainder of the year. We continue to price ahead of trend and remain disciplined in our objective of maintaining margin over pursuing membership gains. 
On the expense side, we are projecting MLR of 81.5% plus or minus 50 basis points. This MLR guidance incorporates mechanics of the minimum MLR rules, our view of pricing by market, a forward view on medical trends, our mix of business and a pragmatic view that you always have deviations from the mean as you manage your portfolio of 121 measurement cells. This is a slight improvement from 2011, and it's that '11 that we view as sustainable under health care reform in today's operating environment.
In Medicare, the membership story is excellent for both Medicare Advantage and Medicare Part D. As Allen noted earlier, we're starting the year with approximately 250,000 Medicare Advantage members, which is an impressive growth result of about 13% from 2011. Our Medicare Part D business was also very successful during the annual election period as we grew by almost 300,000 members, or about 25%, and we are forecasting continued growth throughout 2012. This growth is a nice mix of retail purchases in our innovative new value plus product and partnership with Walgreens, Walmart and Target, as well as our increased auto-assignment presence in 23 regions for 2012, up from 15 regions in 2011. Based upon our bids and our view of where we exited 2011, we are forecasting MLRs in the low to mid-80s for both Medicare Advantage and Part D.
Staying within government programs, our 10-state Medicaid business is the biggest part of our 2012 growth story with total revenue expected to nearly double from just under $1.4 billion in 2011 to nearly $2.7 billion in 2012. Today, we are just about 915,000 members and expect to be in the zone of 950,000 Medicaid members upon implementation of the new Nebraska contract. We are projecting MLR of approximately 90% in 2012, which is a combination of our same-store business, which runs in the mid- to high-80s, and MLRs in the 90s for the year 1 RFP wins and the newly acquired Family Health Partners business in the Midwest.
So now we've covered the large risk business, you'll notice that although we are still forecasting over $1.1 billion of fee-based revenue, our guidance for fee revenue is down a little, more than 3% due to the loss of one Workers' Compensation Services account. However, you also see a decrease in cost of sales expense item directly associated with Workers' Compensation Services, which more than offset the aggregate fee revenue reduction. Our Fee businesses continue to be an important component of our overall product portfolio, providing valuable unregulated cash flows and are an area that we intend to grow and invest in prospective.
So in conclusion, our efforts in 2011 lay the foundation for the 2012 guidance that we provided today. We firmly believe that growing the top line is critical in today's environment and are pleased to see 2011's efforts bearing fruit in 2012 with the revenue guidance midpoint of nearly $14 billion, coupled with an increase in both operating earnings and EPS. So while we may be pleased with the 2012 growth outlook, by no means are we satisfied. We will continue to invest in the future, focus on managing our portfolio of businesses in a manner that allows us to seize growth opportunities while also maintaining the right balance, limiting our exposure to any one area. We will continue to introduce growth opportunities, both organically and through acquisition, to strategically position Coventry to deliver the long-term results that our shareholders have come to expect.
Operator, this now concludes our prepared remarks, and we are ready to open the line for questions."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","[Operator Instructions] We'll go first to Doug Simpson with Morgan Stanley.",11,"[Operator Instructions] We'll go first to Doug Simpson with Morgan Stanley."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So Randy, maybe just to expand a little bit. I think you said 81.5% for the commercial MLR in 2012. Did I hear you right?",25,"So Randy, maybe just to expand a little bit. I think you said 81.5% for the commercial MLR in 2012. Did I hear you right?"
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes.",1,"Yes."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Is that -- okay. So can you just sort of walk us through -- the Q4 MLR came in, I think, on the commercial side higher than people were expecting. You talked about the inclusion of -- or the inability to include certain costs in the rebate calc, and that",72,"Is that -- okay. So can you just sort of walk us through -- the Q4 MLR came in, I think, on the commercial side higher than people were expecting. You talked about the inclusion of -- or the inability to include certain costs in the rebate calc, and that obviously, I think you said 50 bps for the year. So roughly 200 basis points into the Q4 number. Is that fair?"
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","It's more like 140 into the Q4 result.",9,"It's more like 140 into the Q4 result."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So it added 140 to the commercial MLR in Q4?",10,"So it added 140 to the commercial MLR in Q4?"
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes.",1,"Yes."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. So can you just help us sort of think about a map from the 2011 experience into 2012? Just how -- sort of maybe walk us through your thoughts around the commercial MLR from 1 year to the next given sort of those dynamics and your Q4 jumping off poin",51,"Okay. So can you just help us sort of think about a map from the 2011 experience into 2012? Just how -- sort of maybe walk us through your thoughts around the commercial MLR from 1 year to the next given sort of those dynamics and your Q4 jumping off point."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","As we think about 2012, there were certain trend drivers that we think are not going to recur into 2012. One of the things, was you might recall, we experienced lower prior period of volume during 2011 and 2010. And you can see from today's earnings relea",115,"As we think about 2012, there were certain trend drivers that we think are not going to recur into 2012. One of the things, was you might recall, we experienced lower prior period of volume during 2011 and 2010. And you can see from today's earnings release that our DCP increased by 4% from the prior year end. So I feel comfortable that, that pressure is not going to recur. As we go in, we've also improved our cost structure, as I mentioned, around our pharmacy particularly, and we have some other actions we're taking around cost structure that give us a pretty good feeling about where we're going to be in 2012 versus 2011."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. And then -- and just in terms of your commentary on utilization and trend in the Q4 period, it didn't sound like you saw anything new or different there. But can you just give us maybe more color on that front?",42,"Okay. And then -- and just in terms of your commentary on utilization and trend in the Q4 period, it didn't sound like you saw anything new or different there. But can you just give us maybe more color on that front?"
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Sure. As we think about trend in general, what we're seeing, as I talk about inpatient, commercial bed days were down low- to mid-single digits in Q4 2010. Medicare Advantage bed days were down low- to mid-single digits. And commercial admits were down mi",104,"Sure. As we think about trend in general, what we're seeing, as I talk about inpatient, commercial bed days were down low- to mid-single digits in Q4 2010. Medicare Advantage bed days were down low- to mid-single digits. And commercial admits were down mid-single digits from Q4, and Medicare Advantage admits were down low- to mid-single digits from Q4 2010. So the position we're seeing is somewhat uniform utilization trends across primary care, surgical specialists and lab. And on the outpatient side, the areas that we see higher utilization in include areas like dialysis, injectable drugs and cardiovascular, other areas we're seeing trend pressuring."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. And then maybe just switching gears on the use of capital. You guys obviously bought back some stock in Q4. I think the cash balance is right about $900 million now. How do you think about deploying that, thinking about the M&A backdrop, the opportu",123,"Okay. And then maybe just switching gears on the use of capital. You guys obviously bought back some stock in Q4. I think the cash balance is right about $900 million now. How do you think about deploying that, thinking about the M&A backdrop, the opportunity to buy back stock? I mean, if you look out 12 months, would you expect to still have that sizable of a cash balance? Or if you don't see things out there on the M&A front, would you look to kind of bring that down and think about keeping your debt capacity as your dry powder for deals to the extent they present themselves. How long would you guys kind of run with a heavy cash balance?"
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think you can expect 2012 to look like 2011. We spent $328 million in share repurchase, did a major transaction and worked on some things that didn't materialize. We will continue looking for significant size to M&A transactions, and if those opportunit",114,"I think you can expect 2012 to look like 2011. We spent $328 million in share repurchase, did a major transaction and worked on some things that didn't materialize. We will continue looking for significant size to M&A transactions, and if those opportunities don't present themselves, we will opportunistically do share repurchase. Are we going to use the whole $900 million up and live with our credit line? I doubt it because we think that there's going to be continuing consolidation. The margins are under pressure. The business is going to get tougher, and we feel like there will be opportunities to grow our business substantially, and we're going to keep some dry powder."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. And then maybe just sneak just one last one in. Just on, I think, this call you probably talked a little bit more about the duals than you have in the past. Can you just give us a sense, I mean, how -- what's your expectation for that in terms of ti",77,"Okay. And then maybe just sneak just one last one in. Just on, I think, this call you probably talked a little bit more about the duals than you have in the past. Can you just give us a sense, I mean, how -- what's your expectation for that in terms of timing with respect to your book of business and how much effort are you making on that front at this point in terms of resources?"
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, we're making -- what we're doing today is making certain that we can absorb almost a 0.25 million of new members that have never been in managed-care before across the whole spectrum in Kentucky. We are investing in a new IT system that improves our",141,"Well, we're making -- what we're doing today is making certain that we can absorb almost a 0.25 million of new members that have never been in managed-care before across the whole spectrum in Kentucky. We are investing in a new IT system that improves our patient management capabilities. And we think that we can't predict exactly what dual-eligible population will be, but we work on it all the time. The timeframe when these things present themselves are uncertain. We worked on an opportunity in Kansas, which has not yet born any fruit, but we're working on RFPs in -- all the time. And so we'll have opportunities. I can't predict which quarter they present themselves, but we're investing in experience. We're investing in systems. We're investing in staff and infrastructure for the Medicaid business, and we're going to grow it."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","We'll take our next question from Tom Carroll with Stifel, Nicolaus.",12,"We'll take our next question from Tom Carroll with Stifel, Nicolaus."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I wanted to come back to your commentary on the Kentucky Medicaid business. It sounds like things are well there. But I guess maybe just 2 questions. Was Kentucky the primary reason for the large MLR increase in your Medicaid book? And then secondly, it s",100,"I wanted to come back to your commentary on the Kentucky Medicaid business. It sounds like things are well there. But I guess maybe just 2 questions. Was Kentucky the primary reason for the large MLR increase in your Medicaid book? And then secondly, it seems like there might be some issues in the market transitioning from Fee-for-Service to Managed Care. I think we saw that the secretary of Health and Family Services resigned yesterday. Just maybe just, again, reiterate, is there any reason we should assume or any reason to believe this could drag earnings a bit in 2012?"
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","I'd answer that by saying there are no surprises in Kentucky. We understood what it would be like to convert. I think we had more enrollment success than maybe we would've guessed, but we understood when we embarked on this that it would be an arduous, di",226,"I'd answer that by saying there are no surprises in Kentucky. We understood what it would be like to convert. I think we had more enrollment success than maybe we would've guessed, but we understood when we embarked on this that it would be an arduous, difficult first 6 months or 8 months or 10 months to convert the population and the providers and the experience base there to a managed population. We have only 2 months of experience in terms of cost there, and with that 2 months of experience, there are a lot of unknowns and a lot of gaps in terms of the billing process to the providers, do we have the bills on the same schedule that we would have on existing businesses. And so there are a lot of questions because it's so new, and I think that our reserves on that front would reflect Coventry's -- in my own personal, long-term view, which is make certain if you don't know that you're properly reserved, and those will come down as we gain experience and as we get data and as we know more about the population. But there are no surprises there. It's -- we understood what we are embarking on, and I would say that it's going reasonably well with a lot of work left to be done."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","That's great to hear. Do you expect any type of MLR improvement throughout the year? Or is this more of a 2013 effort?",24,"That's great to hear. Do you expect any type of MLR improvement throughout the year? Or is this more of a 2013 effort?"
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","No, I expect us to gain experience and knowledge and improve our ability to make progress there as the year progresses. It's something I can't predict by month or anything like that. But no, I have a high degree of confidence that we will improve the care",121,"No, I expect us to gain experience and knowledge and improve our ability to make progress there as the year progresses. It's something I can't predict by month or anything like that. But no, I have a high degree of confidence that we will improve the care for that population, improve communication with the providers, get to know the Commonwealth of Kentucky better. And just a lot of work to be done there, but we have every confidence that it'll get better as the year progresses and that long term, this will be a good opportunity for us. There haven't been any surprises. We understood when we bid and was awarded the business, we had a lot of work to do."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","One last one on your commercial rebates. Is there any chance you could quantify that for us?",17,"One last one on your commercial rebates. Is there any chance you could quantify that for us?"
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","We generally don't disclose the amount of our rebate. I would just say we're at a normal level of what we would anticipate, and that was significantly reduced from our initial view going into 2011.",36,"We generally don't disclose the amount of our rebate. I would just say we're at a normal level of what we would anticipate, and that was significantly reduced from our initial view going into 2011."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","We'll take our next question from Carl McDonald with Citi.",11,"We'll take our next question from Carl McDonald with Citi."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","On the cost trend, it sounds like you're seeing the same type of utilization that pretty much everybody else in the industry is seeing, which is, say, not very much. And yet, your overall cost trend at, call it, 7%, 8% is meaningfully higher than the sort",82,"On the cost trend, it sounds like you're seeing the same type of utilization that pretty much everybody else in the industry is seeing, which is, say, not very much. And yet, your overall cost trend at, call it, 7%, 8% is meaningfully higher than the sort of 5% to 5.5% that a lot of other companies are talking about. So within the unit cost, can you talk about where you think the biggest area of differential is and what's driving that?"
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","I really can't comment on what they're including in their numbers, Carl. But as far as ours are concerned, we feel like we're reporting them on a consistent basis. As it relates to unit costs for inpatient, we're seeing high single digits, which is -- it'",212,"I really can't comment on what they're including in their numbers, Carl. But as far as ours are concerned, we feel like we're reporting them on a consistent basis. As it relates to unit costs for inpatient, we're seeing high single digits, which is -- it's mostly unit cost driven in terms of what we're looking at in inpatient, outpatients, low double digits, which is mostly unit cost driven. Positions mid-single-digit, which is kind of split evenly. So we're kind of seeing -- we don't really see a change there. We see -- one of the things contributing to the trend year-over-year for us is the impact of the -- as I mentioned in my script, was the impact of the health care reform changes from September 23 of 2010, that required us to go to 0 copays on preventative and other things. It had a up to 200 basis point impact on our trend number. So depending on the mix of business between us and the competition and the benefit designs that they may have had with us having more small group business with maybe higher deductibles and copayments to begin with, we might have had a bigger impact from that than they did. But that's speculation on my part."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then back in Kentucky, what loss ratio did you assume for November and December there?",16,"And then back in Kentucky, what loss ratio did you assume for November and December there?"
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","We don't really break out loss ratios by market like that. I would just say that we've assumed a loss ratio in the early months with normal transition of care and phasing in of managed care processes, a higher loss ratio in the first 2 months that would -",59,"We don't really break out loss ratios by market like that. I would just say that we've assumed a loss ratio in the early months with normal transition of care and phasing in of managed care processes, a higher loss ratio in the first 2 months that would -- we would expect to go down throughout the year."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","As consistent with our long-standing practices, adequate.",8,"As consistent with our long-standing practices, adequate."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then if you -- I'm just going to pick a number and say it's 100% that you assumed in the fourth quarter. It looks like the loss ratio in the other Medicaid the markets would have deteriorated something like 350 basis points. Is the driver there?",47,"And then if you -- I'm just going to pick a number and say it's 100% that you assumed in the fourth quarter. It looks like the loss ratio in the other Medicaid the markets would have deteriorated something like 350 basis points. Is the driver there?"
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","You shouldn't make those assumptions.",6,"You shouldn't make those assumptions."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","I would just comment on that, that the loss ratios in our other Medicaid markets did not deteriorate in the fourth quarter.",22,"I would just comment on that, that the loss ratios in our other Medicaid markets did not deteriorate in the fourth quarter."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Did not deteriorate? I'm sorry, I didn't get that. You said did not deteriorate in the fourth quarter?",18,"Did not deteriorate? I'm sorry, I didn't get that. You said did not deteriorate in the fourth quarter?"
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Did not deteriorate.",3,"Did not deteriorate."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","We'll take our next question from Josh Raskin with Barclays.",11,"We'll take our next question from Josh Raskin with Barclays."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just on the 2 big new drivers for 2012, Kentucky and PDP, when do you think you're going to have enough claims data to start getting a better sense of where those trends are relative to sort of your underwritten expectations?",41,"Just on the 2 big new drivers for 2012, Kentucky and PDP, when do you think you're going to have enough claims data to start getting a better sense of where those trends are relative to sort of your underwritten expectations?"
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","I'll feel better in 3 or 4 months. It's -- I'm -- we're learning about billing practices, and it's new to all the providers, so I think that the -- heard but not received information is not going to be good for a bit. We have a large team on the ground th",93,"I'll feel better in 3 or 4 months. It's -- I'm -- we're learning about billing practices, and it's new to all the providers, so I think that the -- heard but not received information is not going to be good for a bit. We have a large team on the ground there in the next couple of weeks, making the rounds with all the major large provider groups. And -- but I think if you would think of 3 to 4 months, we should have a much better feel on cost."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. And then I guess in Kentucky, I hate to sort of keep harping on this, but it's a big win for you guys. There was a pretty big movement in the member selection period. And so I'm just curious, have you guys put in some consideration, changed your tho",71,"Okay. And then I guess in Kentucky, I hate to sort of keep harping on this, but it's a big win for you guys. There was a pretty big movement in the member selection period. And so I'm just curious, have you guys put in some consideration, changed your thoughts around potential adverse selection or what some of these members you're doing based on the difference in benefits in the market?"
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","No, the benefits are very close to the same. We think that the outsized enrollment period has a direct proportion to the large team we put on the ground there and the numbers of providers that we got early at competitive rates. And we did not use a third",122,"No, the benefits are very close to the same. We think that the outsized enrollment period has a direct proportion to the large team we put on the ground there and the numbers of providers that we got early at competitive rates. And we did not use a third party to do the contracting. We've got a lot of health plans and a lot of people and a lot of experience there, and we put 60 or 70 of our own people on the ground there for 2 months. So we think the enrollment is unrelated to very, very minor difference in benefits and much more directly related to having people's current primary care physician or physician groups in our network earlier."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. And then just last quick question on the PBM contract. Could you just give us the length on that and that any color on the improvement in terms of your costs for drugs now?",35,"Okay. And then just last quick question on the PBM contract. Could you just give us the length on that and that any color on the improvement in terms of your costs for drugs now?"
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","In terms of the contract extended for Medicare through 2015, the commercial contract will be extended through 2016. And I can't really comment on the impacts on our cost structure, but just to say that it was a key driver for our product positioning in Pa",141,"In terms of the contract extended for Medicare through 2015, the commercial contract will be extended through 2016. And I can't really comment on the impacts on our cost structure, but just to say that it was a key driver for our product positioning in Part D for 2012 and a key factor for us in terms of our cost in preparing for the exchanges going forward. And the other aspect about it is really increased flexibility that we have regarding elements of the contract for the future as we're able -- so we can adapt more easily to health care changes in the marketplace going forward. So Medco has been a critical partner for us and strategic partner for us, and we continue to work that relationship and work with them to try and get to the best possible results."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. Is that through the end of '15 for Medicare and end of '16 for commercial?",16,"Okay. Is that through the end of '15 for Medicare and end of '16 for commercial?"
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes.",1,"Yes."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","We'll take our next question from Charles Boorady with Crdit Suisse.",12,"We'll take our next question from Charles Boorady with Crdit Suisse."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Not to harp on Kentucky but I just wanted to recall. Was that in your original guidance? It couldn't have been, right, because you were awarded it during the year? But basically, it looks like the fourth quarter and your full year results would have been",90,"Not to harp on Kentucky but I just wanted to recall. Was that in your original guidance? It couldn't have been, right, because you were awarded it during the year? But basically, it looks like the fourth quarter and your full year results would have been much stronger without Kentucky. While you're not saying it, we can back in to the fact that it was pretty dilutive to your quarter if that's what drove up the Medicaid loss ratio that wouldn't have deteriorated without Kentucky. Am I reading that right?"
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes.",1,"Yes."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Got it. Good. And then the Nebraska expansion, did you say that is in your 2012 guidance?",17,"Got it. Good. And then the Nebraska expansion, did you say that is in your 2012 guidance?"
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","It's not a case of new information. At this particular point in time, we don't know, and no one -- neither would anyone else after 60 days. And it's just consistent with our current practices here to not overpromise and to make certain that our reserve po",105,"It's not a case of new information. At this particular point in time, we don't know, and no one -- neither would anyone else after 60 days. And it's just consistent with our current practices here to not overpromise and to make certain that our reserve position is adequate. It's nothing more than not knowing, and I don't know how else you would know. We started -- acquired new businesses for 15 years here and started new businesses, maybe one not quite this large. We just don't know at this particular point in time. But there isn't any unknown, adverse information that we have."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Got it. Totally understood, and I think it's a prudent way that companies book new business in new markets, especially in that space. I was really more getting at what your results would look like were it not for that new business because it would be iron",62,"Got it. Totally understood, and I think it's a prudent way that companies book new business in new markets, especially in that space. I was really more getting at what your results would look like were it not for that new business because it would be ironic to be penalized by investors for a big win just because of some upfront dilution."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","It's very short term, and it's going to all roll out here in a few months. And I would rather that people wonder if we're too conservative today and then sit in front of you 2 quarters from now and say we didn't know and we're not going to make our number",72,"It's very short term, and it's going to all roll out here in a few months. And I would rather that people wonder if we're too conservative today and then sit in front of you 2 quarters from now and say we didn't know and we're not going to make our numbers. So it's very consistent with the prudence that we run our business here, and it will develop relatively quickly."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Got it. Got it. And in terms of the comments on the minimum MLR and the 50 bps higher impact from classifications, did that get offset by SG&A? Or was there a net income impact because of the need to rebate some of the impact of that 50 bps?",49,"Got it. Got it. And in terms of the comments on the minimum MLR and the 50 bps higher impact from classifications, did that get offset by SG&A? Or was there a net income impact because of the need to rebate some of the impact of that 50 bps?"
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes, there was a MLR impact of that additional rebate.",10,"Yes, there was a MLR impact of that additional rebate."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","There was an MLR impact. But was there net income impact also?",12,"There was an MLR impact. But was there net income impact also?"
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes.",1,"Yes."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay, got it. And then finally, in the Workers' Comp business, we didn't really talk about this in a while, but could you just tell us a little bit more about what your prospects are for that business? You talked about your desire to grow your fee-based s",79,"Okay, got it. And then finally, in the Workers' Comp business, we didn't really talk about this in a while, but could you just tell us a little bit more about what your prospects are for that business? You talked about your desire to grow your fee-based services. But what drove the account loss in Workers' Comp? And can you tell us about your backlog or give us other indications of your growth prospects in the fee-based businesses broadly?"
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","I'm going to let -- most of you have not met Mike Bahr. Mike runs all of the commercial business in our company, which includes Workers' Comps. And that's relatively new since October of this year Tim Nolan is not new to our company but is new to running",112,"I'm going to let -- most of you have not met Mike Bahr. Mike runs all of the commercial business in our company, which includes Workers' Comps. And that's relatively new since October of this year Tim Nolan is not new to our company but is new to running all of our government business. I'm going to let Mike Bahr answer the question about Workers' Comp because we changed it in October because there's so many common network issues and development of network resources that -- across the 2 companies, and we think it will run better integrated with the management and leadership in our company and the commercial area. Mike?"
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Charles, Workers' Comp, it is an area we're looking to grow. It's an area we're looking for opportunities to grow. As you said, it's unregulated revenue, and that's a great place to be these days. So the loss of the group, it was our second largest group,",128,"Charles, Workers' Comp, it is an area we're looking to grow. It's an area we're looking for opportunities to grow. As you said, it's unregulated revenue, and that's a great place to be these days. So the loss of the group, it was our second largest group, if I recall, and it was just a competitive environment. And so for us, it's -- we're in a position where we continue to look for opportunities to grow and invest in that line of business. But there's nothing specific with Workers' Comp that created the issue. So I mean, it's a line that runs well. We're centralizing some of our businesses to improve our network structure, particularly in areas where we don't have health plans. And so we're pretty optimistic."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I know that's a long lead time sale, but can you give any give a sense for what your backlog looks like generally in either Workers' Comp or the fee-based business more broadly?",34,"I know that's a long lead time sale, but can you give any give a sense for what your backlog looks like generally in either Workers' Comp or the fee-based business more broadly?"
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","I really can't. To be honest, I'm not in the detail on that side of it. So I can't answer that. I know that the large group we lost, some of the employers they work with are looking to come back to us for services, and we're certainly open to doing that.",53,"I really can't. To be honest, I'm not in the detail on that side of it. So I can't answer that. I know that the large group we lost, some of the employers they work with are looking to come back to us for services, and we're certainly open to doing that."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","It's been stable for a number of years, stable meaning slight increases in revenue. We're heavily affected by the recession and the employment market and employers being much more careful about occupational safety. So it's a transaction-based business tha",86,"It's been stable for a number of years, stable meaning slight increases in revenue. We're heavily affected by the recession and the employment market and employers being much more careful about occupational safety. So it's a transaction-based business that's an acronym for claim-based or accident-based business. And in a tough environment, it's continued to add new customers and grow revenues slightly and EBITDA a little more than revenues. So it's working well for us, and we're trying to figure out how to make it better."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Was the capability or price that you lost the business on when you said things are getting more competitive?",19,"Was the capability or price that you lost the business on when you said things are getting more competitive?"
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","No, no, no, it was price.",6,"No, no, no, it was price."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","And we'll take our last question from Kevin Fischbeck with Bank of America.",14,"And we'll take our last question from Kevin Fischbeck with Bank of America."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","You mentioned that the rebate position, it sounds like, in Q4 was actually kind of similar to where it was, I guess, in Q3. But -- and you said that in 2012, it will be probably a little bit lower. Can you just give a little -- a sense of where you think",63,"You mentioned that the rebate position, it sounds like, in Q4 was actually kind of similar to where it was, I guess, in Q3. But -- and you said that in 2012, it will be probably a little bit lower. Can you just give a little -- a sense of where you think your pools will be across the 3 areas of business?"
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes. I think the -- as we look at the rebate and where we do have rebates that are concentrated still in our top 5 rate cells and small business, large group and individual. And it varies by state where those are located. But generally, if you think about",102,"Yes. I think the -- as we look at the rebate and where we do have rebates that are concentrated still in our top 5 rate cells and small business, large group and individual. And it varies by state where those are located. But generally, if you think about the rebates, for us, they're predominantly in small group and then individual and in large group kind of in that, relative size. In terms of rebates, we think we've done a good job of managing them. We think we can get better at it in 2012, and we'll continue to work on that."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","We need to get better, and we will.",8,"We need to get better, and we will."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Is it a matter -- do you think the blocks of business will be relatively similar as far as percentage in rebates, it's just that they'll be paying a little bit less of a rebate? Or would you expect that to change?",42,"Is it a matter -- do you think the blocks of business will be relatively similar as far as percentage in rebates, it's just that they'll be paying a little bit less of a rebate? Or would you expect that to change?"
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","No. We would hope there will be less in the way of rebates, and we translate that to being better positioned in the markets from a price standpoint. But not an exact science, not easy.",35,"No. We would hope there will be less in the way of rebates, and we translate that to being better positioned in the markets from a price standpoint. But not an exact science, not easy."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","And remember, your averaging over the multiple years as you move out to 3 years, so it becomes more predictable.",20,"And remember, your averaging over the multiple years as you move out to 3 years, so it becomes more predictable."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. And then given that this is the first year of rebates, 2012 being the first year actually paying the rebates, can you just go through the kind of the cash flow, maybe bridge for 2012 for us?",38,"Okay. And then given that this is the first year of rebates, 2012 being the first year actually paying the rebates, can you just go through the kind of the cash flow, maybe bridge for 2012 for us?"
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, as it relates to rebates, there's a runout period in 2012, that will firm up the rebate calculations to what the actual results are. Once that's finalized, the payments will be made midyear. So that's the timeframe for when that gets transacted.",43,"Well, as it relates to rebates, there's a runout period in 2012, that will firm up the rebate calculations to what the actual results are. Once that's finalized, the payments will be made midyear. So that's the timeframe for when that gets transacted."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","But I guess is there a way to think if you have $900 million of cash at corporate as of now where that number might be at year end if you don't deploy any capital?",35,"But I guess is there a way to think if you have $900 million of cash at corporate as of now where that number might be at year end if you don't deploy any capital?"
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","All of the rebates are in regulated subs, so accrued forward the cash backing in, separate and apart from the $900 million, which is sitting at the corporate entity. So it will have no impact in the $900 million.",39,"All of the rebates are in regulated subs, so accrued forward the cash backing in, separate and apart from the $900 million, which is sitting at the corporate entity. So it will have no impact in the $900 million."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. So -- but I guess it's still too early to kind of say at this point where the dividends of the subs might be for 2012?.",27,"Okay. So -- but I guess it's still too early to kind of say at this point where the dividends of the subs might be for 2012?."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Typically, we run 85% to 90% of the current year net income, and so we're scoping out the level of dividends that we expect, inclusive of our free cash from nonregulated subs. We don't expect it'll be any different than that historical zone.",43,"Typically, we run 85% to 90% of the current year net income, and so we're scoping out the level of dividends that we expect, inclusive of our free cash from nonregulated subs. We don't expect it'll be any different than that historical zone."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","One more question, please.",4,"One more question, please."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","Okay. We'll take that from Matt Borsch with Goldman Sachs.",10,"Okay. We'll take that from Matt Borsch with Goldman Sachs."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Yes. Just wondering if you could talk a little bit about the dual opportunity and how you see yourselves positioned. And I'm curious if you think that growing there is going to be more a function of your Medicaid markets, your Medicaid experience or Medic",93,"Yes. Just wondering if you could talk a little bit about the dual opportunity and how you see yourselves positioned. And I'm curious if you think that growing there is going to be more a function of your Medicaid markets, your Medicaid experience or Medicare? Or do you really think it's important to build to blend the 2 together? I guess alternatively, is this going to be wide open where companies that you wouldn't normally expect to participate will be competing for this -- with a solid basis for being in that business?"
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","I don't know if I can say much more than I did in my prepared comment. And I think that the fact that 8 of the 10 states that we currently do Medicaid in are applied to CMS, so to dual eligibles into managed care that some of the new RFPs are going to --",238,"I don't know if I can say much more than I did in my prepared comment. And I think that the fact that 8 of the 10 states that we currently do Medicaid in are applied to CMS, so to dual eligibles into managed care that some of the new RFPs are going to -- where they didn't in the past, are going to include dual eligibles as part of what we're bidding on. The -- and so over time, there'll be plenty of opportunities. We'll get some. You did -- it's just unpredictable in terms of when the RFPs come out or they keep their original schedule and how quickly we can grow the business. And I wouldn't mind having a little more experience with what we have, too. And so not like I'd like to take on 300,000 dual eligibles tomorrow, but we will, over time, get our share. The timeframe is just not predictable. But I think in terms of where we do business, the resources we have now to respond to RFPs, what we've learned about this business in the last 3 years. If you think back, we didn't add any Medicaid business for 5 years at one particular point in time. And we didn't have any infrastructure, didn't really have a department, any people, any expertise 3 years ago. So we're learning quickly and adding resources quickly, and we'll get our share."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. And -- okay. Just last on a different topic on the commercial. When we look at the Commercial Risk per member revenue, is that -- how much has that impacted the PMPMs statistics? How much are they impacted by the rebating? Are they a little bit lowe",88,"Okay. And -- okay. Just last on a different topic on the commercial. When we look at the Commercial Risk per member revenue, is that -- how much has that impacted the PMPMs statistics? How much are they impacted by the rebating? Are they a little bit lower because of the rebating? And I was just wondering if you would be able to provide the fourth quarter group Commercial Risk, PMPM and MLR, just given that, that would tie up the year on the old basis of reporting?"
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","In terms of -- the rebates does impact, obviously, the revenue level. Then in terms of tying up the MLR on a Group Risk basis, we anticipate that the MLR was -- would be 40 basis points higher on a separate  basis.",42,"In terms of -- the rebates does impact, obviously, the revenue level. Then in terms of tying up the MLR on a Group Risk basis, we anticipate that the MLR was -- would be 40 basis points higher on a separate  basis."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Executives","Thank you for joining us today. Operator, we're complete. Thank you.",11,"Thank you for joining us today. Operator, we're complete. Thank you."
27133,157003674,218001,"Coventry Health Care Inc., Q4 2011 Earnings Call, Feb 08, 2012",2012-02-08,"Earnings Calls","Coventry Health Care, Inc.","Operator","All right. Thank you. This will conclude today's conference call.",10,"All right. Thank you. This will conclude today's conference call."
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","Good morning, and welcome to Coventry Health Care's First Quarter 2012 Earnings Conference Call. Today's conference is being recorded [Operator Instructions] Today's call will begin with an opening remarks by Chief Executive Officer of Coventry Health Car",50,"Good morning, and welcome to Coventry Health Care's First Quarter 2012 Earnings Conference Call. Today's conference is being recorded [Operator Instructions] Today's call will begin with an opening remarks by Chief Executive Officer of Coventry Health Care, Mr. Allen Wise, after a brief forward-looking statement read by Mr. Drew Asher."
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Ladies and gentlemen, during this call, we will make forward-looking statements. Certain risks and uncertainties, including those referenced in our press release and described in the company's filings with the SEC on Form 10-K for the year ended December",61,"Ladies and gentlemen, during this call, we will make forward-looking statements. Certain risks and uncertainties, including those referenced in our press release and described in the company's filings with the SEC on Form 10-K for the year ended December 31, 2011, may materially impact those statements and could cause actual future results to differ materially from those anticipated and discussed. Allen?"
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Good morning, and thank you for your interest in Coventry Health Care. Earlier today, we reported the best quarter in the history of our company both in terms of revenue and earnings per share. Q1 revenue was $3.7 billion, and that's up 21% from the first",2361,"Good morning, and thank you for your interest in Coventry Health Care. Earlier today, we reported the best quarter in the history of our company both in terms of revenue and earnings per share. Q1 revenue was $3.7 billion, and that's up 21% from the first quarter last year. And earnings per share of $1.20 driven by strength across 6 of our 7 businesses, specially our Medicare Advantage business. 
As you can see in our current Medicaid Medical loss ratio, we had some serious work to do in our recently added Medicaid business, but all of Coventry's other businesses: Commercial, Medicare Advantage, Medicare Part D and our Fee-based businesses were on track or ahead of plan for the quarter. With regard to SG&A, we closed a t a very strong result with the rate of 13.6%, which is down 280 basis points from the first quarter of 2011. 
Today, I'd like to touch on each of our businesses and share with you our current perspective and probably more importantly where we're heading. And let's start with Medicare. The strength of the quarter in terms of Medicare Advantage was primarily driven by 3 factors: A very successful open enrollment season, which resulted in sequential membership growth of 13% or 28,000 members. The second was a very favorable outcome from the risk adjustment data validation audit process persistent to methodology changes issued by CMS during the quarter enabling us to reduce our related reserve that were built over the last several years. And third, strong operating results in Medicare Advantage even absent the operating earnings driven by the RADV reserve release. 
I believe it's worth a moments thing on Medicare Advantage. We operate Medicare Advantage Health Plans at 15 states. 14 of these states growing coming into 2012. We're pleased with the momentum of this business and expect to continue to expand our footprint and membership base over the next few years. We have taken what we believe was a prudent posture over the last few years and accruing our best estimate of RADV liability even in the absence of perfect parity. 
The update in guidance from CMS were able to reflect the reduction in the RADV reserve of $133 million or $0.58 per share contributing to strong Medicare operating results in the quarter. This is important for a couple of reasons. First of all, it should give you insight into the prudence and reserving for this type of exposure, which I believe was not necessarily consistent industrywide. And perhaps more important, we were able to substantially reduce a headwind in our Medicare Advantage bids since we'll now adapt to the updated CMS RADV guidance. 
As we look ahead, this, along with strong execution and performance of our Medicare business to continue to support the competitiveness of our Medicare Advantage products. 
Other Medicare business, Part D, also had a very good first quarter. Coventry has national Part D footprint and is #5 nationwide in market share. As you may recall from the open enrollment period coming into 2012, we're able to expand our auto-assigned footprint from 15 to 23 regions and launched a third product with a preferred network creating attractive value proposition for seniors. And results were very satisfying. We grew 28% sequentially in the first quarter 2012, ending 315,000 members. Our Part D medical loss ratio is consistent with prior year Q1 and on track for the first full year forecast of low to the mid-80s of medical loss ratios.
Our combined and Medicare business represents approximately $4.3 billion of annual revenue or about 30% of the company's total revenue. From our perspective, Medicare has an attractive growth and margin profile and we're all to an excellent start in 2012.
Moving onto our Fee-based businesses, Coventry's diversified across 3 business signs: Workers' Compensation service, employee administration and Rental Network. Our Fee business has produced over $1.1 billion in free revenue with higher-margin characteristics that are risk business. First quarter of 2012 was slightly ahead of our previous plan and as you can see, we increased our forecast of fee revenue for the full year. These Fee business is an important part of our diversified portfolio and they generate strong earnings upon unregulated cash flow. 
Moving onto our Commercial business. We continue to focus on building and signing new contracts for high performance networks as I've covered last quarter. Regardless of the outcome of reform, we believe driving to low-cost structure will best position Coventry, enable us to create products to provide a compelling value proposition for both employees, and individuals as an employer groups. We currently saw a Group commercial products through health plans in 25 states. We spend the last 6 years in developing individual products and capabilities and currently sell individual products alongside our historically strong group products in all of those states. 
The gaining factor for Coventry ending a commercial market, either organically or through acquisition, is cost structure. In many cases a network oppose a cost structure is a key asset in an acquisition and often negotiated as a part of a transaction. In other cases, we're able to use a collective set of Company assets including our locally based health plans and other national businesses to maintain a top tier cost structure and existing markets and negotiate favorable cost structure in new markets. We expect our high performance networks to play an important part in both the existing and new markets. 
Ultimately, we look forward to seizing growth driven by the Health Care Reform jump ball, or quickly adopted Health Care Reform cost changes. 
Nimbleness and local marker intelligence through our Health Plan presence is historically been a key strength in our commercial Health Plan business for at least 15 years. We expect our efforts will position us for success regardless of the direction of Health Care Reform. 
I'm moving on to Medicaid. Our Medicaid business is experienced significant growth coming into 2012. We're currently in 10 states covering members and program spanning, temporary aid in needy families, age blinds and disabled, bills and chip members. Coventry's managed Medicaid populations and programs since the early days have state based managed care adoption over a decade and a half ago. Our Medicaid experience solutions certainly contributed to Coventry's successful pre-procurement of Missouri, our largest state presence in terms of membership which was announced by the state of Missouri during the first quarter. In addition, we look forward to adding to our position in Nebraska later in 2012 based on the when discussed in our last conference call. 
We also today has some news to report on the Medicaid RFP fee from. This week, our Pennsylvania subsidiary Health America was awarded 2 letters of intent to contract which will cover new managed care regions in eastern and Western Pennsylvania. As you may recall, we already have a Medicaid footprint in south eastern and southwestern Pennsylvania. The Commonwealth of Pennsylvania has selected 4 carriers in the West for a targeted effective date of September 1, 2012, to manage approximately 165,000 eligibles. Pre-carriers are selected in the east including Health America for a targeted implementation in Q1 2013 to manage approximately 215,000 eligibles. 
So as a result, we look forward to serving our share of the 380,000 members when these programs live. 
Our mature Medicaid business performed consistent with our expectations for the first quarter. With respect to our new Medicaid businesses, as you will recall close to Family Health Partners acquisition on January 1 of this year which our results reflect the first few months of our ownership there. I'm pleased with our relationship with Children's Mercy Hospital in Kansas City, key partner in providing quality care to children in Missouri and Kansas. As you would expect, this relationship was certainly an important element of the transaction. The integration of the acquired business is on track 3 months post closing and a successful procurement outcome in Missouri is a very good start to this acquisition. 
Our remaining relatively new Medicaid business is Kentucky, which is for us producing very negative financial results. Actually we're getting our tails kicked. Kentucky is in early stages of the 36-month contract, which was effective November 1, 2011. Now that we have 5 months of data, it's clear that our poor financial results really result from 3 areas: one of which was anticipated and 2 of which were not. First area is a result of adverse risk selection. How did this happen? Well the RFP which responded to and all other bidders responded to, required a robust list of contractor providers in all 7 regions in order to bid. If the response was an adequate in any 1 of the 7 regions, responding companies would've been eliminated for all regions. Coventry responded in this stringent standard and compiled in all regions even though the provider cost and health status of the Commonwealth of Kentucky citizens is more challenging in regions 7 and 8. Not all company selected responded the matter in the matter that we did but nevertheless allowed to participate in all regions. And the result was what you expect which we received a disproportionate number of members with high utilization enrolled in high-cost systems. Our company also exacerbated our problem by being the only carrier not to require copayments in pharmacy.
In the RFP, the Commonwealth of Kentucky committed to an appropriate risk adjustment mechanism to adjust or partially adjust for pre-reverse risk whether this time, we've been unable to cope obtain a commitment for compensation which would address the adverse risk action required by the contract that we have with them. As discussion is ongoing and while we cannot be specific as to the timing, we feel that this discussions will be successful. The second and unanticipated area was at least one air from the Commonwealth that the book and we bid the business with regard to passthrough payments to hospital for medical education. This was clearly an oversight with the Commonwealth and while we have not been able to obtain agreement from the Kentucky at this time, from this front, what we believe we will ultimately be successful and obtain adjustment for this hospital past prepayments.
Third area is the basics of managed care, which was anticipated. How do we take better care of members in a more cost-effective manner? It was expected and we now have the data to address the basics of approved care for the members and the initiative Tessera to control costs and improve care. These areas include pharmaceutical abuses, mental health issues, too many non par providers and so many other areas. We are currently working on about 50 initiatives, which will deliver value to the Kentucky Medicaid program and improve outcomes for the members.
Bottom line, we're confident our discussions with a Commonwealth of Kentucky and our Medicaid issues will make this a viable program for the future. Hopefully you've listened carefully to our discussion about Kentucky as we will not entertain any questions on this subject during the Q&A portion. We're obviously on an ongoing discussion with the Commonwealth of Kentucky in many areas as well as many providers and it would be inappropriate to talk about details of these discussions in this forum. 
One more thought on Kentucky. It's important to reiterate that the population previously operated and completely unmonitored earlier., only talk about the members but also positions especially vendors, pharmacies and so on. About assure you that we resources of the company to Baird the work of the Commonwealth an appropriate solutions such as proper risk adjustment and fair and equal treatment on implementing dozens of healthcare initiatives should bring medical cost down perspectively. More resources our company finding the proper long-term solution, make it financially sound and workable  while improving the care for the members. And while we work on improvements in Kentucky, our other diversified business continue to perform well and we're seeking out and other selective growth opportunities across our broad set of businesses. 
Our balance sheet is in excellent condition as I referenced in the last earning call with the reduced level of debt and we currently have $900 million of deployable cash on hand as of March 31, as well as an untapped credit facility of $750 million. At the regularly scheduled board meeting in mid-March, we spent time on capital deployment avenues including M&A, share repurchase and is the first time in the companies history our board approved the dividend to complement these other methods of delivering value to our shareholders. Those of you who are shareholders as of March 23, should have received your first quarterly dividend on April 9. While the level of cash generated on our businesses and our capitalization we believe we can continue to value to shareholders and M&A share repurchase while also provided for dividend that today analyzes to approximately $7 million. Recap our first quarter capital deployment activity we close and acquisition, a down $234 million of debt and declared our first shareholder dividend. We are planning to continue with the share repurchase program beginning in Q2 at level somewhere 2012, absent any compelling M&A opportunities or other usage. While we are evaluate and react each quarter to needs and opportunities, we are committed to a continuation of capital deployment. I'm really pleased with the position by diversified set the businesses and resulting opportunities that should be able to seize over the next few years and Medicare Advantage, Medicaid, eligibles and potential opportunities in the commercial market. In addition to the companies organic opportunities, we'll also selectively deploy capital to grow our business footprint. The benefit of having us set of well diversified businesses in a strong balance sheet, is a strength that allows us to invest to new opportunities and survive the challenges that New Ventures often bring. While I'm disappointed in the early start of the Kentucky contract, we will continue to seek new Medicaid opportunities along with growing our other businesses to bring the long-term value necessary for owners. And with those comments, I'll conclude my part of the presentation and our Chief Financial Officer, Randy Giles, will take you through the financials. Randy?"
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Thank you, Allen. This morning I want to begin by discussing our consolidated performance in the first quarter and then spend the remainder of my time reviewing our first quarter results and full year outlook for each of our key businesses. GAAP earnings",2718,"Thank you, Allen. This morning I want to begin by discussing our consolidated performance in the first quarter and then spend the remainder of my time reviewing our first quarter results and full year outlook for each of our key businesses. GAAP earnings per share for the first quarter was $1.20, which include the $0.58 benefit in the release of the reserves related to RADV as Allen described in his prepared remarks and $0.62 of earnings generated by the company's operations excluding the RADV item. As you saw on this morning's earnings release, our full year GAAP EPS guidance range is $3.10 to $3.30 inclusive of favorable impact of the RADV reserve release as well as other updates that will detail further in my commentary this morning.
It's important to note that this guidance range does not reflect the impact of anticipated share repurchases in 2012 beyond those required the whole share count flat as where we ended 2011. Our consolidated revenue guidance now exceeds $14 billion at the midpoint with the similar mix of business roughly 40% commercial, 30% Medicare, 20% Medicaid and just under 10% being other. As in our previous guidance, we're reflecting movement to a more balanced mix over 2011. This strategically diversification across our balanced portfolio of businesses gives us a flexibility to adapt to today's fluid regulatory environment and seize opportunities across the products spectrum.
The results for the first quarter of 2012 were characterized by performance meeting or exceeding our expectations in 6 out of our 7 core businesses, with an outstanding result on SG&A as our cost control efforts coupled with leveraging top line growth continue to bear fruit for the organization. Our Q1 revenue of $3.7 billion, which is ahead of our previous guidance range drove the increase to our full year guidance midpoint $14.1 billion in revenue, which would be a record revenue level for the company reflecting a significant acceleration of the company's growth rate over 2011. 
Starting with the Commercial business. First quarter MLR of 79.9%, keeps us on track for a full year MLR guidance range of 81% to 82%. This is consistent with the 81.6% result that we reported for full year 2011 which was the first year impacted by minimum MLRs relations. We are currently projecting total Commercial Risk revenues of just under $6 billion for the year. The individual business expected to generate approximately $425 million of that total. The remaining group risk revenues are expected to be roughly 40% small group and 60% large group, consistent with the mix that we saw in 2011. We currently estimate that approximately 25% of our Commercial Risk revenue is in the rebate position today. We will continue to evaluate strategies to effectively utilize rebate capital by providing more value to our customers, improving the attractiveness of our products, providing quality initiatives with hospitals and physicians to improve SEDAR scores, and the initiative to reduce future Healthcare cost. The thing in our commercial book, our view of fundamental prospective trend remains unchanged in the range of 8%, plus or minus 50 basis points. In the rearview mirror, we are seeing trends in the high sevens and continue to migrate higher in the very low levels seen during the second half of 2010 consistent with what we shared with you last quarter. Again these trends include the impact from the healthcare reform regulations implemented the September 23, 2010, which was fully incorporated into the current period were only partially included in the baseline. 
In the cost trend, which continues to be the larger driver of overall trend is stable. As we look at trend by component, in the first quarter we saw a slightly negative trend for inpatient days per thousand and we're projecting inpatient utilization trends to be flat to slightly positive prospectively, which is consistent with our prior prospective view given the historically low comparison levels that we're seeing during 2011. Utilization trends that we are seeing in the outpatient position categories continues to show signs of a slight increase similar to what we have observed over the last 2 quarters both remaining is slightly positive territory. This migration from negative outpatient physician utilization trend slightly positive as been gradually and has been anticipated in our pricing. 
Before I leave the commercial business, there is one other item that I would like to highlight this morning. In the first quarter, we signed a binding term sheet with Magellan's NIA subsidiary spending our strategic partnership, radiology, management services. This term sheet, renewed agreements that were set to expire the near-term structured overall terms of the agreement significantly lowered our capitative medical cost for this category of service. 
Moving on to government programs. Our Medicare results for the first quarter were driven by outstanding performance during the annual election period which I'd like to highlight in a little more detail. Starting with Medicare Part D. We solidified our number 5 national market share with the third highest absolute growth in the industry and the second highest growth on a percentage basis among our large peers as our innovative new product first help value plus enrolled approximately 375,000 members, increasing our total Part D membership to $1,158,000 at quarter end. We like our position for 2012 and expect to continue the Part D membership throughout the remainder of 2012. 
We're also pleased with enrollment results for our locally contracted Medicare Advantage products as we added 28,000 new members, which was the third is percentage growth, our large competitors including growth in 1 of our 15 states increasing total Medicare Advantage Membership to 250,000 members at quarter end.
Medicare Advantage MLR of 74.1% reported or 82.9% for the quarter, excluding the favorable impact from RADV reserve releases is clearly a very strong start of the year consistent with our full year MLR guidance excluding RADV impact in the mid-to low 80s. This result were supported by mid-single digit reduction in days per thousand from the prior year quarter. Medicare part D results for the first quarter was also strong. In terms of growth our MLR of 94.9% keeps us on track for our full year MLR guidance in the low to mid-80s. 
We'll now discuss our Medicaid business in detail as we saw MLR in the first quarter that I want to address and also talk about some of the initiatives that we're working on to improve these results throughout the remainder of 2012. First, let me remind you that we have Medicaid business in test is to date the total Medicaid Membership of 924,000 at quarter end, which is increased by 97% from the prior year quarter as we work towards our goal of enrolling 1 million Medicaid members. With the exception of the ramp-up in Kentucky, our Medicaid business is performing well both in terms of organic membership growth and MLR performance. MLR outline some of the challenges that we are experiencing Kentucky which I would like now elaborate on. Our outdated guidance incorporates a projection for Medicaid MLR in the mid-90s for the full year, increase from our previous guidance of approximately 90% driven entirely by Kentucky. As we discussed in the fourth quarter 2011 earnings call, the Commonwealth of Kentucky quickly transitioned a highly unmanaged Medicaid population to managed care November 2011. Coventry build on this business is always an underlying assumption that projected historically elevated to spending levels and through the implementation of the traditional managed care protocols an improvement of patient care reducing both excessive utilization and wasteful spending over time. This process has been more challenging than we have forecast. As our reported MLR in the first quarter 2012 were 120.9% is higher than what we recorded the fourth quarter of 2011. We like to reiterate Allen's comments that we are very disappointed in this outcome. We are focused many other companies senior executives in addressing the situation. We have also strengthen our management in the ground significant resources. Reasons that I'm sure you'd understand I could not get into specifics in this decision that we're having with the Commonwealth but let me broadly outline for you but we are doing both in terms of the revenue side as well as medical cost initiatives. On the revenue side, we're in discussions with a Commonwealth are under appropriate mechanism for risk adjustment payments as stipulated in our contract. At this point, it also remains unclear whether these payments are going to be made retroactively to the contract an inception date or whether it be perspective owner. 
Also working to address certain date the book areas some example supplemental payments which we have more match our revenue with underlying cost structure dynamics of this contract. And finally, as we disclosed previously, we have a 5.3% rate increase which will take effect on October 1 of this year. 
On the expense side, our management team and some of our top clinical professionals and other areas of organization are fully engaged in implementing more than 50 real-time ongoing action items based upon emerging data to address higher cost areas. This cleared the pharmacy behavioral health cause in particular exceeding our previous book projections now that we have a stable population based been able to effectively deploy our solutions for these specific pressure areas. As an example do run with a pharmacy costs should benefit from an ongoing increase in generic utilization through all major branded drugs converting to generic here in 2012. We've also develop initiatives to address areas is up your questionable prescribing patterns which is all part of turning unmanaged program into managed care. Our summer initiative network construction profiling and collaboration efforts, fraud and abuse increased pre authorization process, increasing member cost-sharing and so on. In the first quarter, the rules around transitional care from the unmanaged period ended -- we are now able to implement processes to improve care coordination and manage cost. Also in the first quarter, the reimbursement level for non-part for writers was reduced from 100% and the Kentucky Medicaid fee is scheduled to 90%. On extensive list of other initiatives as well covering all categories of expense as being worked on every day and evaluated by senior management. But all of these are not things that we can turn around immediately, we expect continued improvement during 2012 to resolve matters with a Commonwealth and bring run rate with cost down based upon the initiatives outlined above. We're actually focused of rectifying this isolated situation. 
Before I conclude my Medicaid commentary, I would like to highlight that 75% of our membership with the resides in other states other than Kentucky's performing well both in terms of financial results in terms of seizing growth opportunities. In the last earnings call, we highlighted our contract to win Nebraska and market share and be the only participant with the statewide presence when that contract commences in the third quarter of this year. Also announced a new contract in Pennsylvania commencing during the second quarter as we were awarded entry into the Southwest region of Pennsylvania's Medicaid program, Health Choices. We began enrolling new members on April 1 and that region expect to gradually grow our market share through auto assignment somewhat growing presence in the Southeast region. I'm excited to announce that on the heels that are launched in that Southwest region we were just notified recently as Allen mentioned but we have been awarded significant letters of intent to contract in both the new west,  new east zones of Pennsylvania as well with total Medicaid of approximately 380,000. U.S. contracts is expected to commence in September then the New East contract beginning in March of 2013 not expect to have a material impact on our financial results for 2012. While our winning Missouri was at this air only new business our very pleased our Medicaid team is able to obtain #1 market position in that state including the recently acquired Family Health Partners business which represents our largest presence in terms of membership today. 
Now moving on to our fee-based businesses. Our updated guidance incorporates an improved view of management services revenue driven by higher than expected revenue Workers' Compensation business as well as their Paul Ridzon Health Plan ASO. Increase in our guidance for the cost of sales line item reflects a portion of growth that we are seeing Worker's Compensation services. Our fee businesses are an important part of our product portfolio strategy driving the reverification from our large risk base business with valuable unregulated cash flows and area that we intend to grow and invest in prospectively. 
SG&A results for the quarter and corresponding full year guidance reflect the continued progress that the company is making towards cost structured that we believe is an important Coventry's long-term strategy. For the first quarter, we reported SG&A expense of $502.9 million, 13.6% of revenue driven by careful management of headcount and other cost even as we continue to grow the top line revenue. In addition, we are seeing increased traction our broker pass through strategy the commercial group business which is an official impact on our SG&A expense levels. Our revised full year SG&A guidance midpoint of 14.9% of revenue is an improvement of 160 basis points from 202011 is particularly satisfying when you considered additional expense that we are incurring with compliance with new healthcare regulations, investments in our recently added businesses, as well as increasing investments that we're making for future growth. 
The full year guidance include our normal assumption for elevated level spent during the fourth quarter related to the Medicare a be through typical January 11 expenses for the Commercial Risk business. As you saw in this morning's press release, our cash flow from operations for the quarter is $420.5 million, 246% of net income. This result include the receipt of an extra payment from CMS in the quarter as well as a positive adjustment related to the RADV reserve release. Adjusting for the site if our cash flow from operations is $123 million or more typical 139% of net income. 
Moving on to our balance sheet and cash flows. Our investment portfolio remained in a high-quality position for the first quarter as the net unrealized gain of $100 million in March 31, an increase from $97 million at the end of 2011. At the end of the quarter we have $900 million of deployable cash flow is a parent consistent with the level that we just disclosed in our prior earnings call which was as of January 31. As usual, the second quarter will begin our annual regulated subsidiary dividend process. First quarter was quite an uneventful one on the capital deployment front. We began was a Family Court partners acquisition early January, we paid off our $234 million senior notes that came due later the month. On March 12, the companies now dividend in its history which was subsequently paid on April 9. I mentioned that we committed to point capital to our share repurchase beginning the second quarter and targeting levels comparable to 2011. Important to note that our PPS guidance range does not include anticipated share repurchases in 2012 down those required the whole flat where we ended 2011. Acquisition within our top priority to use our cash was dividend share repurchase reflecting our goal of maintaining a well-balanced capital deployment strategy. 
Debt to cap is at a very reasonable level 25.2% at quarter end. We have an undrawn $750 million credit facility with the scheduled to expire doing 2016, which combined with our free cash of $900 million provides capacitive $1.65 billion and significant financial flexibility as we evaluate perspective opportunity. 
In conclusion, I'm encouraged to see significant progress being made across all of our businesses as we work towards our 2012 financial objectives position the company for tomorrow. We have tripled our projected revenue growth rate part of prior year. We've added more than $700,000 new members as compared to the prior year quarter. With personally focus on identifying the right investments for the future pursuing growth opportunities across our portfolio businesses and improving our financial performance of existing businesses the strength in the company to produce long-term value for our shareholders. Operator this now concludes our prepared remarks, and we are ready to open the lines for questions."
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","[Operator Instructions] We take our question from Tom Carroll with Diffely Clouse.",12,"[Operator Instructions] We take our question from Tom Carroll with Diffely Clouse."
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I have a high-level question on Medicaid. If I back out Kentucky, it seems that your other Medicaid markets are operating in the high 80s in terms of the an MLR and if I combine that with the comments you made today, is a high 80s MLR a level we should th",111,"I have a high-level question on Medicaid. If I back out Kentucky, it seems that your other Medicaid markets are operating in the high 80s in terms of the an MLR and if I combine that with the comments you made today, is a high 80s MLR a level we should think about for Coventry's Medicaid business and kind of 2013 and beyond? And then secondly more of a smaller market question. I know it's a small market for you but the Maryland Medicaid plan has seen some slowing growth. Is there an opportunity to maybe divest that business in focused elsewhere or try to improve it? What's up there?"
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","This is Randy. As far as our Target Medicaid MLR long-term we think that's can be run in the mid-high 80s. So that would be our Target for long-term to answer that question. As it relates to our Maryland operation, we really don't discuss kind of our outl",107,"This is Randy. As far as our Target Medicaid MLR long-term we think that's can be run in the mid-high 80s. So that would be our Target for long-term to answer that question. As it relates to our Maryland operation, we really don't discuss kind of our outlook on M&A activities around our existing businesses. Now we're looking to grow all of our existing markets we've actually somewhere smaller markets good reason expansion we're actually expanding in one of our smaller markets in Virginia recently were expanding this out softness were just a. Were looking to grow those businesses and evaluate each one on the standalone basis."
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","And our next question comes from Josh Raskin from Barclays.",10,"And our next question comes from Josh Raskin from Barclays."
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I understand Allen that you're after sort of avoid talking about the negotiations with the state but I was just wondering if you could sort of from a technical standpoint, when did you realize that this was an issue. You're locked in for service of 3-year",124,"I understand Allen that you're after sort of avoid talking about the negotiations with the state but I was just wondering if you could sort of from a technical standpoint, when did you realize that this was an issue. You're locked in for service of 3-year period from a pricing perspective but variability to simply cut date and walk at any point. And then I guess the other issue in terms in my mind, it looks like you're already implying from a financial standpoint, it's look like you're already implying improvement in the next couple of quarters sounded like you didn't think that the immediate impact on or action so I'm just and it curious what's driving that improvement as you move forward?"
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think as to the when, so far reserves and November, December are consistent with my comments, we knew that going from the start, costar to manage the population was going to take some time. I think as we started to get the data in the first quarter and",255,"I think as to the when, so far reserves and November, December are consistent with my comments, we knew that going from the start, costar to manage the population was going to take some time. I think as we started to get the data in the first quarter and I would characterize that as being late February, we became aware of the dispersion of proportionate membership and high-cost regions with high utilization high-cost regions so the light part of February, we came much more knowledgeable about what our problems beyond this managing the population was. When you go from other start, I think the lessons learned here is that I would be reluctant to participate in any new initiative that's pushed through in 90 to 120 days with only 60 days or so to prepare for the population. So those are lessons learned. But I think to the 50 initiative that we have in the healthcare front, on the healthcare management front are beginning and will begin to show some improvement, which is far do recent guidance for the rest of the. I think the number of providers data on who's more efficient as opposed to less efficient. We will be refining that process that will bring improvement to the year. And ultimately, consistent with my prepared comments, I think that we will be successful in reaching an accommodation with the Commonwealth consistent with a contract that we signed. So it's everybody's going to get better. And that's about what I can say about it."
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then just one quick question on the Kansas Medicaid award. Could you help us size your current exposure there in terms of revenues and I guess even give some commentary around profitability relative to the overall?",37,"And then just one quick question on the Kansas Medicaid award. Could you help us size your current exposure there in terms of revenues and I guess even give some commentary around profitability relative to the overall?"
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","We're in the middle of the discussion process with the State of Kansas now and I think there will be some clarity on world that leads in the next 30 to 60 days. We don't have anything today that's remarkable -- remotely definitive we're in the middle of d",50,"We're in the middle of the discussion process with the State of Kansas now and I think there will be some clarity on world that leads in the next 30 to 60 days. We don't have anything today that's remarkable -- remotely definitive we're in the middle of discussions."
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I was asking how big is it currently?",8,"I was asking how big is it currently?"
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","About $350 million in revenue. About 150,000 members.",8,"About $350 million in revenue. About 150,000 members."
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","In the profits on that assume that your overall X Kentucky?",11,"In the profits on that assume that your overall X Kentucky?"
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well is a brand-new acquisition throughout HP and it's performing through our expectation. It's not where I think long-term ...",21,"Well is a brand-new acquisition throughout HP and it's performing through our expectation. It's not where I think long-term ..."
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","For what we know, after 90 days.",7,"For what we know, after 90 days."
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","We move now to Charles Brady with Crdit Suisse.",9,"We move now to Charles Brady with Crdit Suisse."
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just a few points for clarification because your comments were very fullsome and helpful in Kentucky. First, you talk about the issue with competitors not living up to their contractual obligations regarding service areas and I wonder it sounds like that",69,"Just a few points for clarification because your comments were very fullsome and helpful in Kentucky. First, you talk about the issue with competitors not living up to their contractual obligations regarding service areas and I wonder it sounds like that cost you financial harm and I just want to remedies you might have there against those competitors or is it really an issue you see with the state?"
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well I think it's the first issue is the state didn't hold everyone accountable to the requirements of the RFP. We usually do, we complied in good faith and some of the people didn't. The remedy is of course there is the contract has risk adjusted revenue",144,"Well I think it's the first issue is the state didn't hold everyone accountable to the requirements of the RFP. We usually do, we complied in good faith and some of the people didn't. The remedy is of course there is the contract has risk adjusted revenue remedies and that's data that's being discussed with the Commonwealth as we speak so there is a remedy or at least a partial remedy in the contract to adjust for the higher risk population. So that's part of the solution. I think after the -- half of our problem roughly is revenue base, which we believe is supported by the contract and that we we received some relief. Be specific is the wind and half of it is what we understood when we went like this maybe unmanaged population with a bunch of work to do."
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. The risk adjuster, how much did you accrue for assume risk payments in the first quarter?",17,"Okay. The risk adjuster, how much did you accrue for assume risk payments in the first quarter?"
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","We didn't accrue anything.",5,"We didn't accrue anything."
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","We didn't accrue anything because we've discussed with I think it's clarity we didn't have any with his resolution with the Commonwealth and within accrue anything until the check's clear.",31,"We didn't accrue anything because we've discussed with I think it's clarity we didn't have any with his resolution with the Commonwealth and within accrue anything until the check's clear."
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. So it's in the contract that you would be old this risk-adjusted things until you actually receive the cash for them you're not accruing the expected receipt. Is it in your guidance in mid-90s?",35,"Okay. So it's in the contract that you would be old this risk-adjusted things until you actually receive the cash for them you're not accruing the expected receipt. Is it in your guidance in mid-90s?"
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","That's consistent with the company's practice ever since I've been the CEO. And let's go off of Kentucky now because any details would be counterproductive to our discussions with the Commonwealth and with providers in the Commonwealth.",38,"That's consistent with the company's practice ever since I've been the CEO. And let's go off of Kentucky now because any details would be counterproductive to our discussions with the Commonwealth and with providers in the Commonwealth."
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","Let's go now to Scott Fidel from Deutsche Bank.",10,"Let's go now to Scott Fidel from Deutsche Bank."
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Atlantis got a question in terms of your comfort level more broadly on Medicaid right now. In terms on taking one's much additional growth given the challenges that you're seeing in Kentucky. Just particularly given your discussion about how much manageme",85,"Atlantis got a question in terms of your comfort level more broadly on Medicaid right now. In terms on taking one's much additional growth given the challenges that you're seeing in Kentucky. Just particularly given your discussion about how much management resources on the Medicaid side that you want to put into Kentucky and the 15 initiatives that you have going on there. How do you feel about management diluted about dedicate right now to address all of the other expenses that you're going on?"
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","When you think about Medicaid, we have a 15-year history going back to 1994 in Missouri. In the early -- in the late '90s, we had some places we would go from father rates cut by the Delaware at one time so the company went through a period of time where",347,"When you think about Medicaid, we have a 15-year history going back to 1994 in Missouri. In the early -- in the late '90s, we had some places we would go from father rates cut by the Delaware at one time so the company went through a period of time where we were sort of not sort of where we were holding doing what we have not very aggressive in pursuing opportunities. When I came back to the CEO spot in January of 2009, I thought the world has changed a lot in for your so we began developing resources and hopefully expertise and started putting corporate resources in the growing the business in the future in Nebraska was four-speed that we want on that front and I won't go through the history. We have was recently within the last quarter bought them on remote 25 years of our business and within the very successful reinvigorating our Commonwealth of Pennsylvania business in this year's along with Maryland and Delaware in the years and the past. So we have continually added people and added resources. And so strategically, I think it's a good business. I think it's like all of our businesses that you're going get better that we used to be that I think there's margin pressure on all of our businesses so best people and the bestpeople practices. So I think Kentucky was certainly an expensive education but we're learning proven I think we can compete for new business with everybody else and I think on the over man front where this Medicare Advantage Part D, I feel the same way with Medicaid that we have the structure, we have the better people would ever had, we are continuing to learn, we're continuing to do a better job taking care of the population so it's a part of our future and despite of a little with along the way our the but along the way where undaunted we think there's a lot of opportunity were going to continue to produce resource at and that revenue source."
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Just had analyst comments. I'd like to differentiate Kentucky a little bit from some of the other markets we're expanding like Pennsylvania and the other expansion opportunities that are in the immediate term for us. Those expansion opportunities includin",152,"Just had analyst comments. I'd like to differentiate Kentucky a little bit from some of the other markets we're expanding like Pennsylvania and the other expansion opportunities that are in the immediate term for us. Those expansion opportunities including Nebraska and Pennsylvania are in states where we have existing Health Plan this is, existing resources and we have existing Medicaid business. We have capabilities in people already and assess already deployed in those states. So as we think about expansion opportunities in those areas now with our HHP acquisition potentially Kansas, we have assets that have record asses we already have health plans we have a huge commercial business in Kansas already so other than Kentucky is a different situation where we're going to we for you have no resources on the ground. But with this other situation, we do have other resources we have expertise with Medicaid in those states already."
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. This a follow-up question just on your review of trend and prescriber to clarify did you just say sort of our run the high 7s in the look back basis and 1Q maybe just now that you have a lot more claims coming for the 4Q just interested in sort of h",75,"Okay. This a follow-up question just on your review of trend and prescriber to clarify did you just say sort of our run the high 7s in the look back basis and 1Q maybe just now that you have a lot more claims coming for the 4Q just interested in sort of how you view -- how trend progress sequentially from 4Q to 1Q '12 which obviously there's not much claims experience at this point?"
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Our trend is really unchanged from the fourth quarter as we look at our period development how this developing for the last year, it's coming in stronger than 2010 at a higher level. So we feel good about kind of our current forecast and where we think th",76,"Our trend is really unchanged from the fourth quarter as we look at our period development how this developing for the last year, it's coming in stronger than 2010 at a higher level. So we feel good about kind of our current forecast and where we think that. The trend is really see very similar our views very similar to the fourth quarter. We don't see change in that I look in this point in time."
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","Our next question will go to Carl McDonald with Citi.",10,"Our next question will go to Carl McDonald with Citi."
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Could you talk about how you think about premium deficiency reserves and when the right situation to use one is and when one not?",24,"Could you talk about how you think about premium deficiency reserves and when the right situation to use one is and when one not?"
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Premium deficiency reserves obviously work with our accounts and around individual contracts and look at the entire contract period as required and we look at those on individual contracts by contract basis. And if that make sense or another situation we",82,"Premium deficiency reserves obviously work with our accounts and around individual contracts and look at the entire contract period as required and we look at those on individual contracts by contract basis. And if that make sense or another situation we look at our entire block of business. So we look at that, we evaluate that the every quarter and we make an assessment and we work with our auditors and we have review our analysis and that's where the process works."
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","And that's specific to Kentucky we don't know what the revenue is until we reach position with the Commonwealth and I don't know that after 5 months of exactly have a close of hand alone on the medical expenses you will 3 months from now so when you have",70,"And that's specific to Kentucky we don't know what the revenue is until we reach position with the Commonwealth and I don't know that after 5 months of exactly have a close of hand alone on the medical expenses you will 3 months from now so when you have all of the facts if it's appropriate, along with that's what we'll do we don't have all the facts yet."
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. And then a quick follow-up. It looks like the change in the Medicaid loss ratio if it's Kentucky pushes of the Kentucky loss ratio season hundred basis points give or take what are your assumptions for the Kentucky and medical loss ratio guidance?",44,"Okay. And then a quick follow-up. It looks like the change in the Medicaid loss ratio if it's Kentucky pushes of the Kentucky loss ratio season hundred basis points give or take what are your assumptions for the Kentucky and medical loss ratio guidance?"
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","We don't really break out contract specific guidance around individual loss ratios. I'll comment on the Dean car increase and MLR guidance for the Medicare line is related to Kentucky.",31,"We don't really break out contract specific guidance around individual loss ratios. I'll comment on the Dean car increase and MLR guidance for the Medicare line is related to Kentucky."
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","For our final question, we go to Doug Simpson with Morgan Stanley.",12,"For our final question, we go to Doug Simpson with Morgan Stanley."
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just to be a little bit of a dead horse here. As we're thinking about Kentucky, maybe a different way to look up about that call that 15, 16 points in the MLR that will be implied if you attribute the entire $0.58 to the premium associated with Kentucky.",135,"Just to be a little bit of a dead horse here. As we're thinking about Kentucky, maybe a different way to look up about that call that 15, 16 points in the MLR that will be implied if you attribute the entire $0.58 to the premium associated with Kentucky. How would you characterize your expectation in the balance of the year if I heard you right, you're not including an incremental pass through receipts or anything under risk adjuster front. Is it kind of correct to think about the seasonality that we would have expected as of yesterday? And then burden each quarter by that roughly 15, 16 points in the MLR? And is that -- would that get us in the rights zipcode in terms of thinking of seasonality and the contribution from Kentucky?"
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think we can't do much more than we've done, which is let's say half of it is in revenue based on what we're discussion, the other half is medical initiatives, explain that we have 50 initiatives, 50 that we're also refining our provider system there an",214,"I think we can't do much more than we've done, which is let's say half of it is in revenue based on what we're discussion, the other half is medical initiatives, explain that we have 50 initiatives, 50 that we're also refining our provider system there and concentrating more on membership and where we're going to get a better result. I don't think that we can the day by day or week by week but we know cumulatively effective management will improve our position as the year progresses. And we know that we have a large revenue increase coming October 1. So when you add the discussions up, the medical initiatives, the revenue, we know we're getting to get, we're going to go from a terrible picture to an improving picture as the year progresses and that's about as good as we can do as this point. I think that Q2 will bring clarity to the resolution with a Commonwealth and I think Q2's going to bring us some clarity for 3 more months of data and medical initiatives were we're starting to work revenue this is so many unanswered question for the entire year. I think that Q2 will bring a partial answer to what the rest of the year looks like."
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I may have missed this, I apologize if I did. Randy, did you say that how RADV benefit was treated on the income statement?",24,"I may have missed this, I apologize if I did. Randy, did you say that how RADV benefit was treated on the income statement?"
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","I wasn't an increase to revenue.",7,"I wasn't an increase to revenue."
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So just drop the revenue straightaway? Okay.",7,"So just drop the revenue straightaway? Okay."
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes.",1,"Yes."
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","Ladies and gentlemen, that does conclude today's question-and-answer question. I'd like to turn the conference back over to Mr. Wise for any additional or closing remarks.",26,"Ladies and gentlemen, that does conclude today's question-and-answer question. I'd like to turn the conference back over to Mr. Wise for any additional or closing remarks."
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well we don't have any additional remarks and thank you so much for joining us today.",17,"Well we don't have any additional remarks and thank you so much for joining us today."
27133,204626278,291007,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","Ladies and gentlemen, that does conclude today's conference. Once again, thank you for your participation.",15,"Ladies and gentlemen, that does conclude today's conference. Once again, thank you for your participation."
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","Good morning, and welcome to Coventry Health Care's First Quarter 2012 Earnings Conference Call. Today's conference is being recorded [Operator Instructions] Today's call will begin with an opening remarks by Chief Executive Officer of Coventry Health Car",54,"Good morning, and welcome to Coventry Health Care's First Quarter 2012 Earnings Conference Call. Today's conference is being recorded [Operator Instructions] Today's call will begin with an opening remarks by Chief Executive Officer of Coventry Health Care, Mr. Allen Wise, after a brief forward-looking statement read by Mr. Drew Asher. Please go ahead Drew."
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Ladies and gentlemen, during this call, we will make forward-looking statements. Certain risks and uncertainties, including those referenced in our press release and described in the company's filings with the SEC on Form 10-K for the year ended December",61,"Ladies and gentlemen, during this call, we will make forward-looking statements. Certain risks and uncertainties, including those referenced in our press release and described in the company's filings with the SEC on Form 10-K for the year ended December 31, 2011, may materially impact those statements and could cause actual future results to differ materially from those anticipated and discussed. Allen?"
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Good morning, and thank you for your interest in Coventry Health Care. Earlier today, we reported the best quarter in the history of our company both in terms of revenue and earnings per share. Q1 revenue was $3.7 billion, and that's up 21% from the first",2380,"Good morning, and thank you for your interest in Coventry Health Care. Earlier today, we reported the best quarter in the history of our company both in terms of revenue and earnings per share. Q1 revenue was $3.7 billion, and that's up 21% from the first quarter of last year. And earnings per share of $1.20 driven by strength across 6 of our 7 businesses, specially our Medicare Advantage business. 
As you can see in our current Medicaid medical loss ratio, we had some serious work to do in our recently added Medicaid business, but all of Coventry's other businesses: Commercial, Medicare Advantage, Medicare Part D and our Fee-based businesses were on track or ahead of plan for the quarter. With regard to SG&A, we closed at a very strong result with the rate of 13.6%, which is down 280 basis points from the first quarter of 2011. 
Today, I'd like to touch on each of our businesses and share with you our current perspective and probably more importantly where we're heading. And let's start with Medicare. The strength of the quarter in terms of Medicare Advantage was primarily driven by 3 factors: A very successful open enrollment season, which resulted in sequential membership growth of 13% or 28,000 members. The second was a very favorable outcome from the risk adjustment data validation audit process proceed to methodology changes issued by CMS during the quarter enabling us to reduce our related reserve that were built over the last several years. And third, strong operating results in Medicare Advantage even absent the operating earnings driven by the RADV reserve release. 
I believe it's worth a moments staying on Medicare Advantage. We operate Medicare Advantage Health Plans in 15 states. 14 of these states growing coming into 2012. We're pleased with the momentum of this business and expect to continue to expand our footprint and membership base over the next few years. We have taken what we believe was a prudent posture over the last few years and accruing our best estimate of RADV liability even in the absence of perfect clarity. 
The update in guidance from CMS were able to reflect the reduction in the RADV reserve of $133 million or $0.58 per share contributing to the strong Medicare operating results in the quarter. This is important for a couple of reasons. First of all, it should give you insight into the prudence in reserving for this type of exposure, which I believe was not necessarily consistent industrywide. And perhaps more important, we were able to substantially reduce a headwind in our Medicare Advantage bids since we'll now adapt to the updated CMS RADV guidance. 
As we look ahead, this, along with strong execution and performance of our Medicare business to continue to support the competitiveness of our Medicare Advantage products. 
Other Medicare business, Part D, also had a very good first quarter. Coventry has a national Part D footprint and is #5 nationwide in market share. As you may recall from the open enrollment period coming into 2012, we're able to expand our auto-assigned footprint from 15 to 23 regions and launched a third product with a preferred network creating attractive value proposition for seniors. And the results were very satisfying. We grew 28% sequentially in the first quarter 2012, ending 315,000 members. Our Part D medical loss ratio is consistent with prior year Q1 and on track for the first full year forecast of low to the mid-80s of medical loss ratios.
Our combined and Medicare business represents approximately $4.3 billion of annual revenue or about 30% of the company's total revenue. From our perspective, Medicare has an attractive growth and margin profile and where all did an excellent start in 2012.
Moving on to our Fee-based businesses, Coventry's diversified across 3 business signs: Workers' Compensation service, better employee administration and Rental Network. Our Fee businesses produced over $1.1 billion in free revenue with higher-margin characteristics than our Risk business. First quarter of 2012, was slightly ahead of our previous plan and as you can see, we increased our forecast of fee revenue for the full year. These Fee businesses are important part of our diversified portfolio and they generate strong earnings upon unregulated cash flow. 
Moving onto our Commercial business. We continue to focus on building and signing new contracts for high performance networks, as I've covered last quarter. Regardless of the outcome of reform, we believe driving to a low-cost structure will best position Coventry, enable us to create products to provide a compelling value proposition for both employees, [indiscernible] individuals and employer groups. We currently sell a Group commercial products through our health plans in 25 states. We spent the last 6 years developing individual products and capabilities and currently sell individual products alongside our historically strong Group products in all of those states. 
The gaining factor for Coventry ending a commercial market, either organically or through acquisition, is cost structure. In many cases a network oppose of cost structure is a key asset in an acquisition and often negotiated as a part of a transaction. In other cases, we're able to use a collective set of Company assets including our locally-based health plans and other national businesses to maintain a top tier cost structure and existing markets and negotiate favorable cost structure in new markets. We expect our high performance networks to play an important part in both the existing and new markets. 
Ultimately, we look forward to seizing growth driven by the Health Care Reform jump ball, or quickly adopt a Health Care Reform cost changes. 
Nimbleness and local marker intelligence through our Health Plan presence is historically been a key strength in our commercial Health Plan business for at least 15 years. We expect our efforts will position us for success regardless of the direction of Health Care Reform. 
I'm moving on to Medicaid. Our Medicaid business has experienced significant growth coming into 2012. We're currently in 10 states carrying members in program spanning, temporary aid in needy families, age blind and disabled, bills and CHIP members. Coventry's Health stage managed Medicaid populations and programs since the early days of state-based managed care adoption over 1.5 decade. Our Medicaid experience in solutions certainly contributed to Coventry's successful pre-procurement of Missouri, our largest state presence in terms of membership which was announced by the state of Missouri during the first quarter. In addition, we look forward to adding to our position in Nebraska later in 2012, based on the when discussed in our last conference call. 
We also today has some news to report on the Medicaid RFP front. This week, our Pennsylvania subsidiary Health America, was awarded 2 letters of intent to contract which will cover new managed care regions in Eastern and Western Pennsylvania. As you may recall, we already have a Medicaid footprint in South Eastern and Southwestern Pennsylvania. The Commonwealth of Pennsylvania has selected 4 carriers in the West for a targeted effective date of September 1, 2012, to manage approximately 165,000 eligibles. Pre-carriers are selected in the East including Health America for a targeted implementation date in Q1 2013 to manage approximately 215,000 eligibles. 
So as a result, we look forward to serving our share of the 380,000 members when these programs go live. 
Our mature Medicaid business performed consistent with our expectations for the first quarter. With respect to our new Medicaid businesses, as you will recall close to Family Health Partners acquisition on January 1 of this year, which our results reflect the first few months of our ownership there. I'm pleased with our relationship with Children's Mercy Hospital in Kansas City, key partner in providing quality care to children in Missouri and Kansas. As you would expect, this relationship was certainly an important element of the transaction. The integration of the acquired business is on track 3 months post closing and a successful procurement outcomes in Missouri was a very good start to this acquisition. 
Our remaining relatively new Medicaid business is Kentucky, which is for us producing very negative financial results. Actually we're getting our tails kicked. Kentucky is on early stages of the 36-month contract, which was effective November 1, 2011. Now that we have 5 months of data, it's clear that our poor financial results really result from 3 areas: one of which was anticipated and 2 of which were not. First area is a result of adverse risk selection. How did this happen? Well the RFP which we responded to and all other bidders responded to, required a robust list of contractor providers in all 7 regions in order to bid. If the response was inadequate in any one of the 7 regions, responding companies would've been eliminated for all regions. Coventry responded in this stringent standard and compiled in all regions, even though the provider cost and health status of the Commonwealth of Kentucky citizens is more challenging in regions 7 and 8. Not all company selected responded to the matter in the matter that we did but were nevertheless allowed to participate in all regions. And the result was what you would expect, which is we received a disproportionate number of members with high utilization enrolled in high-cost systems. Our company also exacerbated our problem by being the only carrier not to require copayments in pharmacy.
In the RFP, the Commonwealth of Kentucky committed to an appropriate risk adjustment mechanism to adjust or partially adjust to pre-adverse risk but at this time, we've been unable to obtain their commitment for compensation which would address the adverse risk selection as required by the contract that we have with them. As discussion is ongoing and while we cannot be specific as to the timing, we feel that this discussions will be successful. 
The second and unanticipated area was at least one error from the Commonwealth's data book when we bid the business with regard to pass-through payments to hospital for medical education. This was clearly an oversight with the Commonwealth and while we have not been able to attain agreement from Kentucky at this time, from this front, we believe we will ultimately be successful and obtain adjustment for this hospital pass-through payments.
Third area is the basics of managed care, which was anticipated. How do we take better care of members in a more cost-effective manner? It was expected and we now have the data to address the basics of approved care for the members and the initiative necessary to control costs and improve care. These areas include pharmaceutical abuses, mental health issues, too many non par providers and so many other areas. We are currently working on about 50 initiatives, which will deliver value to the Kentucky Medicaid program and improve outcomes for the members.
Bottom line, we're confident our discussions with a Commonwealth of Kentucky and our medical initiatives will make this a viable program for the future. Hopefully you've listened carefully to our discussion about Kentucky as we will not entertain any questions on this subject during the Q&A portion. We're obviously on an ongoing discussion with the Commonwealth of Kentucky in many areas as well as many providers and it would be inappropriate to talk about details of these discussions in this forum. 
One more thought on Kentucky. It's important to reiterate that the population previously operated in a completely unmanaged arena. And I'm not only talking about the members but also physicians especially vendors, pharmacies and so on. I want to assure you that we bet all the resources of the company to bear the work with the Commonwealth on appropriate solutions such as proper risk adjustment and fair and equal treatment on implementing dozens of healthcare initiatives should bring medical cost down perspectively. More resources our company are focused on finding the proper long-term solution, make it financially sound and workable  while improving the care for the members. But while we work on improvements in Kentucky, our other diversified business continue to perform well and we're seeking out an other selective growth opportunities across our broad set of businesses. 
Our balance sheet is in excellent condition as I referenced in the last earning call with the reduced level of debt. And we currently have $900 million of deployable cash on hand as of March 31, as well as an untapped credit facility of $750 million. At the regularly scheduled Board meeting in mid-March, we spent time on capital deployment avenues including M&A, share repurchase and for the first time in the companies history our Board approved the dividend to complement these other methods of delivering value to our shareholders. Those of you who are shareholders as of March 23, should have received your first quarterly dividend on April 9. 
While the level of cash generated in our businesses and our capitalization, we believe we continue to deliver value to shareholders and M&A share repurchase while also providing for dividend that today analyzes to approximately $70 million. 
Recap our first quarter capital deployment activity we close on acquisition, paid down $234 million of debt and declared our first shareholder dividend. We are planning to continue with the share repurchase program beginning in Q2 at level somewhere 2012, absent any compelling M&A opportunities or other usage. While we will evaluate and react each quarter to needs and opportunities, we are committed to a continuation of capital deployment. I'm really pleased with the position with our diversified set the businesses and resulting opportunities that we should be able to seize over the next few years in Medicare Advantage, Medicaid, bill eligibles and potential opportunities in the commercial market. 
In addition to the companies organic opportunities, we'll also selectively deploy capital to grow our business footprint. The benefit of having a set of well diversified businesses and a strong balance sheet, is a strength which allows us to invest to new opportunities and survive the challenges that new ventures often bring. While I'm disappointed in the early start of the Kentucky contract, we will continue to seek new Medicaid opportunities along with growing our other businesses to bring the long-term value necessary for owners. And with those comments, I'll conclude my part of the presentation and our Chief Financial Officer, Randy Giles, will take you through the financials. Randy?"
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Thank you, Allen. This morning I want to begin by discussing our consolidated performance in the first quarter and then spend the remainder of my time reviewing our first quarter results and full year outlook for each of our key businesses. GAAP earnings",2813,"Thank you, Allen. This morning I want to begin by discussing our consolidated performance in the first quarter and then spend the remainder of my time reviewing our first quarter results and full year outlook for each of our key businesses. GAAP earnings per share for the first quarter was $1.20, which include the $0.58 benefit from the release of the reserves related to RADV as Allen described in his prepared remarks and $0.62 of earnings generated by the company's operations excluding the RADV item. 
As you saw on this morning's earnings release, our full year GAAP EPS guidance range is $3.10 to $3.30 inclusive of favorable impact of the RADV reserve release as well as other updates that I will detail further in my commentary this morning.
It's important to note that this guidance range does not reflect the impact of anticipated share repurchases in 2012, beyond those required the whole share count flat was where we ended 2011. Our consolidated revenue guidance now exceeds $14 billion at the midpoint with the similar mix of business roughly 40% commercial, 30% Medicare, 20% Medicaid and just under 10% being other. As in our previous guidance, we're reflecting movement to a more balanced mix over 2011. This strategically diversification across our balanced portfolio of businesses gives us a flexibility to adapt to today's fluid regulatory environment and seize opportunities across the products spectrum.
The results for the first quarter of 2012, were characterized by performance meeting or exceeding our expectations in 6 out of our 7 core businesses, with an outstanding result on SG&A as our cost control efforts coupled with leveraging top line growth continue to bear fruit for the organization. Our Q1 revenue of $3.7 billion, which is ahead of our prior guidance range drove the increase to our full year guidance midpoint $14.1 billion in revenue, which would be a record revenue level for the company reflecting a significant acceleration in the company's growth rate over 2011. 
Starting with the Commercial business. First quarter MLR of 79.9%, keeps us on track for a full year MLR guidance range of 81% to 82%. This is consistent with the 81.6% result that we reported for full year 2011, which was the first year impacted by minimum MLRs regulations. We are currently projecting total Commercial Risk revenues of just under $6 billion for the year. The individual business expected to generate approximately $425 million of that total. The remaining Group risk revenues are expected to be roughly 40% small group and 60% large group, consistent with the mix that we saw in 2011. We currently estimate that approximately 25% of our Commercial Risk revenue is in the rebate position today. We will continue to evaluate strategies to effectively utilize rebate capital by providing more value to our customers, improving the attractiveness of our products, promoting quality initiatives with hospitals and physicians to improve HEDIS scores, and initiatives to reduce future Healthcare cost. 
Staying at our commercial book, our view of fundamental prospective trend remains unchanged in the range of 8%, plus or minus 50 basis points. In the rearview mirror, we are seeing trends in the high 7s and have continued to migrate higher from the very low levels seen during the second half of 2010 consistent with what we shared with you last quarter. Again these trends include the impact from the healthcare reform regulations implemented the September 23, 2010, which are fully incorporated into the current period but are only partially included in the baseline. 
In the cost trend, which continues to be the largest driver of overall trend is stable. As we look at trend by component, in the first quarter we saw a slightly negative trend for inpatient days per thousand and we're projecting inpatient utilization trends to be flat to slightly positive prospectively, which is consistent with our prior prospective view given the historically low comparison levels that we're seeing during 2011. 
Utilization trends that we are seeing in the outpatient position categories continues to show signs of a slight increase similar to what we've observed over the last 2 quarters with both remaining in slightly positive territory. This migration from negative outpatient physician utilization trend slightly positive has been gradual and has been anticipated in our pricing. 
Before I leave the Commercial business, there's one other item that I would like to highlight this morning. In the first quarter, we signed a binding term sheet with Magellan's NIA subsidiary [indiscernible] expanding our strategic partnership, radiology management services. This term sheet, renewed agreements that were set to expire the near-term restructured the overall terms of the agreement to significantly lower our capitative medical cost for this category of service. 
Moving on to government programs. Our Medicare results for the first quarter were driven by outstanding performance during the annual election period which I'd like to highlight in a little more detail. Starting with Medicare Part D. We solidified our number 5 national market share with the third highest absolute growth in the industry and the second highest growth on a percentage basis among our large peers as our innovative new product First Health Value Plus enrolled approximately 375,000 members, increasing our total Part D membership to $1,158,000 at quarter end. We like our positioning for 2012 and expect to continue to grow Part D membership throughout the remainder of 2012. 
We're also pleased with enrollment results for our locally-contracted Medicare Advantage products as we added 28,000 new members, which was the third best percentage growth among our large competitors and included growth in all the -- 1 of our 15 states increasing total Medicare Advantage Membership to 250,000 members at our quarter end.
Our Medicare Advantage MLR of 74.1% reported or 82.9% for the quarter, excluding the favorable impact from RADV reserve releases was clearly a very strong start of the year consistent with our full year MLR guidance excluding RADV impact in the mid-to low 80s. This result were supported by mid-single digit reduction in days per thousand from the prior year quarter. Our Medicare part D results for the first quarter were also strong in terms of growth and our MLR of 94.9% keeps us on track for our full year MLR guidance in the low to mid-80s. 
I will now discuss our Medicaid business in detail as we saw MLR pressure in the first quarter that I want to address and also talk about some of the initiatives that we're working on to improve these results throughout the remainder of 2012. First, let me remind you that we have Medicaid business in 10 states to date with total Medicaid Membership of 924,000 at quarter end, which is increased by 97% from the prior year quarter as we work towards our goal of enrolling 1 million Medicaid members. 
With the exception of the ramp-up in Kentucky, our Medicaid business is performing well both in terms of organic membership growth and MLR performance. Allen already outlined some of the challenges that we are experiencing Kentucky which I would like to now elaborate on. 
Our outdated guidance incorporates a projection for Medicaid MLR in the mid-90s for the full year, increase from our previous guidance of approximately 90% driven entirely by Kentucky. As we discussed in the fourth quarter of 2011 earnings call, the Commonwealth of Kentucky quickly transitioned a highly unmanaged Medicaid population to Manage Care in November 2011. 
When Coventry bid on this business, there was always an underlying assumption that projected taking historically elevated to spending levels and through the implementation of traditional Manage Care protocols an improvement of patient care reducing both excessive utilization and wasteful spending over time. This process has been more challenging than we have forecasted, as our reported MLR in the first quarter 2012 of 120.9% was higher than what we recorded in fourth quarter of 2011. I would like to reiterate Allen's comment that we are very disappointed in this outcome. And we've focused many of the company's senior executives in addressing the situation. We have also strengthen management on the ground and continued to add significant resources. For reasons that I'm sure you'd understand I cannot get into specifics on the discussions that we're having with the Commonwealth but let me broadly outline for you what we are doing both in terms of the revenue side as well as on medical cost initiatives. 
On the revenue side, we're in discussions with the Commonwealth around the appropriate mechanism for risk adjustment payments as stipulated in our contract. At this point, it also remains unclear whether these payments will be made retroactively to the contract inception date or whether it'll be prospective only. 
We're also working to address certain data book errors, for example around supplemental payments which would more properly match our revenue with underlying cost structure dynamics of this contract. And finally, as we disclosed previously, we have a 5.3% rate increase which will take effect on October 1 of this year. 
On the expense side, our management team and some of our top clinical professionals from other areas of the organization are fully engaged in implementing more than 50 real-time ongoing action items based upon emerging data to address higher cost areas. 
This cleared the pharmacy in behavioral health cost, in particular, are exceeding our previous projections. And now that we have a stable population based, we've been able to more effectively deploy our solutions for these specific pressure areas. 
As an example, the run rate of pharmacy costs should benefit from an ongoing increase in generic utilization as well as 4 major branded drugs converting to generic during 2012. We've also develop initiatives to address areas which appeared to have questionable prescribing patterns which is all part of turning an unmanaged program into Manage Care. 
We have similar initiatives covering network construction, provider profiling and collaboration efforts, fraud and abuse,  an increased pre authorization process, increase in member cost-sharing and so on. 
During the first quarter, the rules around transitional care from the unmanaged period ended. We are now able to implement processes to improve care coordination and manage cost. Also in the first quarter, the reimbursement level for non par providers was reduced from 100% that the Kentucky Medicaid fee is scheduled to 90%. 
We have an extensive list of other initiatives as well, covering all categories of healthcare expense. They are being worked on every day and evaluated by senior management. Though all these are not things that we can turn around immediately, we expect continued improvement during 2012, as we resolve matters with the Commonwealth and bring run rate with cost down based upon the initiatives outlined above. We're actually focused of rectifying this isolated situation. 
Before I conclude my Medicaid commentary, I would like to highlight the 75% of our membership which resides states other than Kentucky that is performing well both in terms of financial results in terms of seizing growth opportunities. In the last earnings call, we highlighted our contract to win Nebraska, where we will have the #1 market share and be the only participant with the statewide presence when that contract commences in the third quarter of this year. 
We also announced a new contract in Pennsylvania commencing during the second quarter as we were awarded entry into the Southwest region of Pennsylvania's Medicaid program, Health Choices. We began enrolling new members on April 1, and that region expect to gradually grow our market share there through auto assignment similar to our growing presence in the Southeast region. I'm excited to announce that on the heels of our launched in that Southwest region, we were just notified recently, as Allen mentioned that we have been awarded significant letters of intent to contract in both the New West and New East zones of Pennsylvania as well with total Medicaid eligibles of approximately 380,000. The newest contract is expected to commence in September with the New East contract beginning in March of 2013. They're not expected to have a material impact on our financial results for 2012. 
While our winning Missouri was not necessarily a new business, I'm very pleased that our Medicaid team is able to attain a #1 market position in that state including the recently acquired Family Health Partners business which represents our largest presence in terms of membership today. 
Now moving on to our Fee-based businesses. Our updated guidance incorporates an improved view of management services revenue driven by higher than expected revenue from our Workers' Compensation business as well as their volumes in Health Plan ASO. The increase in our guidance for the cost of sales line item reflects a portion of growth that we are seeing Worker's Compensation services. Our Fee businesses are an important part of our product portfolio strategy providing reversification from our large risk base business with valuable unregulated cash flows and earn on area that we intend to grow and invest in prospectively. 
Our SG&A results for the quarter and corresponding full year guidance reflect the continued progress that the company is making towards driving a low cost structure that we believe is the most critical component of Coventry's long-term strategy. 
For the first quarter, we reported SG&A expense of $502.9 million or 13.6% of revenue driven by careful management of headcount and other cost even as we continue to grow the top line revenue. In addition, we are seeing increased traction in our broker pass-through strategy, the Commercial Group business which has a beneficial impact on our SG&A expense levels. 
Our revised full year SG&A guidance midpoint of 14.9% of revenue is an improvement of 160 basis points from 2011 and is particularly satisfying when you considered additional expense that we are incurring for compliance with new healthcare regulations, investments in our recently added businesses, as well as increasing investments that we're making for future growth. 
The full year guidance includes our normal assumption for an elevated level spend during the fourth quarter related to the Medicare A and B, as well as typical January 1 renewal expenses for the Commercial Risk business. 
As you saw on this morning's press release, our cash flow from operations for the quarter was $420.5 million or 246% of net income. This results include the receipt of an extra payment from CMS in the quarter as well as a positive adjustment related to the RADV reserve release. So after adjusting for these items, our cash flow from operations was $123 million or more typical 139% of net income. 
Moving on to our balance sheet and cash flows. Our investment portfolio remained in a high-quality position for the first quarter with the net unrealized gain of $100 million in March 31, an increase from $97 million at the end of 2011. At the end of the quarter we have $900 million of deployable free cash that's apparent, consistent with the level that we just disclosed in our prior earnings call which was as of January 31. 
As usual, during the second quarter we'll begin our annual regulated subsidiary dividend process. The first quarter was quite an eventful one on the capital deployment front. To begin, we closed the Family Health Partners acquisition early January, then we paid off our $234 million of senior notes that came due later in the month. Finally on March 12, the company announced our first dividend in its history which was subsequently paid on April 9. 
As Allen mentioned, we are also committed to point capital per share repurchase beginning in the second quarter and targeting levels comparable to 2011. It's important to note that our PPS guidance range does not include anticipated share repurchases in 2012, beyond those required the whole share count flat where we ended 2011. Acquisitions remain our top priority for use of our cash with a recent dividend initiation in commitment share repurchase reflecting our goal of maintaining a well-balanced capital deployment strategy. 
Our debt to cap is at a very reasonable level 25.2% at quarter end. We have an undrawn $750 million credit facility that isn't scheduled to expire until 2016, which combined with our free cash of $900 million provides capacitive $1.65 billion and significant financial flexibility as we evaluate perspective opportunity. 
So in conclusion, I'm encouraged to see significant progress being made across all of our businesses as we work towards our 2012 financial objectives and position the company for tomorrow. We have tripled our projected revenue growth rate from the prior year. And we've added more than $700,000 new members as compared to the prior year quarter. I'm personally focus on identifying the right investments for the future, pursuing growth opportunities across our portfolio businesses and improving our financial performance of existing businesses to strengthen the company to produce long-term value for our shareholders. Operator this now concludes our prepared remarks, and we are ready to open the lines for questions."
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","[Operator Instructions] We take our question from Tom Carroll with Stifel, Nicolaus.",12,"[Operator Instructions] We take our question from Tom Carroll with Stifel, Nicolaus."
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I have a high-level question on Medicaid. If I back out Kentucky, it seems that your other Medicaid markets are operating in the high 80s in terms of an MLR and if I combine that with the comments you made today, is a high 80s MLR a level we should think",109,"I have a high-level question on Medicaid. If I back out Kentucky, it seems that your other Medicaid markets are operating in the high 80s in terms of an MLR and if I combine that with the comments you made today, is a high 80s MLR a level we should think about for Coventry's Medicaid business in kind of 2013 and beyond? And then secondly, more of a smaller market question, I know it's a small market for you but the Maryland Medicaid plan has seen some slowing growth. Is there opportunity to maybe divest that business and focused elsewhere or try to improve it? What's up there?"
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","This is Randy. As far as our target for Medicaid MLR long-term, we think that's can be run in the mid-high 80s. So that would be our target for long-term to answer that question. As it relates to our Maryland operation, we really don't discuss kind of our",111,"This is Randy. As far as our target for Medicaid MLR long-term, we think that's can be run in the mid-high 80s. So that would be our target for long-term to answer that question. As it relates to our Maryland operation, we really don't discuss kind of our outlook on M&A activities around our existing businesses. But we're looking to grow all of our existing markets. We've actually in some of our smaller markets had some good reason expansions. We're actually expanding in one of our smaller markets in Virginia recently. We're expanding the Southwest Virginia, so we're looking to grow those businesses and evaluate each one on the standalone basis."
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","And our next question comes from Josh Raskin with Barclays.",10,"And our next question comes from Josh Raskin with Barclays."
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I understand Allen, you're apartheid, sort of avoid talking about the negotiations with the state but I was just wondering if you could sort of help us just from a technical standpoint, when did you realize that this was an issue? You're locked in for sor",130,"I understand Allen, you're apartheid, sort of avoid talking about the negotiations with the state but I was just wondering if you could sort of help us just from a technical standpoint, when did you realize that this was an issue? You're locked in for sort of a 3-year period from a pricing perspective but the variability to simply cut date and walk at any point. And then I guess the other issue, in terms in my mind, it looks like you're already implying just from a financial standpoint, it looks like you're already implying improvement in the next couple of quarters and it sounded like you didn't think there'd be immediate impact on or actions, so I'm just kind of curious what's driving that improvement as you move forward?"
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think as to the when, so far reserves in November and December are consistent with my comments. We knew that going from the dead start, cold start to manage the population was going to take some time. I think as we started to getting data in the first q",268,"I think as to the when, so far reserves in November and December are consistent with my comments. We knew that going from the dead start, cold start to manage the population was going to take some time. I think as we started to getting data in the first quarter, and I would characterize that as being late February, we became aware of the disproportionate membership in high-cost regions but high utilization on high-cost regions so in the late part of February, we became much more knowledgeable about what our problems beyond just managing the population was. When you go from a dead start, I think the lessons learned here is that I would be reluctant to participate in any new initiative that's pushed through a 90 to 120 days with only 60 days or so to prepare for the population. Those are lessons learned. But I think that the 50 initiatives that we have on the healthcare front, on the healthcare management front will -- are beginning and will begin to show some improvement, which is part of the reason for a guidance for the rest of the year. I think the number of providers that more date on who's more efficient as opposed to less efficient, we will be refining that process. That will bring improvement through the year. And ultimately, consistent with my prepared comments, I think that we will be successful in reaching an accommodation with the Commonwealth consistent with the contract that we signed. So yes, I believe it is going to get better and that's about what I can say about it."
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay, and then just one quick question on the Kansas Medicaid Award. Could you help us size your current exposure there in terms of revenues and I guess if you even, if you want to give some commentary around profitability relative to the overall?",44,"Okay, and then just one quick question on the Kansas Medicaid Award. Could you help us size your current exposure there in terms of revenues and I guess if you even, if you want to give some commentary around profitability relative to the overall?"
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","We're in the middle of the discussion process with the State of Kansas now and I think there will be some clarity on where that leads in the next 30 to 60 days. But we don't have anything today that's remarkable -- remotely definitive. We're in the middle",51,"We're in the middle of the discussion process with the State of Kansas now and I think there will be some clarity on where that leads in the next 30 to 60 days. But we don't have anything today that's remarkable -- remotely definitive. We're in the middle of discussions."
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I guess just -- I was just asking how big is it currently?",13,"I guess just -- I was just asking how big is it currently?"
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","It's about $350 million in revenue. And about 150,000 members.",11,"It's about $350 million in revenue. And about 150,000 members."
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And the profits on that business are similar to your overall X Kentucky?",13,"And the profits on that business are similar to your overall X Kentucky?"
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well it's a brand-new acquisition through FHP and it's performing to our expectation. It's not where, it's going to be as a long-term but...",25,"Well it's a brand-new acquisition through FHP and it's performing to our expectation. It's not where, it's going to be as a long-term but..."
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","For what we know, after 90 days.",7,"For what we know, after 90 days."
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","We move now to Charles Boorady with Crdit Suisse.",9,"We move now to Charles Boorady with Crdit Suisse."
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just a few points for clarification because your comments were very fullsome and helpful in Kentucky. First, you talked about the issue with competitors not living up to their contractual obligations regarding service areas and I wonder, it sounds like th",69,"Just a few points for clarification because your comments were very fullsome and helpful in Kentucky. First, you talked about the issue with competitors not living up to their contractual obligations regarding service areas and I wonder, it sounds like that cost you financial harm and I just wonder what remedies you might have there against those competitors or is it really an issue you see with the state?"
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well I think, it's the first issue is the state didn't hold everyone accountable to the requirements of the RFP. We did what we usually do, we complied in good faith and some of the people didn't. The remedy is of course there is the contract has a risk a",144,"Well I think, it's the first issue is the state didn't hold everyone accountable to the requirements of the RFP. We did what we usually do, we complied in good faith and some of the people didn't. The remedy is of course there is the contract has a risk adjusted revenue remedies and that's data that's being discussed with the Commonwealth as we speak. So there is a remedy or at least a partial remedy in the contract to adjust for the higher risk population. So that's part of the solution. I think that the -- half of our problem roughly is revenue base, which we believe is supported by the contract and that we will receive some relief, can't specific as to when and half of is what we understood when we went previously unmanaged population with a bunch of work to do."
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. The risk adjuster, how much did you accrue for assumed risk payments in the first quarter?",17,"Okay. The risk adjuster, how much did you accrue for assumed risk payments in the first quarter?"
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","We didn't accrue anything.",5,"We didn't accrue anything."
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","We didn't accrue anything because as I've discussed with, I think with clarity is that we have no resolution with the Commonwealth and we don't accrue anything until the check's clear.",32,"We didn't accrue anything because as I've discussed with, I think with clarity is that we have no resolution with the Commonwealth and we don't accrue anything until the check's clear."
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. So even though it's in the contract that you would be owed this risk-adjusted payments until you actually receive the cash for them, you're not accruing the expected receipt. Is it in your guidance from mid-90s?",37,"Okay. So even though it's in the contract that you would be owed this risk-adjusted payments until you actually receive the cash for them, you're not accruing the expected receipt. Is it in your guidance from mid-90s?"
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","That's consistent with this company's practice ever since I've been the CEO. And let's go off of Kentucky now because any details would be counterproductive to our discussions with the Commonwealth and with providers in the Commonwealth.",38,"That's consistent with this company's practice ever since I've been the CEO. And let's go off of Kentucky now because any details would be counterproductive to our discussions with the Commonwealth and with providers in the Commonwealth."
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","We go now to Scott Fidel with Deutsche Bank.",9,"We go now to Scott Fidel with Deutsche Bank."
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Allen, I just had a question in terms of just your comfort levels more broadly on Medicaid right now, in terms on taking so much additional growth given the challenges that you're seeing in Kentucky. Just particularly given your discussion about how much",87,"Allen, I just had a question in terms of just your comfort levels more broadly on Medicaid right now, in terms on taking so much additional growth given the challenges that you're seeing in Kentucky. Just particularly given your discussion about how much management resources on the Medicaid side that you want to put into Kentucky and the 50initiatives that you have going on there. How do you feel about management then within Medicaid right now to address all the other expansion that you have going on?"
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","If you think about Medicaid, we have a 15-year history going back to 1994 in Missouri. In the early -- in the late '90s, we had some places that we withdrew from Florida, when rates were arbitrarily cut by lot and the Delaware at one time. So the company",374,"If you think about Medicaid, we have a 15-year history going back to 1994 in Missouri. In the early -- in the late '90s, we had some places that we withdrew from Florida, when rates were arbitrarily cut by lot and the Delaware at one time. So the company went through a period of time where we were sort of, not sort of, where we were holding in doing what we have but not very aggressive in pursuing new opportunities. When I came back to the CEO spot in January of 2009, I thought the world has changed a lot in 4 years, so we began developing resources and hopefully expertise and started putting corporate resources in the growing of business for the future. And Nebraska was the first bid that we won on that front and I won't go through the history. We have most recently within the last quarter brought Tim Nolan, whom I've known for 25 years on our business and who's in the very successful reinvigorating our Commonwealth of Pennsylvania business in this year's and along with Maryland and Delaware in the years in the past and so we have continually added people and added resources. And so strategically, I think it's a good business. I think it's like all of our businesses that you're going get better that we used to be. I think there's margin pressure on all of our businesses so you have to have best people and best business practices. So I think Kentucky was certainly an expensive education but we learning is we go, we've proven I think that we can compete for new business with everybody else. And I think on the government front with this Medicare Advantage Part D, I feel the same way about Medicaid that we have the structure, we have the better people than we've ever had. We are continuing to learn, we're continuing to do a better job taking care of the population. So it's a part of our future and inspite of a little blip with along the way or a big blip along the way where undaunted and which we think there's a lot of opportunity were going to continue to produce resource in that revenue source."
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Just to add to Allen's comments. I'd like to differentiate Kentucky a little bit from some of the other markets we're expanding like Pennsylvania and the other expansion opportunities that are in the immediate term for us. Those expansion opportunities in",165,"Just to add to Allen's comments. I'd like to differentiate Kentucky a little bit from some of the other markets we're expanding like Pennsylvania and the other expansion opportunities that are in the immediate term for us. Those expansion opportunities including Nebraska and Pennsylvania are in states where we have existing Health Plan business, existing resources and we have existing Medicaid business. So we have capabilities and people are already, and assets are already deployed in those states. And so as we think about the expansion opportunities in those areas and now with our FHP acquisition, potentially Kansas, we have assets and we'd required assets where we already have health plans, we have a huge commercial business in Kansas already. So I look at Kentucky as a different situation where we're going into a state where we actually have no resources on the ground. But in this other situations, we actually do have resources and we have expertise with Medicaid in those states already."
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. Then just have a follow-up question just on your review of trend and first Randy just to clarify did you say that you thought of sort of running in the high 7s on the look back basis in 1Q. And maybe just now that you've had a lot more claims come i",86,"Okay. Then just have a follow-up question just on your review of trend and first Randy just to clarify did you say that you thought of sort of running in the high 7s on the look back basis in 1Q. And maybe just now that you've had a lot more claims come in for the 4Q, just interested in sort of how you view -- how trend progress sequentially from 4Q to 1Q '12 which obviously there's not as much claims experienced on at this point?"
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Our view on trend is really unchanged from the fourth quarter. As we look at prior period development and how this developing for the last year, it's coming in stronger than 2010 at a higher level. So we feel good about kind of our trend forecast and wher",80,"Our view on trend is really unchanged from the fourth quarter. As we look at prior period development and how this developing for the last year, it's coming in stronger than 2010 at a higher level. So we feel good about kind of our trend forecast and where we peg that. And trend is really very similar, our views are very similar to fourth quarter. We don't see a change in that if I look at this point in time."
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","For our next question we'll go to Carl McDonald with Citi.",12,"For our next question we'll go to Carl McDonald with Citi."
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Could you talk about how you think about premium deficiency reserves and when the right situation to use one is and when one not?",24,"Could you talk about how you think about premium deficiency reserves and when the right situation to use one is and when one not?"
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Premium deficiency reserves obviously work with our accounts and around individual contracts and look at the entire contract period as required. And we look at those on individual contract by contract basis. And if that make sense or another situation, we",81,"Premium deficiency reserves obviously work with our accounts and around individual contracts and look at the entire contract period as required. And we look at those on individual contract by contract basis. And if that make sense or another situation, we look at our entire block of business. So we look at that, we evaluate that every quarter and we make an assessment and we work with our auditors and have them review our analysis and that's where the process works."
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","And that's specific to Kentucky, which we don't know at this -- we don't know what the revenue is until we reach a decision with the Commonwealth and I don't know that after 5 months of that to exactly have a close of hand alone on the medical expenses yo",80,"And that's specific to Kentucky, which we don't know at this -- we don't know what the revenue is until we reach a decision with the Commonwealth and I don't know that after 5 months of that to exactly have a close of hand alone on the medical expenses you will 3 months from now, so when you have all the facts if it's appropriate, along with law that's what we'll. Do we don't have all the facts yet."
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. And then a quick follow-up. It looks like the change in the Medicaid loss ratio, if it's all released, Kentucky pushes up the Kentucky loss ratio 1,600 basis points give or take. What is your assumption for the Kentucky loss ratio that you've embedd",48,"Okay. And then a quick follow-up. It looks like the change in the Medicaid loss ratio, if it's all released, Kentucky pushes up the Kentucky loss ratio 1,600 basis points give or take. What is your assumption for the Kentucky loss ratio that you've embedded in the guidance?"
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","We don't really break out contract specific guidance around individual loss ratios. I'll comment on the deal kind of increase and our MLR guidance for the Medicaid line is related to Kentucky.",33,"We don't really break out contract specific guidance around individual loss ratios. I'll comment on the deal kind of increase and our MLR guidance for the Medicaid line is related to Kentucky."
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","For our final question, we go to Doug Simpson with Morgan Stanley.",12,"For our final question, we go to Doug Simpson with Morgan Stanley."
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just to be a little bit of a dead horse here. As we're thinking about Kentucky, maybe a different way to look at it if you think about that, call it 15, 16 points on the MLR that will be implied if you attribute the entire $0.58 to the premium associated",140,"Just to be a little bit of a dead horse here. As we're thinking about Kentucky, maybe a different way to look at it if you think about that, call it 15, 16 points on the MLR that will be implied if you attribute the entire $0.58 to the premium associated with Kentucky. How would you characterize your expectation in the balance of the year? If I heard you right, you're not including any incremental pass-through receipts or anything on risk adjuster front. Is it kind of correct to think about the seasonality that we would have expected as of yesterday and then burden each quarter by that roughly 15, 16 points on the MLR? I mean, is that -- will that get us in the right zip code in terms of thinking of seasonality and the contribution from Kentucky?"
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think we can't do much more than we've done, which is, say, half of it is in revenue based that we're discussion. The other half is medical initiatives. We explain that we have 50 initiatives going, that we're also refining our provider system there and",224,"I think we can't do much more than we've done, which is, say, half of it is in revenue based that we're discussion. The other half is medical initiatives. We explain that we have 50 initiatives going, that we're also refining our provider system there and concentrating more on the membership and where we're going to get a better result. I don't think that we can predict day by day or week by week. But we know the cumulatively effective medical management will improve our position as the year progresses. We know that we have a large revenue increase coming October 1. So when you add the discussions up, the medical initiatives, the revenue, we know that we're going to get, we're going to go from a terrible picture to an improving picture as the year progresses and that's about as good as we can do at this particular point. I think that Q2 will bring clarity to the resolution with a the Commonwealth. And I think that Q2's going to bring us some clarity, the 3 more months of data or medical initiatives where they're starting to work and with the revenue. This won't drag on so many unanswered questions for the entire year. I think that Q2 will bring a partial answer to what the rest of the year looks like."
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. I may have missed this, I apologize if I did. Randy, did you say that how the RADV benefit was treated on the income statement?",26,"Okay. I may have missed this, I apologize if I did. Randy, did you say that how the RADV benefit was treated on the income statement?"
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","It was an increase to revenue.",6,"It was an increase to revenue."
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. Just drop it right into the revenue straightaway?",9,"Okay. Just drop it right into the revenue straightaway?"
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes.",1,"Yes."
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","Ladies and gentlemen, that does conclude today's question-and-answer session. I'd like to turn the conference back over to Mr. Wise for any additional or closing remarks.",26,"Ladies and gentlemen, that does conclude today's question-and-answer session. I'd like to turn the conference back over to Mr. Wise for any additional or closing remarks."
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","No, we don't have any additional remarks and thank you so much for joining us today.",16,"No, we don't have any additional remarks and thank you so much for joining us today."
27133,204626278,291319,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","Ladies and gentlemen, that concludes today's conference. Once again, thank you for your participation.",14,"Ladies and gentlemen, that concludes today's conference. Once again, thank you for your participation."
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","Good morning, and welcome to Coventry Health Care's First Quarter 2012 Earnings Conference Call. Today's conference is being recorded [Operator Instructions] Today's call will begin with an opening remarks by the Chief Executive Officer of Coventry Health",55,"Good morning, and welcome to Coventry Health Care's First Quarter 2012 Earnings Conference Call. Today's conference is being recorded [Operator Instructions] Today's call will begin with an opening remarks by the Chief Executive Officer of Coventry Health Care, Mr. Allen Wise, after a brief forward-looking statement read by Mr. Drew Asher. Please go ahead Drew."
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Ladies and gentlemen, during this call, we will make forward-looking statements. Certain risks and uncertainties, including those referenced in our press release and described in the company's filings with the SEC on Form 10-K for the year ended December",61,"Ladies and gentlemen, during this call, we will make forward-looking statements. Certain risks and uncertainties, including those referenced in our press release and described in the company's filings with the SEC on Form 10-K for the year ended December 31, 2011, may materially impact those statements and could cause actual future results to differ materially from those anticipated and discussed. Allen?"
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Good morning, and thank you for your interest in Coventry Health Care. Earlier today, we reported the best quarter in the history of our company both in terms of revenue and earnings per share. Q1 revenue was $3.7 billion, and that's up 21% from the first",2379,"Good morning, and thank you for your interest in Coventry Health Care. Earlier today, we reported the best quarter in the history of our company both in terms of revenue and earnings per share. Q1 revenue was $3.7 billion, and that's up 21% from the first quarter of last year. And earnings per share of $1.20 driven by strength across 6 of our 7 businesses, especially our Medicare Advantage business. 
As you can see in our current Medicaid medical loss ratio, we have some serious work to do in our recently added Medicaid business, but all of Coventry's other businesses: Commercial, Medicare Advantage, Medicare Part D and our Fee-based businesses were on track or ahead of plan for the quarter. With regard to SG&A, we posted a very strong result with the rate of 13.6%, which is down 280 basis points from the first quarter of 2011. 
Today, I'd like to touch on each of our businesses and share with you our current perspective and probably more importantly where we're heading. And let's start with Medicare. The strength of the quarter in terms of Medicare Advantage was primarily driven by 3 factors: a very successful open enrollment season, which resulted in sequential membership growth of 13% or 28,000 members; the second was a very favorable outcome from the risk adjustment data validation audit process pursuant to methodology changes issued by CMS during the quarter enabling us to reduce our related reserve that we've built over the last several years; and third, strong operating results in Medicare Advantage even absent the operating earnings driven by the RADV reserve release. 
I believe it's worth a moment staying on Medicare Advantage. We operate Medicare Advantage Health Plans in 15 states, 14 of these states growing coming into 2012. We're pleased with the momentum of this business and expect to continue to expand our footprint and membership base over the next few years. We have taken what we believed was a prudent posture over the last few years and accruing our best estimate of RADV liability even in the absent of perfect clarity. 
The update in guidance from CMS were able to reflect the reduction in the RADV reserve of $133 million or $0.58 per share contributing to the strong Medicare operating results in the quarter. This is important for a couple of reasons. First of all, it should give you insight into the prudence in reserving for this type of exposure, which I believe was not necessarily consistent industry wide. And perhaps more important, we were able to substantially reduce a headwind in our Medicare Advantage bids since we'll now adapt to the updated CMS RADV guidance. 
As we look ahead, this along with strong execution and performance of our Medicare business to continue to support the competitiveness of our Medicare Advantage products. 
Other Medicare business, Part D, also had a very good first quarter. Coventry has a national Part D footprint and is #5 nationwide in market share. As you may recall from the open enrollment period coming into 2012, we're able to expand our auto-assigned footprint from 15 to 23 regions and launched a third product with a preferred network creating attractive value proposition for seniors. And the results were very satisfying. We grew 28% sequentially in the first quarter 2012, adding 315,000 members. Our Part D medical loss ratio is consistent with prior year Q1 and on track for the first full year forecast of low to the mid-80s of medical loss ratios.
Our combined and Medicare business represents approximately $4.3 billion of annual revenue or about 30% of the company's total revenue. From our perspective, Medicare has an attractive growth and margin profile and we're off to an excellent start in 2012.
Moving on to our Fee-based businesses, Coventry's diversified across 3 business signs: Workers' Compensation service, federal employee administration and Rental Network. Our Fee businesses produced over $1.1 billion in free revenue with higher-margin characteristics than our Risk business. First quarter of 2012, was slightly ahead of our previous plan and as you can see, we increased our forecast of fee revenue for the full year. These Fee businesses are important part of our diversified portfolio and they generate strong earnings with unregulated cash flow. 
Moving onto our Commercial business. We continue to focus on building and signing new contracts for high performance networks, as I've covered last quarter. Regardless of the outcome of reform, we believe driving to a low-cost structure will best position Coventry, enable us to create products to provide a compelling value proposition for both employees, for both individuals and employer groups. We currently sell Group commercial products through our health plans in 25 states. We spent the last 6 years developing individual products and capabilities, and currently sell individual products alongside our historically strong Group products in all of those states. 
The gaining factor for Coventry entering a commercial market, either organically or through acquisition, is cost structure. Many cases a network components of cost structure is a key asset in an acquisition and often negotiated as a part of the transaction. In other cases, we're able to use a collective set of company assets including our locally-based health plans and other national businesses to maintain a top tier cost structure in existing markets and negotiate favorable cost structure in new markets. We expect our high performance networks to play an important part in both the existing and new markets. 
Ultimately, we look forward to seizing growth driven by the Health Care Reform jump ball, or quickly adapt if Health Care Reform course changes. 
Nimbleness and local marker intelligence through our Health Plan presence has historically been a key strength in our commercial Health Plan business for at least 15 years. We expect our efforts will position us for success regardless of the direction of Health Care Reform. 
I'm moving on to Medicaid. Our Medicaid business has experienced significant growth coming into 2012. We're currently in 10 states carrying members in program spanning temporary aid in needy families, age blind and disabled, bills and CHIP members. Coventry has helped states manage Medicaid populations and programs since the early days of state-based managed care adoption over 1.5 decade ago. Our Medicaid experience in solutions certainly contributed to Coventry's successful pre-procurement of Missouri, our largest state presence in terms of membership which was announced by the state of Missouri during the first quarter. In addition, we look forward to adding to our position in Nebraska later in 2012, based on the win discussed in our last conference call. 
We also today have some news to report on the Medicaid RFP front. This week, our Pennsylvania subsidiary Health America, was awarded 2 letters of intent to contract which will cover new managed care regions in Eastern and Western Pennsylvania. As you may recall, we already have a Medicaid footprint in South Eastern and Southwestern Pennsylvania. The Commonwealth of Pennsylvania selected 4 carriers in the West for a targeted effective date of September 1, 2012, to manage approximately 165,000 eligibles. 3 carriers were selected in the East including Health America for a targeted implementation date in Q1 2013 to manage approximately 215,000 eligibles. 
So as a result, we look forward to serving our share of the 380,000 members when these programs go live. 
Our mature Medicaid business performed consistent with our expectations for the first quarter. With respect to our new Medicaid businesses, as you will recall, close to Family Health Partners acquisition on January 1 of this year, which our results reflect the first few months of our ownership there. I'm pleased with our relationship with Children's Mercy Hospital in Kansas City, key partner in providing quality care to children in Missouri and Kansas. As you would expect, this relationship was certainly an important element of the transaction. The integration of the acquired business is on track 3 months post closing and the successful procurement outcomes in Missouri was a very good start to this acquisition. 
Our remaining relatively new Medicaid business is Kentucky, which is for us producing very negative financial results. Actually we're getting our tails kicked. Kentucky is in early stages of a 36-month contract, which was effective November 1, 2011. Now that we have 5 months of data, it's clear that our poor financial results really result from 3 areas: 1 of which was anticipated and 2 of which were not. First area is a result of adverse risk selection. How did this happen? Well the RFP which we responded to and all other bidders responded to, required a robust list of contractor providers in all 7 regions in order to bid. If the response was inadequate in any one of the 7 regions, responding companies would've been eliminated for all regions. Coventry responded to this stringent standard and compiled in all regions, even though the provider cost and health status of the Commonwealth of Kentucky citizens is more challenging in regions 7 and 8. Not all companies selected responded in the matter that we did but were nevertheless allowed to participate in all regions. And the result is what you would expect, which is we received a disproportionate number of members with high utilization enrolled in high-cost systems. Our company also exacerbated our problem by being the only carrier not to require copayments in pharmacy.
In the RFP, the Commonwealth of Kentucky committed to an appropriate risk adjustment mechanism to adjust or partially adjust for adverse risk but at this time, we've been unable to obtain their commitment for compensation which would address the adverse risk selection as required by the contract that we have with them. As discussion is ongoing and while we cannot be specific as to the timing, we feel that these discussions will be successful. 
The second and unanticipated area was at least one error from the Commonwealth's data book when we bid the business with regard to pass-through payments to hospitals for medical education. This was clearly an oversight by the Commonwealth and while we have not been able to attain agreement from Kentucky at this time, on this front, we believe we will ultimately be successful and obtain adjustment for these hospital pass-through payments.
Third area is the basics of managed care, which was anticipated. How do we take better care of members in a more cost-effective manner? It was expected and we now have the data to address the basics of approved care for the members and the initiative necessary to control costs and improve care. These areas include pharmaceutical abuses, mental health issues, too many non-par providers and so many other areas. We are currently working on about 50 initiatives, which will deliver value to the Kentucky Medicaid program and improve outcomes for the members.
Bottom line, we're confident our discussions with the Commonwealth of Kentucky and our medical initiatives will make this a viable program for the future. Hopefully you've listened carefully to our discussion about Kentucky as we will not entertain any questions on this subject during the Q&A portion. We're obviously in ongoing discussions with the Commonwealth of Kentucky in many areas as well as many providers and it would be inappropriate to talk about details of these discussions in this forum. 
One more thought on Kentucky. It's important to reiterate that the population previously operated in a completely unmanaged arena. And I'm not only talking about the members but also physicians especially vendors, pharmacies and so on. I want to assure you that we put all the resources of the company to bear the work with the Commonwealth on appropriate solutions such as proper risk adjustment and fair and equal treatment on implementing the dozens of healthcare initiatives that should bring medical cost down perspectively. More resources in our company are focused on finding the proper long-term solution, make it financially sound and workable while improving the care for the members. But while we work on improvements in Kentucky, our other diversified businesses continue to perform well and we're seeking out an other selective growth opportunities across our broad set of businesses. 
Our balance sheet is in excellent condition as I referenced in the last earning call with the reduced level of debt. And we currently have $900 million of deployable cash on hand as of March 31, as well as an untapped credit facility of $750 million. At our regularly scheduled Board meeting in mid-March, we spent time on capital deployment avenues including M&A, share repurchase and for first time in the companies history our Board approved a dividend to complement these other methods of delivering value to our shareholders. Those of you who were shareholders as of March 23, should have received your first quarterly dividend on April 9. 
While the level of cash generated in our businesses and our capitalization, we believe we continue to deliver value to shareholders and M&A share repurchase while also providing for dividend that today analyzes to approximately $70 million. 
Recap our first quarter capital deployment activity we closed an acquisition, paid down $234 million of debt and declared our first shareholder dividend. We are planning to continue with the share repurchase program beginning in Q2 at level somewhere 2012, absent any compelling M&A opportunities or other usage. While we will evaluate and react each quarter to needs and opportunities, we are committed to a continuation of capital deployment. I'm really pleased with the positioning of our diversified set of businesses and the resulting opportunities that we should be able to seize over the next few years in Medicare Advantage, Medicaid, bill eligibles and potential opportunities in the commercial market. 
In addition to the company's organic opportunities, we'll also selectively deploy capital to grow our business footprint. The benefit of having a set of well diversified businesses and a strong balance sheet, is a strength which allows us to invest in new opportunities and survive the challenges that new ventures often bring. While I'm disappointed in the early start to the Kentucky contract, we will continue to seek new Medicaid opportunities along with growing our other businesses to bring the long-term value necessary for owners. And with those comments, I'll conclude my part of the presentation and our Chief Financial Officer, Randy Giles, will take you through the financials. Randy?"
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Thank you, Allen. This morning I want to begin by discussing our consolidated performance in the first quarter and then spend the remainder of my time reviewing our first quarter results and full year outlook for each of our key businesses. GAAP earnings",2812,"Thank you, Allen. This morning I want to begin by discussing our consolidated performance in the first quarter and then spend the remainder of my time reviewing our first quarter results and full year outlook for each of our key businesses. GAAP earnings per share for the first quarter was $1.20, which includes the $0.58 benefit from the release of reserves related to RADV as Allen described in his prepared remarks and $0.62 of earnings generated by the company's operations excluding the RADV item. 
As you saw on this morning's earnings release, our full year GAAP EPS guidance range is $3.10 to $3.30 inclusive of favorable impact of the RADV reserve release as well as other updates that I will detail further in my commentary this morning.
It's important to note that this guidance range does not reflect the impact of anticipated share repurchases in 2012, beyond those required to hold share count flat was where we ended 2011. Our consolidated revenue guidance now exceeds $14 billion at the midpoint with the similar mix of business roughly 40% commercial, 30% Medicare, 20% Medicaid and just under 10% being other. As in our previous guidance, we're reflecting movement to a more balanced mix over 2011. This strategic diversification across a balanced portfolio of businesses gives us a flexibility to adapt to today's fluid regulatory environment and seize opportunities across the products spectrum.
The results for the first quarter of 2012, were characterized by performance meeting or exceeding our expectations in 6 out of our 7 core businesses, with an outstanding result on SG&A as our cost control efforts coupled with leveraging top line growth continue to bear fruit for the organization. Our Q1 revenue of $3.7 billion puts us ahead of our prior guidance range and drove the increase to our full year guidance midpoint $14.1 billion in revenue, which would be a record revenue level for the company reflecting a significant acceleration in the company's growth rate over 2011. 
Starting with the Commercial business. First quarter MLR of 79.9%, keeps us on track for our full year MLR guidance range of 81% to 82%. This is consistent with the 81.6% result that we reported for full year 2011, which was the first year impacted by minimum MLR regulations. We are currently projecting total Commercial Risk revenues of just under $6 billion for the year, the individual business expected to generate approximately $425 million of that total. The remaining Group risk revenues are expected to be split roughly 40% small group and 60% large group, consistent with the mix that we saw in 2011. We currently estimate that approximately 25% of our Commercial Risk revenue is in a rebate position today. We will continue to evaluate strategies to effectively utilize rebate capital by providing more value to our customers; improving the attractiveness of our products; promoting quality initiatives with hospitals and physicians to improve HEDIS scores; and initiatives to reduce future Healthcare cost. 
Staying at our commercial book, our view of fundamental prospective trend remains unchanged in the range of 8%, plus or minus 50 basis points. In the rearview mirror, we are seeing trends in the high 7s and have continued to migrate higher from the very low levels seen during the second half of 2010 consistent with what we shared with you last quarter. Again these trends include the impact from the healthcare reform regulations implemented on September 23, 2010, which are fully incorporated into the current period but are only partially included in the baseline. 
Unit cost trend, which continues to be the largest driver of overall trend is stable. As we look at trend by component, in the first quarter we saw a slightly negative trend for inpatient days per thousand and we're projecting inpatient utilization trends to be flat to slightly positive prospectively, which is consistent with our prior prospective view given the historically low comparison levels that we're seeing during 2011. 
Utilization trends that we are seeing in the outpatient physician categories continues to show signs of a slight increase similar to what we observed over the last 2 quarters, both remaining in slightly positive territory. This migration from negative outpatient physician utilization trend to slightly positive, has been gradual and has been anticipated in our pricing. 
Before I leave the Commercial business, there's one other item that I would like to highlight this morning. In the first quarter, we signed a binding term sheet with Magellan's NIA subsidiary [indiscernible] expanding our strategic partnership, radiology management services. This term sheet renewed agreements that were set to expire in the near-term, restructured the overall terms of the agreement and significantly lowered our capitative medical cost for this category of service. 
Moving on to government programs. Our Medicare results for the first quarter were driven by outstanding performance during the annual election period which I'd like to highlight in a little more detail. Starting with Medicare Part D. We solidified our #5 [ph]  national market share with the third highest absolute growth in the industry and the second highest growth on a percentage basis among our large peers as our innovative new product First Health Value Plus enrolled approximately 375,000 members, increasing our total Part D membership to $1,158,000 at quarter end. We like our positioning for 2012 and expect to continue to grow Part D membership throughout the remainder of 2012. 
We're also pleased with enrollment results for our locally-contracted Medicare Advantage products as we added 28,000 new members, which was the third best percentage growth among our large competitors and included growth in all but 1 of our 15 states increasing total Medicare Advantage Membership to 250,000 members at quarter end.
Our Medicare Advantage MLR of 74.1% reported or 82.9% for the quarter, excluding the favorable impact from RADV reserve releases, was clearly a very strong start to the year consistent with our full year MLR guidance excluding RADV impact in the mid-to low 80s. These results were supported by mid-single digit reduction in days per thousand from the prior year quarter. Our Medicare part D results for the first quarter were also strong in terms of growth and our MLR of 94.9% keeps us on track for our full year MLR guidance in the low to mid-80s. 
I will now discuss our Medicaid business in detail as we saw MLR pressure in the first quarter that I want to address and also talk about some of the initiatives that we're working on to improve these results throughout the remainder of 2012. First, let me remind you that we have Medicaid business in 10 states today with total Medicaid Membership of 924,000 at quarter end, which has increased by 97% from the prior year quarter as we work towards our goal of enrolling 1 million Medicaid members. 
With the exception of the ramp-up in Kentucky, our Medicaid business is performing well both in terms of organic membership growth and MLR performance. Allen already outlined some of the challenges that we are experiencing in Kentucky which I would like to now elaborate on. 
Our outdated guidance incorporates a projection for Medicaid MLR in the mid-90s for the full year, increased from our previous guidance of approximately 90% driven entirely by Kentucky. As we discussed in the fourth quarter of 2011 earnings call, the Commonwealth of Kentucky quickly transitioned a highly unmanaged Medicaid population to managed care beginning in November 2011. 
When Coventry bid on this business, there was always an underlying assumption that projected taking historically elevated to spending levels and through the implementation of traditional managed care  protocols an improvement of patient care reducing both excessive utilization and wasteful spending over time. This process has been more challenging than we had forecast, as our reported MLR in the first quarter 2012 of 120.9% was higher than what we recorded in fourth quarter of 2011. I would like to reiterate Allen's comment that we are very disappointed in this outcome, and have focused many of the company's most senior executives on addressing the situation. We have also strengthened management on the ground and continue to add significant resources. For reasons that I'm sure you understand I cannot get into specifics on the discussions that we're having with the Commonwealth, but let me broadly outline for you what we are doing both in terms of the revenue side as well as on medical cost initiatives. 
On the revenue side, we're in discussions with the Commonwealth around the appropriate mechanism for risk adjustment payments as stipulated in our contract. At this point, it also remains unclear whether these payments will be made retroactively to the contract inception date or whether they will be prospective only. 
We're also working to address certain data book errors, for example around supplemental payments which would more properly match our revenue with underlying cost structure dynamics of this contract. And finally, as we've disclosed previously, we have a 5.3% rate increase which will take effect on October 1 of this year. 
On the expense side, our management team and some of our top clinical professionals from other areas of the organization are fully engaged in implementing more than 50 real-time ongoing action items based upon emerging data to address higher cost areas. 
It is clear that pharmacy and behavioral health cost, in particular, are exceeding our previous projections. Now that we have a stable population based, we've been able to more effectively deploy our solutions for these specific pressure areas. 
As an example, the run rate of pharmacy costs should benefit from an ongoing increase in generic utilization, as well as 4 major branded drugs converting to generic during 2012. We've also developed initiatives to address areas which appear to have questionable prescribing patterns which is all part of turning an unmanaged program into managed care. 
We have similar initiatives covering network construction; provider profiling and collaboration efforts; fraud and abuse; an increased pre-authorization process; increasing member cost-sharing and so on. 
During the first quarter, the rules around transitional care from the unmanaged period ended. We are now able to implement processes to improve care coordination and manage cost. Also in the first quarter, the reimbursement level for non-par providers was reduced from 100% of the Kentucky Medicaid fee scheduled to 90%. 
We have an extensive list of other initiatives as well, covering all categories of healthcare expense. They are being worked on every day and evaluated by senior management. Though all these are not things that we can turn around immediately, we expect continued improvement during 2012, as we resolve matters with the Commonwealth and bring run rate  cost down based upon the initiatives outlined above. We're absolutely focused of rectifying this isolated situation. 
Before I conclude my Medicaid commentary, I would like to highlight the 75% of our membership which resides in states other than Kentucky that is performing well both in terms of financial results, in terms of seizing growth opportunities. In the last earnings call, we highlighted our contract award in Nebraska, where we will have the #1 market share and be the only participant with a statewide presence when that contract commences in the third quarter of this year. 
We also announced a new contract in Pennsylvania commencing during the second quarter as we were awarded entry into the Southwest region of Pennsylvania's Medicaid program, Health Choices. We began enrolling new members on April 1, and that region expect to gradually grow our market share there through auto assignment similar to our growing presence in the Southeast region. I'm excited to announce that on the heels of our launch in the Southwest region, we were just notified recently, as Allen mentioned, that we have been awarded significant new letters of intent to contract in both the New West and New East zones of Pennsylvania as well with total Medicaid eligibles of approximately 380,000. The New West contract is expected to commence in September with the New East contract beginning in March of 2013. They're not expected to have a material impact on our financial results for 2012. 
While our win in Missouri was not necessarily a new business, I'm very pleased that our Medicaid team was able to retain our #1 market position in that state including the recently acquired Family Health Partners business which represents our largest presence in terms of membership today. 
Now moving on to our Fee-based businesses. Our updated guidance incorporates an improved view of management services revenue driven by higher than expected revenue from our Workers' Compensation business as well as better volumes in Health Plan ASO. The increase in our guidance for the cost of sales line item reflects a portion of growth that we are seeing Worker's Compensation services. Our Fee businesses are an important part of our product portfolio strategy providing diversification from our large risk-based business with valuable unregulated cash flows and are an area that we intend to grow and invest in prospectively. 
Our SG&A results for the quarter and corresponding full year guidance reflect the continued progress that the company is making towards driving a low cost structure that we believe is the most critical component of Coventry's long-term strategy. 
For the first quarter, we reported SG&A expense of $502.9 million or 13.6% of revenue driven by careful management of headcount and other cost even as we continue to grow the top line revenue. In addition, we are seeing increased traction in our broker pass-through strategy, the Commercial Group business which has a beneficial impact on our SG&A expense levels. 
Our revised full year SG&A guidance midpoint of 14.9% of revenue is an improvement of 160 basis points from 2011. It is particularly satisfying when you consider the additional expense that we are incurring for compliance with new healthcare regulations, investments in our recently added businesses, as well as increasing investments that we're making for future growth. 
The full year guidance includes our normal assumption for an elevated level spend during the fourth quarter related to the Medicare AEP, as well as typical January 1 renewal expenses for the Commercial Risk business. 
As you saw on this morning's press release, our cash flow from operations for the quarter was $420.5 million or 246% of net income. These results include the receipt of an extra payment from CMS in the quarter as well as a positive adjustment related to the RADV reserve release. So after adjusting for these items, our cash flow from operations was $123 million or more typical 139% of net income. 
Moving on to our balance sheet and cash flows. Our investment portfolio remained in a high-quality position for the first quarter with the net unrealized gain of $100 million at March 31, an increase from $97 million at the end of 2011. At the end of the quarter we had $900 million of deployable free cash that's apparent, consistent with the level that we disclosed in our prior earnings call which was as of January 31. 
As usual, during the second quarter we'll begin our annual regulated subsidiary dividend process. The first quarter was quite an eventful one on the capital deployment front. To begin, we closed the Family Health Partners acquisition early January, then we paid off our $234 million of senior notes that came due later in the month. Finally on March 12, the company announced our first dividend in its history which was subsequently paid on April 9. 
As Allen mentioned, we are also committed to point capital per share repurchase beginning in the second quarter and targeting levels comparable to 2011.  It's important to note that our EPS guidance range does not include anticipated share repurchases in 2012, beyond those required to hold share count flat where we ended 2011. Acquisitions remain our top priority for use of our cash with a recent dividend initiation in commitment share repurchase reflecting our goal of maintaining a well-balanced capital deployment strategy. 
Our debt to cap is at a very reasonable level 25.2% at quarter end. We have an undrawn $750 million credit facility that isn't scheduled to expire until 2016, which combined with our free cash of $900 million provides capacity of $1.65 billion and significant financial flexibility as we evaluate perspective opportunity. 
So in conclusion, I'm encouraged to see significant progress being made across all of our businesses as we work towards our 2012 financial objectives and position the company for tomorrow. We have tripled our projected revenue growth rate from the prior year. And we've added more than $700,000 new members as compared to the prior year quarter. I'm personally focus on identifying the right investments for the future, pursuing growth opportunities across our portfolio businesses, and improving the financial performance of existing businesses to strengthen the company to produce long-term value for our shareholders. Operator this now concludes our prepared remarks, and we are ready to open the lines for questions."
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","[Operator Instructions] We take our question from Tom Carroll with Stifel, Nicolaus.",12,"[Operator Instructions] We take our question from Tom Carroll with Stifel, Nicolaus."
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I have a high-level question on Medicaid. If I back out Kentucky, it seems that your other Medicaid markets are operating in the high 80s in terms of an MLR and if I combine that with the comments you made today, is a high 80s MLR a level we should think",109,"I have a high-level question on Medicaid. If I back out Kentucky, it seems that your other Medicaid markets are operating in the high 80s in terms of an MLR and if I combine that with the comments you made today, is a high 80s MLR a level we should think about for Coventry's Medicaid business in kind of 2013 and beyond? And then secondly, more of a smaller market question, I know it's a small market for you but the Maryland Medicaid plan has seen some slowing growth. Is there opportunity to maybe divest that business and focus elsewhere or try to improve it? What's up there?"
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","This is Randy. As far as our target for Medicaid MLR long-term, we think that's can be run in the mid-high 80s. So that would be our target for long-term to answer that question. As it relates to our Maryland operation, we really don't discuss kind of our",111,"This is Randy. As far as our target for Medicaid MLR long-term, we think that's can be run in the mid-high 80s. So that would be our target for long-term to answer that question. As it relates to our Maryland operation, we really don't discuss kind of our outlook on M&A activities around our existing businesses. But we're looking to grow all of our existing markets. We've actually, in some of our smaller markets, had some good recent expansions. We're actually expanding in one of our smaller markets in Virginia recently. We're expanding the Southwest Virginia, so we're looking to grow those businesses and evaluate each one on the standalone basis."
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","And our next question comes from Josh Raskin with Barclays.",10,"And our next question comes from Josh Raskin with Barclays."
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I understand Allen, you're effort to sort of avoid talking about the negotiations with the state, but I was just wondering if you could sort of help us just from a technical standpoint, when did you realize that this was an issue? You're locked in for sor",132,"I understand Allen, you're effort to sort of avoid talking about the negotiations with the state, but I was just wondering if you could sort of help us just from a technical standpoint, when did you realize that this was an issue? You're locked in for sort of a 3-year period from a pricing perspective but is there ability to simply cut bait and walk at any point? And then I guess the other issue, in terms, in my mind, it looks like you're already implying just from a financial standpoint, it looks like you're already implying improvement in the next couple of quarters and it sounded like you didn't think there'd be immediate impact on your actions, so I'm just kind of curious what's driving that improvement as you move forward?"
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think as to the win, so if our reserves in November and December are consistent with my comments, we knew that going from a dead start, cold start to manage the population was going to take some time. I think that as we started to getting data in the fi",272,"I think as to the win, so if our reserves in November and December are consistent with my comments, we knew that going from a dead start, cold start to manage the population was going to take some time. I think that as we started to getting data in the first quarter, and I would characterize that as being late February, we became aware of the disproportionate membership in high-cost regions -- both high utilization and high-cost regions -- so in the late part of February, we became much more knowledgeable about what our problems beyond just managing the population was. When you go from a dead start, I think the lessons learned here is that I would be reluctant to participate in any new initiative that's pushed through a 90 to 120 days with only 60 days or so to prepare for the population. Those are lessons learned. But I think that the 50 initiatives that we have on the healthcare front, on the healthcare management front will -- are beginning and will begin to show some improvement, which is part of the reason for a guidance for the rest of the year. I think the number of providers that have more data on who's more efficient as opposed to less efficient, we will be refining that process. That will bring improvement through the year. And ultimately, consistent with my prepared comments, I think that we will be successful in reaching an accommodation with the Commonwealth consistent with the contract that we signed. So it's ugly but it's going to get better and that's about what I can say about it."
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay, and then just one quick question on the Kansas Medicaid Award. Could you help us size your current exposure there in terms of revenues and I guess if you even, if you want to give some commentary around profitability relative to the overall book?",45,"Okay, and then just one quick question on the Kansas Medicaid Award. Could you help us size your current exposure there in terms of revenues and I guess if you even, if you want to give some commentary around profitability relative to the overall book?"
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","We're in the middle of the discussion process with the state of Kansas now and I think there will be some clarity on where all that leads in the next 30 to 60 days. We don't have anything today that's remotely definitive. We're in the middle of discussion",49,"We're in the middle of the discussion process with the state of Kansas now and I think there will be some clarity on where all that leads in the next 30 to 60 days. We don't have anything today that's remotely definitive. We're in the middle of discussions."
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I guess just -- I was just asking how big is it currently?",13,"I guess just -- I was just asking how big is it currently?"
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","It's about $350 million in revenue. And about 150,000 members.",11,"It's about $350 million in revenue. And about 150,000 members."
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And the profits on that business are similar to your overall X Kentucky?",13,"And the profits on that business are similar to your overall X Kentucky?"
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well it's a brand new acquisition through FHP and it's performing to our expectation. It's not where it's going to be as a long-term but...",26,"Well it's a brand new acquisition through FHP and it's performing to our expectation. It's not where it's going to be as a long-term but..."
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","For what we know, after 90 days.",7,"For what we know, after 90 days."
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","We move now to Charles Boorady with Crdit Suisse.",9,"We move now to Charles Boorady with Crdit Suisse."
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just a few points for clarification because your comments were very fullsome and helpful in Kentucky. First, you talked about the issue with competitors not living up to their contractual obligations regarding service areas and I wonder, it sounds like th",69,"Just a few points for clarification because your comments were very fullsome and helpful in Kentucky. First, you talked about the issue with competitors not living up to their contractual obligations regarding service areas and I wonder, it sounds like that caused you financial harm and I just wonder what remedies you might have there against those competitors or is it really an issue you see with the state?"
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well I think, it's the first issue is the state didn't hold everyone accountable to the requirements of the RFP. We did what we usually do, we complied in good faith and some of the people didn't. The remedy is of course there is the contract has a risk a",152,"Well I think, it's the first issue is the state didn't hold everyone accountable to the requirements of the RFP. We did what we usually do, we complied in good faith and some of the people didn't. The remedy is of course there is the contract has a risk adjusted revenue remedies and that's data that's being discussed with the Commonwealth as we speak. So there is a remedy or at least a partial remedy in the contract to adjust for the higher risk population. So that's part of the solution. I think that half of our problem roughly is revenue base, which we believe is supported by the contract and that we will receive some relief. Can't be specific as to when and half of it is what we understood when we went in a state like this, we had some previously unmanaged population with a bunch of work to do."
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. The risk adjuster, how much did you accrue for assumed risk payments in the first quarter?",17,"Okay. The risk adjuster, how much did you accrue for assumed risk payments in the first quarter?"
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","We didn't accrue anything.",5,"We didn't accrue anything."
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","We didn't accrue anything because as I've discussed with, I think with clarity, is that we have no resolution with the Commonwealth and we don't accrue anything until the checks clear.",32,"We didn't accrue anything because as I've discussed with, I think with clarity, is that we have no resolution with the Commonwealth and we don't accrue anything until the checks clear."
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. So even though it's in the contract that you would be owed this risk-adjusted payments until you actually receive the cash for them, you're not accruing the expected receipt. Is it in your guidance from mid-90s?",37,"Okay. So even though it's in the contract that you would be owed this risk-adjusted payments until you actually receive the cash for them, you're not accruing the expected receipt. Is it in your guidance from mid-90s?"
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","That's consistent with this company's practice ever since I've been the CEO. And let's get off of Kentucky now because any details would be counterproductive to our discussions with the Commonwealth and with providers in the Commonwealth.",38,"That's consistent with this company's practice ever since I've been the CEO. And let's get off of Kentucky now because any details would be counterproductive to our discussions with the Commonwealth and with providers in the Commonwealth."
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","We go now to Scott Fidel with Deutsche Bank.",9,"We go now to Scott Fidel with Deutsche Bank."
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Allen, I just had a question in terms of just your comfort levels more broadly on Medicaid right now, in terms of taking on so much additional growth given the challenges that you're seeing in Kentucky. Just particularly given your discussion about how mu",89,"Allen, I just had a question in terms of just your comfort levels more broadly on Medicaid right now, in terms of taking on so much additional growth given the challenges that you're seeing in Kentucky. Just particularly given your discussion about how much management resources on the Medicaid side that you want to put into Kentucky and the 50 initiatives that you have going on there. How do you feel about management then within Medicaid right now to address all the other expansion that you have going on?"
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","If you think about Medicaid, we have a 15 year history going back to 1994 in Missouri. In the early -- in the late '90s, we had some places that we withdrew from, Florida when rates were arbitrarily cut by a lot and the Delaware at one time. So the compan",380,"If you think about Medicaid, we have a 15 year history going back to 1994 in Missouri. In the early -- in the late '90s, we had some places that we withdrew from, Florida when rates were arbitrarily cut by a lot and the Delaware at one time. So the company went through a period of time where we were sort of, not sort of, where we were holding and doing what we have but not very aggressive in pursuing new opportunities. When I came back to the CEO spot in January of 2009, I thought the world had changed a lot in 4 years, so we began developing resources and hopefully expertise and started putting corporate resources in the growing of business for the future. And Nebraska was the first bid that we won on that front and I won't go through the history. We have most recently within the last quarter brought Tim Nolan, whom I've known for 25 years on our business and who's in the very successful reinvigorating our Commonwealth of Pennsylvania business in his years and along with Maryland and Delaware in the years in the past, and so we have continually added people and added resources. And so strategically, I think it's a good business. I think it's like all of our other businesses that you're going to have to get better that we used to be. I think there's margin pressure on all of our businesses so you have to have best people and best business practices. So I think Kentucky was certainly an expensive education but we're learning as we go. We've proven I think that we can compete for new business with everybody else. And I think on the government front with this Medicare Advantage Part D, I feel the same way about Medicaid that we have the structure, we have the better people than we've ever had. We are continuing to learn. We're continuing to do a better job taking care of the population. So it's a part of our future and in spite of a little blip along the way, or a big blip along the way, we're undaunted and we think that there's a lot of opportunity. We're going to continue to put resources in that revenue source."
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Just to add to Allen's comments. I'd like to differentiate Kentucky a little bit from some of the other markets we're expanding like Pennsylvania and the other expansion opportunities that are in the intermediate term for us. Those expansion opportunities",163,"Just to add to Allen's comments. I'd like to differentiate Kentucky a little bit from some of the other markets we're expanding like Pennsylvania and the other expansion opportunities that are in the intermediate term for us. Those expansion opportunities including Nebraska and Pennsylvania are in states where we have existing Health Plan business, existing resources and we have existing Medicaid business. We have capabilities and people already, and assets already deployed in those states. So as we think about the expansion opportunities in those areas and now with our FHP acquisition, potentially in Kansas, we have assets and we've acquired assets where we already have health plans. We have a huge commercial business in Kansas already, so I look at Kentucky as a different situation where we were going into a state where we actually had no resources on the ground. But in these other situations, we actually do have resources and we have expertise with Medicaid in those states already."
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. Then just had a follow-up question just on your view of trend and first, Randy, just to clarify did you say that you thought was sort of running in the high 7s on the look back basis in 1Q. And maybe just now that you've had a lot more claims come i",86,"Okay. Then just had a follow-up question just on your view of trend and first, Randy, just to clarify did you say that you thought was sort of running in the high 7s on the look back basis in 1Q. And maybe just now that you've had a lot more claims come in for the 4Q, just interested in sort of how you view -- how trend progress sequentially from 4Q to 1Q '12 which obviously there's not as much claims experience on at this point?"
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Our view on trend is really unchanged from the fourth quarter. As we look at prior period development and how that's developing for the last year, it's coming in stronger than 2010 at a higher level. So we feel good about kind of our trend forecast and wh",78,"Our view on trend is really unchanged from the fourth quarter. As we look at prior period development and how that's developing for the last year, it's coming in stronger than 2010 at a higher level. So we feel good about kind of our trend forecast and where we peg that. And trend is really very similar, our views are very similar to fourth quarter. We don't see a change in that outlook at this point in time."
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","Our next question we'll go to Carl McDonald with Citi.",11,"Our next question we'll go to Carl McDonald with Citi."
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Could you talk about how you think about premium deficiency reserves and when the right situation to use one is and when not?",23,"Could you talk about how you think about premium deficiency reserves and when the right situation to use one is and when not?"
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Premium deficiency reserves obviously work with our accountants and around the individual contracts and look at the entire contract period as required. And we look at those on individual contract by contract basis. And if that make sense or another situat",83,"Premium deficiency reserves obviously work with our accountants and around the individual contracts and look at the entire contract period as required. And we look at those on individual contract by contract basis. And if that make sense or another situation, we look at our entire block of business. So we look at that, we evaluate that every quarter and we make an assessment and we work with our auditors and have them review our analysis and that's the way the process works."
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","If that's specific to Kentucky, which we don't know at this -- we don't know what the revenue is until we reach a decision with the Commonwealth and I don't know that after 5 months that you exactly have a close handle on the medical expenses you will 3 m",79,"If that's specific to Kentucky, which we don't know at this -- we don't know what the revenue is until we reach a decision with the Commonwealth and I don't know that after 5 months that you exactly have a close handle on the medical expenses you will 3 months from now. So when you have all the facts if it's appropriate, along with the in way, that's what we'll do. We don't have all the facts yet."
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. And then a quick follow-up. It looks like the change in the Medicaid loss ratio, if it's all related to Kentucky pushes up the Kentucky loss ratio 1,600 basis points give or take. What is your assumption for the Kentucky loss ratio that you've embed",49,"Okay. And then a quick follow-up. It looks like the change in the Medicaid loss ratio, if it's all related to Kentucky pushes up the Kentucky loss ratio 1,600 basis points give or take. What is your assumption for the Kentucky loss ratio that you've embedded in the guidance?"
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","We don't really break out contract specific guidance around individual loss ratios. I'll comment on the deal kind of increase and our MLR guidance for the Medicaid line is related to Kentucky.",33,"We don't really break out contract specific guidance around individual loss ratios. I'll comment on the deal kind of increase and our MLR guidance for the Medicaid line is related to Kentucky."
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","For our final question, we go to Doug Simpson with Morgan Stanley.",12,"For our final question, we go to Doug Simpson with Morgan Stanley."
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just to beat a little bit of a dead horse here. As we're thinking about Kentucky, maybe a different way to look at it if you think about that, call it 15, 16 points on the MLR that will be implied if you attribute the entire $0.58 to the premium associate",138,"Just to beat a little bit of a dead horse here. As we're thinking about Kentucky, maybe a different way to look at it if you think about that, call it 15, 16 points on the MLR that will be implied if you attribute the entire $0.58 to the premium associated with Kentucky. How would you characterize your expectation in the balance of the year? If I heard you right, you're not including any incremental pass-through receipts or anything on risk adjuster front. Is it kind of correct to think about the seasonality that we would have expected as of yesterday and then burden each quarter by that roughly 15, 16 points on the MLR? Is that -- would that get us in the right zip code in terms of thinking of seasonality and the contribution from Kentucky?"
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think we can't do much more than we've done, which is, say, half of it is a revenue base that we're in discussion. The other half is medical initiatives. We explain that we have 50 initiatives going, that we're also refining our provider system there an",226,"I think we can't do much more than we've done, which is, say, half of it is a revenue base that we're in discussion. The other half is medical initiatives. We explain that we have 50 initiatives going, that we're also refining our provider system there and concentrating more on the membership and where we're going to get a better result. I don't think that we can predict day by day or week by week. But we know the cumulative effective of medical management will improve our position as the year progresses. We know that we have a large revenue increase coming October 1. So when you add the discussions up, the medical initiatives, the revenue we know that we're going to get, we're going to go from a terrible picture to an improving picture as the year progresses and that's about as good as we can do at this particular point. I think that Q2 will bring clarity to the resolution with the Commonwealth. And I think that Q2's going to bring us some clarity, the 3 more months of data or medical initiatives where they're starting to work and with the revenue. This won't drag on with so many unanswered questions for the entire year. I think that Q2 will bring a partial answer to what the rest of the year looks like."
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay, and then I may have missed this, I apologize if I did. Randy, did you say that how the RADV benefit was treated on the income statement?",28,"Okay, and then I may have missed this, I apologize if I did. Randy, did you say that how the RADV benefit was treated on the income statement?"
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","It was an increase to revenue.",6,"It was an increase to revenue."
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. Just drop it right into the revenue straightaway?",9,"Okay. Just drop it right into the revenue straightaway?"
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes.",1,"Yes."
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","Ladies and gentlemen, that does conclude today's question-and-answer session. I'd like to turn the conference back over to Mr. Wise for any additional or closing remarks.",26,"Ladies and gentlemen, that does conclude today's question-and-answer session. I'd like to turn the conference back over to Mr. Wise for any additional or closing remarks."
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","No, we don't have any additional remarks and thank you so much for joining us today.",16,"No, we don't have any additional remarks and thank you so much for joining us today."
27133,204626278,292079,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","Ladies and gentlemen, that concludes today's conference. Once again, thank you for your participation.",14,"Ladies and gentlemen, that concludes today's conference. Once again, thank you for your participation."
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","Good morning, and welcome to Coventry Health Care's First Quarter 2012 Earnings Conference Call. Today's conference is being recorded [Operator Instructions] Today's call will begin with an opening remarks by the Chief Executive Officer of Coventry Health",55,"Good morning, and welcome to Coventry Health Care's First Quarter 2012 Earnings Conference Call. Today's conference is being recorded [Operator Instructions] Today's call will begin with an opening remarks by the Chief Executive Officer of Coventry Health Care, Mr. Allen Wise, after a brief forward-looking statement read by Mr. Drew Asher. Please go ahead Drew."
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Ladies and gentlemen, during this call, we will make forward-looking statements. Certain risks and uncertainties, including those referenced in our press release and described in the company's filings with the SEC on Form 10-K for the year ended December",61,"Ladies and gentlemen, during this call, we will make forward-looking statements. Certain risks and uncertainties, including those referenced in our press release and described in the company's filings with the SEC on Form 10-K for the year ended December 31, 2011, may materially impact those statements and could cause actual future results to differ materially from those anticipated and discussed. Allen?"
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Good morning, and thank you for your interest in Coventry Health Care. Earlier today, we reported the best quarter in the history of our company both in terms of revenue and earnings per share. Q1 revenue was $3.7 billion, and that's up 21% from the first",2378,"Good morning, and thank you for your interest in Coventry Health Care. Earlier today, we reported the best quarter in the history of our company both in terms of revenue and earnings per share. Q1 revenue was $3.7 billion, and that's up 21% from the first quarter of last year. And earnings per share of $1.20 driven by strength across 6 of our 7 businesses, especially our Medicare Advantage business. 
As you can see in our current Medicaid medical loss ratio, we have some serious work to do in our recently added Medicaid business, but all of Coventry's other businesses: Commercial, Medicare Advantage, Medicare Part D and our Fee-based businesses were on track or ahead of plan for the quarter. With regard to SG&A, we posted a very strong result with the rate of 13.6%, which is down 280 basis points from the first quarter of 2011. 
Today, I'd like to touch on each of our businesses and share with you our current perspective and probably more importantly where we're heading. And let's start with Medicare. The strength of the quarter in terms of Medicare Advantage was primarily driven by 3 factors: a very successful open enrollment season, which resulted in sequential membership growth of 13% or 28,000 members; the second was a very favorable outcome from the risk adjustment data validation audit process pursuant to methodology changes issued by CMS during the quarter enabling us to reduce our related reserve that we've built over the last several years; and third, strong operating results in Medicare Advantage even absent the operating earnings driven by the RADV reserve release. 
I believe it's worth a moment staying on Medicare Advantage. We operate Medicare Advantage Health Plans in 15 states, 14 of these states growing coming into 2012. We're pleased with the momentum of this business and expect to continue to expand our footprint and membership base over the next few years. We have taken what we believed was a prudent posture over the last few years and accruing our best estimate of RADV liability even in the absent of perfect clarity. 
The update in guidance from CMS were able to reflect the reduction in the RADV reserve of $133 million or $0.58 per share contributing to the strong Medicare operating results in the quarter. This is important for a couple of reasons. First of all, it should give you insight into the prudence in reserving for this type of exposure, which I believe was not necessarily consistent industry wide. And perhaps more important, we were able to substantially reduce a headwind in our Medicare Advantage bids since we'll now adapt to the updated CMS RADV guidance. 
As we look ahead, this along with strong execution and performance of our Medicare business to continue to support the competitiveness of our Medicare Advantage products. 
Other Medicare business, Part D, also had a very good first quarter. Coventry has a national Part D footprint and is #5 nationwide in market share. As you may recall from the open enrollment period coming into 2012, we're able to expand our auto-assigned footprint from 15 to 23 regions and launched a third product with a preferred network creating attractive value proposition for seniors. And the results were very satisfying. We grew 28% sequentially in the first quarter 2012, adding 315,000 members. Our Part D medical loss ratio is consistent with prior year Q1 and on track for the first full year forecast of low to the mid-80s of medical loss ratios.
Our combined and Medicare business represents approximately $4.3 billion of annual revenue or about 30% of the company's total revenue. From our perspective, Medicare has an attractive growth and margin profile and we're off to an excellent start in 2012.
Moving on to our Fee-based businesses, Coventry's diversified across 3 business signs: Workers' Compensation service, federal employee administration and Rental Network. Our Fee businesses produced over $1.1 billion in free revenue with higher-margin characteristics than our Risk business. First quarter of 2012, was slightly ahead of our previous plan and as you can see, we increased our forecast of fee revenue for the full year. These Fee businesses are important part of our diversified portfolio and they generate strong earnings with unregulated cash flow. 
Moving onto our Commercial business. We continue to focus on building and signing new contracts for high performance networks, as I've covered last quarter. Regardless of the outcome of reform, we believe driving to a low-cost structure will best position Coventry, enable us to create products to provide a compelling value proposition for both employees, for both individuals and employer groups. We currently sell Group commercial products through our health plans in 25 states. We spent the last 6 years developing individual products and capabilities, and currently sell individual products alongside our historically strong Group products in all of those states. 
The gaining factor for Coventry entering a commercial market, either organically or through acquisition, is cost structure. Many cases a network components of cost structure is a key asset in an acquisition and often negotiated as a part of the transaction. In other cases, we're able to use a collective set of company assets including our locally-based health plans and other national businesses to maintain a top tier cost structure in existing markets and negotiate favorable cost structure in new markets. We expect our high performance networks to play an important part in both the existing and new markets. 
Ultimately, we look forward to seizing growth driven by the Health Care Reform jump ball, or quickly adapt if Health Care Reform course changes. 
Nimbleness and local marker intelligence through our Health Plan presence has historically been a key strength in our commercial Health Plan business for at least 15 years. We expect our efforts will position us for success regardless of the direction of Health Care Reform. 
I'm moving on to Medicaid. Our Medicaid business has experienced significant growth coming into 2012. We're currently in 10 states carrying members in program spanning temporary aid in needy families, age blind and disabled, bills and CHIP members. Coventry has helped states manage Medicaid populations and programs since the early days of state-based managed care adoption over 1.5 decades ago. Our Medicaid experience in solutions certainly contributed to Coventry's successful pre-procurement of Missouri, our largest state presence in terms of membership which was announced by the state of Missouri during the first quarter. In addition, we look forward to adding to our position in Nebraska later in 2012, based on the win discussed in our last conference call. 
We also today have some news to report on the Medicaid RFP front. This week, our Pennsylvania subsidiary Health America, was awarded 2 letters of intent to contract which will cover new managed care regions in Eastern and Western Pennsylvania. As you may recall, we already have a Medicaid footprint in South Eastern and Southwestern Pennsylvania. The Commonwealth of Pennsylvania selected 4 carriers in the West for a targeted effective date of September 1, 2012, to manage approximately 165,000 eligibles. Three carriers were selected in the East including Health America for a targeted implementation date in Q1 2013 to manage approximately 215,000 eligibles. 
So as a result, we look forward to serving our share of the 380,000 members when these programs go live. 
Our mature Medicaid business performed consistent with our expectations for the first quarter. With respect to our new Medicaid businesses, as you will recall, close to Family Health Partners acquisition on January 1 of this year, which our results reflect the first few months of our ownership there. I'm pleased with our relationship with Children's Mercy Hospital in Kansas City, key partner in providing quality care to children in Missouri and Kansas. As you would expect, this relationship was certainly an important element of the transaction. The integration of the acquired business is on track 3 months post closing and the successful procurement outcomes in Missouri was a very good start to this acquisition. 
Our remaining relatively new Medicaid business is Kentucky, which is for us producing very negative financial results. Actually we're getting our tails kicked. Kentucky is in early stages of a 36-month contract, which was effective November 1, 2011. Now that we have 5 months of data, it's clear that our poor financial results really result from 3 areas: 1 of which was anticipated and 2 of which were not. First area is a result of adverse risk selection. How did this happen? Well the RFP which we responded to and all other bidders responded to, required a robust list of contractor providers in all 7 regions in order to bid. If the response was inadequate in any one of the 7 regions, responding companies would've been eliminated for all regions. Coventry responded to this stringent standard and compiled in all regions, even though the provider cost and health status of the Commonwealth of Kentucky citizens is more challenging in regions 7 and 8. Not all companies selected responded in the matter that we did but were nevertheless allowed to participate in all regions. And the result is what you would expect, which is we received a disproportionate number of members with high utilization enrolled in high-cost systems. Our company also exacerbated our problem by being the only carrier not to require copayments in pharmacy.
In the RFP, the Commonwealth of Kentucky committed to an appropriate risk adjustment mechanism to adjust or partially adjust for adverse risk but at this time, we've been unable to obtain their commitment for compensation which would address the adverse risk selection as required by the contract that we have with them. As discussion is ongoing and while we cannot be specific as to the timing, we feel that these discussions will be successful. 
The second and unanticipated area was at least one error from the Commonwealth's data book when we bid the business with regard to pass-through payments to hospitals for medical education. This was clearly an oversight by the Commonwealth and while we have not been able to attain agreement from Kentucky at this time, on this front, we believe we will ultimately be successful and obtain adjustment for these hospital pass-through payments.
Third area is the basics of managed care, which was anticipated. How do we take better care of members in a more cost-effective manner? It was expected and we now have the data to address the basics of approved care for the members and the initiative necessary to control costs and improve care. These areas include pharmaceutical abuses, mental health issues, too many non-par providers and so many other areas. We are currently working on about 50 initiatives, which will deliver value to the Kentucky Medicaid program and improve outcomes for the members.
Bottom line, we're confident our discussions with the Commonwealth of Kentucky and our medical initiatives will make this a viable program for the future. Hopefully you've listened carefully to our discussion about Kentucky as we will not entertain any questions on this subject during the Q&A portion. We're obviously in ongoing discussions with the Commonwealth of Kentucky in many areas as well as many providers and it would be inappropriate to talk about details of these discussions in this forum. 
One more thought on Kentucky. It's important to reiterate that the population previously operated in a completely unmanaged arena. And I'm not only talking about the members but also physicians especially vendors, pharmacies and so on. I want to assure you that we put all the resources of the company to bear the work with the Commonwealth on appropriate solutions such as proper risk adjustment and fair and equal treatment on implementing the dozens of healthcare initiatives that should bring medical cost down perspectively. More resources in our company are focused on finding the proper long-term solution, make it financially sound and workable while improving the care for the members. But while we work on improvements in Kentucky, our other diversified businesses continue to perform well and we're seeking out another selective growth opportunities across our broad set of businesses. 
Our balance sheet is in excellent condition as I referenced in the last earning call with the reduced level of debt. And we currently have $900 million of deployable cash on hand as of March 31, as well as an untapped credit facility of $750 million. At our regularly scheduled board meeting in mid-March, we spent time on capital deployment avenues including M&A, share repurchase and for first time in the companys history, our board approved a dividend to complement these other methods of delivering value to our shareholders. Those of you who were shareholders as of March 23, should have received your first quarterly dividend on April 9. 
While the level of cash generated in our businesses and our capitalization, we believe we continue to deliver value to shareholders and M&A share repurchase while also providing for dividend that today analyzes to approximately $70 million. 
Recap our first quarter capital deployment activity we closed an acquisition, paid down $234 million of debt and declared our first shareholder dividend. We are planning to continue with the share repurchase program beginning in Q2 at level somewhere 2012, absent any compelling M&A opportunities or other usage. While we will evaluate and react each quarter to needs and opportunities, we are committed to a continuation of capital deployment. I'm really pleased with the positioning of our diversified set of businesses and the resulting opportunities that we should be able to seize over the next few years in Medicare Advantage, Medicaid, bill eligibles and potential opportunities in the commercial market. 
In addition to the company's organic opportunities, we'll also selectively deploy capital to grow our business footprint. The benefit of having a set of well diversified businesses and a strong balance sheet, is a strength which allows us to invest in new opportunities and survive the challenges that new ventures often bring. While I'm disappointed in the early start to the Kentucky contract, we will continue to seek new Medicaid opportunities along with growing our other businesses to bring the long-term value necessary for owners. And with those comments, I'll conclude my part of the presentation and our Chief Financial Officer, Randy Giles, will take you through the financials. Randy?"
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Thank you, Allen. This morning I want to begin by discussing our consolidated performance in the first quarter and then spend the remainder of my time reviewing our first quarter results and full year outlook for each of our key businesses. GAAP earnings",2812,"Thank you, Allen. This morning I want to begin by discussing our consolidated performance in the first quarter and then spend the remainder of my time reviewing our first quarter results and full year outlook for each of our key businesses. GAAP earnings per share for the first quarter was $1.20, which includes the $0.58 benefit from the release of reserves related to RADV as Allen described in his prepared remarks and $0.62 of earnings generated by the company's operations excluding the RADV item. 
As you saw on this morning's earnings release, our full year GAAP EPS guidance range is $3.10 to $3.30 inclusive of favorable impact of the RADV reserve release as well as other updates that I will detail further in my commentary this morning.
It's important to note that this guidance range does not reflect the impact of anticipated share repurchases in 2012, beyond those required to hold share count flat was where we ended 2011. Our consolidated revenue guidance now exceeds $14 billion at the midpoint with the similar mix of business roughly 40% commercial, 30% Medicare, 20% Medicaid and just under 10% being other. As in our previous guidance, we're reflecting movement to a more balanced mix over 2011. This strategic diversification across a balanced portfolio of businesses gives us a flexibility to adapt to today's fluid regulatory environment and seize opportunities across the products spectrum.
The results for the first quarter of 2012, were characterized by performance meeting or exceeding our expectations in 6 out of our 7 core businesses, with an outstanding result on SG&A as our cost control efforts coupled with leveraging top line growth continue to bear fruit for the organization. Our Q1 revenue of $3.7 billion puts us ahead of our prior guidance range and drove the increase to our full year guidance midpoint $14.1 billion in revenue, which would be a record revenue level for the company reflecting a significant acceleration in the company's growth rate over 2011. 
Starting with the Commercial business. First quarter MLR of 79.9%, keeps us on track for our full year MLR guidance range of 81% to 82%. This is consistent with the 81.6% result that we reported for full year 2011, which was the first year impacted by minimum MLR regulations. We are currently projecting total Commercial Risk revenues of just under $6 billion for the year, the individual business expected to generate approximately $425 million of that total. The remaining Group risk revenues are expected to be split roughly 40% small group and 60% large group, consistent with the mix that we saw in 2011. We currently estimate that approximately 25% of our Commercial Risk revenue is in a rebate position today. We will continue to evaluate strategies to effectively utilize rebate capital by providing more value to our customers; improving the attractiveness of our products; promoting quality initiatives with hospitals and physicians to improve HEDIS scores; and initiatives to reduce future Healthcare cost. 
Staying at our commercial book, our view of fundamental prospective trend remains unchanged in the range of 8%, plus or minus 50 basis points. In the rearview mirror, we are seeing trends in the high 7s and have continued to migrate higher from the very low levels seen during the second half of 2010 consistent with what we shared with you last quarter. Again these trends include the impact from the healthcare reform regulations implemented on September 23, 2010, which are fully incorporated into the current period but are only partially included in the baseline. 
Unit cost trend, which continues to be the largest driver of overall trend is stable. As we look at trend by component, in the first quarter we saw a slightly negative trend for inpatient days per thousand and we're projecting inpatient utilization trends to be flat to slightly positive prospectively, which is consistent with our prior prospective view given the historically low comparison levels that we're seeing during 2011. 
Utilization trends that we are seeing in the outpatient physician categories continues to show signs of a slight increase similar to what we observed over the last 2 quarters, both remaining in slightly positive territory. This migration from negative outpatient physician utilization trend to slightly positive, has been gradual and has been anticipated in our pricing. 
Before I leave the Commercial business, there's one other item that I would like to highlight this morning. In the first quarter, we signed a binding term sheet with Magellan's NIA subsidiary [indiscernible] expanding our strategic partnership, radiology management services. This term sheet renewed agreements that were set to expire in the near-term, restructured the overall terms of the agreement and significantly lowered our capitative medical cost for this category of service. 
Moving on to government programs. Our Medicare results for the first quarter were driven by outstanding performance during the annual election period which I'd like to highlight in a little more detail. Starting with Medicare Part D. We solidified our #5 [ph]  national market share with the third highest absolute growth in the industry and the second highest growth on a percentage basis among our large peers as our innovative new product First Health Value Plus enrolled approximately 375,000 members, increasing our total Part D membership to $1,158,000 at quarter end. We like our positioning for 2012 and expect to continue to grow Part D membership throughout the remainder of 2012. 
We're also pleased with enrollment results for our locally-contracted Medicare Advantage products as we added 28,000 new members, which was the third best percentage growth among our large competitors and included growth in all but 1 of our 15 states increasing total Medicare Advantage Membership to 250,000 members at quarter end.
Our Medicare Advantage MLR of 74.1% reported or 82.9% for the quarter, excluding the favorable impact from RADV reserve releases, was clearly a very strong start to the year consistent with our full year MLR guidance excluding RADV impact in the mid-to low 80s. These results were supported by mid-single digit reduction in days per thousand from the prior year quarter. Our Medicare part D results for the first quarter were also strong in terms of growth and our MLR of 94.9% keeps us on track for our full year MLR guidance in the low to mid-80s. 
I will now discuss our Medicaid business in detail as we saw MLR pressure in the first quarter that I want to address and also talk about some of the initiatives that we're working on to improve these results throughout the remainder of 2012. First, let me remind you that we have Medicaid business in 10 states today with total Medicaid Membership of 924,000 at quarter end, which has increased by 97% from the prior year quarter as we work towards our goal of enrolling 1 million Medicaid members. 
With the exception of the ramp-up in Kentucky, our Medicaid business is performing well both in terms of organic membership growth and MLR performance. Allen already outlined some of the challenges that we are experiencing in Kentucky which I would like to now elaborate on. 
Our outdated guidance incorporates a projection for Medicaid MLR in the mid-90s for the full year, increased from our previous guidance of approximately 90% driven entirely by Kentucky. As we discussed in the fourth quarter of 2011 earnings call, the Commonwealth of Kentucky quickly transitioned a highly unmanaged Medicaid population to managed care beginning in November 2011. 
When Coventry bid on this business, there was always an underlying assumption that projected taking historically elevated to spending levels and through the implementation of traditional managed care  protocols an improvement of patient care reducing both excessive utilization and wasteful spending over time. This process has been more challenging than we had forecast, as our reported MLR in the first quarter 2012 of 120.9% was higher than what we recorded in fourth quarter of 2011. I would like to reiterate Allen's comment that we are very disappointed in this outcome, and have focused many of the company's most senior executives on addressing the situation. We have also strengthened management on the ground and continue to add significant resources. For reasons that I'm sure you understand I cannot get into specifics on the discussions that we're having with the Commonwealth, but let me broadly outline for you what we are doing both in terms of the revenue side as well as on medical cost initiatives. 
On the revenue side, we're in discussions with the Commonwealth around the appropriate mechanism for risk adjustment payments as stipulated in our contract. At this point, it also remains unclear whether these payments will be made retroactively to the contract inception date or whether they will be prospective only. 
We're also working to address certain data book errors, for example around supplemental payments which would more properly match our revenue with underlying cost structure dynamics of this contract. And finally, as we've disclosed previously, we have a 5.3% rate increase which will take effect on October 1 of this year. 
On the expense side, our management team and some of our top clinical professionals from other areas of the organization are fully engaged in implementing more than 50 real-time ongoing action items based upon emerging data to address higher cost areas. 
It is clear that pharmacy and behavioral health cost, in particular, are exceeding our previous projections. Now that we have a stable population based, we've been able to more effectively deploy our solutions for these specific pressure areas. 
As an example, the run rate of pharmacy costs should benefit from an ongoing increase in generic utilization, as well as 4 major branded drugs converting to generic during 2012. We've also developed initiatives to address areas which appear to have questionable prescribing patterns which is all part of turning an unmanaged program into managed care. 
We have similar initiatives covering network construction; provider profiling and collaboration efforts; fraud and abuse; an increased pre-authorization process; increasing member cost-sharing and so on. 
During the first quarter, the rules around transitional care from the unmanaged period ended. We are now able to implement processes to improve care coordination and manage cost. Also in the first quarter, the reimbursement level for non-par providers was reduced from 100% of the Kentucky Medicaid fee scheduled to 90%. 
We have an extensive list of other initiatives as well, covering all categories of healthcare expense. They are being worked on every day and evaluated by senior management. Though all these are not things that we can turn around immediately, we expect continued improvement during 2012, as we resolve matters with the Commonwealth and bring run rate  cost down based upon the initiatives outlined above. We're absolutely focused of rectifying this isolated situation. 
Before I conclude my Medicaid commentary, I would like to highlight the 75% of our membership which resides in states other than Kentucky that is performing well both in terms of financial results, in terms of seizing growth opportunities. In the last earnings call, we highlighted our contract award in Nebraska, where we will have the #1 market share and be the only participant with a statewide presence when that contract commences in the third quarter of this year. 
We also announced a new contract in Pennsylvania commencing during the second quarter as we were awarded entry into the Southwest region of Pennsylvania's Medicaid program, Health Choices. We began enrolling new members on April 1, and that region expect to gradually grow our market share there through auto assignment similar to our growing presence in the Southeast region. I'm excited to announce that on the heels of our launch in the Southwest region, we were just notified recently, as Allen mentioned, that we have been awarded significant new letters of intent to contract in both the New West and New East zones of Pennsylvania as well with total Medicaid eligibles of approximately 380,000. The New West contract is expected to commence in September with the New East contract beginning in March of 2013. They're not expected to have a material impact on our financial results for 2012. 
While our win in Missouri was not necessarily a new business, I'm very pleased that our Medicaid team was able to retain our #1 market position in that state including the recently acquired Family Health Partners business which represents our largest presence in terms of membership today. 
Now moving on to our Fee-based businesses. Our updated guidance incorporates an improved view of management services revenue driven by higher than expected revenue from our Workers' Compensation business as well as better volumes in Health Plan ASO. The increase in our guidance for the cost of sales line item reflects a portion of growth that we are seeing Worker's Compensation services. Our Fee businesses are an important part of our product portfolio strategy providing diversification from our large risk-based business with valuable unregulated cash flows and are an area that we intend to grow and invest in prospectively. 
Our SG&A results for the quarter and corresponding full year guidance reflect the continued progress that the company is making towards driving a low cost structure that we believe is the most critical component of Coventry's long-term strategy. 
For the first quarter, we reported SG&A expense of $502.9 million or 13.6% of revenue driven by careful management of headcount and other cost even as we continue to grow the top line revenue. In addition, we are seeing increased traction in our broker pass-through strategy, the Commercial Group business which has a beneficial impact on our SG&A expense levels. 
Our revised full year SG&A guidance midpoint of 14.9% of revenue is an improvement of 160 basis points from 2011. It is particularly satisfying when you consider the additional expense that we are incurring for compliance with new healthcare regulations, investments in our recently added businesses, as well as increasing investments that we're making for future growth. 
The full year guidance includes our normal assumption for an elevated level spend during the fourth quarter related to the Medicare AEP, as well as typical January 1 renewal expenses for the Commercial Risk business. 
As you saw on this morning's press release, our cash flow from operations for the quarter was $420.5 million or 246% of net income. These results include the receipt of an extra payment from CMS in the quarter as well as a positive adjustment related to the RADV reserve release. So after adjusting for these items, our cash flow from operations was $123 million or more typical 139% of net income. 
Moving on to our balance sheet and cash flows. Our investment portfolio remained in a high-quality position for the first quarter with the net unrealized gain of $100 million at March 31, an increase from $97 million at the end of 2011. At the end of the quarter we had $900 million of deployable free cash that's apparent, consistent with the level that we disclosed in our prior earnings call which was as of January 31. 
As usual, during the second quarter we'll begin our annual regulated subsidiary dividend process. The first quarter was quite an eventful one on the capital deployment front. To begin, we closed the Family Health Partners acquisition early January, then we paid off our $234 million of senior notes that came due later in the month. Finally on March 12, the company announced our first dividend in its history which was subsequently paid on April 9. 
As Allen mentioned, we are also committed to point capital per share repurchase beginning in the second quarter and targeting levels comparable to 2011.  It's important to note that our EPS guidance range does not include anticipated share repurchases in 2012, beyond those required to hold share count flat where we ended 2011. Acquisitions remain our top priority for use of our cash with a recent dividend initiation in commitment share repurchase reflecting our goal of maintaining a well-balanced capital deployment strategy. 
Our debt to cap is at a very reasonable level 25.2% at quarter end. We have an undrawn $750 million credit facility that isn't scheduled to expire until 2016, which combined with our free cash of $900 million provides capacity of $1.65 billion and significant financial flexibility as we evaluate perspective opportunity. 
So in conclusion, I'm encouraged to see significant progress being made across all of our businesses as we work towards our 2012 financial objectives and position the company for tomorrow. We have tripled our projected revenue growth rate from the prior year. And we've added more than $700,000 new members as compared to the prior year quarter. I'm personally focus on identifying the right investments for the future, pursuing growth opportunities across our portfolio businesses, and improving the financial performance of existing businesses to strengthen the company to produce long-term value for our shareholders. Operator this now concludes our prepared remarks, and we are ready to open the lines for questions."
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","[Operator Instructions] We take our question from Tom Carroll with Stifel, Nicolaus.",12,"[Operator Instructions] We take our question from Tom Carroll with Stifel, Nicolaus."
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I have a high-level question on Medicaid. If I back out Kentucky, it seems that your other Medicaid markets are operating in the high 80s in terms of an MLR and if I combine that with the comments you made today, is a high 80s MLR a level we should think",109,"I have a high-level question on Medicaid. If I back out Kentucky, it seems that your other Medicaid markets are operating in the high 80s in terms of an MLR and if I combine that with the comments you made today, is a high 80s MLR a level we should think about for Coventry's Medicaid business in kind of 2013 and beyond? And then secondly, more of a smaller market question, I know it's a small market for you but the Maryland Medicaid plan has seen some slowing growth. Is there opportunity to maybe divest that business and focus elsewhere or try to improve it? What's up there?"
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","This is Randy. As far as our target for Medicaid MLR long-term, we think that's can be run in the mid-high 80s. So that would be our target for long-term to answer that question. As it relates to our Maryland operation, we really don't discuss kind of our",111,"This is Randy. As far as our target for Medicaid MLR long-term, we think that's can be run in the mid-high 80s. So that would be our target for long-term to answer that question. As it relates to our Maryland operation, we really don't discuss kind of our outlook on M&A activities around our existing businesses. But we're looking to grow all of our existing markets. We've actually, in some of our smaller markets, had some good recent expansions. We're actually expanding in one of our smaller markets in Virginia recently. We're expanding the Southwest Virginia, so we're looking to grow those businesses and evaluate each one on the standalone basis."
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","And our next question comes from Josh Raskin with Barclays.",10,"And our next question comes from Josh Raskin with Barclays."
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I understand Allen, you're effort to sort of avoid talking about the negotiations with the state, but I was just wondering if you could sort of help us just from a technical standpoint, when did you realize that this was an issue? You're locked in for sor",132,"I understand Allen, you're effort to sort of avoid talking about the negotiations with the state, but I was just wondering if you could sort of help us just from a technical standpoint, when did you realize that this was an issue? You're locked in for sort of a 3-year period from a pricing perspective but is there ability to simply cut bait and walk at any point? And then I guess the other issue, in terms, in my mind, it looks like you're already implying just from a financial standpoint, it looks like you're already implying improvement in the next couple of quarters and it sounded like you didn't think there'd be immediate impact on your actions, so I'm just kind of curious what's driving that improvement as you move forward?"
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think as to the win, so if our reserves in November and December are consistent with my comments, we knew that going from a dead start, cold start to manage the population was going to take some time. I think that as we started to getting data in the fi",272,"I think as to the win, so if our reserves in November and December are consistent with my comments, we knew that going from a dead start, cold start to manage the population was going to take some time. I think that as we started to getting data in the first quarter, and I would characterize that as being late February, we became aware of the disproportionate membership in high-cost regions -- both high utilization and high-cost regions -- so in the late part of February, we became much more knowledgeable about what our problems beyond just managing the population was. When you go from a dead start, I think the lessons learned here is that I would be reluctant to participate in any new initiative that's pushed through a 90 to 120 days with only 60 days or so to prepare for the population. Those are lessons learned. But I think that the 50 initiatives that we have on the healthcare front, on the healthcare management front will -- are beginning and will begin to show some improvement, which is part of the reason for a guidance for the rest of the year. I think the number of providers that have more data on who's more efficient as opposed to less efficient, we will be refining that process. That will bring improvement through the year. And ultimately, consistent with my prepared comments, I think that we will be successful in reaching an accommodation with the Commonwealth consistent with the contract that we signed. So it's ugly but it's going to get better and that's about what I can say about it."
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay, and then just one quick question on the Kansas Medicaid Award. Could you help us size your current exposure there in terms of revenues and I guess if you even, if you want to give some commentary around profitability relative to the overall book?",45,"Okay, and then just one quick question on the Kansas Medicaid Award. Could you help us size your current exposure there in terms of revenues and I guess if you even, if you want to give some commentary around profitability relative to the overall book?"
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","We're in the middle of the discussion process with the state of Kansas now and I think there will be some clarity on where all that leads in the next 30 to 60 days. We don't have anything today that's remotely definitive. We're in the middle of discussion",49,"We're in the middle of the discussion process with the state of Kansas now and I think there will be some clarity on where all that leads in the next 30 to 60 days. We don't have anything today that's remotely definitive. We're in the middle of discussions."
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I guess just -- I was just asking how big is it currently?",13,"I guess just -- I was just asking how big is it currently?"
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","It's about $350 million in revenue. And about 150,000 members.",11,"It's about $350 million in revenue. And about 150,000 members."
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And the profits on that business are similar to your overall X Kentucky?",13,"And the profits on that business are similar to your overall X Kentucky?"
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well it's a brand new acquisition through FHP and it's performing to our expectation. It's not where it's going to be as a long-term but...",26,"Well it's a brand new acquisition through FHP and it's performing to our expectation. It's not where it's going to be as a long-term but..."
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","For what we know, after 90 days.",7,"For what we know, after 90 days."
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","We move now to Charles Boorady with Crdit Suisse.",9,"We move now to Charles Boorady with Crdit Suisse."
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just a few points for clarification because your comments were very fullsome and helpful in Kentucky. First, you talked about the issue with competitors not living up to their contractual obligations regarding service areas and I wonder, it sounds like th",69,"Just a few points for clarification because your comments were very fullsome and helpful in Kentucky. First, you talked about the issue with competitors not living up to their contractual obligations regarding service areas and I wonder, it sounds like that caused you financial harm and I just wonder what remedies you might have there against those competitors or is it really an issue you see with the state?"
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well I think, it's the first issue is the state didn't hold everyone accountable to the requirements of the RFP. We did what we usually do, we complied in good faith and some of the people didn't. The remedy is of course there is the contract has a risk a",152,"Well I think, it's the first issue is the state didn't hold everyone accountable to the requirements of the RFP. We did what we usually do, we complied in good faith and some of the people didn't. The remedy is of course there is the contract has a risk adjusted revenue remedies and that's data that's being discussed with the Commonwealth as we speak. So there is a remedy or at least a partial remedy in the contract to adjust for the higher risk population. So that's part of the solution. I think that half of our problem roughly is revenue base, which we believe is supported by the contract and that we will receive some relief. Can't be specific as to when and half of it is what we understood when we went in a state like this, we had some previously unmanaged population with a bunch of work to do."
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. The risk adjuster, how much did you accrue for assumed risk payments in the first quarter?",17,"Okay. The risk adjuster, how much did you accrue for assumed risk payments in the first quarter?"
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","We didn't accrue anything.",5,"We didn't accrue anything."
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","We didn't accrue anything because as I've discussed with, I think with clarity, is that we have no resolution with the Commonwealth and we don't accrue anything until the checks clear.",32,"We didn't accrue anything because as I've discussed with, I think with clarity, is that we have no resolution with the Commonwealth and we don't accrue anything until the checks clear."
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. So even though it's in the contract that you would be owed this risk-adjusted payments until you actually receive the cash for them, you're not accruing the expected receipt. Is it in your guidance from mid-90s?",37,"Okay. So even though it's in the contract that you would be owed this risk-adjusted payments until you actually receive the cash for them, you're not accruing the expected receipt. Is it in your guidance from mid-90s?"
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","That's consistent with this company's practice ever since I've been the CEO. And let's get off of Kentucky now because any details would be counterproductive to our discussions with the Commonwealth and with providers in the Commonwealth.",38,"That's consistent with this company's practice ever since I've been the CEO. And let's get off of Kentucky now because any details would be counterproductive to our discussions with the Commonwealth and with providers in the Commonwealth."
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","We go now to Scott Fidel with Deutsche Bank.",9,"We go now to Scott Fidel with Deutsche Bank."
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Allen, I just had a question in terms of just your comfort levels more broadly on Medicaid right now, in terms of taking on so much additional growth given the challenges that you're seeing in Kentucky. Just particularly given your discussion about how mu",89,"Allen, I just had a question in terms of just your comfort levels more broadly on Medicaid right now, in terms of taking on so much additional growth given the challenges that you're seeing in Kentucky. Just particularly given your discussion about how much management resources on the Medicaid side that you want to put into Kentucky and the 50 initiatives that you have going on there. How do you feel about management then within Medicaid right now to address all the other expansion that you have going on?"
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","If you think about Medicaid, we have a 15 year history going back to 1994 in Missouri. In the early -- in the late '90s, we had some places that we withdrew from, Florida when rates were arbitrarily cut by a lot and the Delaware at one time. So the compan",380,"If you think about Medicaid, we have a 15 year history going back to 1994 in Missouri. In the early -- in the late '90s, we had some places that we withdrew from, Florida when rates were arbitrarily cut by a lot and the Delaware at one time. So the company went through a period of time where we were sort of, not sort of, where we were holding and doing what we have but not very aggressive in pursuing new opportunities. When I came back to the CEO spot in January of 2009, I thought the world had changed a lot in 4 years, so we began developing resources and hopefully expertise and started putting corporate resources in the growing of business for the future. And Nebraska was the first bid that we won on that front and I won't go through the history. We have most recently within the last quarter brought Tim Nolan, whom I've known for 25 years on our business and who's in the very successful reinvigorating our Commonwealth of Pennsylvania business in his years and along with Maryland and Delaware in the years in the past, and so we have continually added people and added resources. And so strategically, I think it's a good business. I think it's like all of our other businesses that you're going to have to get better that we used to be. I think there's margin pressure on all of our businesses so you have to have best people and best business practices. So I think Kentucky was certainly an expensive education but we're learning as we go. We've proven I think that we can compete for new business with everybody else. And I think on the government front with this Medicare Advantage Part D, I feel the same way about Medicaid that we have the structure, we have the better people than we've ever had. We are continuing to learn. We're continuing to do a better job taking care of the population. So it's a part of our future and in spite of a little blip along the way, or a big blip along the way, we're undaunted and we think that there's a lot of opportunity. We're going to continue to put resources in that revenue source."
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Just to add to Allen's comments. I'd like to differentiate Kentucky a little bit from some of the other markets we're expanding like Pennsylvania and the other expansion opportunities that are in the intermediate term for us. Those expansion opportunities",163,"Just to add to Allen's comments. I'd like to differentiate Kentucky a little bit from some of the other markets we're expanding like Pennsylvania and the other expansion opportunities that are in the intermediate term for us. Those expansion opportunities including Nebraska and Pennsylvania are in states where we have existing Health Plan business, existing resources and we have existing Medicaid business. We have capabilities and people already, and assets already deployed in those states. So as we think about the expansion opportunities in those areas and now with our FHP acquisition, potentially in Kansas, we have assets and we've acquired assets where we already have health plans. We have a huge commercial business in Kansas already, so I look at Kentucky as a different situation where we were going into a state where we actually had no resources on the ground. But in these other situations, we actually do have resources and we have expertise with Medicaid in those states already."
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. Then just had a follow-up question just on your view of trend and first, Randy, just to clarify did you say that you thought was sort of running in the high 7s on the look back basis in 1Q. And maybe just now that you've had a lot more claims come i",86,"Okay. Then just had a follow-up question just on your view of trend and first, Randy, just to clarify did you say that you thought was sort of running in the high 7s on the look back basis in 1Q. And maybe just now that you've had a lot more claims come in for the 4Q, just interested in sort of how you view -- how trend progress sequentially from 4Q to 1Q '12 which obviously there's not as much claims experience on at this point?"
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Our view on trend is really unchanged from the fourth quarter. As we look at prior period development and how that's developing for the last year, it's coming in stronger than 2010 at a higher level. So we feel good about kind of our trend forecast and wh",78,"Our view on trend is really unchanged from the fourth quarter. As we look at prior period development and how that's developing for the last year, it's coming in stronger than 2010 at a higher level. So we feel good about kind of our trend forecast and where we peg that. And trend is really very similar, our views are very similar to fourth quarter. We don't see a change in that outlook at this point in time."
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","Our next question we'll go to Carl McDonald with Citi.",11,"Our next question we'll go to Carl McDonald with Citi."
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Could you talk about how you think about premium deficiency reserves and when the right situation to use one is and when not?",23,"Could you talk about how you think about premium deficiency reserves and when the right situation to use one is and when not?"
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Premium deficiency reserves obviously work with our accountants and around the individual contracts and look at the entire contract period as required. And we look at those on individual contract by contract basis. And if that make sense or another situat",83,"Premium deficiency reserves obviously work with our accountants and around the individual contracts and look at the entire contract period as required. And we look at those on individual contract by contract basis. And if that make sense or another situation, we look at our entire block of business. So we look at that, we evaluate that every quarter and we make an assessment and we work with our auditors and have them review our analysis and that's the way the process works."
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","If that's specific to Kentucky, which we don't know at this -- we don't know what the revenue is until we reach a decision with the Commonwealth and I don't know that after 5 months that you exactly have a close handle on the medical expenses you will 3 m",79,"If that's specific to Kentucky, which we don't know at this -- we don't know what the revenue is until we reach a decision with the Commonwealth and I don't know that after 5 months that you exactly have a close handle on the medical expenses you will 3 months from now. So when you have all the facts if it's appropriate, along with the in way, that's what we'll do. We don't have all the facts yet."
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. And then a quick follow-up. It looks like the change in the Medicaid loss ratio, if it's all related to Kentucky pushes up the Kentucky loss ratio 1,600 basis points give or take. What is your assumption for the Kentucky loss ratio that you've embed",49,"Okay. And then a quick follow-up. It looks like the change in the Medicaid loss ratio, if it's all related to Kentucky pushes up the Kentucky loss ratio 1,600 basis points give or take. What is your assumption for the Kentucky loss ratio that you've embedded in the guidance?"
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","We don't really break out contract specific guidance around individual loss ratios. I'll comment on the deal kind of increase and our MLR guidance for the Medicaid line is related to Kentucky.",33,"We don't really break out contract specific guidance around individual loss ratios. I'll comment on the deal kind of increase and our MLR guidance for the Medicaid line is related to Kentucky."
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","For our final question, we go to Doug Simpson with Morgan Stanley.",12,"For our final question, we go to Doug Simpson with Morgan Stanley."
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just to beat a little bit of a dead horse here. As we're thinking about Kentucky, maybe a different way to look at it if you think about that, call it 15, 16 points on the MLR that will be implied if you attribute the entire $0.58 to the premium associate",138,"Just to beat a little bit of a dead horse here. As we're thinking about Kentucky, maybe a different way to look at it if you think about that, call it 15, 16 points on the MLR that will be implied if you attribute the entire $0.58 to the premium associated with Kentucky. How would you characterize your expectation in the balance of the year? If I heard you right, you're not including any incremental pass-through receipts or anything on risk adjuster front. Is it kind of correct to think about the seasonality that we would have expected as of yesterday and then burden each quarter by that roughly 15, 16 points on the MLR? Is that -- would that get us in the right zip code in terms of thinking of seasonality and the contribution from Kentucky?"
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think we can't do much more than we've done, which is, say, half of it is a revenue base that we're in discussion. The other half is medical initiatives. We explain that we have 50 initiatives going, that we're also refining our provider system there an",226,"I think we can't do much more than we've done, which is, say, half of it is a revenue base that we're in discussion. The other half is medical initiatives. We explain that we have 50 initiatives going, that we're also refining our provider system there and concentrating more on the membership and where we're going to get a better result. I don't think that we can predict day by day or week by week. But we know the cumulative effective of medical management will improve our position as the year progresses. We know that we have a large revenue increase coming October 1. So when you add the discussions up, the medical initiatives, the revenue we know that we're going to get, we're going to go from a terrible picture to an improving picture as the year progresses and that's about as good as we can do at this particular point. I think that Q2 will bring clarity to the resolution with the Commonwealth. And I think that Q2's going to bring us some clarity, the 3 more months of data or medical initiatives where they're starting to work and with the revenue. This won't drag on with so many unanswered questions for the entire year. I think that Q2 will bring a partial answer to what the rest of the year looks like."
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay, and then I may have missed this, I apologize if I did. Randy, did you say that how the RADV benefit was treated on the income statement?",28,"Okay, and then I may have missed this, I apologize if I did. Randy, did you say that how the RADV benefit was treated on the income statement?"
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","It was an increase to revenue.",6,"It was an increase to revenue."
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. Just drop it right into the revenue straightaway?",9,"Okay. Just drop it right into the revenue straightaway?"
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes.",1,"Yes."
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","Ladies and gentlemen, that does conclude today's question-and-answer session. I'd like to turn the conference back over to Mr. Wise for any additional or closing remarks.",26,"Ladies and gentlemen, that does conclude today's question-and-answer session. I'd like to turn the conference back over to Mr. Wise for any additional or closing remarks."
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","No, we don't have any additional remarks and thank you so much for joining us today.",16,"No, we don't have any additional remarks and thank you so much for joining us today."
27133,204626278,292110,"Coventry Health Care Inc., Q1 2012 Earnings Call, Apr 27, 2012",2012-04-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","Ladies and gentlemen, that concludes today's conference. Once again, thank you for your participation.",14,"Ladies and gentlemen, that concludes today's conference. Once again, thank you for your participation."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","Good morning, and welcome to today's Coventry Health Care's Second Quarter 2012 Earnings Conference Call. Today's call is being recorded [Operator Instructions] Today's call will begin with opening and remarks by Chairman and Chief Executive Officer of Co",57,"Good morning, and welcome to today's Coventry Health Care's Second Quarter 2012 Earnings Conference Call. Today's call is being recorded [Operator Instructions] Today's call will begin with opening and remarks by Chairman and Chief Executive Officer of Coventry Health Care, Mr. Allen Wise, after a brief forward-looking statements read by Mr. Drew Asher. Please go ahead, Drew."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Ladies and gentlemen, during this call we will make forward-looking statements. Certain risks and uncertainties, including those referenced in our press release and described in the company's annual report on Form 10-K for the year ended December 31, 2011",80,"Ladies and gentlemen, during this call we will make forward-looking statements. Certain risks and uncertainties, including those referenced in our press release and described in the company's annual report on Form 10-K for the year ended December 31, 2011, the company's quarterly report on Form 10-Q for the quarter ended March 31, 2012, and all subsequent filings with the SEC may materially impact those statements and could cause actual future results to differ materially from those anticipated and discussed. Allen?"
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Good morning, and thank you for your interest in Coventry Health Care. Earlier today, we reported earnings per share of $0.65 for the quarter bringing year-to-date earnings per share to $1.85. The quarter was marked by significant improvement in Medicaid",1866,"Good morning, and thank you for your interest in Coventry Health Care. Earlier today, we reported earnings per share of $0.65 for the quarter bringing year-to-date earnings per share to $1.85. The quarter was marked by significant improvement in Medicaid performance, sequential growth in Medicare products, continued SG&A leverage and cash deployment for share repurchase. We are on track for our 2012 EPS forecast of $3.10, to $3.30 per share and therefore, are again reiterating full year 2012 guidance. 
I'll cover some of our business highlights and perhaps, more importantly, where we feel we're headed for tomorrow. Let's start with government programs, which now represents about 1/2 of the company's revenue. You may recall from the first quarter that our Medicare Advantage business, spanning 15 states had an excellent annual enrollment period with 13% sequential membership growth in the first quarter of 2012. Since Q1, we've continued to add membership each month in our Medicare Advantage business and we're at 253,000 members at the end of the second quarter. We are well-positioned in our Health Plan footprint from a cost structure, distribution and product standpoint and as such, expect to continue the growth and strong performance as we look multiple years ahead. During Q2, we our bids for 2013 and we're optimistic about the future serving the senior population. The story is similar for Medicare Part D. We experienced significant growth in Q1, followed by continued growth in each month of the second quarter. In fact, Medicare Part D grew by 36,000 members in Q2, averaging growth of about 12,000 members per month. We expect to continue growing throughout 2012 based on our positioning of our value cost product and the attractive value proposition we've been able to create for the senior population. To round up Medicare, the margins on these products continue to be on track with our forecast and consistent with prior year's. In Medicaid, coming into 2012, we experienced substantial growth effectively doubling our revenue to about $2.9 billion, led by the 2011 Kentucky win, the FHP acquisition and our granite wins in both Nebraska and Pennsylvania. Our challenge is to manage that growth and demonstrate that we're able to improve and manage bottom-line performance. Continuing the bottom-line performance thought, I'd like to continue the Medicaid discussion with a much more in-depth review of Kentucky. You may remember during Q1 conference call when I advised you that after 5 months of data it was obvious to us that we have severe earnings pressure and other challenges with regard to our 32-month contract with the Commonwealth of Kentucky with approximately 230,000 members. At that time, I identified some of our major problems in the areas of adverse risk selection, especially in regions 7 and 8, lack of compensation from the Commonwealth for past due payments to hospitals due to errors or omissions in the data book and a challenge of managing the health and care of a very large population with limited preparation time. These problems are exacerbated by the fact that there's not been a managed care program in Kentucky previously and the fact that there wasn't permanent leadership in the Cabinet for health and family services in the early days of the program. Our challenges were made even more difficult due to litigation due to litigation from 1 of our largest providers group in region 8 that prevent us from exercising the 30-day notice of termination provision, even though our agreement clearly allowed us to do so, almost a perfect storm. Well enough history and I'm pleased to report that we're making very significant progress in many, if not most of the areas, which created a very poor financial result during the first 5 months of the contract. First, there's now permanent leadership at the Cabinet level for health and family services, which is resolved in the necessary and meaningful dialogue to develop a program that works for both Coventry and the Commonwealth of Kentucky. Second, we received a partial adjustment regarding risk-adjusted revenue, which we were contractually owed. And this revenue produced perspective relief beginning April 1, 2012. Third, we received an adjustment of pass-through for hospital payments effective on May 1, 2012 that is retrospective back to November 1 of 2011. Accordingly, it reimburses to Health Plan for these past due costs for the entire contract period. In the area of patient management, I'd advised you on the last conference call the way that we'd identified 50 initiatives to take better care of the members and we have made, and we'll continue to make, very significant progress in this area. Commonwealth of Kentucky is a DRG state and we've been able to reduce costs and very numerous one-day admissions, which in many cases, we're replaced with observation periods, as is the practice in most hospitals throughout the country. You may also recall that we bid the business with a significant rate increase in year 2. In October of this year, we'll received a rate increase between 5.3% and 7%. The difference between the 5.3% and the 7% is that while we don't have a final, final agreement, we should receive additional risk-adjusted revenue beginning October 1 in addition to the agreed-upon 5.3% rate increase. And while we received a partial increase prospectively for this risk adjusted revenue, and resolve the hospital pass-through issue, we have not received reimbursement retrospectively for risk-adjusted revenue, which are we strongly feel is due. We filed an appeal to address this issue and if that fails, we'll litigate the issue. Kind of final thoughts on Kentucky and even though we were delayed by provider litigation, we will be able to move forward with terminating providers that do not meet our utilization and quality criteria so that we can continue to develop a more efficient delivery system as the year progresses. My personal belief is in the worst case, that Kentucky will be breakeven in 2013 and I feel that the more likely outcome is that we will have a reasonable profit on this business for 2013. 
In other Medicaid news, we're off to a great start in Nebraska out with our expansion on track from a recent RFP commenced on July 1st of June and we've enrolled more than 1/2 of the available membership, adding approximately 40,000 members resulting in a #1 statewide market position. We serve Nebraskans in Medicaid since 2010. We've had a Health Plan presence in Nebraska since 1998. We also look forward to 3 new Pennsylvania regions, which are being rolled out in a staggered fashion over the next 3 quarters starting with the Southwest in Q3, followed by the new West and ending with the new East in Q1 of 2013. And we'll continue to pursue these new opportunities where we believe we can bring our suit of capabilities to serve state and government program populations. One final Medicaid topic, which is Kansas. Based on the state's proposed terms for the new 2013 Medicaid contract and our corresponding bid posture, we did not win the state of Kansas Medicaid contract effective January 1, 2013. You may recall that FHP, which we acquired in January of 2012 operated in both Missouri and Kansas. We won the Missouri rebid earlier in the year, which is where most of the performance and value of this FHP resided and accordingly with the loss of the Kansas contract, we wrote off $7.7 million intangible in the quarter. Effective July 1, we did extend the existing Kansas contract for the remainder of 2012 and we believe is an appropriate rate increase. While suffice it is to say, we learned some lessons in Kentucky and although disappointed with the outcome and Kansas, we will not sacrifice operational or financial prudence in the search for just growth. We feel good about the growth dynamics included in the federal poverty level expansion in Medicaid and the dual eligible migration to managed care and we look forward to seizing our fair share, which should be significant opportunities over the next 3 to 5 years. 
Moving onto a few comments on the commercial business. We feel that we're well-positioned for the future from a cost structure standpoint and our local Health Plan footprint and we look forward to significant opportunities in 2014. For the past decade, we have certainly experienced from normal challenges and opportunity in the commercial book but 1 thing has been constant, our cost structure, which has been sound and the commercial business has always been profitable. The earnings and cash flow from the commercial business has enabled us to invest in M&A, as well as organic opportunities in government programs. And while the commercial business represents about 40% of Coventry's revenue today, we are targeting a portfolio with a balanced spread across Medicare, Medicaid and Commercial with our Fee business being a complementary part of a diversified revenue earnings and cash flow stream. I don't really have any new news on the Commercial environment, which is a bit challenging as there are many carriers seeking membership and what I feel is best stable pool of business and more likely today a diminishing pool. Despite the discussions and speculations about healthcare reform over the past year, we really never altered our focus in terms of preparing for the opportunities in 2014 and beyond. While the efforts to position Coventry for 2014 is the high performance network model of teaming up with leading health systems and physician groups and together, we expect to deliver a superior value proposition to commercial and Medicare members in terms of care coordination, quality, access and cost. We expect the commercial individual market to expand dramatically over the next few years. And we feel we'll be well-positioned to see that growth opportunity as well. In the area of capital activity, we deployed $300 million of cash on share repurchase in the second quarter, which represents about 6.5% of the outstanding shares and since Q2 is a quarter, when we received most of our regulated dividends, our deployable cash balance really didn't change significantly as we ended the second quarter with approximately $850 million of deployable cash on hand. 
So in summary, I'm very pleased with the positioning of our diversified business model as we look to the future. Given our exposure to and capabilities in Government Programs, we will continue to participate in growth opportunities in Medicaid expansion, Medicare and new eligibles. We also expect our Health Plan cost structure in many markets to be a winner in the 2014 commercial exchange jump ball. As usual, we take nothing for granted and we work everyday on cost structure and product positioning. We're committed to continuing to improvements in Kentucky. And we'll continue to use a strong balance sheet when appropriate in attracting for capital deployment. On balance, we feel very positive about the diversity of our products and our balance sheet. We've never been stronger. We're better positioned to continue positive growth in Medicare Advantage and Part D. I've feel we are positioned by resources, focus, commitment and experience to make substantial new Medicaid gains in the future. 
Those general comments. I'd like for Randy Giles, our CFO, to provide some financial details. Randy?"
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Thank you, Allen. This morning, we reported earnings per share of $0.65, which includes a $0.03 impairment charge resulting from the nonrenewal of our Medicare contract with the state of Kansas. This result allows us to reaffirm our 2012 full year EPS gui",2043,"Thank you, Allen. This morning, we reported earnings per share of $0.65, which includes a $0.03 impairment charge resulting from the nonrenewal of our Medicare contract with the state of Kansas. This result allows us to reaffirm our 2012 full year EPS guidance range of $3.10, to $3.30 per share. I am pleased with the results that we reported today with reflect improved performance in our Medicaid business, sequential growth in our Medicare products continued SG&A efficiency and effective use of deployable capital. Our mix of business continues to shift towards more balanced levels across Commercial Risk, Medicare and Medicaid products with an important level of non-risk revenue provided by our fee-based businesses. We believe that a diversified portfolio of businesses provides a critical ability to both seize growth opportunities and provides the best positioning for continued growth and profitability. 
Let's begin with our government programs businesses, where I'm pleased to report significant improvement in Medicaid during the second quarter. Medicaid MLR of 93.3% is a 670 basis points sequential improvement was driven primarily by the significant improvement in Kentucky during the quarter. Excluding the impact of Kentucky our consolidated Q2 Medicaid MLR was an outstanding result, at 83.5% or a decrease of 340 basis points over the prior-year period. Our Kentucky Medicaid business improved from 120.9% MLR that we reported in Q1to 110.8% for the second quarter. A sequential improvement of 1,010 basis points, which was driven by favorable trends for both revenue and expense during the quarter. On the revenue front, during the quarter, we received more clarity from the Commonwealth regarding risk-adjusted payments owed to Coventry while we continue to discuss the underlying methodology of the risk-adjustment calculation with the Commonwealth, Coventry begin recognizing the positive revenue impact of a monthly risk-adjusted payment with an 8% quarter during the second quarter. As we disclosed during the investor conference during June, a supplemental payment issue has been resolved favorably, which had a positive impact on revenues in the second quarter, and will continue throughout the remainder of the year. In addition, we'll be receiving a 5.3% contract rate increase on October 1, which will provide $4 million of incremental revenue from them [ph]  Plus any amount that result from continued discussions on risk adjustment as Allen mentioned. In terms of medical expense, we continue to make progress with our risk of targeted cost initiatives and expect the fruits of our labor to resolve in continued cost improvement during the second half of 2012 that throughout the remainder of the contract. We're in continued discussions with the Commonwealth regarding various aspects of the Medicaid program that we will continue to update you on as they develop. We remain on track to exit 2012 with the results such that Kentucky Medicaid will not have a material impact on our 2013 earnings performance. As you will recall from our last earnings call, I highlighted that we were warranted expansion to our existing prisons in the state of Nebraska just that went live on July 1. The contract is off a great start as we added nearly 40,000 members according to the initial data out of approximately 60,000 new eligibles. This brings us to approximately 90,000 members today statewide with the #1 market share. We also expanded in Virginia effective July 1 as the state expanded in the Southwest region where Coventry has been awarded 7,000 new members. And finally, in Florida we recently re-awarded a contract as of the states healthy kids Medicaid program to 16 counties serving approximately 20,000 members, which is generally consistent with our presence today. We participate in multiple programs in the Florida Medicaid market and view this rebid as an encouraging sign as we think about further expansion programs as the state is for 2013 and beyond. We are also successful on our rebid efforts in Missouri, which is Coventry's largest Medicaid state by membership and has been performing well throughout 2012 this contract was effective July 1 and initial open enrollment results yielded growth of an additional 25,000 members to solidify our #1 presence statewide. This out steady momentum across our Medicaid businesses, puts us on pace to exceed our 1 million member goal during the third quarter of the year. 
With that being said, we were unsuccessful in 1 big during the second quarter, as we will not be renewing our contract with the Kansas Medicaid program, which is scheduled to end on December 31 of this year. Contract terms offered by the state were very complex in nature and present a unique challenge for Managed Care Organizations. The bid prudently based on the data that was available, most of which was our own experience, as well as requirements that the stateless putting forth for the new contract. Although our contract terminated on June 30 this year, we've been able to reach an agreement to provide managed care services through the remainder of the year at an acceptable rate. Because this contract was held by recently acquired Family Health Partners subsidiary we took an impairment charge in the second quarter of the $7.7 million or $0.03 per share to write-down certain intangibles associated with the Kansas portion of FHP. Just to remind you, the Kansas Medicaid contract represented approximately $350 million annual revenue with a year-to-date MLR into the 90s such that it was essentially a breakeven contract. While we are disappointed with the opportunity we remain quite optimistic about the growth trajectory for our Medicaid business in total and the growth initiatives that we have on the horizon. 
Turning to our Medicare business. Medicare Advantage continues to see favorable trends and we added 3,000 members during Q2. The second quarter MLR of 84.1% is in line with expectations and is consistent with our full year MLR guidance of low to mid-80s, excluding the impact of the RADV reserve release. As Allen mentioned, we have submitted our 2013 bids and I'm confident that we are well-positioned both operationally and financially to servicing the population in the future. Our Medicare Part D business experienced very impressive sequential growth during the second quarter as the 36,000 members that we added was the best growth in the entire industry. The year-to-date Medicare Part D MLR of 92.5% is consistent with our 2011 year-to-date MLR performance and keeps us on track for our full year MLR guidance of low to mid-80s. Similar to my commentary on Medicare and Managed, I like our positioning in the 2013 Medicare Part D bids in light of these continued stable results. 
Moving onto the Commercial business, this morning we reported MLR of 83% for the second quarter, and 81.5% year-to-date. As you saw on the commentary in our earnings release, there's 1 specific item as automatically pushing out this result relative to 2011 but importantly does not significantly impact overall earnings profile of the Commercial Risk business. We've been able to implement capacity initiatives in the majority in the majority of our geographic areas across both large and small group business in 2012, which is an important strategy to create a more appropriate comparison in the minimum MLR definitions. The affect of this process on a GAAP financial though, is to mathematically reduce revenue for the broker commission component that otherwise would've been reported in our risk revenue total, which increases our MLR this year as compared to the prior year. There are of course many other moving parts in this nearly $6 billion block of business but I thought it would be instructive to spike up this specific factor, which drives our slightly higher Commercial Risk MLR result without a material impact to the overall earnings profile of the business. During this item our full year is now 81.5% to 82.5%, which at the midpoint is an increase of 40 basis points from the prior year. Staying in our commercial book, once again our view of fundamental prospective trend remains unchanged in the range of 8% plus or minus 50 basis points. We continue to see trends in the high 7s looking into the rearview mirror, which migrated higher from the very low levels seen during the second half of 2010. Unit cost trend was continuing to be the largest driver of overall trend, is stable. As we look at trend by component in the second quarter, we saw the trend for inpatient days were 1000 remains slightly negative and we're projecting inpatient utilization trends to be flat to slightly positive. Perspective position trends appear to have stabilized after showing some slight uptick over the last few quarters while the other utilization trends that we're seeing in the outpatient category continue to take up towards. This various trend dynamics have been gradual and importantly, have been anticipated in our pricing. You will recall that we first mentioned seeing this migration in the third quarter of 2011. 
Our fee-based business has all performed in line with expectations in the quarter and we have increased slightly for this second consecutive quarter corrected our broadly improved year across all lines of our Fee-based businesses. We continue to be pleased with our Fee-based businesses as they have consistently generated steady levels of valuable unregulated cash flow and earnings. 
Turning now to SG&A, I'm very pleased with the second quarter results that we reported today and the lower full year expense level that we have included in the new guidance ranges. Just to put this into context, in 2011 reported an SG&A rate of 16.5% of revenue, which was reduced to 15.4% of revenue in our initial guidance and has now been reduced to 14% of revenue today. This is the second consecutive quarter where we have been able to increase our overall revenue range while lowering our SG&A projection, a leveraging dynamic that we think is critical to succeed in today's environment and even more so as we look to the future. While we continue to leverage our efficient operating structure in the near term, and enjoy the benefit on the SG&A line from our broker pass-through initiatives, we are also very mindful of the investments that we'll need to make for the future and are preparing accordingly. 
I would now like to spend some time on our balance sheet and cash flow performance for the second quarter. Our investment portfolio continues to be in excellent shape and has a net unrealized gain a position of $108 million at June 30, increase of $8 million from the prior quarter. Following through on our commitment to capital towards share repurchase, we bought back 9.3 million shares during the second quarter for $300 million, which represents approximately 6.5% of our outstanding shares. Not only is this level of activity comparable to our total share repurchase activity for all of 2011 it also represents the highest share repurchase level in a single quarter in the company's history. Also during the second quarter, our board of directors approved our second quarterly cash dividend, which was payed to shareholders to record on July 9. In addition to deploying cash and repurchase shares, we completed our dividend process during the second quarter collecting $215 million from our regulated subsidiaries. We ended the second quarter with $850 million in deployable free cash at the parent, which even after $300 million of share repurchase, which combined with our undrawn $750 million credit facility provides $1.6 billion in accessible capital capacity. As of June 30, our debt-to-capital ratio stands at 26% falling well within our typical leverage levels. So as I reflect on our results for the quarter and the progress that we have made across all of our businesses, I'm very satisfied with how the company is positioned and the fact, that we are advantaged in many areas. Health Care Reform continues to move forward and while this was surely create changes in the marketplace, it will also create significant opportunities for those that have a low-cost structure in connection to the [indiscernible] we believe that we have a capital and free cash flow stability to adapt quickly and support the growth prospects that we see for the future. 
Thank you again for your interest in Coventry Health Care. Operator, this now concludes our prepared remarks and we are ready to open the lines for questions."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","[Operator Instructions] And we'll go to Tom Carroll with Stifel.",10,"[Operator Instructions] And we'll go to Tom Carroll with Stifel."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So question on Kentucky, what was the Kentucky Medicaid premium in the quarter?",13,"So question on Kentucky, what was the Kentucky Medicaid premium in the quarter?"
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Tom, it was $249 million.",5,"Tom, it was $249 million."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","$249 million, great, and do you expect sequential MLR improvement to continue there? I mean the data point that you gave us adjusted continued improvement, would you agree with that?",30,"$249 million, great, and do you expect sequential MLR improvement to continue there? I mean the data point that you gave us adjusted continued improvement, would you agree with that?"
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","We do.",2,"We do."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Any magnitude? I mean another 10 percentage points of the decrease rather/",12,"Any magnitude? I mean another 10 percentage points of the decrease rather/"
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","I don't know. We've made very substantial and consistent progress. There's a lot of opportunities remaining on the revenue side. Ultimately, can't look at this point and can't guarantee it but ultimately, I believe we're entitled to retroactive risk-adjus",202,"I don't know. We've made very substantial and consistent progress. There's a lot of opportunities remaining on the revenue side. Ultimately, can't look at this point and can't guarantee it but ultimately, I believe we're entitled to retroactive risk-adjusted revenue, we'll pursue that to the end and we'll continue to make substantial progress in admissions and taking better [indiscernible] we continue to weed out prescription drug abuse, pain center types of mills. We will make future progress in refining our delivery system, which was made more difficult by some litigation by the biggest provider of group there. So we've made a lot of progress and we have a lot of opportunity and it was a pretty bold statement for me to say that worst case next year breakeven in my view is we're going to make a reasonable profit. So it's kind of hard to predict month by month and quarter by quarter because we've seen 1 great quarter of improvement and I see no reason why that trend won't continue. I wouldn't say it's going to be another 1,000 basis points in the next quarter
Tom, obviously the bigger step down would come with a rate increase effective 10 1."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And just a follow-up on your Commercial cost trend side, it sounds like you're not seeing anything outside of what you were expecting so nothing like the blues being more competitive than you thought or utilization rising more so than you thought. Just tr",69,"And just a follow-up on your Commercial cost trend side, it sounds like you're not seeing anything outside of what you were expecting so nothing like the blues being more competitive than you thought or utilization rising more so than you thought. Just trying to reconcile the slight increase in your consolidated MLR number for the year. Would you suggest that's all related to the broker pass-through mechanism?"
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Our view of the commercial environment is consistent with really what we've talked about for the last 5 or 6 quarters, which is it's a very competitive. It's beyond competitive in Western P.A. but it isn't dramatically different than we've experienced in",170,"Our view of the commercial environment is consistent with really what we've talked about for the last 5 or 6 quarters, which is it's a very competitive. It's beyond competitive in Western P.A. but it isn't dramatically different than we've experienced in 15 years in the business, which there's always a couple of marketplaces where it borders on irrational and so we will lose membership until that settles down. I believe it's probably a diminishing pool of business. There isn't any job growth and I think for the most part in the data that -- I would suggest that we lose membership within existing groups meaning employees can't afford the coverage and drop it but it basically, there has not been any substantial change this quarter over the last quarter. It's competitive and not a growing pool of business but because of our cost structure and our experience in the long-term in the marketplace where we are, we don't really see any deterioration for the rest of the year."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","On your question about MLR, last year we recorded an MLR of 81.6% our guidance today increased to 82% all of that 40 basis points year-over-year increase is explained by increased broker pass-through activity in 2012.",36,"On your question about MLR, last year we recorded an MLR of 81.6% our guidance today increased to 82% all of that 40 basis points year-over-year increase is explained by increased broker pass-through activity in 2012."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","And we'll go next to Josh Raskin with Barclays.",10,"And we'll go next to Josh Raskin with Barclays."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just first question on the broker commission. Just so I understand, you guys are basically increasing that ratio by taking out. You said there's no impact but I know you guys paid $15 million in rebates for the last year so is there no impact on your expe",66,"Just first question on the broker commission. Just so I understand, you guys are basically increasing that ratio by taking out. You said there's no impact but I know you guys paid $15 million in rebates for the last year so is there no impact on your expected rebates either or ultimately will there be a little bit of a benefit in terms of the P&L?"
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","The strategy is actually, I think the broker pass-through affects all markets, our rebates on healthcare reform we've rebates minimum MLR are really concentrated in a handful of markets. So the fact is, we basically have taken this broker commission pass-",83,"The strategy is actually, I think the broker pass-through affects all markets, our rebates on healthcare reform we've rebates minimum MLR are really concentrated in a handful of markets. So the fact is, we basically have taken this broker commission pass-through strategy in all our markets and so it's pretty broad-based so it doesn't really lineup one-to-one. You're right, there could be theoretically be a benefit in those markets where there are rebates there is one, but it's not concentrated in those markets."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And is there a reason you guys chose now to accelerate that strategy.",13,"And is there a reason you guys chose now to accelerate that strategy."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think the strategy was deployed last year, but it really involves working with each broker and each group to try and get that set up so it really deploys as those cases renew and so now that we've gone through a year, most of the groups have gone throug",60,"I think the strategy was deployed last year, but it really involves working with each broker and each group to try and get that set up so it really deploys as those cases renew and so now that we've gone through a year, most of the groups have gone through that renewal cycle and are moving over to broker pass-through."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then just second question on Kentucky, were there any -- I guess, 2 parts, were there any what you would consider out-of-period payments that came, sounds like you have some stock retroactive back to April or even last November so I'm just curious if",79,"And then just second question on Kentucky, were there any -- I guess, 2 parts, were there any what you would consider out-of-period payments that came, sounds like you have some stock retroactive back to April or even last November so I'm just curious if there was sort of a one-time event that hit the MLR in Q2 that you can spike out and then what's the estimate on sort of the full year loss in Kentucky for 2012?"
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","There weren't any out of period payments and the revenue for the date that I gave you in my presentation.",21,"There weren't any out of period payments and the revenue for the date that I gave you in my presentation."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","The supplemental payments, they go back to November, that's a couple of million bucks. There's risk adjust for the payments we received were all just within the same Q2 period. We haven't received any retro-risk payments if that's what you're asking for.",42,"The supplemental payments, they go back to November, that's a couple of million bucks. There's risk adjust for the payments we received were all just within the same Q2 period. We haven't received any retro-risk payments if that's what you're asking for."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So if the payments got back, it might have been a couple of million but not a huge deal the risk adjusted was all for Q2 and then, the full year loss.",32,"So if the payments got back, it might have been a couple of million but not a huge deal the risk adjusted was all for Q2 and then, the full year loss."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Can you restate your question again?",6,"Can you restate your question again?"
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Yes, just curious what your expectations in terms of full year sort of pretax loss in Kentucky will look like this year.",22,"Yes, just curious what your expectations in terms of full year sort of pretax loss in Kentucky will look like this year."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well we really don't spike out individual contract performance like that. I mean you can't kind of back into it but with the losses that we've incurred in the first quarter and the MLRs that we've had year-to-date, the contracts -- we reported MLR year-to",111,"Well we really don't spike out individual contract performance like that. I mean you can't kind of back into it but with the losses that we've incurred in the first quarter and the MLRs that we've had year-to-date, the contracts -- we reported MLR year-to-date of 115.6% that gives you -- and we're projecting that, that will decrease over time. We expect the most significant MLR improvement at this point this on information that we have visibility on being in the fourth quarter. So we expect that to phase down toward the breakeven as we go into the rest of the year and again, enter 2013 with no material pressure."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","What you say breakeven, do you mean 100% MLR or do you mean breakeven profit, including the SG&A?",18,"What you say breakeven, do you mean 100% MLR or do you mean breakeven profit, including the SG&A?"
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","No, we mean breakeven after we pay our SG&A expenses. 100% is not breakeven.",14,"No, we mean breakeven after we pay our SG&A expenses. 100% is not breakeven."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I didn't know if we're talking about gross margins there or operating..",13,"I didn't know if we're talking about gross margins there or operating.."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","And I think it's difficult not to be -- to go much deeper and not to be misleading, we feel we have a retroactive risk-adjustment amounts due. We filed an appeal on that front. We feel like they're supported contractually if that appeal is not successful,",156,"And I think it's difficult not to be -- to go much deeper and not to be misleading, we feel we have a retroactive risk-adjustment amounts due. We filed an appeal on that front. We feel like they're supported contractually if that appeal is not successful, we'll litigate the issue. How we ultimately resolve all of that, can't get any worse if we resolve that successfully, it's going to affect the year. We made a lot of progress on the revenue side, a lot of progress on the cost side in Q2 and we think that will continue in Q3 and even a 5.3% increase on $250,000 million puts us in a substantially better shot. We think the worst days are behind us in Kentucky and we've done many of the things and we'll do many of the things it takes for this to be successful, a humbling and valuable lesson, but we will prevail."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","We'll go next to Carl McDonald with Citi.",9,"We'll go next to Carl McDonald with Citi."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","WellPoint earlier in the week, position the commercial business, a change relative to what they've been thinking about earlier in terms of both it sounded like both pricing and cost trends seems like you and United have a sort of a more consistent view. S",86,"WellPoint earlier in the week, position the commercial business, a change relative to what they've been thinking about earlier in terms of both it sounded like both pricing and cost trends seems like you and United have a sort of a more consistent view. So just it'd be just interesting when you hear WellPoint said that they think things are changing and things are getting more aggressive. Did that give you pause or would you attribute that all to a difference expectations coming into the year."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think we always spend a lot of time worrying about what we don't know. But I think if you would review our comments on the commercial environment and trends back for 6 quarters that we were probably 1 of the 1st companies that said the diminishing utili",319,"I think we always spend a lot of time worrying about what we don't know. But I think if you would review our comments on the commercial environment and trends back for 6 quarters that we were probably 1 of the 1st companies that said the diminishing utilization wasn't going to continue forever. We don't know what caused it we don't know what was going to change it. I think we've been consistently saying there was some pressure on outpatient cost and not unlike in Kentucky. I think we're the first people who are doing this is in Kentucky that said we've got problems here and disclosed that the minute that we knew it and went to work on it. I think our view in commercial, if you examined our comments for the prior quarters, as I've said, it's a little tougher environment. We don't see any, to change so it always gives you pause to say it's safe to once again, think about what's occurred and where the future goes. Our practice here is to think about the worst all the time and we have, I don't know, 50 initiatives on the unit cost side where we think we've gotten a little bit behind and that's kind of how we view the business here, which is always with little bit of fear and a little bit of suspicion and a lot of realities. I don't understand. We are in most of the markets or many of the markets or most of the markets were WellPoint the way we would be with United and some of the other blues. So I don't know what would have suddenly happen. These things evolve over long periods of time and I don't understand things that suddenly occur. So I can't be helpful there. But we don't see anything different than we've reported in the last several quarters and we've reported today."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then on Kentucky, to get to breakeven, the 111% has to go to say, 93% or 94%. Is there any way of giving us a sense how much of that 1700, 1800 basis point improvement is things that you've already achieved, say, the rate increase in some of the provi",75,"And then on Kentucky, to get to breakeven, the 111% has to go to say, 93% or 94%. Is there any way of giving us a sense how much of that 1700, 1800 basis point improvement is things that you've already achieved, say, the rate increase in some of the provider renegotiations our cancellation versus how much of the stuff that still needs to be accomplished like the, say that retroactive risk the grid adjustment."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","No, I think it is a little bit probably of both. It's always a little bit difficult to be able to measure precisely what you've achieved, the things that we have done 2 months ago will show up 2 months from now. When the numbers are in, the claims are pai",445,"No, I think it is a little bit probably of both. It's always a little bit difficult to be able to measure precisely what you've achieved, the things that we have done 2 months ago will show up 2 months from now. When the numbers are in, the claims are paid and now it's a sense -- I think it's a continuous process and I think that some of the things that developed in this quarter, we're really in a work that we did the quarter before. So I think that we have made progress. I think there's a lot more opportunities in refining our delivery system, a lot more opportunities in continuing to take better care of the patients. If you follow the media, at least 4 times or 3 times last quarter, Kentucky leads is always highlighted as the, the Commonwealth is one of the places where prescription drug abuse is the worst. So we have 50 initiatives and some of those are continuously. You're really never never finished. I just think that in areas like reduced admissions and getting observation days, which is the practice in most hospitals and I think is guidelines at CMS issued and continues to refine. We've made a lot of progress and think that revenue increase in Q4 is huge, but I think on the patient management side and admission, those will go on for a long time. We've been in business, in the Medicaid business in Missouri since 1994 and life changes. For a long time our trend was 8%, the state gave us and 8% increase and life was good and 2008, the revenue got tougher and so we continually evaluate our cost structure and how we deliver the care. And so we've done a lot of work in Missouri, which is a huge state for us, too, in terms of our contracts. We had a contract forever with the worsening University decision group that was 180% of Medicaid, which worked in the old days when revenue was easier to come by and you'd have a very broad delivery system and make a reasonable profit. That kind contract's canceled last quarter. So I want to get off the subject of Kentucky. It really never stops and a decent amount of experience, we think that we're getting closer to a partnership in Kentucky. We have better dialogue with them, this has to work for the Commonwealth, has to work for us and we think that we've made progress and we'll continue to make progress and I can't do much better than to stick our next port only but we're not going to make profit next year."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Just to add to Allen's comment. We think we can make breakeven with 4% admin and the 96% loss ratio in Kentucky. So the hurdle's not quite as large as you thought. In addition, 1 other point, I think that we've kind of already got visibility on it is that",151,"Just to add to Allen's comment. We think we can make breakeven with 4% admin and the 96% loss ratio in Kentucky. So the hurdle's not quite as large as you thought. In addition, 1 other point, I think that we've kind of already got visibility on it is that we are putting co-pay with additional copayments in Kentucky, open enrollment in the fourth quarter so we're going to see an economic benefit from that that's already structured. The provider, higher cost provider adjustments, will also happen in the fourth quarter, and we're already we're already committed to those. So there's a couple of these things that go on the cost side and the revenue side. We have pretty good line of sight on but there's obviously a lot more on the cost initiatives on the revenue side that we have to do to give all the way to breakeven."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","And we'll go next to Kevin Fischbeck with Bank of America.",12,"And we'll go next to Kevin Fischbeck with Bank of America."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","As you mentioned, you're not the only the company experiencing issues in Kentucky and 1 of your competitors talk about changed the methodology for retro assignments and have you guys factored that into your thought process and what do you think the impact",48,"As you mentioned, you're not the only the company experiencing issues in Kentucky and 1 of your competitors talk about changed the methodology for retro assignments and have you guys factored that into your thought process and what do you think the impact to you guys might be."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think there's a couple of big changes happening there in terms of retro assignments and a way that's going to work. So it's not just retro assignment. The Commonwealth is committed to changing in the auto assignment process in general and we think there",165,"I think there's a couple of big changes happening there in terms of retro assignments and a way that's going to work. So it's not just retro assignment. The Commonwealth is committed to changing in the auto assignment process in general and we think there's there some high-cost categories for us like dual eligibles and some of the other categories where we have a disproportionate share so we think that shift will benefit us from some of the other categories and we think in general, that shift might end up being neutral just in general. So overall, we think that's a positive for all MCOs because an average, it means the average revenue that the Commonwealth is paying is going to increase because currently, a majority of the selection criteria is based on who has the lowest premium in a given rate cell. So we think that's going to end to, lead into margin and the higher PM PM [ph] revenue in the contract."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","That's interesting and then just a quick clarification about the things you guys had said earlier. If you think about the core Kentucky MLR, I guess, the pass-throughs and the retro portion was maybe a couple of million dollars that might have been 100 ba",103,"That's interesting and then just a quick clarification about the things you guys had said earlier. If you think about the core Kentucky MLR, I guess, the pass-throughs and the retro portion was maybe a couple of million dollars that might have been 100 basis points to MLR, is that the right way to think about it and then in relation to Tom's question, you said for the sequential improvement in MLR. Is that -- do you expect that even with not having that 100 basis point tailwind or should we be thinking about that as kind of offsetting that tailwind eventually."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","In terms of the pass-through payments, there's only an ongoing thing. There is increase in the third quarter in supplemental payments level that we expect to see. They will hit in the third quarter but again, that's just a pass-through so we'll be getting",126,"In terms of the pass-through payments, there's only an ongoing thing. There is increase in the third quarter in supplemental payments level that we expect to see. They will hit in the third quarter but again, that's just a pass-through so we'll be getting more supplemental payment revenue and then we'll be passing more over through an equal amount. So we see that supplemental payment as just kind of smoothing out. You go forward and just being in sync. We don't see it slip 1 way or another. Second quarter, and first quarter obviously had some shifting between a supplemental cost between our payments between first and second quarter but I will see that at as a huge issue. There's a couple of million dollars."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think, if you, go back just 1 quarter when we didn't make any comments about Kentucky other than saying we had big problems. We've made a lot of progress. I think there'll be a lot more clarity about the next 12 months in another quarter and in terms, w",128,"I think, if you, go back just 1 quarter when we didn't make any comments about Kentucky other than saying we had big problems. We've made a lot of progress. I think there'll be a lot more clarity about the next 12 months in another quarter and in terms, we know it's a revenue what the projection is going to be, we'll have further insights into the value of the initiatives that we've been working on for the, really, 6 months. I think we've made really huge, huge gains in the financials and huge gains in our insights about where we're at. I think 1 more quarter will give us a lot better insights to more accurately be able to project what the next 12 months looks like."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Another point I would make is, we have ongoing significant discussions with the Commonwealth and their leadership and we're working hard with them to try and make this program financially viable for the long-term and that's in their best interest as well",54,"Another point I would make is, we have ongoing significant discussions with the Commonwealth and their leadership and we're working hard with them to try and make this program financially viable for the long-term and that's in their best interest as well and so they're engaged in production discussions with us in that regard."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I understand what you're saying about the broker commission change impacting MLR and I guess, your SG&A guidance as well. But I why wasn't this in your original guidance around those 2, and then that's it.",37,"I understand what you're saying about the broker commission change impacting MLR and I guess, your SG&A guidance as well. But I why wasn't this in your original guidance around those 2, and then that's it."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","It's more of an execution thing. We weren't clear on the time on when that actually will start falling through the payments as these things came through. I would say broker pass-through this year is up like 400% over last year's run rate. So we just actua",70,"It's more of an execution thing. We weren't clear on the time on when that actually will start falling through the payments as these things came through. I would say broker pass-through this year is up like 400% over last year's run rate. So we just actually seen it actually coming through. We don't want to reflected until we saw what the numbers actually kind of check out as."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Was that a state like approval from process are was that just the way the contract's kind of turned over?",21,"Was that a state like approval from process are was that just the way the contract's kind of turned over?"
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","In certain states, you can't do it. So it is a state approval process also relates to how the contracts turnover and also whether the brokers wanted to bill that directly to the customer or they wanted us to bill for them.",42,"In certain states, you can't do it. So it is a state approval process also relates to how the contracts turnover and also whether the brokers wanted to bill that directly to the customer or they wanted us to bill for them."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","And we'll go next to Justin Lake with JPMorgan.",10,"And we'll go next to Justin Lake with JPMorgan."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I just wanted to roll down on this commission issue one last time for everyone who's obviously there's some concerns going on in the commercial market with the MLR trajectory and what's going on with price cost. On a year-over-year basis, you're MLR is up",98,"I just wanted to roll down on this commission issue one last time for everyone who's obviously there's some concerns going on in the commercial market with the MLR trajectory and what's going on with price cost. On a year-over-year basis, you're MLR is up 230 basis points in the second quarter. It looks like -- can you spike out for us how much of that specifically was due to commissions or maybe give us the number of dollar amount or premiums if we can do the math ourselves that came out in the second quarter year-over-year."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes, if you look at full year 2012 and compare that to 2011, there's year-to-date, you have 120 basis points increase, about 35 to 40 basis points of that is driven by higher level of broker pass-through in 2012 then compared to 2011, 80 basis points is d",94,"Yes, if you look at full year 2012 and compare that to 2011, there's year-to-date, you have 120 basis points increase, about 35 to 40 basis points of that is driven by higher level of broker pass-through in 2012 then compared to 2011, 80 basis points is driven by really higher seasonality in 2012 for the same time period than we saw in 2011 and actually, the seasonality for the last half of the year that we're projecting for 2012 is actually more favorable than seasonality patterns for 2011 for the same time period."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So you're saying that 80 basis points of seasonality should reverse itself at the back half of the year?",20,"So you're saying that 80 basis points of seasonality should reverse itself at the back half of the year?"
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","And that's what we're expecting, yes.",7,"And that's what we're expecting, yes."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","What's driven all that seasonality?",6,"What's driven all that seasonality?"
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","It's actually the calendar, the number of days and the type of days drives our seasonality models and our IBNR and so just the slope is a little less steep through this year than last year if you just look at the calendar it also as importantly the type o",64,"It's actually the calendar, the number of days and the type of days drives our seasonality models and our IBNR and so just the slope is a little less steep through this year than last year if you just look at the calendar it also as importantly the type of days and the historical claims activity based on the day of the week."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then just drilling down a little bit on cost trend. It sounds like you were still in that high 7 range so a little bit below the 8% midpoint. Can you talk to us about how that looked through the quarter and whether the outpatient utilization that you",85,"And then just drilling down a little bit on cost trend. It sounds like you were still in that high 7 range so a little bit below the 8% midpoint. Can you talk to us about how that looked through the quarter and whether the outpatient utilization that you noted there is -- do you see that continuing growth throughout the year and do you expect it to be North of that towards the high-end of that 8% by the end, coming out of 2012."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think the big thing we're watching for is when does inpatient utilization go to positive and this slightly negative is approaching 0. The question is that going to positive territory. At that point, I think that puts us, that reconciles our rearview 7%",176,"I think the big thing we're watching for is when does inpatient utilization go to positive and this slightly negative is approaching 0. The question is that going to positive territory. At that point, I think that puts us, that reconciles our rearview 7% to our forward view, 8%. And so that's kind of the difference between the 2, as we think about it. In general, just in terms of utilization, our inpatient commercial bed days down low single digits from Q2 2011. Medicare Advantage bed days were flat. Medicaid bed days were down low to mid-single digits from Q2 of 2011 commercial admits were down low single digits. Medicare Advantage admits were down mid-single digits from Q2 2011. In terms of the forward view, expect inpatient to be driven in the high single digits, almost entirely unit cost driven. Outpatient, low double digits mostly unit cost driven. Position, mid-single digits, still toward unit cost and pharmacy, mid- to high single digits even with that's kind of the detail on our rearview and forward view."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So last question is asked as you're thinking out through 2013 and we're going to probably in the next couple of months at the start getting an idea where pricing shakes out and obviously that's going to depend on your forward view or trend. Is it fair to",98,"So last question is asked as you're thinking out through 2013 and we're going to probably in the next couple of months at the start getting an idea where pricing shakes out and obviously that's going to depend on your forward view or trend. Is it fair to thing that looking out, given your concerns on the potential or at least conservatism around the potential for upward pressure that you would probably price with some caution again, going into 2013 just like you did in 2012 for some uptick there versus your kind of current 8% [indiscernible]?"
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, in terms of absolute pricing level, our pricing level '12 is on absolute basis, higher than 2011 on Commercial. As we think about the future in '13 and beyond, I think our pricing remains pretty consistent in the same kind of posture. Once you get i",105,"Well, in terms of absolute pricing level, our pricing level '12 is on absolute basis, higher than 2011 on Commercial. As we think about the future in '13 and beyond, I think our pricing remains pretty consistent in the same kind of posture. Once you get in '13, there's going to be health care reform impacts that we'll need to begin pricing for and so as we start getting closer to '14. And so as we've mapped all that out and start reflecting some of that in our pricing, that's going to put some upward pressure on pricing we think in the industry in general."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","Our final question for today will come from Ana Gupte with Sanford Bernstein.",13,"Our final question for today will come from Ana Gupte with Sanford Bernstein."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just wanted to follow up on the previous question again. So 230 bps on the commercial loss ratio, quarter-over-quarter, I mean year-over-year for the same quarter. So you're saying it's 120 bps for half year in 2011 relative to 2012 and what I'm trying to",109,"Just wanted to follow up on the previous question again. So 230 bps on the commercial loss ratio, quarter-over-quarter, I mean year-over-year for the same quarter. So you're saying it's 120 bps for half year in 2011 relative to 2012 and what I'm trying to get is you must have seen a reduction in Medical Loss Ratio rebates as well, right, to offset this broker commission issue so if this 35 to 40 bips net of the reduced rebates and then secondly with $99 million in reserves last year, what is the favorable reserve development that you saw this year and how much of that was commercial or not?"
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Let me start with your second question on prior element. We're going to disclose the full details on our Q filing in the few weeks but as a means of preview, we have seen restatement levels during the first 6 months of 2012, which are consistent with, or",223,"Let me start with your second question on prior element. We're going to disclose the full details on our Q filing in the few weeks but as a means of preview, we have seen restatement levels during the first 6 months of 2012, which are consistent with, or slightly better than the prior year's. So we don't see much impact on the run rate on MLR from just prior development being significantly different year-over-year. For the quarter, as it relates to medical reserves, we did increase our DCP by 1/3 of a day sequentially from the prior quarter. So combined with the prior pre-development year-to-date, we feel like we have a good current reserve levels. So I just want to kind of hit that reserve piece. As far as rebate levels, we did in the -- we have rebate reserve for health care reform of $52 million at the end of the year and we have filed and made modifications to that accrual this year related to that based on changes on clarifications in the guidance around the 4 prong test and all those issues related to the calculations and final flavors that we see after the books were closed for year end for individual product. So we're able to pull that down to $14 million, that was the final number for 2011."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So you came down from $53 million to $14 million so again just trying to walk through it's the 120 bps on the half year basis and if you just had to do it on a quarter-over-quarter basis, the 230, you're seeing reserves that was no difference, there's a p",106,"So you came down from $53 million to $14 million so again just trying to walk through it's the 120 bps on the half year basis and if you just had to do it on a quarter-over-quarter basis, the 230, you're seeing reserves that was no difference, there's a piece of it on rebates. I'm just trying to understand how do you net out any change in spread on pricing cost. Are you seeing anything worsening year-over-year on just the spread between underwriting, pricing and cost, net of rebates, net of reserves, net of broker commissions, what's kind of the clean way to look at this?"
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","If you take out the reduction in the minimum MLR reserve for 2011, that's about 125 basis point benefit for the first half year run rate, compare it to run rate from last year. If we did -- that was really offset. We saw some increase in catastrophic clai",63,"If you take out the reduction in the minimum MLR reserve for 2011, that's about 125 basis point benefit for the first half year run rate, compare it to run rate from last year. If we did -- that was really offset. We saw some increase in catastrophic claims beyond what we anticipated that offset that benefit in a limited number of markets."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then going forward, as you're looking at your 8% trend, you're seeing high 7s, so you're probably somewhere in the spread range as you're pricing the business for the back half of the year on renewals and then going to 2013, are you seeing a competiti",61,"And then going forward, as you're looking at your 8% trend, you're seeing high 7s, so you're probably somewhere in the spread range as you're pricing the business for the back half of the year on renewals and then going to 2013, are you seeing a competition showing any hardening of pricing or is it getting softer or about the same."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think it's about the same, the pricing environment that we've been in for a while now for a number of quarters. I think my anticipation would be is that they would begin to harden their pricing just based on their financial results that we we're seeing",60,"I think it's about the same, the pricing environment that we've been in for a while now for a number of quarters. I think my anticipation would be is that they would begin to harden their pricing just based on their financial results that we we're seeing it makes sense but I can't predict what they're going to do."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","There's a little bit more breathing room rather than just the 25 bps because in the base measurement period, you also the introduction of the September 2010 reform elements that pushed cost up and so as that kind of falls away and rips through both the nu",63,"There's a little bit more breathing room rather than just the 25 bps because in the base measurement period, you also the introduction of the September 2010 reform elements that pushed cost up and so as that kind of falls away and rips through both the numerator in the denominator, that should give us some relief on our fundamental trend as well."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think the other thing as we've signed some contracts, major contracts with some medical providers for us that we've talked about on previous earnings calls, that improved our core structure in those areas and improves it over, beyond just 2012.",42,"I think the other thing as we've signed some contracts, major contracts with some medical providers for us that we've talked about on previous earnings calls, that improved our core structure in those areas and improves it over, beyond just 2012."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So net net, you have a positive spread of probably, maybe 50 bps and you're seeing potential for hardening beyond that in the marketplace.",24,"So net net, you have a positive spread of probably, maybe 50 bps and you're seeing potential for hardening beyond that in the marketplace."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes and actually, our actual pricing trend is higher than 8% as of before we build in those 2 things are medical trend and pricing trend aren't exactly the same number.",31,"Yes and actually, our actual pricing trend is higher than 8% as of before we build in those 2 things are medical trend and pricing trend aren't exactly the same number."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Thank you for joining us today. This concludes our comments.",10,"Thank you for joining us today. This concludes our comments."
27133,213709750,332678,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","Ladies and gentlemen, again that does conclude today's conference. We thank you all for joining.",15,"Ladies and gentlemen, again that does conclude today's conference. We thank you all for joining."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","Good morning, and welcome to today's Coventry Health Care's Second Quarter 2012 Earnings Conference Call. Today's call is being recorded. [Operator Instructions] Today's call will begin with opening remarks by Chairman and Chief Executive Officer of Coven",56,"Good morning, and welcome to today's Coventry Health Care's Second Quarter 2012 Earnings Conference Call. Today's call is being recorded. [Operator Instructions] Today's call will begin with opening remarks by Chairman and Chief Executive Officer of Coventry Health Care, Mr. Allen Wise, after a brief forward-looking statement read by Mr. Drew Asher. 
Please go ahead, Drew."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Ladies and gentlemen, during this call we will make forward-looking statements. Certain risks and uncertainties, including those referenced in our press release and described in the company's annual report on Form 10-K for the year ended December 31, 2011",80,"Ladies and gentlemen, during this call we will make forward-looking statements. Certain risks and uncertainties, including those referenced in our press release and described in the company's annual report on Form 10-K for the year ended December 31, 2011, the company's quarterly report on Form 10-Q for the quarter ended March 31, 2012, and all subsequent filings with the SEC, may materially impact those statements and could cause actual future results to differ materially from those anticipated and discussed. Allen?"
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Good morning, and thank you for your interest in Coventry Health Care. Earlier today, we reported earnings per share of $0.65 for the quarter bringing year-to-date earnings per share to $1.85. The quarter was marked by significant improvement in Medicaid",1869,"Good morning, and thank you for your interest in Coventry Health Care. Earlier today, we reported earnings per share of $0.65 for the quarter bringing year-to-date earnings per share to $1.85. The quarter was marked by significant improvement in Medicaid performance, sequential growth in Medicare products, continued SG&A leverage and cash deployment for share repurchase. We are on track for our 2012 EPS forecast of $3.10 to $3.30 per share and therefore, are again reiterating [ph] full year 2012 guidance. 
I'll cover some of our business highlights and perhaps, more importantly, where we feel we're headed for tomorrow. Let's start with government programs, which now represents about 1/2 of the company's revenue. You may recall from the first quarter that our Medicare Advantage business, spanning 15 states, had an excellent annual enrollment period with 13% sequential membership growth in the first quarter of 2012. 
Since Q1, we've continued to add membership each month in our Medicare Advantage business, and we're at 253,000 members at the end of the second quarter. We are well positioned in our Health Plan footprint from a cost structure, distribution and product standpoint and as such, expect to continue the growth and strong performance as we look multiple years ahead. During Q2, we followed our bids for 2013, and we're quite optimistic about the future serving the senior population. 
The story is similar for Medicare Part D. We experienced significant growth in Q1, followed by continued growth in each month of the second quarter. In fact, Medicare Part D grew by 36,000 members in Q2, averaging growth of about 12,000 members per month. We expect to continue growing throughout 2012 based on our positioning of our Value Plus product and the attractive value proposition we've been able to create for the senior population. To round up Medicare, the margins on these products continue to be on track with our forecast and consistent with prior years. 
In Medicaid, coming into 2012, we experienced substantial growth, effectively doubling our revenue to about $2.9 billion, led by the 2011 Kentucky win, the FHP acquisition and organic wins in both Nebraska and Pennsylvania. Our challenge is to manage that growth and demonstrate that we're able to improve and manage bottom line performance. 
Continuing the bottom line performance thought, I'd like to continue the Medicaid discussion with a much more in-depth review of Kentucky. You may remember during Q1 conference call, when I advised you that after 5 months of data, it was obvious to us that we had severe earnings pressure and other challenges with regard to our 32-month contract with the Commonwealth of Kentucky with approximately 230,000 members. At that time, I identified some of our major problems in the areas of adverse risk selection, especially in Regions 7 and 8, lack of compensation from the Commonwealth for past due payments to hospitals due to errors or omissions in the data book and the challenge of managing the health and care of a very large population with limited preparation time. These problems are exacerbated by the fact that there's not been a managed care program in Kentucky previously and the fact that there wasn't permanent leadership in the cabinet for health and family services in the early days of the program. Our challenges were made even more difficult to litigation due to litigation from one of the largest provider groups in Region 8 that prevent us from exercising the 30-day notice of termination provision, even though our agreement clearly allowed us to do so, almost a perfect storm. 
Well, enough history, and I'm pleased to report that we're making very significant progress in many, if not most of the areas, which created a very poor financial result during the first 5 months of the contract. First, there's now permanent leadership at the cabinet level for health and family services, which is resolved within the necessary and meaningful dialogue to develop a program that works for both Coventry and the Commonwealth of Kentucky. 
Second, we received a partial adjustment regarding risk-adjusted revenue, which we were contractually owed. And this revenue produced perspective relief beginning April 1, 2012. 
Third, we received an adjustment of pass-through for hospital payments effective on May 1, 2012, that is retrospective back to November 1, 2011. Accordingly, it reimburses the Health Plan for these past-due costs for the entire contract period. 
In the area of patient management, I advised you on the last conference call that we did identify 50 initiatives to take better care of the members and we have made, and we'll continue to make, very significant progress in this area. The Commonwealth of Kentucky is a DRG state, and we've been able to reduce costly and very numerous one-day admissions, which in many cases, we're replaced with observation periods, as is the practice in most hospitals throughout the country. 
You may also recall that we bid the business with a significant rate increase in year 2. In October of this year, we'll received a rate increase between 5.3% and 7%. The difference between the 5.3% and the 7% is that while we don't have a final, final agreement, we should receive additional risk-adjusted revenue beginning October 1 in addition to the agreed-upon 5.3% rate increase. 
And while we received the partial increase prospectively for this risk-adjusted revenue and resolved the hospital pass-through issue, we have not received reimbursement retrospectively for risk-adjusted revenue, which we strongly feel is due. We filed an appeal to address this issue and if that fails, we'll litigate the issue. 
Kind of final thoughts on Kentucky, even though we were delayed by provider litigation, we will be able to move forward with terminating providers that do not meet our utilization and quality criteria, so that we continue to develop a more efficient delivery system as the year progresses. My personal belief is, in the worst case, that Kentucky will be breakeven in 2013. And I feel that the more likely outcome is that we will have a reasonable profit on this business for 2013. 
In other Medicaid news, we're off to great start in Nebraska where our expansion contract for a recent RFP win commenced on July 1 of this year, and we've enrolled more than 1/2 of the available membership, adding approximately 40,000 members, resulting in a #1 statewide market position. We serve Nebraskans in Medicaid since 2010. We've had a Health Plan presence in Nebraska since 1998. 
We also look forward to 3 new Pennsylvania regions, which are being rolled out in a staggered fashion over the next 3 quarters, starting with the Southwest in Q3, followed by the New West and ending with the New East in Q1 of 2013. And we'll continue to pursue these new opportunities, where we believe we can bring our suit of capabilities to serve state and government program populations. 
One final Medicaid topic, which is Kansas. Based on the state's proposed terms for the new 2013 Medicaid contract and our corresponding bid posture, we did not win the state of Kansas Medicaid contract effective January 1, 2013. You may recall that FHP, which we acquired in January of 2012, operated in both Missouri and Kansas. We won the Missouri rebid earlier in the year, which is where most of the performance and value of FHP resided. And accordingly, with the loss of the Kansas contract, we wrote off $7.7 million intangible in the quarter. 
Effective July 1, we did extend the existing Kansas contract for the remainder of 2012 and what we believe is an appropriate rate increase. While suffice it is to say, we learned some lessons in Kentucky and although disappointed with the outcome in Kansas, we will not sacrifice operational or financial prudence in the service -- in the search for just growth. We feel good about the growth dynamics included in the federal poverty level expansion in Medicaid and the dual-eligible migration to managed care, and we look forward to seizing our fair share, which should be significant opportunities over the next 3 to 5 years. 
Moving onto a few comments on the Commercial business. We feel that we're well positioned for the future from a cost structure standpoint and our local Health Plan footprint, and we look forward to significant opportunities in 2014. For the past decade, we have certainly experienced some normal challenges and opportunity in the commercial book. But one thing has been constant, our cost structure, which has been sound, and the commercial business has always been profitable. 
The earnings and cash flow from the commercial business has enabled us to invest in M&A, as well as organic opportunities in government programs. And while the commercial business represents about 40% of Coventry's revenue today, we are targeting a portfolio with a balanced spread across Medicare, Medicaid and Commercial with our Fee business being a complementary part of a diversified revenue earnings and cash flow stream. I don't really have any new news on the Commercial environment, which is a bit challenging, as there are many carriers seeking membership and what I feel is the best stable pool of business and more likely, today, a diminishing pool. 
Despite the discussions and speculations about health care reform over the past year, we really never altered our focus in terms of preparing for the opportunities in 2014 and beyond. While the efforts to position Coventry for 2014 is the high-performance network model of teaming up with leading health systems and physician groups and together, we expect to deliver a superior value proposition to Commercial and Medicare members in terms of care coordination, quality, access and cost. We expect the Commercial individual market to expand dramatically over the next few years. And we feel we'll be well positioned to seize that growth opportunity as well. 
In the area of capital activity, we deployed $300 million of cash on share repurchase in the second quarter, which represents about 6.5% of the outstanding shares. And since Q2 is a quarter when we received most of our regulated dividends, our deployable cash balance really didn't change significantly, as we ended the second quarter with approximately $850 million of deployable cash on hand. 
So in summary, I'm very pleased with the positioning of our diversified business model as we look to the future. Given our exposure to and capabilities in government programs, we will continue to participate in growth opportunities in Medicaid expansion, Medicare and dual eligibles. We also expect our Health Plan cost structure in many markets to be a winner in the 2014 commercial exchange jump ball. As usual, we take nothing for granted. We work every day on cost structure and product positioning. We're committed to continuing the improvements in Kentucky. And we'll continue to use our strong balance sheet, when appropriate and attractive, for capital deployment. 
On balance, we feel very positive about the diversity of our products and our balance sheet. We've never been stronger. We're better positioned to continue positive growth in Medicare Advantage and Part D. I feel we're positioned by resources, focus, commitment and experience to make substantial new Medicaid gains in the future. 
Those are general comments. I'd like for Randy Giles, our CFO, to provide some financial details. Randy?"
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Thank you, Allen. This morning, we reported earnings per share of $0.65, which includes a $0.03 impairment charge, resulting from the non-renewal of our Medicaid contract with the state of Kansas. This result allows us to reaffirm our 2012 full year EPS g",2055,"Thank you, Allen. This morning, we reported earnings per share of $0.65, which includes a $0.03 impairment charge, resulting from the non-renewal of our Medicaid contract with the state of Kansas. This result allows us to reaffirm our 2012 full year EPS guidance range of $3.10 to $3.30 per share. I'm pleased with the results we reported today, which reflect improved performance in our Medicaid business, sequential growth in our Medicare products, continued SG&A efficiency and effective use of deployable capital. 
Our mix of business continues to shift towards more balanced levels across Commercial Risk, Medicare and Medicaid products with an important level of non-risk revenue provided by our fee-based businesses. We believe that a diversified portfolio of businesses provides a critical ability to both seize growth opportunities and provide the best positioning for continued growth and profitability. 
Let's begin with our Government Programs businesses, where I'm pleased to report significant improvement in Medicaid during the second quarter. The Medicaid MLR of 93.3% is a 670-basis-point sequential improvement was driven primarily by the significant improvement in Kentucky during the quarter. Excluding the impact of Kentucky, our consolidated Q2 Medicaid MLR was an outstanding result at 83.5% or a decrease of 340 basis points over the prior year period. Our Kentucky Medicaid business improved from 120.9% MLR that we reported in Q1 to 110.8% for the second quarter, a sequential improvement of 1,010 basis points, which was driven by favorable trends for both revenue and expense during the quarter. 
On the revenue front, during the quarter, we received more clarity from the Commonwealth regarding risk-adjusted payments owed to Coventry. While we continue to discuss the underlying methodology of the risk-adjustment calculation with the Commonwealth, Coventry began recognizing the positive revenue impact of a monthly risk-adjusted payment, with an 8% quarter during the second quarter. 
As we disclosed during the investor conference during June, a supplemental payment issue has been resolved favorably, which had a positive impact on revenues the second quarter and will continue throughout the remainder of the year. In addition, we'll be receiving a 5.3% contract rate increase on October 1, which will provide $4 million of incremental revenue per month, plus any amount that result from continued discussions on risk adjustment as Allen mentioned. 
In terms of medical expense, we continue to make progress with our list of targeted cost initiatives and expect the fruits of our labor to resolve and continue cost improvement during the second half of 2012 and throughout the remainder of the contract. We're in continued discussions with the Commonwealth regarding various aspects of the Medicaid program that we will continue to update you on as they develop. 
We remain on track to exit 2012 with the results such that Kentucky Medicaid will not have a material impact on our 2013 earnings performance. As you will recall from our last earnings call, I highlighted that we were awarded an expansion to our existing presence in the state of Nebraska, which just went live on July 1. The contract is off to a great start as we've added nearly 40,000 members according to the initial data, out of approximately 60,000 new eligibles. This brings us to approximately 90,000 members statewide with the #1 market share. 
We also expanded in Virginia effective July 1, as the state expanded in the Southwest region where Coventry has been awarded 7,000 new members. And finally, in Florida we were recently re-awarded a contract to serve the state's Healthy Kids Medicaid program to 16 counties serving approximately 20,000 members, which is generally consistent with our presence today. 
We participate in multiple programs in the Florida Medicaid market and view this rebid as an encouraging sign as we think about further expansion programs that the state is considering for 2013 and beyond. We were also successful on our rebid efforts in Missouri, which is Coventry's largest Medicaid state by membership and has been performing well throughout 2012. This contract was effective July 1 and initial open enrollment results yielded growth of an additional 25,000 members to solidify our #1 presence statewide. This outstanding momentum across our Medicaid businesses puts us on pace to exceed our 1 million member goal during the third quarter of the year. 
With that being said, we were unsuccessful on one bid during the second quarter, as we will not be renewing our contract with the Kansas Medicaid program, which is scheduled to end on December 31 of this year. Contract terms offered by the state were very complex in nature and present unique challenges for managed care organizations, the bid prudently based on the data that was available, most of which was our own experience, as well as the requirements as the state was bidding for the new contract. 
Although our contract terminated on June 30 of this year, we've been able to reach an agreement with the state to provide managed care services through the remainder of the year at an acceptable rate. Because this contract was held by recently acquired Family Health Partners subsidiary, we took an impairment charge in the second quarter of the $7.7 million or $0.03 per share to write down certain intangibles associated with the Kansas portion of FHP. Just to remind you, the Kansas Medicaid contract represented approximately $350 million annual revenue with a year-to-date MLR into the 90s, such that it was essentially a breakeven contract. While we are disappointed with the foregone [ph] opportunity, we remain quite optimistic about the growth trajectory for our Medicaid business in total and the growth initiatives that we have on the horizon. 
Turning to our Medicare business. The Medicare Advantage continues to see favorable membership trends, as we added 3,000 members during Q2. The second quarter MLR of 84.1% is in line with expectations and is consistent with our full year MLR guidance of low to mid-80s, excluding the impact of the RADV reserve release. As Allen mentioned, we have submitted our 2013 bids. I'm confident that we are well positioned, both operationally and financially, to serve the senior population in the future. 
Our Medicare Part D business experienced very impressive sequential growth during the second quarter, as the 36,000 members that we added was the best growth in the entire industry. The year-to-date Medicare Part D MLR of 92.5% is consistent with our 2011 year-to-date MLR performance and keeps us on track for our full year MLR guidance of low to mid-80s. Similar to my commentary on Medicare and managed, I like our positioning in the 2013 Medicare Part D bids in light of these continued stable results. 
Moving on to the Commercial business. This morning we reported MLR of 83% for the second quarter and 81.5% year-to-date. As you saw on the commentary in our earnings release, there's one specific item that is mathematically pushing up this result relative to 2011 but importantly, does not significantly impact overall earnings profile of the Commercial Risk business. We've been able to implement broker capacity initiatives in the majority of our geographic areas across both large and small group business in 2012, which is an important strategy to create a more appropriate comparison in the minimum MLR definitions. The effect of this process on the GAAP financial, though, is to mathematically reduce revenue for the broker commission component that otherwise would've been reported in our risk revenue total, which increases our MLR this year as compared to the prior year. 
There are, of course, many other moving parts in this nearly $6 billion block of business, but I thought it would be instructive to spike up this specific factor, which drives our slightly higher Commercial Risk MLR result, without a material impact to the overall earnings profile of the business. Given this item, our full year guidance is now 81.5% to 82.5%, which, at the midpoint, is an increase of 40 basis points from the prior year. 
Staying in our Commercial book, once again our view of fundamental prospective trend remains unchanged in the range of 8%, plus or minus 50 basis points. We continue to see trends in the high 7s, looking in the rearview mirror, which have migrated higher from the very low levels seen during the second half of 2010. Unit cost trend, which continues to be the largest driver of overall trend, is stable. As we look at trend by component in the second quarter, we saw the trend for inpatient days per 1,000 remains slightly negative, and we're projecting inpatient utilization trends to be flat to slightly positive prospectively. Position trends appear to stabilize after showing some slight uptick over the last few quarters, while the utilization trends, that we're seeing in the outpatient category, continue to tick upwards. These various trend dynamics have been gradual and importantly, have been anticipated in our pricing. You'll recall that we first mentioned seeing this migration in the third quarter of 2011. 
Our Fee-based business has all performed in line with expectations in the quarter, and we have increased guide slightly for this second consecutive quarter, reflecting our broadly improved year across all lines of our Fee-based businesses. We continue to be pleased with our Fee-based businesses, as they have consistently generated steady levels of valuable unregulated cash flow and earnings. 
Turning now to SG&A. I'm very pleased with the second quarter result that we reported today and the lower full year expense level that we have included in the new guidance ranges. Just to put this into context, in 2011, we reported an SG&A rate of 16.5% of revenue, which was reduced to 15.4% of revenue in our initial guidance and has now been reduced to 14% -- 14.8% of revenue today. This is the second consecutive quarter where we have been able to increase our overall revenue range, while lowering our SG&A projection, a leveraging dynamic that we think is critical to succeed in today's environment, and even more so, as we look to the future. While we continue to leverage our efficient operating structure in the near term and enjoy the benefit on the SG&A line from our broker pass-through initiatives, we are also very mindful of the investments that we'll need to make for the future and are preparing accordingly. 
I would now like to spend some time on our balance sheet and cash flow performance for the second quarter. Our investment portfolio continues to be in excellent shape and has a net unrealized gain position of $108 million at June 30, an increase of $8 million from the prior quarter. Following through on our commitment to deploy capital towards share repurchase, we bought back 9.3 million shares during the second quarter for $300 million, which represents approximately 6.5% of our outstanding shares. Not only is this level of activity comparable to our total share repurchase activity for all of 2011, it also represents the highest share repurchase level in a single quarter in the company's history. 
Also during the second quarter, our Board of Directors approved our second quarterly cash dividend, which was payed to shareholders on record on July 9. In addition to deploying cash to repurchase shares, we completed our dividend process during the second quarter, collecting $215 million from our regulated subsidiaries. We ended the second quarter with $850 million in deployable free cash at the parent, which even after $300 million of share repurchase, which combined with our undrawn $750 million credit facility, provides $1.6 billion in accessible capital capacity. 
As of June 30, our debt-to-capital ratio stands at 26%, falling well within our typical leverage levels. So as I reflect on our results for the quarter and the progress that we have made across all of our businesses, I'm very satisfied with how the company is positioned and in fact deal that we're advantaged in many areas. Health Care Reform continues to move forward. And while this will surely create changes in the marketplace, it will also create significant opportunities for those that have a low-cost structure and can execute effectively. We believe that we have the capital and free cash flow stability to [indiscernible], adapt quickly and support the growth prospects that we see for the future. 
Thank you again for your interest in Coventry Health Care. Operator, this now concludes our prepared remarks, and we are ready to open the lines for questions."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","[Operator Instructions] And we'll go to Tom Carroll with Stifel.",10,"[Operator Instructions] And we'll go to Tom Carroll with Stifel."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So question on Kentucky, what was the Kentucky Medicaid premium in the quarter?",13,"So question on Kentucky, what was the Kentucky Medicaid premium in the quarter?"
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Stand by, we'll get you the exact number.",8,"Stand by, we'll get you the exact number."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Great.",1,"Great."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Tom, it was $249 million.",5,"Tom, it was $249 million."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","$249 million, great. And do you expect sequential MLR improvement to continue there? I mean, the data points you gave us suggest continued improvement, would you agree with that?",29,"$249 million, great. And do you expect sequential MLR improvement to continue there? I mean, the data points you gave us suggest continued improvement, would you agree with that?"
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","We do.",2,"We do."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Any magnitude? I mean, another 10 percentage points of decrease, rather?",11,"Any magnitude? I mean, another 10 percentage points of decrease, rather?"
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","I don't know. We've made very substantial and consistent progress. There's a lot of opportunities remaining on the revenue side. Ultimately, can't look at it this point but -- and can't guarantee it. But ultimately, I believe we're entitled to retroactive",195,"I don't know. We've made very substantial and consistent progress. There's a lot of opportunities remaining on the revenue side. Ultimately, can't look at it this point but -- and can't guarantee it. But ultimately, I believe we're entitled to retroactive risk-adjusted revenue. We'll pursue that to the end, and we continue to make substantial progress in admissions and taking better care 
[Audio Gap] 
We continue to weed out prescription drug abuse, pain center types of mills. We will make future progress in refining our delivery system, which was made more difficult by some litigation by the biggest provider group there. So we've made a lot of progress, and we have a lot of opportunity. And I can't -- it was a pretty bold statement for me to say that worst case next year is breakeven and my view is we're going to make a reasonable profit. So it's kind of hard to predict month by month and quarter by quarter because we've seen one great quarter of improvement, and I see no reason why that trend won't continue. I wouldn't say it's going to be another 1,000 basis points in the next quarter."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","And then Tom, obviously, the bigger step-down would come with a rate increase effective [indiscernible.]",15,"And then Tom, obviously, the bigger step-down would come with a rate increase effective [indiscernible.]"
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Great. And just as a follow-up on your Commercial cost trend side, it sounds like you're not seeing anything outside of what you were expecting so nothing like the blues being more competitive than you thought or utilization rising more so than you though",73,"Great. And just as a follow-up on your Commercial cost trend side, it sounds like you're not seeing anything outside of what you were expecting so nothing like the blues being more competitive than you thought or utilization rising more so than you thought. Just trying to reconcile the slight increase in your consolidated MLR number for the year. Would you suggest that's just -- that's all related to the broker pass-through mechanism?"
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Our view of the commercial environment is consistent with really what we've talked about for the last 5 or 6 quarters, which is it's very competitive. It's beyond competitive in Western P.A., but it doesn't -- isn't dramatically different than we've exper",178,"Our view of the commercial environment is consistent with really what we've talked about for the last 5 or 6 quarters, which is it's very competitive. It's beyond competitive in Western P.A., but it doesn't -- isn't dramatically different than we've experienced in 15 years in the business, which is there's always a couple of marketplaces where it just borders on irrational. And so we will lose membership until that settles down. I believe it's probably a diminishing pool of business. There isn't any job growth, and I think that for the most part in the data that I -- I would suggest that we lose membership within existing groups, meaning that employees can't afford the coverage and drop it. But it basically -- there has not been any substantial change this quarter over the last quarter. It's competitive and not a growing pool of business but because of our cost structure and our experience in the long term in the marketplace as we are, we don't really see any deterioration for the rest of the year."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","On your question about MLR, last year we recorded an MLR of 81.6%. Our guidance today increased to 82%. All of that 40-basis-point year-over-year increase is explained by increased broker pass-through activity in 2012.",34,"On your question about MLR, last year we recorded an MLR of 81.6%. Our guidance today increased to 82%. All of that 40-basis-point year-over-year increase is explained by increased broker pass-through activity in 2012."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","And we'll go next to Josh Raskin with Barclays.",10,"And we'll go next to Josh Raskin with Barclays."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just first question just on the broker commission. Just so I understand, you guys are basically increasing that ratio by taking out. You said there's no impact, but I know you guys paid $15 million in rebates for the last year. So is there no impact on yo",67,"Just first question just on the broker commission. Just so I understand, you guys are basically increasing that ratio by taking out. You said there's no impact, but I know you guys paid $15 million in rebates for the last year. So is there no impact on your expected rebates either? Or ultimately, will there be a little bit of a benefit in terms of the P&L?"
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","The strategy is actually -- I think the broker pass-through affects all markets. Our rebates on health care reform rebates minimum MLR are really concentrated in a handful of markets. So the fact is, we basically have taken this broker commission pass-thr",88,"The strategy is actually -- I think the broker pass-through affects all markets. Our rebates on health care reform rebates minimum MLR are really concentrated in a handful of markets. So the fact is, we basically have taken this broker commission pass-through strategy in all our markets. And so it's pretty broad based. So it doesn't really line up one to one. You're right. There could be, theoretically, be a benefit in those markets. Where there are rebates, there is one. But it's not concentrated in those markets."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. And is there a reason you guys chose now to accelerate that strategy?",14,"Okay. And is there a reason you guys chose now to accelerate that strategy?"
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","They're really -- I think the strategy was deployed last year, but it really involves working with each broker and each group to try and get that set up. So it really deploys as those cases renew. And so now that we've gone through a year, most of the gro",64,"They're really -- I think the strategy was deployed last year, but it really involves working with each broker and each group to try and get that set up. So it really deploys as those cases renew. And so now that we've gone through a year, most of the groups have gone through that renewal cycle and are moving over to broker pass-through."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Got it. And then just second question on Kentucky, were there any -- I guess, 2 parts, were there any what you would consider out-of-period payments that came? It sounds like you had some stuff retroactive back to April or even last November. So I'm just",82,"Got it. And then just second question on Kentucky, were there any -- I guess, 2 parts, were there any what you would consider out-of-period payments that came? It sounds like you had some stuff retroactive back to April or even last November. So I'm just curious if there was sort of a one-time event that hit the MLR in Q2 that you could spike out. And then, what's the estimate on sort of the full year loss in Kentucky for 2012?"
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","There weren't any out-of-period payments in the revenue to date, so the dates that I gave you in my presentation...",21,"There weren't any out-of-period payments in the revenue to date, so the dates that I gave you in my presentation..."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","The supplemental payments, they go back to November. That's a couple of million dollars. The risk adjuster was all with -- the payments we received were all just went within the same Q2 period. We haven't received any retro-risk payments. We're -- that's",48,"The supplemental payments, they go back to November. That's a couple of million dollars. The risk adjuster was all with -- the payments we received were all just went within the same Q2 period. We haven't received any retro-risk payments. We're -- that's what we were asking for."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. So the sup [ph] payments gone back, might have been a couple of million but not a huge deal. The risk adjuster was all for Q2. And then the full year loss?",33,"Okay. So the sup [ph] payments gone back, might have been a couple of million but not a huge deal. The risk adjuster was all for Q2. And then the full year loss?"
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","What's your -- can you restate your question again?",10,"What's your -- can you restate your question again?"
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Yes, just curious what your expectations in terms of a full year sort of pre-tax loss in Kentucky is going to look like this year.",25,"Yes, just curious what your expectations in terms of a full year sort of pre-tax loss in Kentucky is going to look like this year."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, we really don't spike out individual contract performance like that. I mean, you kind of back into it. But with the losses that we've incurred in the first quarter and the MLRs that we've had year-to-date, the contracts -- we reported MLR year-to-da",113,"Well, we really don't spike out individual contract performance like that. I mean, you kind of back into it. But with the losses that we've incurred in the first quarter and the MLRs that we've had year-to-date, the contracts -- we reported MLR year-to-date of 115.6%. That gives you -- and we're projecting that, that will decrease over time with -- we'd expect the most significant MLR improvement at this point based on information that we have visibility on being in the fourth quarter. So we expect that to phase down toward the breakeven as we go in through the rest of the year and again enter in 2013 with no material pressure."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. When you say breakeven, do you mean 100% MLR? Or do you mean breakeven profit, including the G&A?",19,"Okay. When you say breakeven, do you mean 100% MLR? Or do you mean breakeven profit, including the G&A?"
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","No, we mean breakeven after we pay our SG&A expenses. 100% is not breakeven.",14,"No, we mean breakeven after we pay our SG&A expenses. 100% is not breakeven."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I didn't know if we're talking gross margins or operating margins.",12,"I didn't know if we're talking gross margins or operating margins."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","And I think it's difficult not to be -- to go much deeper and not to be misleading. We feel we have a retroactive risk-adjustment amounts due. We filed an appeal on that front. We feel like that supported contractually. If that appeal is not successful, w",167,"And I think it's difficult not to be -- to go much deeper and not to be misleading. We feel we have a retroactive risk-adjustment amounts due. We filed an appeal on that front. We feel like that supported contractually. If that appeal is not successful, we'll litigate the issue. How we ultimately resolve all of that? It can't get any worse. If we resolve that successfully, it's going to affect the year. But we made a lot of progress on the revenue side and a lot of progress on the cost side in Q2. And we think that'll continue in Q3. And even a 5.3% increase on a $0.25 billion in revenue puts us in a substantially better shot. We think that the worst days are behind us in Kentucky, and we've done many of the things -- and we'll do many of the things it takes to -- for this to be successful. It's been a humbling and valuable lesson, but we will prevail."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","We'll go next to Carl McDonald with Citi.",9,"We'll go next to Carl McDonald with Citi."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So the first quetsion, WellPoint, earlier in the week, positioned the Commercial business as a change relative to what they've been thinking about earlier in terms of both -- and it sounded like both pricing and cost trends -- it seems like you and United",95,"So the first quetsion, WellPoint, earlier in the week, positioned the Commercial business as a change relative to what they've been thinking about earlier in terms of both -- and it sounded like both pricing and cost trends -- it seems like you and United have a sort of a more consistent view. So I'd just be interested, when you hear WellPoint said they think things are changing and things are getting more aggressive, did that give you pause? Or would you attribute that all just to a difference in expectations coming into the year?"
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Oh, I think we always spend a lot of time worrying about what we don't know. But I think if you would review our comments on the commercial environment and trends back for 6 quarters that we were probably one of the first companies that said the diminishi",322,"Oh, I think we always spend a lot of time worrying about what we don't know. But I think if you would review our comments on the commercial environment and trends back for 6 quarters that we were probably one of the first companies that said the diminishing utilization wasn't going to continue forever. We don't know what caused it and what was going to change it. I think that we have been consistent in saying there was some pressure on outpatient costs. And not unlike Kentucky, I think we're the first people doing business in Kentucky that said, ""We've got problems here."" And disclosed that the minute that we knew it and went to work on it. So I think our view in Commercial, if you'd examine our comments for the prior quarters, as I've said, it's a little tougher environment. We don't see any dramatic change. So it always gives you pause to say it's safe to once again -- I think about what's occurred and where the future goes. But we -- our practice here is to think about the worst all the time and we have, I don't know, 50 initiatives on the unit cost side where we think we've gotten a little bit behind. And that's kind of how we view the business here, which is always with a little bit of fear and a little bit of suspicion and a lot of realities. I don't understand. We are in most of the markets or many of the markets or most of the markets with WellPoint, the way we would be with United and some of the other blues. So I don't know what would have suddenly happened. These things evolve over long periods of time, and I don't understand things that suddenly occur. So I can't be helpful there. But we don't see anything different than we've reported the last several quarters and we've reported today."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then on Kentucky, to get to breakeven, the 111% has to go to, say, 93% or 94%. Is there any way of giving us a sense of how much of that 1,700-, 1,800-basis-point improvement is things that you've already achieved? So say the rate increase -- some of",72,"And then on Kentucky, to get to breakeven, the 111% has to go to, say, 93% or 94%. Is there any way of giving us a sense of how much of that 1,700-, 1,800-basis-point improvement is things that you've already achieved? So say the rate increase -- some of the provider renegotiations or cancellations versus how much the stuff that still needs to be accomplished like the, say, the retroactive risk adjustment."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","No. I think it's probably a little bit of both. It's always a little bit difficult to be able to measure precisely what you've achieved. The things that we have done 2 months ago will show up 2 months from now. When the numbers are in, the claims are paid",454,"No. I think it's probably a little bit of both. It's always a little bit difficult to be able to measure precisely what you've achieved. The things that we have done 2 months ago will show up 2 months from now. When the numbers are in, the claims are paid. And now it's a sense of -- I think it's a continuous process, and I think that some of the things that developed in this quarter were really in a work that we did the quarter before. So I think that we have made progress. I think there's a lot more opportunities in refining our delivery system, a lot more opportunities in continuing to take better care of the patients. If you think -- if you follow the media, at least 4 time or 3 times last quarter, Kentucky leads -- is always highlighted as this -- the Commonwealth is one of the places where prescription drug abuse is the worst. So we have 50 initiatives and some of those are continuous. You're really never, never finished. I just think that in areas like reduced admissions and getting observation days, which is the practice in most hospitals. And I think it's guidelines that CMS issued and continues to refine. We just made a lot of progress, and I think that revenue increase in Q4 is huge. But I think on the patient management side and issue, those will go on for a long time. We've been in business -- Medicaid business in Missouri since 1994 and life changes. For a long time, our trend was 8%. The state gave us an 8% increase and life was good. And 2008, the revenue got tougher and so we continually evaluate our cost structure and how we deliver the care. And so we've done a lot of work in Missouri, which is a huge state for us, too, in terms of our contracts. We had a contract forever with the worsening university physician group that was 180% of Medicaid, which worked in the old days when revenue was easier to come by and you could have a very broad delivery system and make a reasonable profit. That contracts was canceled last quarter. So don't want to get off the subject Kentucky. It really never stops and with a decent amount of experience, and we think that we're getting closer to a partnership in Kentucky. We have better dialogue with them. This has to work for the Commonwealth. It has to work for us. And we think that we've made progress, and we'll continue to make progress. And I can't do much better than to stick our neck [indiscernible], but we're not going to make profit next year."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Just to add to Allen's comment. We think we can make break even at -- with 4% admin and the 96% loss ratio in Kentucky. So the hurdle's not quite as large as you thought. In addition, one other point, I think that we've kind of already got visibility on i",160,"Just to add to Allen's comment. We think we can make break even at -- with 4% admin and the 96% loss ratio in Kentucky. So the hurdle's not quite as large as you thought. In addition, one other point, I think that we've kind of already got visibility on is that we are putting in co-payments -- additional co-payments in Kentucky. We're going to open an enrollment in the fourth quarter. So we're going to see economic benefit from that and that's already structured. The provider -- higher-cost provider adjustments will also happen in the fourth quarter, and we're already -- those were already committed to those. So there's a couple of these things both on cost side and on the revenue side that we have pretty good line of sight on. But there's, obviously, a lot more on the cost initiatives on the revenue side that we have to do to get all the way to breakeven."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","And we'll go next to Kevin Fischbeck with Bank of America.",12,"And we'll go next to Kevin Fischbeck with Bank of America."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","As you mentioned, you're not the only company experiencing issues in Kentucky, and one of your competitors talked about changing the methodology for retro assignments. Have you guys factored that into your thought process? And what do you think the impact",46,"As you mentioned, you're not the only company experiencing issues in Kentucky, and one of your competitors talked about changing the methodology for retro assignments. Have you guys factored that into your thought process? And what do you think the impact to you guys might be?"
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes. I think in terms of -- there's really a couple of big changes happening there in terms of retro assignments in the way that's going to work. So it's not just retro assignment. The Commonwealth is committed to changing the auto assignment process in g",170,"Yes. I think in terms of -- there's really a couple of big changes happening there in terms of retro assignments in the way that's going to work. So it's not just retro assignment. The Commonwealth is committed to changing the auto assignment process in general, and we think there's there some high-cost categories for us like dual eligibles and some of the other categories that -- where we have a disproportionate share. So we think that shift will benefit us from some of the other categories. And we think, in general, that shifting might end up being neutral, just in general. The -- overall, we think that's a positive for all the MCOs because on average, it means the average revenue that the Commonwealth is paying is going to increase. Because currently, a majority of the selection criteria is based on who has the lowest premium in a given rate cell. So we think that's going to end to -- lead to marginally higher PMPM revenue in the contract."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay, that's interesting. And then just to clarify a couple of things you guys had said earlier. If you think about the core Kentucky MLR, I guess, the pass-throughs and the retro portion was maybe a couple of million dollars that might have been 100 basi",102,"Okay, that's interesting. And then just to clarify a couple of things you guys had said earlier. If you think about the core Kentucky MLR, I guess, the pass-throughs and the retro portion was maybe a couple of million dollars that might have been 100 basis points to MLR, is that the right way to think about it? And then, in relation to Tom's question, you said there's sequential improvement in MLR. Is that -- even -- do you expect that even with not having that 100-basis-point tailwind? Or should we be thinking about that as kind of offsetting that tailwind sequentially?"
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","In terms of the pass-through payments, that's obviously an ongoing thing. There is an increase in the third quarter in the supplemental payments -- payment level that we expect to see. They will hit in the third quarter. But again, that's just a pass-thro",136,"In terms of the pass-through payments, that's obviously an ongoing thing. There is an increase in the third quarter in the supplemental payments -- payment level that we expect to see. They will hit in the third quarter. But again, that's just a pass-through. So we'll be getting more supplemental payment revenue, and then we'll be passing more of it through an equal amount. So we see that supplemental payment as you just kind of smoothen out. You go in forward and just being in sync. We don't see that flipping there one way or another. The second quarter and first quarter, obviously, had some shifting between supplemental cost between payments between first and second quarter, but I will see that as a huge issue. It's not -- it was a couple of million dollars."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think there's -- if you'll go back just one quarter, when we didn't make any comments about Kentucky other than saying we had big problems, we made a lot of progress. I think there'll be a lot more clarity about the next 12 months in another quarter. An",131,"I think there's -- if you'll go back just one quarter, when we didn't make any comments about Kentucky other than saying we had big problems, we made a lot of progress. I think there'll be a lot more clarity about the next 12 months in another quarter. And in terms -- we know what the revenue projection is going to be. We'll have further insights into the value of the initiatives that we've been working on for really 6 months. So I think we've made really huge, huge gains in the financials and huge gains in our insights about where we're at. And I think one more quarter will give us a lot better insights to more accurately be able to project what the next 12 months looks like."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Another point I would make is, we have ongoing significant discussions with the Commonwealth and their leadership, and we're working hard with them to try and make this program financially viable for the long term. And that's in their best interest as wel",55,"Another point I would make is, we have ongoing significant discussions with the Commonwealth and their leadership, and we're working hard with them to try and make this program financially viable for the long term. And that's in their best interest as well, and so they're engaged in productive discussions with us in that regard."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. And then just -- I understand what you're saying about the broker commission change impacting MLR and I guess, your SG&A guidance as well. But what's not clear to me is why wasn't this in your original guidance around those 2 [indiscernible]? That's",45,"Okay. And then just -- I understand what you're saying about the broker commission change impacting MLR and I guess, your SG&A guidance as well. But what's not clear to me is why wasn't this in your original guidance around those 2 [indiscernible]? That's it."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","It was more of an execution thing. We weren't clear on the timing or when that would actually start flowing through the payments as these things came through. It's -- I would say broker pass-through this year is up like 400% over last year's run rate. So",73,"It was more of an execution thing. We weren't clear on the timing or when that would actually start flowing through the payments as these things came through. It's -- I would say broker pass-through this year is up like 400% over last year's run rate. So we've just actually seen it actually coming through. We don't want to reflect it until we saw what the numbers actually kind of check out as..."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Was that a state-like approval process? Or was that just the way the contract's kind of turned over?",19,"Was that a state-like approval process? Or was that just the way the contract's kind of turned over?"
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes. In certain states, you can't do it. So it is a state-approval process, also relates to how the contracts turn over and also whether the brokers wanted to bill that directly to the customer or they wanted us to bill it for them.",44,"Yes. In certain states, you can't do it. So it is a state-approval process, also relates to how the contracts turn over and also whether the brokers wanted to bill that directly to the customer or they wanted us to bill it for them."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","And we'll go next to Justin Lake with JPMorgan.",10,"And we'll go next to Justin Lake with JPMorgan."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I just wanted to drill down on this commission issue one last time for everyone who's -- obviously, there's some concerns going on in the commercial market with the MLR trajectory and what's going on with price cost. So on a year-over-year basis, you're M",100,"I just wanted to drill down on this commission issue one last time for everyone who's -- obviously, there's some concerns going on in the commercial market with the MLR trajectory and what's going on with price cost. So on a year-over-year basis, you're MLR is up 230 basis points in the second quarter. It looks like -- can you spike out for us how much of that specifically was due to commissions? Or maybe give us the number of dollar amount of premiums, so we can do the math ourselves, that came out in the second quarter year-over-year."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes. If you look at full year 2012 and you compare that to 2011, there's -- year-to-date, you have a 120-basis-point increase, about 35 to 40 basis points of that is driven by higher level of broker pass-through in 2012 then -- compared to 2011. 80 basis",96,"Yes. If you look at full year 2012 and you compare that to 2011, there's -- year-to-date, you have a 120-basis-point increase, about 35 to 40 basis points of that is driven by higher level of broker pass-through in 2012 then -- compared to 2011. 80 basis points is driven by really higher seasonality in 2012 for the same time period than we saw in 2011. And actually, the seasonality for the last half of the year that we're projecting for 2012 is actually more favorable than seasonality patterns for 2011 for the same time period."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So you're saying that 80 basis points of seasonality should reverse itself at the back half of the year.",20,"So you're saying that 80 basis points of seasonality should reverse itself at the back half of the year."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","That's what we're expecting, yes.",6,"That's what we're expecting, yes."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. What's driven all that seasonality?",6,"Okay. What's driven all that seasonality?"
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Actually, the calendar, the number of days and the type of days kind of drives our seasonality models in our IBNR. And so just in the slope is a little less steep through this year than last year, if you just look at the calendar and also as importantly,",65,"Actually, the calendar, the number of days and the type of days kind of drives our seasonality models in our IBNR. And so just in the slope is a little less steep through this year than last year, if you just look at the calendar and also as importantly, the type of days and the historical claims activity based on the day of the week."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Got it. And then just drilling down a little bit on cost trend. It sounds like you were still in that high-7 range, so a little bit below the 8% midpoint. Can you talk to us about how that looked through the quarter and whether the outpatient utilization",90,"Got it. And then just drilling down a little bit on cost trend. It sounds like you were still in that high-7 range, so a little bit below the 8% midpoint. Can you talk to us about how that looked through the quarter and whether the outpatient utilization that you noted there is -- do you see that continuing to grow through the year? Do you expect it to be north of that towards the high end of that 8% by the end of the year, coming out of 2012?"
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","No. I think the big thing we're watching for is when does inpatient utilization go to positive. And it's slightly negative. It's approaching 0. The question is, is that going to move in to positive territory? At that point, I think that puts us -- that re",184,"No. I think the big thing we're watching for is when does inpatient utilization go to positive. And it's slightly negative. It's approaching 0. The question is, is that going to move in to positive territory? At that point, I think that puts us -- that reconciles our rearview 7% to our forward view, 8%. And so that's kind of the difference between the 2, as we think about it. In general, just in terms of utilization, our inpatient commercial bed days were down low single digits from Q2 2011. Medicare Advantage bed days were flat. Medicaid bed days were down low to mid-single digits from Q2 of 2011. Commercial admits were down low single digits. Medicare Advantage admits were down mid-single digits from Q2 2011. In terms of the foreview, expect inpatient to be -- trend to be driven in the high single digits, almost entirely unit cost driven; outpatient, low double digits, mostly unit cost driven; position, mid-single digits, still toward unit cost; and pharmacy, mid- to high single digits evenly. That's our kind of the detail on our rearview and foreview."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Got it. The last question would just be, as you're thinking out to 2013 and we're going to -- probably in the next couple of months, at the start, getting an idea where pricing shakes out. And obviously, that's going to depend on your foreview or trend. I",104,"Got it. The last question would just be, as you're thinking out to 2013 and we're going to -- probably in the next couple of months, at the start, getting an idea where pricing shakes out. And obviously, that's going to depend on your foreview or trend. Is it fair to thing that looking out in the -- given your concerns on the potential or at least conservatism around the potential for upward pressure that you would probably price with some caution, again, going into 2013, just like you did in 2012 for some uptick there versus your kind of current 8% [indiscernible] ?"
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, in terms of absolute pricing level, our pricing level in '12 is, on an absolute basis, higher than 2011 on Commercial. As we think about the future in '13 and beyond, I think our pricing remains pretty consistently in the same kind of posture. Once",106,"Well, in terms of absolute pricing level, our pricing level in '12 is, on an absolute basis, higher than 2011 on Commercial. As we think about the future in '13 and beyond, I think our pricing remains pretty consistently in the same kind of posture. Once we get in '13, there's going to be health care reform impacts that we'll need to begin pricing for and so as we start getting closer to '14. So as we mapped all that out and start reflecting some of that in our pricing, that's going to put some upward pressure on pricing, we think, in the industry in general."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","Our final question for today will come from Ana Gupte with Sanford Bernstein.",13,"Our final question for today will come from Ana Gupte with Sanford Bernstein."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just wanted to follow up on the previous question again. So 230 bps on the commercial loss ratio quarter-over-quarter -- I mean, year-over-year, for the same quarter. So you're saying it's 120 bps for half year in 2011 relative to 2012. And what I'm tryin",111,"Just wanted to follow up on the previous question again. So 230 bps on the commercial loss ratio quarter-over-quarter -- I mean, year-over-year, for the same quarter. So you're saying it's 120 bps for half year in 2011 relative to 2012. And what I'm trying to get to is, you must have seen a reduction in medical loss ratio rebates as well, right, to offset this broker commission issue. So is this 35 to 40 bps net of the reduced rebates? And then secondly, with $99 million in reserves last year, what is the favorable reserve development that you saw this year? And how much of that was commercial or not?"
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Let me start with your second question on prior period development. We're going to disclose the full details on our Q filing in a few weeks, but as a means of preview, we have seen restatement levels during the first 6 months of 2012, which are consistent",227,"Let me start with your second question on prior period development. We're going to disclose the full details on our Q filing in a few weeks, but as a means of preview, we have seen restatement levels during the first 6 months of 2012, which are consistent with or slightly better than the prior years. So we don't see much impact on the run rate on MLR from just prior period development being significantly different year-over-year. For the quarter, as it relates to medical reserves, we did increase our DCP by 1/3 of a day sequentially from the prior quarter. So combined with the prior period development year-to-date, we feel like we're -- we have a good current reserve levels. So I just want to kind of hit that reserve piece. As far as rebate levels, we did in the -- have rebate reserve for health care reform of $52 million at the end of the year, and we have filed and through -- made modifications to that accrual this year related to that, based on changes and clarifications in the guidance around the 4-pronged test and other issues related to the calculations and final waivers that we see after the books were closed for year end for individual product. So we're able to pull that down to $14 million. That was the final number for 2011."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So you came down from $53 million to $14 million. So again, just trying to walk through this -- is the 120 bps on a half-year basis. And if you just had to do it on a quarter-over-quarter basis, the 230, you're seeing rebates -- I mean, sorry, reserves th",112,"So you came down from $53 million to $14 million. So again, just trying to walk through this -- is the 120 bps on a half-year basis. And if you just had to do it on a quarter-over-quarter basis, the 230, you're seeing rebates -- I mean, sorry, reserves that was no difference. There's a piece of it on rebates. I'm just trying to understand how do you net out any change in spread on pricing cost. Are you seeing anything worsening year-over-year on just the spread between underwriting, pricing and cost, net of rebates, net of reserves, net of broker commissions, what's kind of a clean way to look at this?"
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","If you take out the reduction in the minimum MLR reserve from 2011, that's about a 125-basis-point benefit for the first half year run rate, compared to the run rate from last year. If we did -- that was really offset. We saw some -- an increase in some c",67,"If you take out the reduction in the minimum MLR reserve from 2011, that's about a 125-basis-point benefit for the first half year run rate, compared to the run rate from last year. If we did -- that was really offset. We saw some -- an increase in some catastrophic claims above -- beyond what we anticipated that offset that benefit in a limited number of markets."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then going forward, as you're looking at -- you have 8% trend. You're seeing high 7s. So you're probably somewhere in the 25 spread range as you're pricing your business for the back half of the year on renewals. And then going into 2013, are you seei",64,"And then going forward, as you're looking at -- you have 8% trend. You're seeing high 7s. So you're probably somewhere in the 25 spread range as you're pricing your business for the back half of the year on renewals. And then going into 2013, are you seeing your competition showing any hardening of pricing? Or is it getting softer or about the same?"
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think it's about the same, the pricing environment that we've been in for a while now for a number of quarters. I think my anticipation would be is that they would begin to harden their pricing just based on their financial results that we we're seeing",60,"I think it's about the same, the pricing environment that we've been in for a while now for a number of quarters. I think my anticipation would be is that they would begin to harden their pricing just based on their financial results that we we're seeing it makes sense but I can't predict what they're going to do."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And would you that at all?",6,"And would you that at all?"
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","And the other thing I would add to that is, there's a little bit more breathing room rather than just the 25 bps. Because in the base measurement period, you also had the introduction of the September 2010 reform elements that pushed cost up. And so as th",73,"And the other thing I would add to that is, there's a little bit more breathing room rather than just the 25 bps. Because in the base measurement period, you also had the introduction of the September 2010 reform elements that pushed cost up. And so as that kind of falls away and rips through both the numerator and the denominator, that should give us some relief on our fundamental trend as well."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think the other thing as we've signed some contracts -- major contracts with some medical providers for us that we've talked about on previous earnings calls, that improved our cost structure in those areas and improves it over, beyond just 2012.",43,"I think the other thing as we've signed some contracts -- major contracts with some medical providers for us that we've talked about on previous earnings calls, that improved our cost structure in those areas and improves it over, beyond just 2012."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So net-net, you have a positive spread of probably, maybe 50 bps and you're seeing potential for hardening beyond that in the marketplace.",24,"So net-net, you have a positive spread of probably, maybe 50 bps and you're seeing potential for hardening beyond that in the marketplace."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes. And actually, our actual pricing trend is higher than 8% as well. Before we build in those 2 things, our medical trend and pricing trend aren't exactly the same number.",31,"Yes. And actually, our actual pricing trend is higher than 8% as well. Before we build in those 2 things, our medical trend and pricing trend aren't exactly the same number."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Thank you for joining us today. This concludes our comments.",10,"Thank you for joining us today. This concludes our comments."
27133,213709750,332995,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","Ladies and gentlemen, again, that does conclude today's conference. We thank you all for joining.",15,"Ladies and gentlemen, again, that does conclude today's conference. We thank you all for joining."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","Good morning, and welcome to today's Coventry Health Care Second Quarter 2012 Earnings Conference Call. Today's call is being recorded. [Operator Instructions] Today's call will begin with opening remarks by Chairman and Chief Executive Officer of Coventr",56,"Good morning, and welcome to today's Coventry Health Care Second Quarter 2012 Earnings Conference Call. Today's call is being recorded. [Operator Instructions] Today's call will begin with opening remarks by Chairman and Chief Executive Officer of Coventry Health Care, Mr. Allen Wise, after a brief forward-looking statement read by Mr. Drew Asher. 
Please go ahead, Drew."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Ladies and gentlemen, during this call we will make forward-looking statements. Certain risks and uncertainties, including those referenced in our press release and described in the company's annual report on Form 10-K for the year ended December 31, 2011",80,"Ladies and gentlemen, during this call we will make forward-looking statements. Certain risks and uncertainties, including those referenced in our press release and described in the company's annual report on Form 10-K for the year ended December 31, 2011, the company's quarterly report on Form 10-Q for the quarter ended March 31, 2012, and all subsequent filings with the SEC, may materially impact those statements and could cause actual future results to differ materially from those anticipated and discussed. Allen?"
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Good morning and thank you for your interest in Coventry Health Care. Earlier today, we reported earnings per share of $0.65 for the quarter bringing year-to-date earnings per share to $1.85. The quarter was marked by significant improvement in Medicaid p",1873,"Good morning and thank you for your interest in Coventry Health Care. Earlier today, we reported earnings per share of $0.65 for the quarter bringing year-to-date earnings per share to $1.85. The quarter was marked by significant improvement in Medicaid performance, sequential growth in Medicare products, continued SG&A leverage and cash deployment for share repurchase. We are on track for our 2012 EPS forecast of $3.10 to $3.30 per share and therefore, are again reiterating full year 2012 guidance. 
I'll cover some of our business highlights and perhaps, more importantly, where we feel we're headed for tomorrow. Let's start with government programs, which now represents about 1/2 of the company's revenue. You may recall from the first quarter that our Medicare Advantage business, spanning 15 states, had an excellent annual enrollment period with 13% sequential membership growth in the first quarter of 2012. 
Since Q1, we've continued to add membership each month in our Medicare Advantage business, and were at 253,000 members at the end of the second quarter. We're well positioned in our Health Plan footprint from a cost structure, distribution and product standpoint and as such, expect to continue the growth and strong performance as we look multiple years ahead. During Q2, we filed our bids for 2013, and we're quite optimistic about the future serving the senior population. 
The story is similar for Medicare Part D. We experienced significant growth in Q1, followed by continued growth in each month of the second quarter. In fact, Medicare Part D grew by 36,000 members in Q2, averaging growth of about 12,000 members per month. We expect to continue growing throughout 2012 based on our positioning of our Value Plus product and the attractive value proposition we've been able to create for the senior population. To round out Medicare, the margins on these products continue to be on track with their forecast and consistent with prior years. 
In Medicaid, coming into 2012, we experienced substantial growth, effectively doubling our revenue to about $2.9 billion, led by the 2011 Kentucky win, the FHP acquisition and organic wins in both Nebraska and Pennsylvania. Our challenge is to manage that growth and demonstrate that we're able to improve and manage bottom line performance. 
Continuing the bottom line performance thought, I'd like to continue the Medicaid discussion with a much more in-depth review of Kentucky. You may remember during Q1 conference call, when I advised you that after 5 months of data, it was obvious to us that we had severe earnings pressure and other challenges with regard to our 32-month contract with the Commonwealth of Kentucky with approximately 230,000 members. At that time, I identified some of our major problems in the areas of adverse risk selection, especially in Regions 7 and 8, lack of compensation from the Commonwealth for past due payments to hospitals due to errors or omissions in the data book and the challenge of managing the health and care of a very large population with limited preparation time. These problems are exacerbated by the fact that there's not been a managed care program in Kentucky previously and the fact that there wasn't permanent leadership in the cabinet for health and family services in the early days of the program. Our challenges were made even more difficult to litigation -- due to litigation from one of the largest provider groups in Region 8 to prevent us from exercising the 30-day notice of termination provision, even though our agreement clearly allowed us to do so, almost a perfect storm. 
Well, enough history, and I'm pleased to report that we're making very significant progress in many, if not most of the areas, which created a very poor financial result during the first 5 months of the contract. First, there's now permanent leadership at the cabinet level for health and family services, which has resulted in the necessary and meaningful dialogue to develop a program that works for both Coventry and the Commonwealth of Kentucky. 
Second, we have received a partial adjustment regarding risk-adjusted revenue, which we were contractually owed. And this revenue produced prospective relief beginning April 1, 2012. 
Third, we received an adjustment of pass-through for hospital payments effective on May 1, 2012, that is retrospective back to November 1, 2011. Accordingly, it reimburses the Health Plan for these past-due costs for the entire contract period. 
In the area of patient management, I advised you on the last conference call that we'd identified 50 initiatives to take better care of the members and we have made, and we'll continue to make, very significant progress in this area. The Commonwealth of Kentucky is a DRG state, and we've been able to reduce costly and very numerous one-day admissions, which in many cases, were replaced with observation periods, as is the practice in most hospitals throughout the country. 
You may also recall that we bid the business with a significant rate increase in year 2. In October of this year, we will see a rate increase between 5.3% and 7%. The difference between the 5.3% and the 7% is that while we don't have a final, final agreement, we should receive additional risk-adjusted revenue beginning October 1 in addition to the agreed-upon 5.3% rate increase. 
And while we received a partial increase prospectively for this risk-adjusted revenue and resolved the hospital pass-through issue, we have not received reimbursement retrospectively for risk-adjusted revenue, which we strongly feel is due. We filed an appeal to address this issue and if that fails, we'll litigate the issue. 
Kind of final thoughts on Kentucky, even though we were delayed by provider litigation, we will be able to move forward with terminating providers who do not meet our utilization and quality criteria, so that we continue to develop a more efficient delivery system as the year progresses. My personal belief is, in a worst case, that Kentucky will be breakeven in 2013. And I feel that the more likely outcome is that we will have a reasonable profit on this business for 2013. 
In other Medicaid news, we're off to a great start in Nebraska where our expansion contract for a recent RFP win commenced on July 1 of this year, and we've enrolled more than half of the available membership, adding approximately 40,000 members, resulting in a #1 statewide market position. We've served Nebraskans in Medicaid since 2010. We've had a Health Plan presence in Nebraska since 1998. 
We also look forward to 3 new Pennsylvania regions, which are being rolled out in a staggered fashion over the next 3 quarters, starting with the Southwest in Q3, followed by the New West and ending with the New East in Q1 of 2013. And we'll continue to pursue these new opportunities, where we believe we can bring our suit of capabilities to serve state and government program populations. 
One final Medicaid topic, which is Kansas. Based on the state's proposed terms for the new 2013 Medicaid contract and our corresponding bid posture, we did not win the state of Kansas Medicaid contract effective January 1, 2013. You may recall that FHP, which we acquired in January of 2012, operated in both Missouri and Kansas. We won the Missouri rebid earlier in the year, which is where most of the performance and value of FHP resided. And accordingly, with the loss of the Kansas contract, we wrote off $7.7 million intangible in the quarter. 
Effective July 1, we did extend the existing Kansas contract for the remainder of 2012 at what we believe is an appropriate rate increase. While suffice it is to say, we learned some lessons in Kentucky and although disappointed with the outcome in Kansas, we will not sacrifice operational or financial prudence in the service -- in the search for just growth. We feel good about the growth dynamics included in the federal poverty level expansion in Medicaid and the dual-eligible migration to managed care, and look forward to seizing our fair share, which should be significant opportunities over the next 3 to 5 years. 
Moving onto a few comments on the Commercial business. We feel that we're well positioned for the future from a cost structure standpoint and our local Health Plan footprint, and we look forward to significant opportunities in 2014. For the past decade, we have certainly experienced some normal challenges and opportunity in the commercial book. But one thing has been constant, our cost structure, which has been sound, and the commercial business has always been profitable. 
The earnings and cash flow from the commercial business has enabled us to invest in M&A, as well as organic opportunities in government programs. And while the commercial business represents about 40% of Coventry's revenue today, we are targeting a portfolio with a balanced spread across Medicare, Medicaid and Commercial with our Fee business being a complementary part of a diversified revenue earnings and cash flow stream. Don't really have any new news on the Commercial environment, which is a bit challenging, as there are many carriers seeking membership in what I feel is at best a stable pool of business and more likely today, a diminishing pool. 
Despite the discussions and speculations about health care reform over the past year, we really never altered our focus in terms of preparing for the opportunities in 2014 and beyond. One of the efforts to position Coventry for 2014 is the high-performance network model of teaming up with leading health systems and physician groups and together, we expect to deliver a superior value proposition to Commercial and Medicare members in terms of care coordination, quality, access and cost. We expect the Commercial individual market to expand dramatically over the next few years. And we feel we'll be well positioned to seize that growth opportunity as well. 
In the area of capital activity, we deployed $300 million of cash on share repurchase in the second quarter, which represents about 6.5% of the outstanding shares. And since Q2 is a quarter when we receive most of our regulated dividends, our deployable cash balance really didn't change significantly, as we ended the second quarter with approximately $850 million of deployable cash on hand. 
So in summary, I'm very pleased with the positioning of our diversified business model as we look to the future. Given our exposure to and capabilities in government programs, we will continue to participate in growth opportunities in Medicaid expansion, Medicare and dual eligibles. We also expect our Health Plan cost structure in many markets to be a winner in the 2014 commercial exchange jump ball. As usual, we take nothing for granted. We work every day on cost structure and product positioning. We're committed to continuing the improvements in Kentucky. And we'll continue to use our strong balance sheet, when appropriate and attractive, for capital deployment. 
On balance, we feel very positive about the diversity of our products and our balance sheet. We have never been stronger or better positioned to continue positive growth in Medicare Advantage and Part D. And I feel that we're positioned by resources, focus, commitment and experience to make substantial new Medicaid gains in the future. 
With those general comments. I'd like for Randy Giles, our CFO, to provide some financial details. Randy?"
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Thank you, Allen. This morning, we reported earnings per share of $0.65, which includes a $0.03 impairment charge, resulting from the non-renewal of our Medicaid contract with the state of Kansas. This result allows us to reaffirm our 2012 full year EPS g",2059,"Thank you, Allen. This morning, we reported earnings per share of $0.65, which includes a $0.03 impairment charge, resulting from the non-renewal of our Medicaid contract with the state of Kansas. This result allows us to reaffirm our 2012 full year EPS guidance range of $3.10 to $3.30 per share. I'm pleased with the results we have reported today, which reflect improved performance in our Medicaid business, sequential growth in our Medicare products, continued SG&A efficiency and effective use of deployable capital. 
Our mix of business continues to shift towards more balanced levels across Commercial Risk, Medicare and Medicaid products with an important level of non-risk revenue provided by our fee-based businesses. We believe that a diversified portfolio of businesses provides a critical ability to both seize growth opportunities and provide the best positioning for continued growth and profitability. 
Let's begin with our Government Programs businesses, where I'm pleased to report significant improvement in Medicaid during the second quarter. Medicaid MLR of 93.3% is a 670-basis-point sequential improvement was driven primarily by the significant improvement in Kentucky during the quarter. Excluding the impact of Kentucky, our consolidated Q2 Medicaid MLR was an outstanding result at 83.5% or a decrease of 340 basis points over the prior year period. Our Kentucky Medicaid business improved from the 120.9% MLR that we reported in Q1 to 110.8% for the second quarter, a sequential improvement of 1,010 basis points, which was driven by favorable trends for both revenue and expense during the quarter. 
On the revenue front, during the quarter, we received more clarity from the Commonwealth regarding risk-adjustment payments owed to Coventry. While we'll continue to discuss the underlying methodology of the risk-adjustment calculation with the Commonwealth, Coventry began recognizing the positive revenue impact of a monthly risk-adjustment payment, with an 8% quarter during the second quarter. 
As we disclosed in the investor conference during June, the supplemental payment issue has been resolved favorably, which had a positive impact on revenue in the second quarter and will continue throughout the remainder of the year. In addition, we'll be receiving a 5.3% contract rate increase on October 1, which will provide $4 million of incremental revenue per month, plus any amounts that result from continued discussions on risk adjustment, as Allen mentioned. 
In terms of medical expense, we continue to make progress with our list of targeted cost initiatives and expect the fruits of our labor to resolve in continued cost improvement during the second half of 2012 and throughout the remainder of the contract. We're in continued discussions with the Commonwealth regarding various aspects of the Medicaid program that we will continue to update you on as they develop. 
We remain on track to exit 2012 with the results such that Kentucky Medicaid will not have a material impact on our 2013 earnings performance. As you will recall from our last earnings call, I highlighted that we were awarded an expansion to our existing presence in the state of Nebraska, which just went live on July 1. The contract is off to a great start as we've added nearly 40,000 members according to the initial data, out of approximately 60,000 new eligibles. This brings us to approximately 90,000 members statewide with the #1 market share. 
We also expanded in Virginia effective July 1, as the state expanded in the Southwest region where Coventry has been awarded 7,000 new members. And finally, in Florida we were recently re-awarded a contract to serve the state's Healthy Kids Medicaid program to 16 counties serving approximately 20,000 members, which is generally consistent with our presence today. 
We participate in multiple programs in the Florida Medicaid market and view this rebid as an encouraging sign as we think about further expansion programs that the state is considering for 2013 and beyond. We were also successful in our rebid efforts in Missouri, which is Coventry's largest Medicaid state by membership and has been performing well throughout 2012. This contract was effective July 1 and initial open enrollment results yielded growth of an additional 25,000 members to solidify our #1 presence statewide. This outstanding momentum across our Medicaid businesses puts us on pace to exceed our 1 million member goal during the third quarter of the year. 
With that being said, we were unsuccessful on one bid during the second quarter, as we will not be renewing our contract with the Kansas Medicaid program, which is scheduled to end on December 31 of this year. Contract terms offered by the state were very complex in nature and presented unique challenges for managed care organizations. We bid prudently based on the data that was available, most of which was our own experience, as well as the requirements that the state was putting forward for the new contract. 
Although our contract terminated on June 30 of this year, we've been able to reach an agreement with the state to provide managed care services through the remainder of the year at an acceptable rate. Because this contract was held by recently acquired Family Health Partners subsidiary, we took an impairment charge in the second quarter of the $7.7 million or $0.03 per share to write down certain intangibles associated with the Kansas portion of FHP. Just to remind you, the Kansas Medicaid contract represented approximately $350 million annual revenue with a year-to-date MLR into the 90s, such that it was essentially a breakeven contract. While we are disappointed with the foregone opportunity, we remain quite optimistic about the growth trajectory for our Medicaid business in total and the growth initiatives that we have on the horizon. 
Turning to our Medicare business, Medicare Advantage continues to see favorable membership trends, as we added 3,000 members during Q2. The second quarter MLR of 84.1% is in line with expectations and is consistent with our full year MLR guidance of low to mid-80s, excluding the impact of the RADV reserve release. As Allen mentioned, we have submitted our 2013 bids. I'm confident that we are well positioned, both operationally and financially, to serve the senior population in the future. 
Our Medicare Part D business experienced very impressive sequential growth during the second quarter, as the 36,000 members that we added was the best growth in the entire industry. The year-to-date Medicare Part D MLR of 92.5% is consistent with our 2011 year-to-date MLR performance and keeps us on track for our full year MLR guidance of low to mid-80s. Similar to my commentary on Medicare and managed, I like our positioning in the 2013 Medicare Part D bids in light of these continued stable results. 
Moving on to the Commercial business. This morning we reported MLR of 83% for the second quarter and 81.5% year-to-date. As you saw on the commentary in our earnings release, there's one specific item that is mathematically pushing up this result relative to 2011 but importantly, does not significantly impact the overall earnings profile of the Commercial Risk business. We have been able to implement broker capacity initiatives in the majority of our geographic areas across both large and small group business in 2012, which is an important strategy to create a more appropriate comparison to minimum MLR definitions. The effect of this process on the GAAP financials, though, is to mathematically reduce revenue for the broker commission component that otherwise would've been reported in our risk revenue total, which increases our MLR this year as compared to the prior year. 
There are, of course, many other moving parts in this nearly $6 billion block of business, but I thought it would be instructive to spike out this specific factor, which drives our slightly higher Commercial Risk MLR result, without a material impact to the overall earnings profile of the business. Given this item, our full year guidance is now 81.5% to 82.5%, which, at the midpoint, is an increase of 40 basis points from the prior year. 
Staying in our Commercial book, once again our view of fundamental prospective trend remains unchanged in the range of 8%, plus or minus 50 basis points. We continue to see trends in the high 7s, looking in the rearview mirror, which have migrated higher from the very low levels seen during the second half of 2010. Unit cost trend, which continues to be the largest driver of overall trend, is stable. As we look at trend by component in the second quarter, we saw the trend for inpatient days per 1,000 remain slightly negative, and we're projecting inpatient utilization trends to be flat to slightly positive prospectively. Physician trends appear to have stabilized after showing some slight uptick over the last few quarters, while the utilization trends that we are seeing in the outpatient category, continue to tick upwards. These various trend dynamics have been gradual and importantly, have been anticipated in our pricing. You'll recall that we first mentioned seeing this migration in the third quarter of 2011. 
Our Fee-based business has all performed in line with expectations in the quarter, and we have increased guidance slightly for this second consecutive quarter, reflecting a broadly improved view across all lines of our Fee-based businesses. We continue to be pleased with our Fee-based businesses, as they have consistently generated steady levels of valuable unregulated cash flow and earnings. 
Turning now to SG&A. I'm very pleased with the second quarter result that we reported today and the lower full year expense level that we have included in the new guidance ranges. Just to put this into context, in 2011, we reported an SG&A rate of 16.5% of revenue, which was reduced to 15.4% of revenue in our initial guidance and has now been reduced to 14% -- 14.8% of revenue today. This is the second consecutive quarter where we have been able to increase our overall revenue range, while lowering our SG&A projection, a leveraging dynamic that we think is critical to succeed in today's environment, and even more so, as we look to the future. While we continue to leverage our efficient operating structure in the near term and enjoy the benefit on the SG&A line from our broker pass-through initiatives, we are also very mindful of the investments that we'll need to make for the future and are preparing accordingly. 
I would now like to spend some time on our balance sheet and cash flow performance for the second quarter. Our investment portfolio continues to be in excellent shape and is in a net unrealized gain position of $108 million at June 30, an increase of $8 million from the prior quarter. Following through on our commitment to deploy capital towards share repurchase, we bought back 9.3 million shares during the second quarter for $300 million, which represents approximately 6.5% of our outstanding shares. Not only is this level of activity comparable to our total share repurchase activity for all of 2011, it also represents the highest share repurchase level in a single quarter in the company's history. 
Also during the second quarter, our Board of Directors approved our second quarterly cash dividend, which was paid to shareholders on record on July 9. In addition to deploying cash to repurchase shares, we completed our dividend process during the second quarter, collecting $215 million from our regulated subsidiaries. We ended the second quarter with $850 million in deployable free cash at the parent, which even after $300 million of share repurchase, which combined with our undrawn $750 million credit facility, provides $1.6 billion in accessible capital capacity. 
As of June 30, our debt-to-cap ratio stands at 26%, falling well within our typical leverage levels. So as I reflect on our results for the quarter and the progress that we have made across all of our businesses, I'm very satisfied with how the company is positioned and in fact feel that we're advantaged in many areas. Health Care Reform continues to move forward. And while this will surely create changes in the marketplace, it will also create significant opportunities for those that have a low-cost structure and can execute effectively. We believe that we have the capital and free cash flexibility to prepare, adapt quickly and support the growth prospects that we see for the future. 
Thank you again for your interest in Coventry Health Care. Operator, this now concludes our prepared remarks, and we are ready to open the lines for questions."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","[Operator Instructions] And we'll go to Tom Carroll with Stifel.",10,"[Operator Instructions] And we'll go to Tom Carroll with Stifel."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So question on Kentucky, what was the Kentucky Medicaid premium in the quarter?",13,"So question on Kentucky, what was the Kentucky Medicaid premium in the quarter?"
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Stand by, we'll get you the exact number.",8,"Stand by, we'll get you the exact number."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Great.",1,"Great."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Tom, it was $249 million.",5,"Tom, it was $249 million."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","$249 million, great. And do you expect sequential MLR improvement to continue there? I mean, the data points you gave us suggest continued improvement, would you agree with that?",29,"$249 million, great. And do you expect sequential MLR improvement to continue there? I mean, the data points you gave us suggest continued improvement, would you agree with that?"
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","We do.",2,"We do."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Any magnitude? I mean, another 10 percentage points of decrease, rather?",11,"Any magnitude? I mean, another 10 percentage points of decrease, rather?"
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","I don't know. We've made very substantial and consistent progress. There's a lot of opportunities remaining on the revenue side. Ultimately, can't book it this point but -- and can't guarantee it. But ultimately, I believe we're entitled to retroactive ri",195,"I don't know. We've made very substantial and consistent progress. There's a lot of opportunities remaining on the revenue side. Ultimately, can't book it this point but -- and can't guarantee it. But ultimately, I believe we're entitled to retroactive risk-adjusted revenue. And we'll pursue that to the end, and we continue to make substantial progress in admissions and taking better care of the patients. We continue to weed out prescription drug abuse, pain center types of mills. We will make future progress in refining our delivery system, which was made more difficult by some litigation by the biggest provider group there. So we've made a lot of progress, and we have a lot of opportunity. And I can't -- it was a pretty bold statement for me to say worst case next year is breakeven and my view is we're going to make a reasonable profit. So it's kind of hard to predict month by month and quarter by quarter because we've seen one great quarter of improvement, and I see no reason why that trend won't continue. I wouldn't say it's going to be another 1,000 basis points in the next quarter."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","And then, Tom, obviously, the bigger step-down would come with a rate increase effective 10/1.",15,"And then, Tom, obviously, the bigger step-down would come with a rate increase effective 10/1."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Great. And just as a follow-up on your Commercial cost trend side, it sounds like you're not seeing anything outside of what you were expecting, so nothing like the Blues being more competitive than you thought or utilization rising more so than you thoug",73,"Great. And just as a follow-up on your Commercial cost trend side, it sounds like you're not seeing anything outside of what you were expecting, so nothing like the Blues being more competitive than you thought or utilization rising more so than you thought. Just trying to reconcile the slight increase in your consolidated MLR number for the year. Would you suggest that's just -- that's all related to the broker pass-through mechanism?"
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Our view of the commercial environment is consistent with really what we've talked about for the last 5 or 6 quarters, which is it's very competitive. It's beyond competitive in Western Pa., but it doesn't -- isn't dramatically different than we've experi",174,"Our view of the commercial environment is consistent with really what we've talked about for the last 5 or 6 quarters, which is it's very competitive. It's beyond competitive in Western Pa., but it doesn't -- isn't dramatically different than we've experienced in 15 years in the business, which is there's always a couple marketplaces where it borders on irrational. And so we will lose membership until that settles down. I believe it's probably a diminishing pool of business. There isn't any job growth, and I think that for the most part in the data that I -- I would suggest that we lose membership within existing groups, meaning that employees can't afford the coverage and drop it. But it basically  there's not been any substantial change this quarter over the last quarter. It's competitive and not a growing pool of business but because of our cost structure and our experience in -- long term in the marketplaces we are, we don't really see any deterioration for the rest of the year."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","On your question about MLR, last year we recorded an MLR of 81.6%. Our guidance today increased to 82%. All of that 40-basis-point year-over-year increase is explained by increased broker pass-through activity in 2012.",34,"On your question about MLR, last year we recorded an MLR of 81.6%. Our guidance today increased to 82%. All of that 40-basis-point year-over-year increase is explained by increased broker pass-through activity in 2012."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","And we'll go next to Josh Raskin with Barclays.",10,"And we'll go next to Josh Raskin with Barclays."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just a first question just on the broker commission. Just so I understand, you guys are basically increasing that ratio by taking out. You said there's no impact, but you guys get $15 million in rebates for the last year. So is there no impact on your exp",66,"Just a first question just on the broker commission. Just so I understand, you guys are basically increasing that ratio by taking out. You said there's no impact, but you guys get $15 million in rebates for the last year. So is there no impact on your expected rebates either? Or ultimately, will there be a little bit of a benefit in terms of the P&L?"
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","The strategy is actually -- I think the broker pass-through affects all markets. Our rebates on health care reform rebates, minimum MLR are really concentrated in a handful of markets. So the fact is, we basically have taken this broker commission pass-th",88,"The strategy is actually -- I think the broker pass-through affects all markets. Our rebates on health care reform rebates, minimum MLR are really concentrated in a handful of markets. So the fact is, we basically have taken this broker commission pass-through strategy in all our markets. And so it's pretty broad based. So it doesn't really line up one for one. You're right. There could be, theoretically, be a benefit in those markets where there are rebates, there is one. But it's not concentrated in those markets."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. And is there a reason you guys chose now to accelerate that strategy?",14,"Okay. And is there a reason you guys chose now to accelerate that strategy?"
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","It really -- I think the strategy was deployed last year, but it really involves working with each broker and each group to try and get that set up. So it really deploys as those cases renew. And so now that we've gone through a year, most of the groups h",63,"It really -- I think the strategy was deployed last year, but it really involves working with each broker and each group to try and get that set up. So it really deploys as those cases renew. And so now that we've gone through a year, most of the groups have gone through that renewal cycle and are moving over to broker pass-through."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Got it. And then just second question on Kentucky, were there any -- I guess, 2 parts, were there any what you would consider out-of-period payments that came? It sounded like you had some stuff retroactive back to April or even last November. So I'm just",83,"Got it. And then just second question on Kentucky, were there any -- I guess, 2 parts, were there any what you would consider out-of-period payments that came? It sounded like you had some stuff retroactive back to April or even last November. So I'm just curious if there was sort of like a one-time event that hit the MLR in 2Q that you could spike out. And then, what's the estimate on sort of the full year loss in Kentucky for 2012?"
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","There weren't any out-of-period payments in the revenue dates, for the dates that I gave you in my presentation...",20,"There weren't any out-of-period payments in the revenue dates, for the dates that I gave you in my presentation..."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","The supplemental payments did go back to November. That's a couple million dollars. The risk adjuster was all with -- the payments we received were all, at this point within the same Q2 period. We haven't received any retro-risk payments. We're -- that's",47,"The supplemental payments did go back to November. That's a couple million dollars. The risk adjuster was all with -- the payments we received were all, at this point within the same Q2 period. We haven't received any retro-risk payments. We're -- that's what we're asking for."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. So the sup payments going back, might have been a couple million but not a huge deal. The risk adjusters were all for Q2. And then the full year loss?",31,"Okay. So the sup payments going back, might have been a couple million but not a huge deal. The risk adjusters were all for Q2. And then the full year loss?"
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","What's your -- can you restate your question again?",10,"What's your -- can you restate your question again?"
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Yes, just curious what your expectation in terms of a full year sort of pre-tax loss in Kentucky is going to look like this year.",25,"Yes, just curious what your expectation in terms of a full year sort of pre-tax loss in Kentucky is going to look like this year."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, we really don't spike out individual contract performance like that. I mean, you can kind of back into it. But with the losses that we've incurred in the first quarter and the MLRs that we've had year-to-date, the contracts -- we reported MLR year-t",113,"Well, we really don't spike out individual contract performance like that. I mean, you can kind of back into it. But with the losses that we've incurred in the first quarter and the MLRs that we've had year-to-date, the contracts -- we reported MLR year-to-date of 115.6%. That gives you -- and we're projecting that, that'll decrease over time with -- we'd expect the most significant MLR improvement at this point based on information that we have, visibility on it being in the fourth quarter. So we expect that to phase down toward a breakeven as we go in through the rest of the year and again enter 2013 with no material pressure."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. When you say breakeven, do you mean 100% MLR? Or do you mean breakeven profit, including the G&A?",19,"Okay. When you say breakeven, do you mean 100% MLR? Or do you mean breakeven profit, including the G&A?"
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","No, we mean breakeven after we pay our SG&A expenses. 100% is not breakeven.",14,"No, we mean breakeven after we pay our SG&A expenses. 100% is not breakeven."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Right, right. I didn't know if we were talking gross margins or operating margins.",14,"Right, right. I didn't know if we were talking gross margins or operating margins."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","And I think it's difficult, not to be -- to go much deeper and not to be misleading. We feel we have retroactive risk-adjustment amounts due. We filed an appeal on that front. We feel like that's supported contractually. If that appeal's not successful, w",164,"And I think it's difficult, not to be -- to go much deeper and not to be misleading. We feel we have retroactive risk-adjustment amounts due. We filed an appeal on that front. We feel like that's supported contractually. If that appeal's not successful, we'll litigate the issue. How we ultimately resolve all of that, it can't get any worse. If we resolve that successfully, it's going to affect the year. But we made a lot of progress on the revenue side and a lot of progress on the cost side in Q2. And we think that'll continue in Q3. And even a 5.3% increase on a $0.25 billion in revenue puts us in a substantially better shot. We think that the worst days are behind us in Kentucky, and we've done many of the things and will do many of the things it takes to -- for this to be successful. It's been a humbling and valuable lesson, but we will prevail."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","We'll go next to Carl McDonald with Citi.",9,"We'll go next to Carl McDonald with Citi."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So first question, WellPoint, earlier in the week, positioned the Commercial business as a change relative to what they'd been thinking about earlier in terms of both -- it sounded like both pricing and cost trends -- it seems like you and United have a s",93,"So first question, WellPoint, earlier in the week, positioned the Commercial business as a change relative to what they'd been thinking about earlier in terms of both -- it sounded like both pricing and cost trends -- it seems like you and United have a sort of a more consistent view. So I'd just be interested, when you hear WellPoint say they think things are changing and things are getting more aggressive, did that give you pause? Or would you attribute that all just to a difference in expectations coming into the year?"
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, I think we always spend a lot of time worrying about what we don't know. But I think if you would review our comments on the commercial environment and trends back for 6 quarters that we were probably one of the first companies that said the diminis",320,"Well, I think we always spend a lot of time worrying about what we don't know. But I think if you would review our comments on the commercial environment and trends back for 6 quarters that we were probably one of the first companies that said the diminishing utilization wasn't going to continue forever. We don't know what caused it and what was going to change it. I think that we have been consistent in saying there was some pressure on outpatient costs. And not unlike Kentucky, I think we're the first people doing business in Kentucky that said, ""We've got problems here."" And disclosed that the minute that we knew it and went to work on it. So I think our view on Commercial, if you'd examine our comments for the prior quarters, have said it's a little tougher environment. We don't see any dramatic change. So it always gives you pause to say -- to once again think about what's occurred and where the future goes. But we -- our practice here is to think about the worst all the time and we have, I don't know, 50 initiatives on the unit cost side where we think we've gotten a little bit behind. And that's kind of how we view the business here, which is always with a little bit of fear and a little bit of suspicion and a lot of reality. So I don't understand  we aren't in most of the markets or many of the markets or most of the markets with WellPoint, the way we would be with United and some of the other Blues. So I don't know what would have suddenly happened. These things evolve over long periods of time, and I don't understand things that suddenly occur. So I can't be helpful there. But we don't see anything different than we've reported the last several quarters and we've reported today."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then on Kentucky, to get to breakeven, the 111% has to go to, say, 93% or 94%. Is there any way of giving us a sense of how much of that 1,700-, 1,800-basis-point improvement is things that you've already achieved? So say the rate increase -- some of",72,"And then on Kentucky, to get to breakeven, the 111% has to go to, say, 93% or 94%. Is there any way of giving us a sense of how much of that 1,700-, 1,800-basis-point improvement is things that you've already achieved? So say the rate increase -- some of the provider renegotiations or cancellations versus how much is stuff that still needs to be accomplished like the, say, the retroactive risk adjustment."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","No. I think it's probably a little bit of both. It's always a little bit difficult to be able to measure precisely what you've achieved. The things that we have done 2 months ago will show up 2 months from now. When the numbers are in, the claims are paid",461,"No. I think it's probably a little bit of both. It's always a little bit difficult to be able to measure precisely what you've achieved. The things that we have done 2 months ago will show up 2 months from now. When the numbers are in, the claims are paid. And now it's a sense of -- I think it's a continuous process, and I think that some of the things that developed in this quarter were really work that we did the quarter before. So I think that we have made progress. I think there's a lot more opportunities, a lot more opportunities in refining our delivery system, a lot more opportunities in continuing to take better care of the patients. If you'll think -- if you follow the media, at least 4 times or 3 times last quarter, Kentucky leads the -- is always highlighted as, the Commonwealth is one of the places where prescription drug abuse is the worst. So we have 50 initiatives and some of those are continuous. You're really never finished. I just think that in areas like reduced admissions and getting observation days, which is the practice in most hospitals. And I think it's guidelines that CMS issued and continues to refine. We just made a lot of progress, and I think the revenue increase in Q4 is huge. But I think on the patient management side and issue, those will go on for a long time. We've been in business -- Medicaid business in Missouri since 1994 and life changes. For a long time, our trend was 8%. The state gave us an 8% increase and life was good. And 2008, the revenue got tougher and so we continually evaluate our cost structure and how we deliver the care. And so we've done a lot of work in Missouri, which is a huge state for us, too, in terms of our contracts. We had a contract forever with the Washington University Physicians group that was 180% of Medicaid, which worked in the old days when revenue was easier to come by and you could have a very broad delivery system and make a reasonable profit. That contracts was canceled last quarter. So don't want to get off the subject Kentucky. It really never stops and with a decent amount of experience, and we think that we're getting closer to a partnership in Kentucky. We have better dialogue with them. This has to work for the Commonwealth, has to work for us. And we think that we've made progress, and we'll continue to make progress. And I can't do much better than to  I've stuck my neck out quite a ways saying I thought we were going to make a profit next year."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Just to add to Allen's comment. We think we can make break even at -- with 4% admin and the 96% loss ratio in Kentucky. So the hurdle's not quite as large as you thought. In addition, one other point, I think that we've kind of already got visibility on i",163,"Just to add to Allen's comment. We think we can make break even at -- with 4% admin and the 96% loss ratio in Kentucky. So the hurdle's not quite as large as you thought. In addition, one other point, I think that we've kind of already got visibility on is that we are putting in co-payments -- additional co-payments in Kentucky. We're going to open enrollment in the fourth quarter. So we're going to see economic benefit from that and that's already structured. The provider  high-cost provider adjustments will also happen in the fourth quarter, and we're already -- those are already  we're already committed to those. So there's a couple of these things that are both on cost side and on the revenue side that we have pretty good line of sight on. But there's, obviously, a lot more on the cost initiatives, the revenue side that we have to do to get all the way to breakeven."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","And we'll go next to Kevin Fischbeck with Bank of America.",12,"And we'll go next to Kevin Fischbeck with Bank of America."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","As you mentioned, you're not the only company experiencing issues in Kentucky, and one of your competitors talked about changing the methodology for retro assignments. Have you guys factored that into your thought process? And what do you think the impact",46,"As you mentioned, you're not the only company experiencing issues in Kentucky, and one of your competitors talked about changing the methodology for retro assignments. Have you guys factored that into your thought process? And what do you think the impact to you guys might be?"
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes. I think in terms of -- there's really a couple of big changes happening there in terms of retro assignment and the way that's going to work. It's not just retro assignment. The Commonwealth is committed to changing the auto assignment process in gene",170,"Yes. I think in terms of -- there's really a couple of big changes happening there in terms of retro assignment and the way that's going to work. It's not just retro assignment. The Commonwealth is committed to changing the auto assignment process in general, and we think there are some high-cost categories for us like dual eligibles and some of the other categories that -- where we have a disproportionate share. So we think that shift will benefit us from some of the other categories. And we think, in general, that shifting might end up being neutral, just in general. The -- overall, we think that's a positive for all the MCOs because on average, it means the average revenue that the Commonwealth is paying is going to increase. Because currently, a majority of the selection criteria is based on who has the lowest premium in a given rate cell. And so we think that's going to end to -- lead to marginally higher PMPM revenue in the contract."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay, that's interesting. And then just to clarify a couple of things you guys had said earlier. If you think about the core Kentucky MLR, I guess, the pass-throughs and the retro portion was maybe a couple million dollars, that might have been 100 basis",101,"Okay, that's interesting. And then just to clarify a couple of things you guys had said earlier. If you think about the core Kentucky MLR, I guess, the pass-throughs and the retro portion was maybe a couple million dollars, that might have been 100 basis points to MLR, is that the right way to think about it? And then, in relation to Tom's question, you said there's sequential improvement in MLR. Is that -- even -- do you expect that even with not having that 100-basis-point tailwind? Or should we be thinking about that as kind of offsetting that tailwind sequentially?"
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","In terms of the pass-through payments, that's obviously an ongoing thing. There is an increase in the third quarter in the supplemental payments -- payment level that we expect to see that will hit in the third quarter. But again, that's just a pass-throu",134,"In terms of the pass-through payments, that's obviously an ongoing thing. There is an increase in the third quarter in the supplemental payments -- payment level that we expect to see that will hit in the third quarter. But again, that's just a pass-through. So we'll be getting more supplemental payment revenue, and then we'll be passing more of it through an equal amount. So we see that supplemental payment as you just kind of smoothing out. You're going forward and just being in sync. We don't see that flipping it one way or another. Second quarter and first quarter, obviously, had some shifting between -- supplemental cost between -- payments between first and second quarter, but I will see that as a huge issue. It's not  it's a couple million dollars."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think there's -- if you'll go back just one quarter, when we didn't make any comments about Kentucky other than saying we had big problems, we had a lot of progress. I think there'll be a lot more clarity about the next 12 months in another quarter. And",130,"I think there's -- if you'll go back just one quarter, when we didn't make any comments about Kentucky other than saying we had big problems, we had a lot of progress. I think there'll be a lot more clarity about the next 12 months in another quarter. And in terms -- we know what the revenue projection's going to be. We'll have further insights into the value of the initiatives that we've been working on for really 6 months. So I think we've made really huge, huge gains in the financials and huge gains in our insights about where we are. And I think one more quarter will give us a lot better insights to more accurately be able to project what the next 12 months looks like."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Another point I would make is, we have ongoing significant discussions with the Commonwealth and their leadership, and we're working hard with them to try and make this program financially viable for the long term. And that's in their best interest as wel",55,"Another point I would make is, we have ongoing significant discussions with the Commonwealth and their leadership, and we're working hard with them to try and make this program financially viable for the long term. And that's in their best interest as well, and so they're engaged in productive discussions with us in that regard."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. And then just, I understand what you're saying about the broker commission change impacting MLR and I guess, your SG&A guidance as well. But what's not clear to me is why wasn't this in your original guidance around those 2 line items?",43,"Okay. And then just, I understand what you're saying about the broker commission change impacting MLR and I guess, your SG&A guidance as well. But what's not clear to me is why wasn't this in your original guidance around those 2 line items?"
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","It was more of an execution thing. We weren't clear on the timing of when that would actually start flowing through the payments as these things came through. It's -- I would say broker pass-through this year is up like 400% over last year's run rate. So",74,"It was more of an execution thing. We weren't clear on the timing of when that would actually start flowing through the payments as these things came through. It's -- I would say broker pass-through this year is up like 400% over last year's run rate. So we've just actually seen it actually coming through. We didn't want to reflect it until we saw what the number was actually going to shake out as."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Was that a state, like, approval process? Or was that just the way the contracts kind of turned over?",19,"Was that a state, like, approval process? Or was that just the way the contracts kind of turned over?"
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes. In certain states, you can't do it. So it is a state approval process, also relates to how the contracts turn over and also whether the broker's wanting to bill that directly to the customer or they wanted us to bill it for them.",45,"Yes. In certain states, you can't do it. So it is a state approval process, also relates to how the contracts turn over and also whether the broker's wanting to bill that directly to the customer or they wanted us to bill it for them."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","And we'll go next to Justin Lake with JPMorgan.",10,"And we'll go next to Justin Lake with JPMorgan."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","I just wanted to drill down on this commission issue one last time for everyone who's -- obviously, there's some concerns going on in the commercial market with the MLR trajectory and what's going on with price cost. So on a year-over-year basis, your MLR",100,"I just wanted to drill down on this commission issue one last time for everyone who's -- obviously, there's some concerns going on in the commercial market with the MLR trajectory and what's going on with price cost. So on a year-over-year basis, your MLR is up 230 basis points in the second quarter, it looks like. Can you spike out for us how much of that specifically was due to commissions? Or maybe give us the number of -- dollar amount of premiums, so we can do the math ourselves, that came out in the second quarter year-over-year?"
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes. If you look at full year 2012 and you compare that to 2011, there's -- year-to-date, you have a 120-basis-point increase, about 35 to 40 basis points of that is driven by higher level of broker pass-through in 2012, then -- compared to 2011. 80 basis",96,"Yes. If you look at full year 2012 and you compare that to 2011, there's -- year-to-date, you have a 120-basis-point increase, about 35 to 40 basis points of that is driven by higher level of broker pass-through in 2012, then -- compared to 2011. 80 basis points is driven by really higher seasonality in 2012 for the same time period than we saw in 2011. And actually, the seasonality for the last half of the year that we're projecting for 2012 is actually more favorable than seasonality patterns for 2011 for the same time period."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So you're saying that 80 basis points of seasonality should reverse itself in the back half of the year.",20,"So you're saying that 80 basis points of seasonality should reverse itself in the back half of the year."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","That's what we're expecting, yes.",6,"That's what we're expecting, yes."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Okay. And what's driven all that seasonality?",7,"Okay. And what's driven all that seasonality?"
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","It's actually the calendar, the number of days and the type of days kind of drives our seasonality models in our IBNR. And so, Justin, the slope is a little less steep through this year than last year, if you just look at the calendar and also as importan",66,"It's actually the calendar, the number of days and the type of days kind of drives our seasonality models in our IBNR. And so, Justin, the slope is a little less steep through this year than last year, if you just look at the calendar and also as importantly, the type of days and the historical claims activity based on the day of the week."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Got it. And then just drilling down a little bit on cost trend. It sounds like you were still in that high-7% range, so a little bit below the 8% midpoint. Can you talk to us about how that looked through the quarter and whether the outpatient utilization",89,"Got it. And then just drilling down a little bit on cost trend. It sounds like you were still in that high-7% range, so a little bit below the 8% midpoint. Can you talk to us about how that looked through the quarter and whether the outpatient utilization that you noted there is -- do you see that continuing to grow through the year? Do you expect to be north of that, towards the high end of that 8% by the end of the -- coming out of 2012?"
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","No. I think the big thing we're watching for is when does inpatient utilization go to positive. It's slightly negative. It's approaching 0. The question is, is that going to move in to positive territory? At that point, I think that puts us -- that reconc",185,"No. I think the big thing we're watching for is when does inpatient utilization go to positive. It's slightly negative. It's approaching 0. The question is, is that going to move in to positive territory? At that point, I think that puts us -- that reconciles our rearview 7% to our forward view of 8%. And so that's kind of the difference between the 2, as we think about it. In general, just in terms of utilization, our inpatient commercial bed days were down low single digits from Q2 2011. Medicare Advantage bed days were flat. Medicaid bed days were down low to mid-single digits from Q2 of 2011. Commercial admits were down low single digits. Medicare Advantage admits were down mid-single digits from Q2 2011. In terms of the foreview, expect inpatient to be -- trend to be driven into the high single digits, almost entirely unit cost driven; outpatient, low double digits, mostly unit cost driven; physician, mid-single digits, tilted toward unit cost; and pharmacy, mid- to high single digits, split evenly. That's our kind of the detail on our rearview and foreview."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Got it. The last question would just be, as you're thinking out to 2013 and we're going to, probably in the next couple of months, have to start getting an idea where pricing shakes out. And obviously, that's going to depend on your forward view or trend.",103,"Got it. The last question would just be, as you're thinking out to 2013 and we're going to, probably in the next couple of months, have to start getting an idea where pricing shakes out. And obviously, that's going to depend on your forward view or trend. Is it fair to think that looking out in the -- given your concerns on the potential or at least conservatism around the potential for upward pressure that you would probably price with some cushion, again, going into 2013, just like you did in 2012 or some uptick there versus your kind of current 8% view?"
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Well, in terms of absolute pricing level, our pricing level in '12 is, on an absolute basis, higher than 2011 on Commercial. As we think about the future in '13 and beyond, I think our pricing remains pretty consistently in the same kind of posture. Once",107,"Well, in terms of absolute pricing level, our pricing level in '12 is, on an absolute basis, higher than 2011 on Commercial. As we think about the future in '13 and beyond, I think our pricing remains pretty consistently in the same kind of posture. Once we get in '13, there's going to be health care reform impacts that we'll need to begin pricing for and so -- as we start getting closer to '14. So as we map all that out and start reflecting some of that in our pricing, that's going to put some upward pressure on pricing, we think, in the industry in general."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","Our final question for today will come from Ana Gupte with Sanford Bernstein.",13,"Our final question for today will come from Ana Gupte with Sanford Bernstein."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","Just wanted to follow up on the previous question again. So 230 bps on the commercial loss ratio quarter-over-quarter -- I mean, year-over-year, for the same quarter. So you're saying it's 120 bps for half year in 2011 relative to 2012? And what I'm tryin",112,"Just wanted to follow up on the previous question again. So 230 bps on the commercial loss ratio quarter-over-quarter -- I mean, year-over-year, for the same quarter. So you're saying it's 120 bps for half year in 2011 relative to 2012? And what I'm trying to get to is, you must have seen a reduction in medical loss ratio rebates as well, right, to offset this broker commission issue. So is this 35 to 40 bps net of the reduced rebates? And then secondly, you had $99 million in reserves last year, what is the favorable reserve development that you saw this year? And how much of that was commercial or not?"
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Let me start with your second question on prior period development. We're going to disclose the full details on our Q filing in a few weeks, but as a means of preview, we have seen restatement levels during the first 6 months of 2012, which are consistent",225,"Let me start with your second question on prior period development. We're going to disclose the full details on our Q filing in a few weeks, but as a means of preview, we have seen restatement levels during the first 6 months of 2012, which are consistent with or slightly better than the prior year. So we don't see much impact on the run rate on MLR from just prior period development being significantly different year-over-year. For the quarter, as it relates to medical reserves, we did increase our DCP by 1/3 of a day sequentially from the prior quarter. So combined with the prior period development year-to-date, we feel like we're -- we have good current reserve levels. So I just wanted to kind of hit that reserve piece. As far as rebate levels, we did in the -- have a rebate reserve for health care reform of $52 million at the end of the year, and we have filed and through -- made modifications to that accrual this year related to that, based on changes and clarifications in the guidance around the 4-prong test and other issues related to the calculations and final waivers that were received the books were closed for year-end for individual product. So we're able to pull that down to $14 million. That was the final number for 2011."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So you came down from $53 million to $14 million. So again, just trying to walk through this, is the 120 bps on a half-year basis. And if you just had to do it on a quarter-over-quarter basis, the 230, you're seeing rebates -- I mean, sorry, reserves that",111,"So you came down from $53 million to $14 million. So again, just trying to walk through this, is the 120 bps on a half-year basis. And if you just had to do it on a quarter-over-quarter basis, the 230, you're seeing rebates -- I mean, sorry, reserves that was no difference. There's a piece of it on rebates. I'm just trying to understand how do you net out any change in spread on pricing cost. Are you seeing anything worsening year-over-year on just the spread between underwriting, pricing and cost, net of rebates, net of reserves, net of broker commissions, what's kind of a clean way to look at this?"
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","If you take out the reduction in the minimum MLR rebate reserve from 2011, that's about a 125-basis-point benefit for the first half year run rate, compared to the run rate from last year. If we did -- that was really offset. We saw some -- an increase in",68,"If you take out the reduction in the minimum MLR rebate reserve from 2011, that's about a 125-basis-point benefit for the first half year run rate, compared to the run rate from last year. If we did -- that was really offset. We saw some -- an increase in some catastrophic claims above and beyond what we anticipated that offset that benefit in a limited number of markets."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And then going forward, as you're looking at -- you have 8% trend. You're seeing high 7s. So you're probably somewhere in the 25 spread range as you're pricing your business for the back half of the year on renewals. And then going into 2013, are you seei",64,"And then going forward, as you're looking at -- you have 8% trend. You're seeing high 7s. So you're probably somewhere in the 25 spread range as you're pricing your business for the back half of the year on renewals. And then going into 2013, are you seeing your competition showing any hardening of pricing? Or is it getting softer or about the same?"
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think it's about the same, the pricing environment that we've been in for a while now for a number of quarters. I think my anticipation would be is that they would begin to harden their pricing just based on their financial results, it would seem to mak",59,"I think it's about the same, the pricing environment that we've been in for a while now for a number of quarters. I think my anticipation would be is that they would begin to harden their pricing just based on their financial results, it would seem to make sense. But I can't predict what they're going to do."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","And would you that at all?",6,"And would you that at all?"
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","The other thing I would add to that is, there's a little bit more breathing room rather than just the 25 bps. Because in the base measurement period, you also had the introduction of the September 2010 reform elements that pushed cost up. And so as that k",72,"The other thing I would add to that is, there's a little bit more breathing room rather than just the 25 bps. Because in the base measurement period, you also had the introduction of the September 2010 reform elements that pushed cost up. And so as that kind of falls away and rips through both the numerator and the denominator, that should give us some relief on our fundamental trend as well."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","I think the other thing is we've signed some contracts, major contracts with some medical providers for us that we've talked about on previous earnings calls, that improved our cost structure in those areas and improves it over, beyond just 2012.",42,"I think the other thing is we've signed some contracts, major contracts with some medical providers for us that we've talked about on previous earnings calls, that improved our cost structure in those areas and improves it over, beyond just 2012."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Analysts","So net-net, you have a positive spread of probably, maybe 50 bps and you're seeing potential for hardening beyond that in the marketplace.",24,"So net-net, you have a positive spread of probably, maybe 50 bps and you're seeing potential for hardening beyond that in the marketplace."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Yes. And actually, our actual pricing trend is higher than 8% as well. Before we build in those 2 things, our medical trend and pricing trend aren't exactly the same number.",31,"Yes. And actually, our actual pricing trend is higher than 8% as well. Before we build in those 2 things, our medical trend and pricing trend aren't exactly the same number."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Executives","Thank you for joining us today. Concludes our comments.",9,"Thank you for joining us today. Concludes our comments."
27133,213709750,333213,"Coventry Health Care Inc., Q2 2012 Earnings Call, Jul 27, 2012",2012-07-27,"Earnings Calls","Coventry Health Care, Inc.","Operator","Ladies and gentlemen, again, that does conclude today's conference. We thank you all for joining.",15,"Ladies and gentlemen, again, that does conclude today's conference. We thank you all for joining."
